Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
gsea,regulation of mitotic cell cycle (GO:0007346),0.7489377857240733,3.0192458926867607,0.0,0.0,0.0,51/100,12.03%,CKS1B;CDK1;MKI67;UBE2C;MAD2L1;UBE2S;FBXO5;CDC20;DLGAP5;CCNB1;ANAPC5;HNRNPU;PLK1;CKS2;BUB1B;PSMB6;NEK2;PSMB5;PKMYT1;BUB3;RCC1;KIF20B;PSMA4;PSMB2;PSMA6;ANAPC15;PSMA3;PIN1;CDC25C;PSMD7;PSMD1;PSMD12;PSMD2;ASNS;PSMA5;PSMD3;PSMB7;PSMC4;PRMT5;CDC25B;PSMD6;DDB1;FZR1;PSMC1;PSMC2;EIF4E;PSMD14;PSMD11;PSMC5;PSME2;PSME3
gsea,cellular macromolecule biosynthetic process (GO:0034645),0.7399606843168505,2.9981832986816173,0.0,0.0,0.0,119/183,16.61%,PCLAF;PTMA;DUT;CDK1;TYMS;MCM3;MCM5;CLSPN;SET;TIPIN;MCM7;RFC4;ORC6;NAP1L1;RFC5;RPS17;FEN1;MCM4;MCM6;RPA3;CDC45;CDC6;MCM2;RPS2;MRPL18;BRIP1;POLA1;POLE;RFC2;MRPL42;RPL14;EEF1G;GSPT1;RMI2;BRCA1;POLD1;POLR2F;TOPBP1;POLD2;RNPS1;RPS15;RPS25;RPS6;MCM10;EXO1;RPL31;RPA1;E2F1;RFC3;MRPL28;POLE3;EIF4G1;TIMELESS;FAM111A;BARD1;RPL41;BLM;POLR2L;RPL4;MRPL13;MRPL51;RAD50;RPS8;TICRR;POLR2C;RNASEH2A;CHEK1;CDK2;RPS18;RPL5;POLE2;MLF1;MCM8;ORC1;POLA2;RPL23A;PABPC4;FARSB;MRPS7;TSFM;RPA2;POLD3;MRPL35;TUFM;EEF1D;ABCF1;MRPS5;RPL10A;RPL15;PPP5C;EEF1B2;DNA2;ORC2;COPS5;MRPS12;MRPS18B;RPSA;GRWD1;MRPL11;CDC7;DBF4;RPLP0;RBBP8;RPS26;MRPL55;RPL8;MRPS18A;POLR2E;POLR2H;MRPL37;NBN;DRG1;MRPL3;RECQL4;RPL10;POLR2B;RSL24D1;EIF4G2;EEFSEC
gsea,gene expression (GO:0010467),0.6822373979829439,2.9884139424057237,0.0,0.0,0.0,139/203,23.68%,PTMA;ALYREF;RPS17;HNRNPU;SRSF2;HSPD1;HNRNPA2B1;HNRNPD;RPS2;MRPL18;DDX39B;U2AF1;MRPL42;HNRNPF;RPL14;GSPT1;POLR2F;NUP107;SLBP;RNPS1;RPS15;SRSF7;SRSF3;RPS25;DKC1;RPS6;EIF4A3;RPL31;E2F1;MAGOH;MRPL28;EIF4G1;NUP85;AAAS;RBM8A;NUP62;SNRNP40;NDC1;SRSF9;NUP37;RPL41;NUP43;U2AF2;POLR2L;RPL4;MRPL13;MRPL51;SYNCRIP;RPS8;POLR2C;RPS18;SRRM1;STUB1;RPL5;SRSF6;MLF1;RPL23A;NUP93;HNRNPK;NUP205;MAGOHB;SARNP;PABPC4;FARSB;MRPS7;MRPL35;ABCF1;MRPS5;SRSF1;NUP133;CPSF2;RPL10A;RPL15;PPP5C;EIF4E;COPS5;MRPS12;MRPS18B;RPSA;THOC3;MRPL11;NUP88;SRSF4;NUP155;RPLP0;DNAJB11;NCBP2;NUP160;RPS26;NUP54;MRPL55;RPL8;MRPS18A;NXT1;POLR2E;POLR2H;GLE1;MRPL37;CELF2;DRG1;MRPL3;NCBP1;NUP35;POM121;RPL10;POLR2B;PRPF4;MPHOSPH10;RSL24D1;DDX20;HNRNPH1;RAE1;RRBP1;CPSF4;CPSF3;NUP210;RPL3;RPS27A;THOC6;RPLP1;PWP1;HNRNPUL1;CPSF1;RANBP2;NUP188;NUFIP1;YARS2;MRPS6;SYMPK;LMF2;POLR2A;MRPL44;THOC5;DROSHA;RPL13;NUP214;HBS1L;NOL9;SEH1L
gsea,DNA metabolic process (GO:0006259),0.6987646595462853,2.9435294236486156,0.0,0.0,0.0,107/204,15.28%,HMGB2;RAN;TOP2A;CDK1;HMGB1;TYMS;MCM3;MCM5;RAD51;GMNN;HELLS;LIG1;MCM7;DCTPP1;RFC4;ORC6;RFC5;UHRF1;FEN1;DNMT1;NPM1;PCNA;MCM4;MCM6;RPA3;CDC45;CDC6;SMC1A;MCM2;RAD51AP1;PTGES3;PRIM1;HMGB3;KPNA2;CENPS;POLA1;POLE;RFC2;PRIM2;RMI2;BRCA1;POLD1;NEIL3;PARK7;TOPBP1;POLD2;RAD21;PARP1;MCM10;EXO1;RPA1;RFC3;POLE3;TIMELESS;TRIM28;NSMCE4A;GEN1;BARD1;RFC1;APEX1;RAD18;BLM;RAD50;TICRR;RNASEH2A;RIF1;CHEK1;TSN;RAD54L;CDK2;POLE2;UBE2T;MCM8;WDHD1;ORC1;POLA2;CDC34;RPA2;UBE2N;POLD3;NUDT1;CDT1;DDB1;VCP;UNG;DNA2;CTC1;ORC2;MSH2;PARP2;LONP1;SMARCB1;DDX21;MSH6;CDC7;DBF4;POLQ;RBBP8;MBD4;PDS5A;XRCC6;TDP1;NBN;CNBP;RECQL4;PDS5B;XRCC5
gsea,"mRNA splicing, via spliceosome (GO:0000398)",0.7212211447507428,2.937695466861197,0.0,0.0,0.0,118/171,18.11%,ALYREF;SNRPD1;YBX1;LSM2;LSM3;HNRNPU;SNRPE;SNRPF;HNRNPA3;SRSF2;HNRNPA2B1;HNRNPD;SNU13;SNRPB;PPIL1;SNRPD3;PCBP1;DDX39B;PPIH;PRPF19;U2AF1;SNRPA1;HNRNPF;POLR2F;RNPS1;SRSF7;SRSF3;SNRNP25;LSM7;EIF4A3;MAGOH;HNRNPA1;LSM8;PHF5A;SNRNP70;RBM8A;NONO;SNRNP40;SNRPA;SRSF9;U2AF2;RBM17;SF3B2;POLR2L;DHX9;SYNCRIP;GEMIN6;POLR2C;SRRT;HNRNPC;DDX1;SRSF10;SRRM1;SRSF6;SF3B3;HNRNPA0;PPIE;EFTUD2;SF3A3;SFPQ;FUS;HNRNPK;RBMX2;PTBP1;MAGOHB;HNRNPR;HNRNPM;STRAP;USP39;PRMT5;PRPF40A;SF3B4;CLNS1A;SRSF1;PNN;CPSF2;SCAF11;DDX46;PRPF31;HSPA8;PRPF8;SRSF4;SF3A2;SF3A1;NCBP2;SRRM2;POLR2E;GEMIN2;POLR2H;SART3;U2SURP;TXNL4A;SART1;DHX15;SMU1;SMN1;WDR77;NCBP1;GTF2F2;POLR2B;WBP11;PRPF4;PRMT7;CCAR1;RBM14;SNRNP200;GEMIN5;DDX42;RBM10;DDX20;RSRC1;HNRNPH1;CSTF2;CPSF4;MTREX;CPSF3;SRPK1;DBR1
gsea,DNA-dependent DNA replication (GO:0006261),0.8050572339494969,2.919124523720141,0.0,0.0,0.0,72/96,12.20%,MCM3;MCM5;RAD51;GMNN;MCM7;RFC4;ORC6;RFC5;MCM4;MCM6;RPA3;CDC45;GINS2;CDC6;MCM2;PRIM1;POLA1;PSMB6;POLE;RFC2;PSMB5;PRIM2;POLD1;TOPBP1;POLD2;PSMA4;MCM10;PSMB2;RPA1;RFC3;PSMA6;POLE3;PSMA3;CDK2AP1;PSMD7;RFC1;BLM;PSMD1;PSMD12;GINS3;PSMD2;GINS4;GINS1;CDK2;PSMA5;POLE2;PSMD3;MCM8;WDHD1;ORC1;POLA2;PSMB7;PSMC4;CDC34;RPA2;PSMD6;POLD3;HMGA1;CDT1;PSMC1;MCMBP;PSMC2;PSMD14;DNA2;ORC2;PSMD11;PSMC5;PSME2;DDX21;PSME3;CDC7;DBF4
gsea,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.7187755128442699,2.8836441644129183,0.0,0.0,0.0,107/156,18.11%,ALYREF;SNRPD1;YBX1;LSM2;LSM3;HNRNPU;SNRPE;SNRPF;HNRNPA3;SRSF2;HNRNPA2B1;HNRNPD;SNU13;SNRPB;PPIL1;SNRPD3;PCBP1;DDX39B;PPIH;PRPF19;U2AF1;SNRPA1;HNRNPF;POLR2F;RNPS1;SRSF7;SRSF3;SNRNP25;LSM7;EIF4A3;MAGOH;HNRNPA1;LSM8;PHF5A;SNRNP70;RBM8A;NONO;SNRNP40;SNRPA;SRSF9;U2AF2;RBM17;SF3B2;POLR2L;DHX9;SYNCRIP;GEMIN6;POLR2C;SRRT;HNRNPC;SRSF10;SRRM1;SRSF6;SF3B3;HNRNPA0;PPIE;EFTUD2;SF3A3;SFPQ;FUS;HNRNPK;RBMX2;PTBP1;MAGOHB;HNRNPR;HNRNPM;USP39;PRPF40A;SF3B4;SRSF1;PNN;CPSF2;DDX46;PRPF31;HSPA8;PRPF8;SRSF4;SF3A2;SF3A1;NCBP2;SRRM2;POLR2E;POLR2H;SART3;U2SURP;TXNL4A;SART1;DHX15;SMU1;NCBP1;GTF2F2;POLR2B;WBP11;PRPF4;CCAR1;RBM14;SNRNP200;GEMIN5;DDX42;RBM10;RSRC1;HNRNPH1;CSTF2;CPSF4;MTREX;CPSF3;DBR1
gsea,regulation of cell cycle (GO:0051726),0.6197749844912739,2.8786275377340313,0.0,0.0,0.0,52/159,16.31%,PCLAF;CKS1B;BIRC5;CCNB2;CENPF;GMNN;MIF;FBXO5;HSP90AB1;CDK4;DLGAP5;CCNB1;HNRNPU;PLK1;CKS2;MYBL2;RBBP4;CDKN3;FIGNL1;DTL;BRCA1;KIF20B;MASTL;MYBBP1A;CALR;BARD1;CDC25A;CDKN2A;CHEK1;CDC123;GADD45GIP1;MLF1;TARDBP;FOXM1;RAD23A;DDIAS;PRR11;HRAS;CDKN1A;WDR12;RACK1;HTRA2;TAF6;DHCR24;NBN;PES1;LIN9;BOP1;TBRG4;SKP2;SND1;EIF4G2
gsea,double-strand break repair (GO:0006302),0.6770655325025943,2.8704031385890456,0.0,0.0,0.0,68/116,22.71%,HMGB2;HMGB1;RAD51;NUCKS1;FEN1;RPA3;CDCA5;RAD51AP1;TRIP13;KPNA2;BRIP1;POLA1;AUNIP;PRPF19;HPF1;BRCA1;RAD21;PARP1;RPA1;BAZ1B;BRCA2;GEN1;BARD1;NSD2;BLM;RAD50;MMS22L;RIF1;EME1;DDX1;SMARCA5;NSMCE1;MCM8;RAD54B;SFPQ;RPA2;RFWD3;UBE2N;VCP;PPP5C;PSMD14;TDP2;DNA2;PARP2;SMC6;RNF168;POLQ;RBBP8;PAXIP1;XRCC6;SMC5;TDP1;NBN;RECQL4;XRCC5;BRCC3;UBE2V2;PALB2;XRCC1;TONSL;RECQL;CHEK2;MTA1;ZSWIM7;XRCC2;ATP23;ABRAXAS1;APLF
gsea,mRNA processing (GO:0006397),0.6925796537975123,2.8687450716243132,0.0,0.0,0.0,118/181,19.38%,ALYREF;SNRPD1;YBX1;LSM2;LSM3;HNRNPU;SNRPE;SNRPF;HNRNPA3;SRSF2;HNRNPA2B1;HNRNPD;SNU13;SNRPB;PPIL1;SNRPD3;PCBP1;DDX39B;PPIH;PRPF19;U2AF1;SNRPA1;HNRNPF;POLR2F;RNPS1;SRSF7;SRSF3;SNRNP25;LSM7;EIF4A3;MAGOH;HNRNPA1;LSM8;PHF5A;SNRNP70;RBM8A;NONO;SNRNP40;SNRPA;SRSF9;U2AF2;RBM17;TCERG1;SF3B2;POLR2L;DHX9;SYNCRIP;GEMIN6;POLR2C;SRRT;HNRNPC;SRSF10;SRRM1;SRSF6;SF3B3;HNRNPA0;PPIE;EFTUD2;SF3A3;SFPQ;FUS;HNRNPK;RBMX2;PTBP1;MAGOHB;SARNP;HNRNPR;HNRNPM;USP39;PRPF40A;SF3B4;SRSF1;PNN;CPSF2;SCAF11;DDX46;PRPF31;HSPA8;PRPF8;THOC3;SRSF4;SF3A2;SF3A1;NCBP2;CPSF6;SRRM2;POLR2E;GEMIN2;POLR2H;SART3;U2SURP;TXNL4A;SART1;DHX15;SMU1;NCBP1;GTF2F2;TBRG4;POLR2B;WBP11;PRPF4;CCAR1;RBM14;SNRNP200;GEMIN5;DDX42;RBM10;RSRC1;HNRNPH1;CSTF2;CPSF4;MTREX;CPSF3;DBR1;THOC6;GTF2F1;HNRNPUL1;CPSF1
gsea,DNA repair (GO:0006281),0.6260264083692367,2.8644727347790253,0.0,0.0,0.0,112/218,23.05%,CDK1;RAD51;NUCKS1;LIG1;RFC4;RFC5;FEN1;NPM1;PCNA;RPA3;SMC1A;CDCA5;RAD51AP1;TRIP13;USP1;KPNA2;BRIP1;CENPS;POLA1;POLE;RFC2;HPF1;RMI2;BRCA1;POLD1;NEIL3;PARK7;TOPBP1;POLD2;RAD21;PARP1;EXO1;RPA1;RFC3;BAZ1B;BRCA2;TIMELESS;TRIM28;NSMCE4A;FAM111A;TRAIP;BARD1;APEX1;NSD2;RAD18;BLM;RAD50;TICRR;RNASEH2A;CHEK1;EME1;DDX1;RAD54L;FANCD2;SMARCA5;NSMCE1;POLE2;UBE2T;WDHD1;RAD23A;RPA2;RFWD3;UBE2N;POLD3;FANCI;NUDT1;DDB1;VCP;PPP5C;UNG;TDP2;FANCM;DNA2;MSH2;PARP2;RNF168;RAD23B;MSH6;POLQ;RBBP8;MBD4;PDS5A;TDP1;NBN;RECQL4;PDS5B;XRCC5;BRCC3;UBE2V2;FANCA;FANCF;FANCL;ZRANB3;XRCC1;POLH;RPS27A;WRNIP1;ASF1A;MLH1;TDG;RECQL;CHEK2;MTA1;PMS2;XRCC2;GTF2H4;FANCB;ABRAXAS1;ATR;APLF;CHD1L;MGME1
gsea,mitotic spindle organization (GO:0007052),0.7710740354952932,2.8607813832254405,0.0,0.0,0.0,74/118,13.10%,STMN1;BIRC5;RAN;SPC24;CDCA8;TPX2;AURKB;MAD2L1;CENPF;KNL1;CENPE;KIF11;PRC1;CDC20;NUDC;DLGAP5;CCNB1;PLK1;CENPA;SMC1A;BUB1;SKA1;TUBG1;NUF2;SPC25;PMF1;CENPH;INCENP;KIFC1;BUB1B;NDC80;CENPM;KIF2C;CENPS;CENPP;KIF23;BUB3;RCC1;RCC2;NUP107;KNTC1;SPDL1;SMC3;RANGAP1;ZWILCH;NUP85;AAAS;STIL;CENPK;KPNB1;NUP37;NUP43;SGO1;DYNLL2;SKA2;AURKA;TTK;CKAP5;CENPN;PCNT;GPSM2;CENPU;CENPI;DSN1;VCP;NUP133;XPO1;NSL1;ERCC6L;MIS12;MAD1L1;KIF18A;NUP160;ZWINT
gsea,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.795189377684266,2.8505149351296835,0.0,0.0,0.0,69/100,13.10%,STMN1;BIRC5;RAN;SPC24;CDCA8;TACC3;AURKB;MAD2L1;CENPF;KNL1;CENPE;KIF11;NUSAP1;CDC20;NUDC;DLGAP5;CCNB1;PLK1;CENPA;BUB1;SKA1;TUBG1;NUF2;SPC25;PMF1;CENPH;INCENP;BUB1B;NDC80;CENPM;KIF2C;CENPS;CENPP;BUB3;RCC1;RCC2;NUP107;KNTC1;SPDL1;RANGAP1;ZWILCH;NUP85;STIL;CENPK;KPNB1;NUP37;NUP43;ESPL1;SGO1;DYNLL2;SKA2;AURKA;TTK;CKAP5;CENPN;PCNT;GPSM2;CENPU;CENPI;DSN1;NUP133;XPO1;NSL1;ERCC6L;MIS12;MAD1L1;KIF18A;NUP160;ZWINT
gsea,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.6051479242540644,2.846083802559603,0.0,0.0,0.0,70/168,21.45%,CDK1;AURKB;UBE2C;MAD2L1;UBE2S;FBXO5;CDC20;CCNB1;ANAPC5;PLK1;HSP90B1;BUB1B;PSMB6;PSMB5;BUB3;PSMA4;PSMB2;PSMA6;ANAPC15;PSMA3;KIF14;PSMD7;PSMD1;PSMD12;AURKA;PSMD2;CCNF;CDK2;PSMA5;STUB1;PSMD3;RAD23A;RNF126;PSMB7;PSMC4;CDC34;PSMD6;DDB1;VCP;FZR1;PSMC1;PSMC2;PSMD14;PSMD11;PSMC5;PSME2;RAD23B;PSME3;NSFL1C;SKP2;CDC16;STT3B;PSMC6;TAF1;EDEM1;NEDD4;RPS27A;FAF1;UBQLN1;RNF5;DERL2;HSPA5;ANAPC1;LTN1;CUL1;MTA1;DNAJC10;CDC27;CDC23;ECPAS
gsea,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.716987480033886,2.8376216379588604,0.0,0.0,0.0,60/98,15.37%,CDK1;TPX2;CENPF;HMMR;FBXO5;CDK4;TUBB4B;CCNB1;HSP90AA1;PLK1;TUBG1;HAUS4;PSMB6;DTL;NEK2;PSMB5;PLK4;YWHAE;RCC2;PSMA4;PSMB2;PSMA6;PSMA3;KIF14;HAUS1;CDC25C;PSMD7;CDC25A;PSMD1;PSMD12;HAUS5;AURKA;PSMD2;TUBA4A;CDK2;PSMA5;CKAP5;PSMD3;PCNT;PSMB7;PSMC4;CDC25B;PSMD6;TUBA1A;PSMC1;HAUS6;PSMC2;PSMD14;PSMD11;PSMC5;PSME2;PSME3;CDC7;HAUS7;NEDD1;NDE1;CCP110;CNTRL;AVEN;ODF2
gsea,positive regulation of transferase activity (GO:0051347),0.7171091599454547,2.833349930429532,0.0,0.0,0.0,24/68,9.50%,AURKB;RFC4;RFC5;HSP90AB1;PCNA;TCP1;DBI;HSP90AA1;PLK1;HNRNPA2B1;HNRNPD;RPS2;PTGES3;RFC2;NEK2;CCT2;DKC1;DSCC1;RFC3;PIN1;RAD50;CHTF18;CCT4;UBE2N
gsea,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.6880490323414092,2.823289829591959,0.0,0.0,0.0,24/72,12.03%,PSMB6;PSMB5;PSMA4;PSMB2;RUVBL2;PSMA6;HDAC1;PSMA3;PSMD7;PSMD1;PSMD12;PSMD2;PSMA5;PSMD3;PSMB7;PSMC4;PSMD6;PSMC1;PSMC2;PSMD14;PSMD11;PSMC5;PSME2;PSME3
gsea,regulation of mitotic cell cycle phase transition (GO:1901990),0.6824095527011121,2.81768431054669,0.0,0.0,0.0,94/129,25.93%,CDK1;TPX2;UBE2C;MAD2L1;CENPF;CENPE;UBE2S;HMMR;FBXO5;CDC20;TUBB4B;CCNB1;HSP90AA1;ANAPC5;PLK1;CDC6;TUBG1;BUB1B;HAUS4;PSMB6;NEK2;PSMB5;PLK4;BUB3;YWHAE;KNTC1;PSMA4;PSMB2;E2F1;PSMA6;ANAPC15;PSMA3;KIF14;HAUS1;PSMD7;PSMD1;PSMD12;HAUS5;AURKA;PSMD2;TUBA4A;ANLN;CDK2;PSMA5;CKAP5;PSMD3;PCNT;PSMB7;PSMC4;PSMD6;TUBA1A;DDB1;FZR1;PSMC1;HAUS6;PSMC2;PSMD14;PSMD11;PSMC5;PSME2;PSME3;HAUS7;NEDD1;NDE1;CCP110;CNTRL;ODF2;CDC16;PSMC6;ZW10;RPS27A;CEP57;CEP192;TFAP4;ANAPC1;CUL1;CDC27;CDC23;ANAPC4;CEP72;CEP70;ALMS1;CEP135;CEP78;RIOK2;HAUS3;DYNC1H1;DCTN1;CEP76;CENPJ;CLASP1;PCM1;CDK5RAP2;ACTR1A
gsea,DNA replication (GO:0006260),0.7863747734386693,2.8119536858868104,0.0,0.0,0.0,58/89,12.59%,PCLAF;DUT;CDK1;MCM3;MCM5;CLSPN;SET;TIPIN;MCM7;RFC4;ORC6;NAP1L1;RFC5;FEN1;MCM4;MCM6;RPA3;CDC45;CDC6;MCM2;BRIP1;POLA1;POLE;RFC2;RMI2;BRCA1;POLD1;TOPBP1;POLD2;MCM10;EXO1;RPA1;RFC3;POLE3;TIMELESS;FAM111A;BARD1;CDK2AP1;RFC1;BLM;RAD50;TICRR;RNASEH2A;CHEK1;CDK2;POLE2;MCM8;WDHD1;ORC1;POLA2;RPA2;MCMBP;DNA2;ORC2;GRWD1;CDC7;DBF4;RBBP8
gsea,ribonucleoprotein complex assembly (GO:0022618),0.7257124181641639,2.795861749649603,0.0,0.0,0.0,67/87,19.52%,SNRPD1;RPS27L;HSP90AB1;HSP90AA1;SNRPE;SNRPF;PTGES3;SNRPB;SNRPD3;DDX39B;PRPF19;RPS15;EIF3A;SRSF9;DHX9;GEMIN6;MRPL20;EIF6;DDX1;SRSF10;RPL5;SRSF6;RPL23A;BRIX1;EIF4H;STRAP;MRPS7;USP39;PRMT5;EIF2S2;CLNS1A;SRSF1;SCAF11;RPSA;SF3A2;RPLP0;RPF2;DENR;CPSF6;NOP2;GEMIN2;LUC7L3;SART3;PPAN;TXNL4A;SART1;SMN1;CELF2;WDR77;RRS1;LUC7L;NCBP1;XRCC5;BOP1;RPL10;PRMT7;SNRNP200;RSL24D1;GEMIN5;DDX20;NLE1;SRPK1;RPL3;EIF4B;EIF5;RRP7A;SHQ1
gsea,regulation of signal transduction by p53 class mediator (GO:1901796),0.6610708125427358,2.7911708975110905,0.0,0.0,0.0,59/99,25.53%,CDK1;TPX2;AURKB;RBBP7;RFC4;RFC5;RPA3;SSRP1;BRIP1;RBBP4;RFC2;RMI2;BRCA1;TOPBP1;RPS15;EXO1;RPA1;RFC3;HDAC1;PIN1;BARD1;NOC2L;BLM;AURKA;RAD50;CHEK1;MBD3;HDAC2;CDK2;RPL5;KMT5A;PRMT5;RPA2;SMYD2;AKT1;DNA2;TAF15;RBBP8;RPF2;TAF6;NOP2;NBN;RRS1;BOP1;CCNG1;TAF1;BRD7;PRR5;MTA2;CHEK2;CHD4;ATR;CSNK2A2;EHMT2;RAD1;RHNO1;TOP3A;HUS1;RAD9A
gsea,ncRNA processing (GO:0034470),0.6818891329235685,2.787592382021875,0.0,0.0,0.0,103/138,23.64%,RPS17;EXOSC8;HNRNPA2B1;RPS2;SNU13;FBL;NOLC1;LYAR;NOP58;RPL14;NOP56;RPS15;RPS25;EBNA1BP2;DKC1;RPS6;RPL31;MRTO4;SSB;RPL41;DDX27;EXOSC7;RPL4;RPP30;SRRT;POP5;RPL5;DIS3;RPL23A;EMG1;WDR18;EXOSC3;PELP1;WDR75;PIH1D1;WDR43;INTS11;RRP1;RPL10A;RPL15;EXOSC2;EXOSC1;NOL11;WDR12;WDR74;RRP1B;RPLP0;HEATR1;RPL8;EXOSC9;FCF1;IMP4;UTP18;DGCR8;UTP11;EXOSC5;WDR36;PES1;RCL1;TBL3;UTP20;NOC4L;BOP1;WDR3;NOP14;RPL10;MPHOSPH10;RRP9;UTP3;DDX10;MTREX;POP4;ESF1;UTP6;RPL3;NOB1;PDCD11;EXOSC4;UTP4;DCAF13;BMS1;WDR46;RPLP1;POP1;WDR55;UTP15;RRP7A;LAS1L;NVL;DDX47;INTS7;RPF1;EXOSC10;MRPL44;MDN1;RRP12;BYSL;DROSHA;RPL13;THG1L;INTS10;TARBP2;NOL9
gsea,protein-DNA complex assembly (GO:0065004),0.7613088139970469,2.78521002672218,0.0,0.0,0.0,51/82,12.03%,HMGB2;MCM3;ANP32B;MCM5;RAD51;GMNN;MCM7;ORC6;NAP1L1;NPM1;MCM4;MCM6;RPA3;CDC6;MCM2;PSMB6;CHAF1A;PSMB5;PARP1;PSMA4;PSMB2;RPA1;PSMA6;PSMA3;PSMD7;PSMD1;PSMD12;PSMD2;CHAF1B;PSMA5;SMARCA5;PSMD3;MCM8;ORC1;PSMB7;PSMC4;RPA2;PSMD6;CDT1;DDB1;PSMC1;PSMC2;PSMD14;ORC2;NAP1L4;PSMD11;PSMC5;PSME2;GRWD1;RAD23B;PSME3
gsea,positive regulation of DNA biosynthetic process (GO:2000573),0.8059530466531798,2.7806900750766084,0.0,0.0,0.0,22/42,8.12%,AURKB;RFC4;RFC5;HSP90AB1;PCNA;TCP1;HSP90AA1;PTGES3;CCT6A;CCT8;RFC2;CCT3;NEK2;CCT7;CCT5;CCT2;DKC1;DSCC1;RFC3;HNRNPA1;CHTF18;CCT4
gsea,ribosome biogenesis (GO:0042254),0.7088866488189158,2.774947101502741,0.0,0.0,0.0,116/134,26.09%,RAN;RPS17;NPM1;EXOSC8;RPS2;SNU13;FBL;NOLC1;LYAR;NOP58;RPL14;NOP56;RPS15;RPS25;EBNA1BP2;DKC1;RPS6;RPL31;MRTO4;RPL41;NOC2L;DDX27;EXOSC7;RPL4;NOP16;EIF6;POP5;RPL5;DIS3;RPL23A;EMG1;WDR18;EXOSC3;ABCE1;PELP1;WDR75;PIH1D1;WDR43;XPO1;RRP1;RPL10A;RPL15;EXOSC2;GTF3A;EXOSC1;NOL11;WDR12;WDR74;RRP1B;RPLP0;RPF2;HEATR1;RPL8;SDAD1;EXOSC9;NIP7;FCF1;IMP4;UTP18;MRPL22;UTP11;EXOSC5;WDR36;RRS1;PES1;RCL1;TBL3;UTP20;NOC4L;BOP1;WDR3;NOP14;RPL10;MPHOSPH10;RRP9;UTP3;DDX10;LTV1;MTREX;POP4;ESF1;UTP6;RPL3;NOB1;PDCD11;EXOSC4;UTP4;DCAF13;BMS1;WDR46;RPLP1;WDR55;UTP15;RRP7A;LAS1L;NVL;DDX47;RPF1;NAF1;EXOSC10;MDN1;RRP12;BYSL;LSG1;RPL13;NOL9;RIOK2;NOM1;MPHOSPH6;CUL4B;DHX29;HELQ;DDX54;KRR1;UTP14A;PWP2
gsea,regulation of cell cycle phase transition (GO:1901987),0.7776906773355,2.771824987005286,0.0,0.0,0.0,39/59,12.20%,CDK1;UBE2C;MAD2L1;UBE2S;FBXO5;CDC20;CCNB1;ANAPC5;PLK1;BUB1B;PSMB6;PSMB5;BUB3;PSMA4;PSMB2;PSMA6;ANAPC15;PSMA3;PSMD7;PSMD1;PSMD12;PSMD2;GTSE1;PSMA5;PSMD3;PSMB7;PSMC4;PSMD6;DDB1;FZR1;PSMC1;PSMC2;PSMD14;CDKN1A;PSMD11;PSMC5;PSME2;PSME3;DBF4
gsea,regulation of mRNA stability (GO:0043488),0.6764625149243831,2.768565469409299,0.0,0.0,0.0,54/94,18.50%,SET;YBX1;NPM1;EXOSC8;HNRNPU;HNRNPD;PSMB6;SERBP1;PSMB5;PSMA4;PSMB2;E2F1;PSMA6;PSMA3;EIF4G1;PSMD7;APEX1;EXOSC7;PSMD1;PSMD12;PSMD2;THRAP3;PSMA5;PSMD3;DIS3;FUS;PSMB7;EXOSC3;PSMC4;PSMD6;AKT1;PSMC1;XPO1;EXOSC2;PSMC2;PSMD14;EXOSC1;HSPA8;KHSRP;PSMD11;PSMC5;PSME2;TAF15;PSME3;EXOSC9;METTL16;EXOSC5;TBRG4;LARP1;PSMC6;TNPO1;ANP32A;RPS27A;EXOSC4
gsea,rRNA processing (GO:0006364),0.7142016606689934,2.766826841900364,0.0,0.0,0.0,109/121,26.09%,RPS17;EXOSC8;NHP2;RPS2;SNU13;FBL;NOLC1;LYAR;NOP58;RPL14;NOP56;RPS15;RPS25;EBNA1BP2;DKC1;RPS6;RPL31;MRTO4;RPL41;RSL1D1;DDX27;EXOSC7;RPL4;EIF6;ERI1;POP5;RPL5;DIS3;RPL23A;EMG1;WDR18;EXOSC3;PELP1;WDR75;PIH1D1;WDR43;RRP1;RPL10A;RPL15;EXOSC2;EXOSC1;NOL11;WDR12;WDR74;RRP1B;RPLP0;RRP15;HEATR1;NOP2;RPL8;EXOSC9;FCF1;IMP4;UTP18;SART1;UTP11;EXOSC5;WDR36;PES1;RCL1;TBL3;UTP20;NOC4L;BOP1;WDR3;NOP14;RPL10;MPHOSPH10;RRP9;UTP3;DDX10;MAK16;MTREX;POP4;ESF1;UTP6;RPL3;NOB1;PDCD11;EXOSC4;UTP4;DCAF13;BMS1;WDR46;RPLP1;WDR55;UTP15;RRP7A;LAS1L;NVL;DDX47;RPF1;THUMPD1;EXOSC10;MRPL1;MDN1;RRP12;BYSL;RPL13;TFB1M;NOL9;RIOK2;MPHOSPH6;PRKDC;HELQ;DDX54;KRR1;UTP14A;PWP2
gsea,chromosome organization (GO:0051276),0.6867419694915133,2.762533855863307,0.0,0.0,0.0,38/70,20.00%,HMGB2;TOP2A;CDCA8;HMGN2;NUCKS1;CENPW;EZH2;NUF2;CENPH;NDC80;SUV39H1;PARP1;HDAC1;POLE3;HDAC2;COPS3;HMGN1;RFWD3;CDT1;DDB1;NUP133;SMARCA4;MSH2;COPS5;NUP155;RAD23B;MSH6;GPS1;COPS4;CENPV;CENPT;RAE1;RPS27A;PHF19;MTF2;LRWD1;COPS7A;SAFB
gsea,double-strand break repair via homologous recombination (GO:0000724),0.7310420766780078,2.748381629446286,0.0,0.0,0.0,41/70,15.03%,MCM3;MCM5;RAD51;NUCKS1;MCM7;FEN1;MCM4;MCM6;RPA3;CDC45;GINS2;MCM2;RAD51AP1;AUNIP;BRCA1;RAD21;PARP1;RPA1;BRCA2;GEN1;BLM;RAD50;GINS4;MMS22L;RAD54L;NSMCE1;MCM8;RAD54B;SFPQ;RPA2;RFWD3;UBE2N;PSMD14;FANCM;SMC6;CDC7;POLQ;RBBP8;SMC5;NBN;RECQL4
gsea,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.7151715747484556,2.7459259337767516,0.0,0.0,0.0,25/59,12.03%,PSMB6;PSMB5;PSMA4;PSMB2;PSMA6;PSMA3;PIN1;RUVBL1;PSMD7;PSMD1;PSMD12;PSMD2;PSMA5;PSMD3;PSMB7;PSMC4;PSMD6;VCP;PSMC1;PSMC2;PSMD14;PSMD11;PSMC5;PSME2;PSME3
gsea,positive regulation of protein localization to nucleus (GO:1900182),0.7506423413081721,2.7396731925529236,0.0,0.0,0.0,19/45,10.02%,RAN;CDK1;TCP1;PLK1;CCT6A;CCT8;TFRC;CCT3;CCT7;CCT5;CCT2;PARK7;DKC1;ECT2;IPO5;TRIM28;GTSE1;CCT4;AKT1
gsea,mitotic cell cycle phase transition (GO:0044772),0.6405322770400471,2.739203333857333,0.0,0.0,0.0,85/139,26.07%,CCNA2;CDK1;CCNB2;TACC3;UBE2C;UBE2S;CDK4;TUBB4B;NASP;CCNB1;HSP90AA1;PLK1;TUBG1;HAUS4;MELK;CDKN3;POLE;NEK2;PKMYT1;PLK4;GSPT1;YWHAE;RCC1;MASTL;E2F1;CCNE1;HAUS1;CDC25C;CDC25A;HAUS5;AURKA;CCNE2;TUBA4A;CDKN2A;CCNF;CDK2;CKAP5;FOXM1;PCNT;CDC34;CDC25B;TUBA1A;BCAT1;HAUS6;EIF4E;CDKN1A;CDC7;DBF4;HAUS7;NEDD1;NDE1;CCP110;CNTRL;ODF2;SKP2;CDC16;WEE1;BORA;CCNG1;CEP57;CEP192;ANAPC1;CUL1;CHEK2;CDC27;CDC23;USP37;OPTN;CEP72;CEP70;ALMS1;CDK6;CEP135;CEP78;HAUS3;DYNC1H1;DCTN1;CUL4B;CEP76;CENPJ;CLASP1;PCM1;CDK5RAP2;ACTR1A;PPP1CB
gsea,rRNA metabolic process (GO:0016072),0.7185907707329743,2.7379440440171714,0.0,0.0,0.0,90/108,22.75%,RPS17;EXOSC8;RPS2;SNU13;FBL;NOLC1;LYAR;NOP58;RPL14;NOP56;RPS15;RPS25;EBNA1BP2;DKC1;RPS6;RPL31;MRTO4;RPL41;DDX27;EXOSC7;RPL4;POP5;RPL5;DIS3;RPL23A;EMG1;WDR18;EXOSC3;PELP1;WDR75;PIH1D1;WDR43;RRP1;RPL10A;RPL15;EXOSC2;EXOSC1;NOL11;WDR12;WDR74;RRP1B;RPLP0;HEATR1;RPL8;NIFK;EXOSC9;FCF1;IMP4;UTP18;UTP11;EXOSC5;WDR36;PES1;RCL1;TBL3;UTP20;NOC4L;BOP1;WDR3;NOP14;RPL10;MPHOSPH10;RRP9;UTP3;DDX10;MTREX;POP4;ESF1;UTP6;RPL3;NOB1;PDCD11;EXOSC4;UTP4;DCAF13;BMS1;WDR46;RPLP1;WDR55;UTP15;RRP7A;LAS1L;NVL;DDX47;RPF1;EXOSC10;MDN1;RRP12;BYSL;RPL13
gsea,regulation of cell cycle process (GO:0010564),0.7119898182681171,2.7341073728661125,0.0,0.0,0.0,31/64,16.39%,MKI67;AURKB;KIF11;TIPIN;FBXO5;PRC1;PLK1;BUB1;RACGAP1;KNSTRN;KIF20A;NEK2;PKMYT1;PLK4;RMI2;RCC1;KIF20B;ECT2;SPAG5;PIN1;CDC25C;AURKA;CHEK1;PRMT5;PRPF40A;DBF4;MAD1L1;CCP110;CALM2;SND1;BORA
gsea,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.702819956964097,2.733855524740736,0.0,0.0,0.0,52/74,20.85%,ALYREF;SRSF2;HNRNPA2B1;DDX39B;U2AF1;NUP107;SLBP;RNPS1;SRSF7;SRSF3;EIF4A3;MAGOH;NUP85;AAAS;RBM8A;NUP62;NDC1;SRSF9;NUP37;NUP43;U2AF2;SRRM1;SRSF6;NUP93;NUP205;MAGOHB;SARNP;SRSF1;NUP133;CPSF2;EIF4E;THOC3;NUP88;SRSF4;NUP155;NCBP2;NUP160;NUP54;NXT1;GLE1;NCBP1;NUP35;POM121;RAE1;CPSF4;CPSF3;NUP210;THOC6;CPSF1;RANBP2;NUP188;SYMPK
gsea,cellular response to DNA damage stimulus (GO:0006974),0.5679601711839241,2.733669864129418,0.0,0.0,0.0,139/245,30.82%,PCLAF;TOP2A;CDK1;RAD51;LIG1;MCM7;RFC4;RFC5;FEN1;NPM1;SMC1A;RAD51AP1;CENPS;POLA1;CBX5;DTL;RFC2;HPF1;CBX3;RMI2;BRCA1;POLD1;PARK7;TOPBP1;SUV39H1;CBX1;PARP1;MCM10;EXO1;MASTL;RPA1;E2F1;RFC3;BAZ1B;POLE3;TIMELESS;TRIM28;NSMCE4A;FAM111A;TRAIP;BARD1;APEX1;RAD18;BLM;RAD50;TICRR;RIF1;CHEK1;RAD54L;POLE2;UBE2T;MCM8;WDR76;WDHD1;RFWD3;NUDT1;DDB1;VCP;BAX;CGAS;UNG;MSH2;PARP2;CDKN1A;SMC6;RNF168;HTRA2;MSH6;POLQ;RBBP8;ASH2L;MBD4;PDS5A;SMC5;TDP1;UBA1;NBN;SLF1;RECQL4;PDS5B;XRCC5;FANCA;FANCF;FANCL;BAK1;ZRANB3;TAF1;MTREX;ETAA1;POLH;RTEL1;USP10;ASF1A;MRNIP;CHCHD6;RECQL;CHEK2;PIDD1;XRCC2;GTF2H4;AATF;ATR;APLF;CHD1L;HELB;ZDHHC16;RAD1;OARD1;FMR1;CUL4B;GNL1;PRKDC;FANCG;HUS1;FBXO45;RAD9A;UBQLN4;MYC;SETX;GTF2H3;YY1;RBBP6;BID;RNF8;DOT1L;DDX11;GTF2H1;RAD17;MUTYH;UBA6;RPAIN;ERCC8;FANCC;FBXO31;MSH3;ALKBH7;SPIDR;WDR48;SLF2
gsea,RNA export from nucleus (GO:0006405),0.7054222376463031,2.722985154669212,0.0,0.0,0.0,54/77,20.85%,RAN;ALYREF;SRSF2;HNRNPA2B1;DDX39B;U2AF1;NUP107;SLBP;RNPS1;SRSF7;SRSF3;EIF4A3;MAGOH;HNRNPA1;NUP85;AAAS;RBM8A;NUP62;NDC1;SRSF9;NUP37;NUP43;U2AF2;SRRM1;SRSF6;NUP93;NUP205;MAGOHB;SARNP;SRSF1;NUP133;CPSF2;EIF4E;THOC3;NUP88;SRSF4;NUP155;NCBP2;NUP160;NUP54;NXT1;GLE1;NCBP1;NUP35;POM121;RAE1;CPSF4;CPSF3;NUP210;THOC6;CPSF1;RANBP2;NUP188;SYMPK
gsea,mRNA export from nucleus (GO:0006406),0.698970589222908,2.7188123784297322,0.0,0.0,0.0,54/77,20.85%,ALYREF;SRSF2;HNRNPA2B1;DDX39B;U2AF1;NUP107;SLBP;RNPS1;SRSF7;SRSF3;EIF4A3;MAGOH;NUP85;AAAS;RBM8A;NUP62;NDC1;SRSF9;NUP37;NUP43;U2AF2;SRRM1;SRSF6;NUP93;NUP205;MAGOHB;SARNP;SRSF1;NUP133;CPSF2;EIF4E;THOC3;NUP88;SRSF4;NUP155;NCBP2;NUP160;NUP54;NXT1;GLE1;NCBP1;NUP35;POM121;RAE1;CPSF4;CPSF3;NUP210;THOC6;CPSF1;RANBP2;NUP188;DDX19A;IWS1;SYMPK
gsea,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.7948676278559449,2.7147059817752957,0.0,0.0,0.0,25/38,13.27%,PSMB6;PSMB5;PSMA4;PSMB2;PSMA6;PDIA3;CALR;PSMA3;PSMD7;PSMD1;PSMD12;PSMD2;PSMA5;PSMD3;PSMB7;PSMC4;PSMD6;PSMC1;PSMC2;PSMD14;PSMD11;PSMC5;PSME2;PSME3;IFI30
gsea,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.8177635815574636,2.7100757497239663,0.0,0.0,0.0,24/35,12.03%,PSMB6;PSMB5;PSMA4;PSMB2;PSMA6;PDIA3;CALR;PSMA3;PSMD7;PSMD1;PSMD12;PSMD2;PSMA5;PSMD3;PSMB7;PSMC4;PSMD6;PSMC1;PSMC2;PSMD14;PSMD11;PSMC5;PSME2;PSME3
gsea,positive regulation of Wnt signaling pathway (GO:0030177),0.673172098213515,2.703979394731287,0.0,0.0,0.0,27/67,12.03%,PSMB6;PSMB5;PSMA4;PSMB2;PSMA6;PSMA3;PIN1;RUVBL1;PSMD7;PSMD1;PSMD12;PSMD2;PSMA5;PSMD3;PSMB7;PSMC4;PSMD6;VCP;DEPDC1B;PSMC1;SMARCA4;PSMC2;PSMD14;PSMD11;PSMC5;PSME2;PSME3
gsea,ubiquitin-dependent protein catabolic process (GO:0006511),0.5694785972437529,2.7006388926613445,0.0,0.0,0.0,62/168,21.41%,AURKB;UBE2C;MAD2L1;UBE2S;UHRF1;CDC20;ANAPC5;PLK1;BUB1B;PSMB6;DTL;PSMB5;BUB3;PSMA4;PSMB2;PSMA6;ANAPC15;PSMA3;KIF14;PSMD7;PSMD1;PSMD12;AURKA;ELOC;PSMD2;PSMA5;STUB1;PSMD3;RAD23A;COPS3;RNF126;PSMB7;PSMC4;CDC34;PSMD6;DDB1;VCP;FZR1;PSMC1;PSMC2;PSMD14;PSMD11;PSMC5;PSME2;RNF168;RAD23B;PSME3;UBA1;NSFL1C;SKP2;CDC16;PSMC6;TAF1;NEDD4;ADRM1;FAF1;UBQLN1;RNF5;ANAPC1;MTA1;CDC27;CDC23
gsea,mRNA transport (GO:0051028),0.6778995703982374,2.696874697836189,0.0,0.0,0.0,52/79,20.85%,ALYREF;SRSF2;HNRNPA2B1;DDX39B;U2AF1;NUP107;SLBP;RNPS1;SRSF7;SRSF3;EIF4A3;MAGOH;NUP85;AAAS;RBM8A;NUP62;NDC1;SRSF9;NUP37;NUP43;U2AF2;SRRM1;SRSF6;NUP93;NUP205;MAGOHB;SARNP;SRSF1;NUP133;CPSF2;EIF4E;THOC3;NUP88;SRSF4;NUP155;NCBP2;NUP160;NUP54;NXT1;GLE1;NCBP1;NUP35;POM121;RAE1;CPSF4;CPSF3;NUP210;THOC6;CPSF1;RANBP2;NUP188;SYMPK
gsea,regulation of establishment of planar polarity (GO:0090175),0.7993861380955061,2.694414768366807,0.0,0.0,0.0,24/42,12.03%,PSMB6;PSMB5;PSMA4;PSMB2;SAPCD2;PSMA6;PSMA3;PSMD7;PSMD1;PSMD12;PSMD2;PSMA5;PSMD3;PSMB7;PSMC4;PSMD6;PSMC1;PSMC2;PFN1;PSMD14;PSMD11;PSMC5;PSME2;PSME3
gsea,type I interferon signaling pathway (GO:0060337),-0.8490650733537916,-2.6944147427125174,0.0,0.0,0.0,21/31,5.87%,STAT1;SAMHD1;IRF1;SP100;ISG15;IFITM1;IRF4;IRF7;ISG20;IRF9;EGR1;IFITM2;IFITM3;GBP2;XAF1;IRF2;IFIT1;IFI27;RSAD2;RNASEL;IFIT3
gsea,cellular response to type I interferon (GO:0071357),-0.8490650733537916,-2.6944147427125174,0.0,0.0,0.0,21/31,5.87%,STAT1;SAMHD1;IRF1;SP100;ISG15;IFITM1;IRF4;IRF7;ISG20;IRF9;EGR1;IFITM2;IFITM3;GBP2;XAF1;IRF2;IFIT1;IFI27;RSAD2;RNASEL;IFIT3
gsea,RNA processing (GO:0006396),0.6792941303384994,2.6907300226989412,0.0,0.0,0.0,62/108,16.77%,SNRPD1;LSM3;HNRNPU;SNRPF;SRSF2;HNRNPA2B1;HNRNPD;SNRPB;SNRPD3;DDX39B;U2AF1;SNRPA1;HNRNPF;RNPS1;SRSF7;SNRNP25;DKC1;MAGOH;RBM8A;NONO;SNRNP40;SRSF9;U2AF2;TCERG1;SF3B2;SYNCRIP;HNRNPC;SRRM1;SF3B3;HNRNPA0;TARDBP;SF3A3;SFPQ;FUS;HNRNPK;PTBP1;MAGOHB;HNRNPR;PABPC4;USP39;SF3B4;SRSF1;SCAF11;KHSRP;PRPF8;SRSF4;SF3A2;SF3A1;NCBP2;CPSF6;GEMIN2;LUC7L3;DHX15;SMU1;CELF2;PPIG;NCBP1;PRPF4;MPHOSPH10;DDX20;RSRC1;HNRNPH1
gsea,G1/S transition of mitotic cell cycle (GO:0000082),0.7265329564385272,2.689750893643056,0.0,0.0,0.0,29/60,12.20%,RRM2;TYMS;FBXO5;CDK4;PCNA;NASP;CDC45;CDC6;DHFR;TFDP1;CDKN3;POLA1;POLE;GSPT1;RCC1;E2F1;CCNE1;CDC25A;CCNE2;CDKN2A;CDK2;ORC1;CDC34;CDT1;BCAT1;EIF4E;CDKN1A;CDC7;DBF4
gsea,protein polyubiquitination (GO:0000209),0.5699843378182686,2.6849541940209765,0.0,0.0,0.0,56/139,22.15%,UBE2C;UBE2S;ANAPC5;PSMB6;DTL;PRPF19;PSMB5;BRCA1;PSMA4;PSMB2;PSMA6;PSMA3;BARD1;PSMD7;PSMD1;PSMD12;PSMD2;CCNF;PSMA5;STUB1;UBE2T;PSMD3;RNF126;PSMB7;PSMC4;THOP1;CDC34;PSMD6;UBE2N;FZR1;PSMC1;PSMC2;PSMD14;PSMD11;PSMC5;PSME2;RNF168;PSME3;DCAF15;BLMH;UBE2E3;SKP2;CDC16;UBE2V2;PSMC6;TAF1;NEDD4;RPS27A;ZFP91;RNF5;ANAPC1;CUL1;ANKRD39;CDC27;CDC23;ANAPC4
gsea,RNA splicing (GO:0008380),0.7520053400706511,2.684385968383984,0.0,0.0,0.0,47/60,18.11%,SNRPD1;SNRPF;SRSF2;SNRPB;SNRPD3;DDX39B;U2AF1;SNRPA1;RNPS1;SRSF7;SNRNP25;MAGOH;RBM8A;NONO;SNRNP40;TCERG1;SF3B2;SYNCRIP;HNRNPC;SRSF10;SRRM1;SF3B3;TARDBP;SF3A3;SFPQ;FUS;PTBP1;MAGOHB;USP39;SF3B4;SCAF11;KHSRP;PRPF8;SRSF4;NCBP2;GEMIN2;LUC7L3;TXNL4A;DHX15;SMU1;PPIG;NCBP1;PRPF4;MPHOSPH10;RSRC1;SRPK1;DBR1
gsea,cellular response to lectin (GO:1990858),0.6851470520093637,2.681001961628563,0.0,0.0,0.0,23/56,12.03%,PSMB6;PSMB5;PSMA4;PSMB2;PSMA6;PSMA3;PSMD7;PSMD1;PSMD12;PSMD2;PSMA5;PSMD3;PSMB7;PSMC4;PSMD6;PSMC1;PSMC2;PSMD14;HRAS;PSMD11;PSMC5;PSME2;PSME3
gsea,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.6851470520093637,2.681001961628563,0.0,0.0,0.0,23/56,12.03%,PSMB6;PSMB5;PSMA4;PSMB2;PSMA6;PSMA3;PSMD7;PSMD1;PSMD12;PSMD2;PSMA5;PSMD3;PSMB7;PSMC4;PSMD6;PSMC1;PSMC2;PSMD14;HRAS;PSMD11;PSMC5;PSME2;PSME3
gsea,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.6851470520093637,2.681001961628563,0.0,0.0,0.0,23/56,12.03%,PSMB6;PSMB5;PSMA4;PSMB2;PSMA6;PSMA3;PSMD7;PSMD1;PSMD12;PSMD2;PSMA5;PSMD3;PSMB7;PSMC4;PSMD6;PSMC1;PSMC2;PSMD14;HRAS;PSMD11;PSMC5;PSME2;PSME3
gsea,mRNA metabolic process (GO:0016071),0.7240960355173554,2.676775143287839,0.0,0.0,0.0,39/59,17.74%,LSM2;LSM3;SNRPE;SNRPF;SRSF2;HNRNPA2B1;SNRPB;SNRPD3;U2AF1;SLBP;SRSF7;NONO;SSB;SRSF9;U2AF2;TCERG1;SF3B2;HNRNPA0;SF3A3;SFPQ;PTBP1;HNRNPR;USP39;SF3B4;SRSF1;SCAF11;PRPF8;SRSF4;SF3A2;SF3A1;NCBP2;CPSF6;GEMIN2;METTL16;DHX15;NCBP1;TBRG4;CPSF3;LSM11
gsea,mitotic sister chromatid segregation (GO:0000070),0.7918712642077813,2.6700359769732587,0.0,0.0,0.0,50/70,15.19%,RAN;SMC2;CDCA8;CDK1;SET;CENPE;NUSAP1;NCAPG;PRC1;NUDC;DLGAP5;CCNB1;PLK1;SMC4;NCAPD2;SMC1A;CEP55;CDCA5;TUBG1;KIF22;NCAPH;KIFC1;NDC80;NCAPG2;KIF2C;KNSTRN;KIF23;NCAPD3;RAD21;NCAPH2;SPDL1;KIF18B;SPAG5;KIF14;NUP62;CENPK;KPNB1;ESPL1;SGO1;NAA50;KMT5A;DSN1;NSL1;MIS12;KIF18A;ZWINT;PDS5A;HASPIN;RRS1;PDS5B
gsea,cellular protein-containing complex assembly (GO:0034622),0.6362694156994009,2.6696462491291073,0.0,0.0,0.0,35/79,18.38%,CENPF;CENPE;CENPW;HSP90AB1;TCP1;DLGAP5;HSP90AA1;CENPA;HSPD1;PTGES3;CCT2;NUP107;PFDN6;NDC1;DHX9;ANLN;HSPA4;NUP93;NUP205;EIF4H;HIGD1A;PSMG2;PSMG1;SAMM50;PSMD11;CLTB;LONP1;CHCHD4;MIS12;DNAAF2;AIFM1;CENPT;PSMG3;ADRM1;EIF4B
gsea,nucleic acid metabolic process (GO:0090304),0.7579124905619948,2.6692078217024595,0.0,0.0,0.0,33/49,16.77%,RAN;FEN1;HNRNPU;HNRNPA3;HNRNPA2B1;HNRNPD;KPNA2;PCBP1;HNRNPF;POLR2F;TOPBP1;HNRNPA1;LSM8;POLR2L;RAD50;POLR2C;HNRNPC;DDX1;HNRNPA0;HNRNPK;PTBP1;HNRNPR;HNRNPM;ANKLE1;DNA2;WDR74;NCBP2;POLR2E;POLR2H;NCBP1;GTF2F2;POLR2B;HNRNPH1
gsea,regulation of canonical Wnt signaling pathway (GO:0060828),0.615225406925171,2.667650331511953,0.0,0.0,0.0,27/108,12.03%,PSMB6;PSMB5;PSMA4;PSMB2;RUVBL2;PSMA6;HDAC1;PSMA3;PIN1;RUVBL1;PSMD7;PSMD1;PSMD12;PSMD2;PSMA5;PSMD3;PSMB7;PSMC4;PSMD6;VCP;PSMC1;PSMC2;PSMD14;PSMD11;PSMC5;PSME2;PSME3
gsea,protein deubiquitination (GO:0016579),0.5648247928520228,2.665302288460833,0.0,0.0,0.0,67/144,27.58%,CCNA2;CDK1;CLSPN;CDC20;USP1;PSMB6;UCHL5;SHMT2;PSMB5;UCHL3;BRCA1;PSMA4;PSMB2;PSMA6;PSMA3;RUVBL1;BARD1;PSMD7;CDC25A;PSMD1;PSMD12;ACTL6A;PSMD2;PSMA5;PSMD3;RAD23A;PSMB7;PSMC4;PSMD6;USP14;VCP;PSMC1;PSMC2;PSMD14;COPS5;PSMD11;PSMC5;PSME2;TOMM20;RAD23B;PSME3;INO80E;ACTB;CCP110;SKP2;USP5;BRCC3;PSMC6;ADRM1;RPS27A;USP10;KAT2A;USP37;HCFC1;ABRAXAS1;FOXK2;OTUD6B;USP34;USP46;TRAF2;USP24;KEAP1;MCRS1;ASXL1;MYC;YY1;USP7
gsea,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.6884110217834171,2.6649794921796746,0.0,0.0,0.0,30/53,21.84%,PSMB6;PSMB5;PSMA4;PSMB2;PSMA6;PSMA3;PSMD7;PSMD1;PSMD12;ELOC;PSMD2;CHEK1;PSMA5;PSMD3;PSMB7;PSMC4;PSMD6;HIGD1A;PSMC1;PSMC2;PSMD14;PSMD11;PSMC5;PSME2;PSME3;PSMC6;EPAS1;RPS27A;GCN1;EGLN1
gsea,peptidyl-lysine modification (GO:0018205),0.659553162260307,2.6629872132994836,0.0,0.0,0.0,30/65,20.35%,NDUFAB1;SAE1;SUMO2;PARK7;NUP107;RANGAP1;NUP85;AAAS;TRIM28;NUP62;UBA2;NDC1;NUP37;NUP43;NUP93;NUP205;GCSH;NUP133;SUMO3;NUP88;NUP155;NUP160;NUP54;NUP35;POM121;RAE1;NUP210;SENP1;RANBP2;NUP188
gsea,G2/M transition of mitotic cell cycle (GO:0000086),0.6654281675077666,2.6614441964627535,0.0,0.0,0.0,58/88,26.07%,CCNA2;CDK1;CCNB2;TUBB4B;CCNB1;HSP90AA1;PLK1;TUBG1;HAUS4;MELK;NEK2;PKMYT1;PLK4;YWHAE;MASTL;HAUS1;CDC25C;CDC25A;HAUS5;AURKA;TUBA4A;CDK2;CKAP5;FOXM1;PCNT;CDC25B;TUBA1A;HAUS6;CDKN1A;HAUS7;NEDD1;NDE1;CCP110;CNTRL;ODF2;SKP2;WEE1;BORA;CEP57;CEP192;CUL1;CHEK2;OPTN;CEP72;CEP70;ALMS1;CEP135;CEP78;HAUS3;DYNC1H1;DCTN1;CEP76;CENPJ;CLASP1;PCM1;CDK5RAP2;ACTR1A;PPP1CB
gsea,import into nucleus (GO:0051170),0.7045295257431486,2.6566081452665125,0.0,0.0,0.0,34/54,20.35%,RAN;SNRPD1;SNRPE;SNRPF;NUTF2;SNRPB;SNRPD3;PHB2;NUP107;IPO5;HNRNPA1;NUP85;NUP62;KPNB1;GEMIN6;CSE1L;NUP93;AKT1;NUP133;HIKESHI;NUP88;NUP155;IPO7;NXT1;GEMIN2;SMN1;IPO9;POM121;GEMIN5;DDX20;TNPO1;IPO11;IPO4;NUP188
gsea,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.7098649931370492,2.6563654698344283,0.0,0.0,0.0,24/48,12.03%,PSMB6;PSMB5;PSMA4;PSMB2;PSMA6;PSMA3;KIF14;PSMD7;PSMD1;PSMD12;PSMD2;CCNF;PSMA5;PSMD3;PSMB7;PSMC4;PSMD6;PSMC1;PSMC2;PSMD14;PSMD11;PSMC5;PSME2;PSME3
gsea,mitochondrial translational elongation (GO:0070125),0.7385062969575529,2.656165249925081,0.0,0.0,0.0,46/52,22.12%,MRPL18;MRPL12;MRPL42;CHCHD1;MRPL28;MRPL17;MRPL13;MRPL51;MRPL20;MRPS28;GADD45GIP1;MRPL15;MRPS7;TSFM;MRPL35;TUFM;MRPS5;MRPS10;MRPL40;MRPL2;MRPS12;MRPS18B;MRPL11;MRPL53;MRPL55;MRPS18A;MRPL39;MRPL37;DAP3;MRPL49;MRPL22;MRPL3;MRPS22;MRPL16;MRPS25;MRPS35;GFM1;MRPL45;MRPL38;MRPS27;MRPS30;MRPS6;MRPS2;MRPL1;PTCD3;MRPL44
gsea,translational termination (GO:0006415),0.7251581165309181,2.655541419095716,0.0,0.0,0.0,46/55,22.12%,MRPL18;MRPL12;MRPL42;GSPT1;CHCHD1;MRPL28;MRPL17;MRPL13;MRPL51;MRPL20;MRPS28;GADD45GIP1;MRPL15;ABCE1;MRPS7;MRPL35;MRPS5;ETF1;MRPS10;MRPL40;MRPL2;MRPS12;MRPS18B;MRPL11;MRPL53;MRPL55;MRPS18A;MRPL39;MRPL37;DAP3;MRPL49;MRPL22;MRPL3;MRPS22;MRPL16;MRPS25;MRPS35;MRPL45;MRPL38;MRPS27;MRPS30;MRPS6;MRPS2;MRPL1;PTCD3;MRPL44
gsea,cell cycle G2/M phase transition (GO:0044839),0.664611821394302,2.6545592944459337,0.0,0.0,0.0,58/88,26.07%,CCNA2;CDK1;CCNB2;TUBB4B;CCNB1;HSP90AA1;PLK1;TUBG1;HAUS4;MELK;NEK2;PKMYT1;PLK4;YWHAE;MASTL;HAUS1;CDC25C;CDC25A;HAUS5;AURKA;TUBA4A;CDK2;CKAP5;FOXM1;PCNT;CDC25B;TUBA1A;HAUS6;CDKN1A;HAUS7;NEDD1;NDE1;CCP110;CNTRL;ODF2;SKP2;WEE1;BORA;CEP57;CEP192;CUL1;CHEK2;OPTN;CEP72;CEP70;ALMS1;CEP135;CEP78;HAUS3;DYNC1H1;DCTN1;CEP76;CENPJ;CLASP1;PCM1;CDK5RAP2;ACTR1A;PPP1CB
gsea,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.7715595520671962,2.6413637581664915,0.0,0.0,0.0,38/54,12.03%,CDK1;AURKB;UBE2C;MAD2L1;UBE2S;FBXO5;CDC20;CCNB1;ANAPC5;PLK1;BUB1B;PSMB6;PSMB5;BUB3;PSMA4;PSMB2;PSMA6;ANAPC15;PSMA3;PSMD7;PSMD1;PSMD12;AURKA;PSMD2;CDK2;PSMA5;PSMD3;PSMB7;PSMC4;PSMD6;FZR1;PSMC1;PSMC2;PSMD14;PSMD11;PSMC5;PSME2;PSME3
gsea,cytoskeleton-dependent cytokinesis (GO:0061640),0.826212748424202,2.63791700046419,0.0,0.0,0.0,15/31,7.40%,STMN1;AURKB;NUSAP1;PLK1;CENPA;CEP55;RACGAP1;CIT;INCENP;KIF20A;KIF23;ECT2;ESPL1;CKAP2;ANLN
gsea,regulation of hematopoietic stem cell differentiation (GO:1902036),0.7509433146691316,2.6378643349688358,0.0,0.0,0.0,23/42,12.03%,PSMB6;PSMB5;PSMA4;PSMB2;PSMA6;PSMA3;PSMD7;PSMD1;PSMD12;PSMD2;MYB;PSMA5;PSMD3;PSMB7;PSMC4;PSMD6;PSMC1;PSMC2;PSMD14;PSMD11;PSMC5;PSME2;PSME3
gsea,regulation of cellular response to stress (GO:0080135),0.6209564384023434,2.637594163943647,0.0,0.0,0.0,41/87,23.68%,HSP90AB1;NPM1;RPA3;HSP90AA1;PTGES3;YWHAE;FKBP4;NUP107;MANF;RPA1;DNAJC2;EIF4G1;NUP85;AAAS;NUP62;NDC1;NUP37;NUP43;RSL1D1;NUP93;NUP205;RPA2;NUP133;HIKESHI;HSPA8;NUP88;NUP155;NUP160;NUP54;NUP35;POM121;RAE1;NUP210;RANBP2;DNAJC7;NUP188;PNPT1;ATR;NUP214;ROCK2;SEH1L
gsea,Fc receptor signaling pathway (GO:0038093),0.629305274467041,2.6344987805177116,0.0,0.0,0.0,22/64,12.03%,PSMB6;PSMB5;PSMA4;PSMB2;PSMA6;PSMA3;PSMD7;PSMD1;PSMD12;PSMD2;PSMA5;PSMD3;PSMB7;PSMC4;PSMD6;PSMC1;PSMC2;PSMD14;PSMD11;PSMC5;PSME2;PSME3
gsea,translational elongation (GO:0006414),0.7104733363289972,2.63122809379588,0.0,0.0,0.0,52/62,22.12%,MRPL18;MRPL12;MRPL42;EEF1G;CHCHD1;MRPL28;MRPL17;MRPL13;MRPL51;MRPL20;MRPS28;GADD45GIP1;MRPL15;MRPS7;TSFM;MRPL35;TUFM;EEF1D;MRPS5;MRPS10;MRPL40;MRPL2;EEF1B2;MRPS12;MRPS18B;MRPL11;RACK1;MRPL53;MRPL55;MRPS18A;MRPL39;MRPL37;DAP3;MRPL49;MRPL22;MRPL3;MRPS22;MRPL16;EEFSEC;MRPS25;MRPS35;GFM1;MRPL45;MRPL38;MRPS27;LTN1;MRPS30;MRPS6;MRPS2;MRPL1;PTCD3;MRPL44
gsea,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.7361099866281807,2.628183756238217,0.0,0.0,0.0,23/43,12.03%,PSMB6;PSMB5;PSMA4;PSMB2;PSMA6;PSMA3;PSMD7;PSMD1;PSMD12;PSMD2;MYB;PSMA5;PSMD3;PSMB7;PSMC4;PSMD6;PSMC1;PSMC2;PSMD14;PSMD11;PSMC5;PSME2;PSME3
gsea,proteasomal protein catabolic process (GO:0010498),0.578789220013327,2.6276776925672003,0.0,0.0,0.0,39/102,21.33%,PSMB6;PRPF19;PSMB5;PSMA4;PSMB2;PSMA6;PSMA3;KIF14;PSMD7;PSMD1;PSMD12;PSMD2;PSMA5;STUB1;PSMD3;RAD23A;RNF126;PSMB7;PSMC4;CDC34;PSMD6;DDB1;VCP;PSMC1;PSMC2;PSMD14;PSMD11;PSMC5;PSME2;RAD23B;PSME3;NSFL1C;SKP2;PSMC6;NEDD4;FAF1;RNF5;MTA1;CCDC47
gsea,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.7832793617942451,2.6270408151596003,0.0,0.0,0.0,23/42,12.03%,PSMB6;PSMB5;PSMA4;PSMB2;PSMA6;PSMA3;PSMD7;PSMD1;PSMD12;PSMD2;PSMA5;PSMD3;PSMB7;PSMC4;PSMD6;PSMC1;PSMC2;PFN1;PSMD14;PSMD11;PSMC5;PSME2;PSME3
gsea,regulation of mRNA catabolic process (GO:0061013),0.6553076271500797,2.6259092138043325,0.0,0.0,0.0,44/75,18.50%,SET;EXOSC8;HNRNPD;PSMB6;SERBP1;PSMB5;PSMA4;PSMB2;PSMA6;PSMA3;EIF4G1;PSMD7;APEX1;EXOSC7;PSMD1;PSMD12;PSMD2;PSMA5;PSMD3;DIS3;PSMB7;EXOSC3;PSMC4;PSMD6;AKT1;PSMC1;XPO1;EXOSC2;PSMC2;PSMD14;EXOSC1;HSPA8;KHSRP;PSMD11;PSMC5;PSME2;PSME3;EXOSC9;EXOSC5;PSMC6;TNPO1;ANP32A;RPS27A;EXOSC4
gsea,negative regulation of Wnt signaling pathway (GO:0030178),0.6207739300275231,2.621030172702107,0.0,0.0,0.0,25/89,12.03%,PSMB6;PSMB5;PSMA4;PSMB2;RUVBL2;PSMA6;HDAC1;PSMA3;PSMD7;PSMD1;PSMD12;PSMD2;PSMA5;PSMD3;PSMB7;PSMC4;PSMD6;PSMC1;PSMC2;PSMD14;PSMD11;PSMC5;PSME2;RACK1;PSME3
gsea,regulation of stem cell differentiation (GO:2000736),0.7287099551141517,2.613190400220619,0.0,0.0,0.0,28/48,17.59%,HNRNPU;PSMB6;PSMB5;PSMA4;PSMB2;PSMA6;PSMA3;PSMD7;NSUN2;PSMD1;PSMD12;PSMD2;MYB;PSMA5;PSMD3;PSMB7;PSMC4;PSMD6;PSMC1;PSMC2;PSMD14;PSMD11;PSMC5;PSME2;PSME3;PSMC6;TCF3;SMYD5
gsea,cellular response to hypoxia (GO:0071456),0.6243917232538977,2.6122903363240644,0.0,0.0,0.0,36/77,19.15%,PSMB6;PSMB5;SUV39H1;PSMA4;PSMB2;PGK1;PSMA6;PSMA3;PSMD7;PSMD1;PSMD12;ELOC;PSMD2;PSMA5;STUB1;PSMD3;P4HB;PSMB7;PSMC4;HP1BP3;PSMD6;HIGD1A;PSMC1;PSMC2;PSMD14;PSMD11;SUV39H2;PSMC5;PSME2;PSME3;FAM162A;PSMC6;EPAS1;HYOU1;RPS27A;UBQLN1
gsea,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.6966132506864154,2.6108809896991456,0.0,0.0,0.0,22/45,16.90%,CCNA2;CCNB2;CCNB1;PLK1;CDC6;CDKN3;PKMYT1;IPO5;CCNE1;CDC25C;CDC25A;BLM;CCNE2;CDKN2A;CCNF;AKT1;GTPBP4;CDKN1A;IPO7;ACTB;BCCIP;CCNG1
gsea,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.698594736818166,2.6108498580916493,0.0,0.0,0.0,35/55,20.29%,FBXO5;CDK4;PSMB6;PSMB5;PSMA4;PSMB2;PSMA6;PSMA3;E2F7;PSMD7;PSMD1;PSMD12;AURKA;PSMD2;CDKN2A;PSMA5;PSMD3;PSMB7;PSMC4;PSMD6;PSMC1;RBL1;PSMC2;PSMD14;CDKN1A;PSMD11;PSMC5;PSME2;PSME3;AVEN;WEE1;PSMC6;BRD7;PINX1;CUL1
gsea,cellular protein metabolic process (GO:0044267),0.595105508810704,2.6102395512671817,0.0,0.0,0.0,80/171,25.03%,UBE2S;RPS17;HSP90B1;RPS2;MRPL18;MRPL42;PDIA6;RPL14;GSPT1;RPS15;RPS25;RPS6;STOML2;RPL31;RPN2;MRPL28;EIF4G1;UBE2M;RPL41;RPN1;RPL4;MRPL13;MRPL51;RPS8;FDX1;RPS18;RPL5;P4HB;RPL23A;PABPC4;FARSB;MRPS7;CDC34;MRPL35;ABCF1;MRPS5;RPL10A;RPL15;ZDHHC2;COPS5;MRPS12;MRPS18B;RPSA;MRPL11;HTRA2;RPLP0;SPCS3;RPS26;SPP1;MRPL55;RPL8;MRPS18A;PRKCSH;MRPL37;FDX2;SEPHS1;MRPL3;RPL10;RSL24D1;RABGGTB;RRBP1;RPL3;RPS27A;RPLP1;SERP1;RNF5;PARL;CHEK2;YARS2;MRPS6;ADPRH;SPG7;ATP23;RPL13;HBS1L;CALU;SRBD1;CST3;PRKDC;UBA3
gsea,translation (GO:0006412),0.6748490183386732,2.603722744808628,0.0,0.0,0.0,76/102,24.22%,RPS17;RPS2;MRPL18;PPA1;MRPL42;RPL14;EEF1G;GSPT1;RPS15;RPS25;RPS6;RPL31;MRPL28;EIF4G1;RPL41;RPL4;MRPL13;MRPL51;RPS8;RPL22L1;RPS18;RPL5;MRPS28;RPL23A;AIMP2;ABCE1;PABPC4;FARSB;MRPS7;TSFM;EEF1E1;MRPL35;TUFM;EEF1D;ABCF1;MRPS5;ETF1;RPL10A;RPL15;MRPL2;EEF1B2;COPS5;MRPS12;MRPS18B;RPSA;MRPL11;RPLP0;RPS26;MRPL55;RPL8;MRPS18A;NOA1;FARSA;MRPL37;DRG1;MRPL3;MRPL16;RPL10;RSL24D1;EEFSEC;RRBP1;RPL3;RPS27A;RPLP1;PPA2;DRG2;YARS2;MRPS6;SARS2;MRPS2;PTCD3;RPL13;HBS1L;DARS2;SRBD1;RARS2
gsea,regulation of translation (GO:0006417),0.6096343906016138,2.6021178699453893,0.0,0.0,0.0,68/115,29.91%,TYMS;YBX1;RPS27L;NCL;NPM1;HNRNPD;DHFR;GAPDH;NOLC1;SHMT1;SHMT2;EIF3B;GSPT1;EIF4A3;EIF3C;CALR;EIF4G1;DHX9;MRPL13;SYNCRIP;EIF6;DDX1;TCOF1;RPL5;CAPRIN1;EIF4H;TSFM;EIF5B;ETF1;TRAP1;EIF3D;EIF4E;RACK1;PASK;NCBP2;PUM3;GLE1;LARP4;NCBP1;RPL10;LARP1;GEMIN5;EIF4G2;EIF4B;EIF5;CNOT9;LARP4B;ILF3;PUS7;GZMB;LTN1;NSUN5;MTG1;CNOT1;CNOT10;FMR1;PRKDC;METAP1;METTL5;NAT10;EIF2A;PYM1;FXR2;ZCCHC4;EIF2B4;MTOR;DDX3X;MIF4GD
gsea,Fc-epsilon receptor signaling pathway (GO:0038095),0.6230235136147825,2.601698025047535,0.0,0.0,0.0,22/64,12.03%,PSMB6;PSMB5;PSMA4;PSMB2;PSMA6;PSMA3;PSMD7;PSMD1;PSMD12;PSMD2;PSMA5;PSMD3;PSMB7;PSMC4;PSMD6;PSMC1;PSMC2;PSMD14;PSMD11;PSMC5;PSME2;PSME3
gsea,chromatin organization (GO:0006325),0.6179919807478652,2.601177077095832,0.0,0.0,0.0,40/90,23.01%,HMGB2;HMGN2;NUCKS1;NPM1;EZH2;RBBP4;HIRIP3;NPM3;CBX3;SUV39H1;NUDT5;SMARCC1;RUVBL2;BAZ1B;HDAC1;RUVBL1;ACTL6A;MYB;HDAC2;SMARCA5;HP1BP3;HMGN1;PIH1D1;SMARCA4;SUV39H2;SMARCB1;TADA2A;ATRX;TAF6L;KAT2A;PHF19;PBRM1;MTF2;LRWD1;MTA2;SAFB;SMARCC2;SETDB1;HCFC1;CHD1L
gsea,mitochondrial translational termination (GO:0070126),0.7275408756664884,2.600981742654766,0.0,0.0,0.0,43/50,22.12%,MRPL18;MRPL12;MRPL42;CHCHD1;MRPL28;MRPL17;MRPL13;MRPL51;MRPL20;MRPS28;GADD45GIP1;MRPL15;MRPS7;MRPL35;MRPS5;MRPS10;MRPL40;MRPL2;MRPS12;MRPS18B;MRPL11;MRPL53;MRPL55;MRPS18A;MRPL39;MRPL37;DAP3;MRPL49;MRPL22;MRPL3;MRPS22;MRPL16;MRPS25;MRPS35;MRPL45;MRPL38;MRPS27;MRPS30;MRPS6;MRPS2;MRPL1;PTCD3;MRPL44
gsea,nucleotide-excision repair (GO:0006289),0.660923297412173,2.600135970444915,0.0,0.0,0.0,33/72,13.73%,LIG1;RFC4;RFC5;PCNA;RPA3;BRIP1;POLA1;POLE;RFC2;PRPF19;POLD1;POLR2F;POLD2;PARP1;RPA1;RFC3;BRCA2;RFC1;POLR2L;POLR2C;PPIE;RAD23A;COPS3;HMGN1;RPA2;POLD3;DDB1;COPS5;RAD23B;GPS1;COPS4;POLR2E;POLR2H
gsea,protein modification by small protein removal (GO:0070646),0.5518983592658556,2.599857665635445,0.0,0.0,0.0,73/152,27.58%,CCNA2;CDK1;CLSPN;CDC20;USP1;PSMB6;UCHL5;PSMB5;UCHL3;BRCA1;PSMA4;PSMB2;PSMA6;PSMA3;RUVBL1;BARD1;PSMD7;CDC25A;PSMD1;PSMD12;ACTL6A;PSMD2;PSMA5;PSMD3;RAD23A;COPS3;PSMB7;PSMC4;PSMD6;USP14;VCP;PSMC1;PSMC2;PSMD14;COPS5;PSMD11;PSMC5;PSME2;TOMM20;RAD23B;PSME3;GPS1;INO80E;COPS4;ACTB;CCP110;SKP2;USP5;BRCC3;PSMC6;ADRM1;RPS27A;USP10;KAT2A;SENP1;COPS7A;USP37;DESI1;HCFC1;ABRAXAS1;FOXK2;OTUD6B;USP34;USP46;TRAF2;USP24;KEAP1;MCRS1;ASXL1;MYC;COPS2;YY1;USP7
gsea,regulation of cellular ketone metabolic process (GO:0010565),0.7993128325839348,2.5997911225385906,0.0,0.0,0.0,23/32,12.03%,PSMB6;PSMB5;PSMA4;PSMB2;PSMA6;ODC1;PSMA3;PSMD7;PSMD1;PSMD12;PSMD2;PSMA5;PSMD3;PSMB7;PSMC4;PSMD6;PSMC1;PSMC2;PSMD14;PSMD11;PSMC5;PSME2;PSME3
gsea,regulation of cellular amino acid metabolic process (GO:0006521),0.832136090049977,2.599385961872954,0.0,0.0,0.0,24/29,12.03%,PSMB6;PSMB5;PSMA4;PSMB2;PSMA6;ODC1;PSMA3;PSMD7;PSMD1;PSMD12;PSMD2;PSMA5;PSMD3;PSMB7;PSMC4;PSMD6;BCKDK;PSMC1;PSMC2;PSMD14;PSMD11;PSMC5;PSME2;PSME3
gsea,base-excision repair (GO:0006284),0.7783497538376691,2.599251347495582,0.0,0.0,0.0,22/37,13.55%,LIG1;RFC4;RFC5;FEN1;PCNA;RPA3;POLE;RFC2;POLD1;NEIL3;POLD2;PARP1;RPA1;RFC3;RFC1;APEX1;RPA2;POLD3;UNG;DNA2;POLQ;MBD4
gsea,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.729470499729838,-2.5986062947025794,0.0,0.0,0.0,15/32,12.19%,CCL5;CLCF1;TNFRSF18;SOCS1;TNF;STAT3;PARP14;CD40;IFNG;INPP5F;LYN;CSF1R;IL2;CSF2;TNFRSF1A
gsea,regulation of protein serine/threonine kinase activity (GO:0071900),0.6729777233827793,2.5969050885204314,0.0,0.0,0.0,23/59,18.13%,CCNA2;CCNB2;CCNB1;EZH2;CDC6;INCENP;CDKN3;PKMYT1;CCNE1;CDC25C;CDC25A;BLM;CCNE2;CCNF;PIH1D1;AKT1;GTPBP4;CDKN1A;ACTB;BCCIP;CALM2;CCNG1;ETAA1
gsea,pre-replicative complex assembly (GO:0036388),0.8149200627527187,2.5946107499987967,0.0,0.0,0.0,35/42,12.03%,MCM3;MCM5;GMNN;MCM7;ORC6;MCM4;MCM6;CDC6;MCM2;PSMB6;PSMB5;PSMA4;PSMB2;PSMA6;PSMA3;PSMD7;PSMD1;PSMD12;PSMD2;PSMA5;PSMD3;MCM8;ORC1;PSMB7;PSMC4;PSMD6;CDT1;PSMC1;PSMC2;PSMD14;ORC2;PSMD11;PSMC5;PSME2;PSME3
gsea,DNA synthesis involved in DNA repair (GO:0000731),0.743523522403624,2.5924840948879404,0.0,0.0,0.0,17/35,10.04%,PCLAF;RFC4;RFC5;PCNA;RPA3;POLA1;DTL;POLE;RFC2;POLD1;POLD2;RPA1;RFC3;RFC1;RPA2;POLD3;VCP
gsea,regulation of apoptotic process (GO:0042981),0.49922863713677224,2.5884592984246577,0.0,0.0,0.0,98/379,20.18%,BIRC5;PTMA;TOP2A;CDK1;PPIA;HMGB1;ANP32B;PA2G4;MAD2L1;MIF;ANP32E;NPM1;NME1;HSP90AA1;PLK1;C1QBP;HSP90B1;HSPD1;NME2;MELK;TFRC;FIGNL1;PHB2;PARK7;HSPA9;PHB;RNPS1;RPS6;ECT2;VDAC1;E2F1;HDAC1;CALR;KIF14;STIL;NUP62;PPID;BARD1;RSL1D1;APEX1;CFL1;ASNS;PRELID1;HDAC2;FXN;ARHGDIA;TARDBP;CASP3;HMGN5;HNRNPK;MTCH2;EEF1E1;HIGD1A;ACTN4;AKT1;VCP;BAX;MYDGF;ATAD3A;PPIF;CD74;COPS5;RACK1;BCLAF1;HTRA2;RRP1B;FAM162A;DHCR24;HAX1;NAA15;UTP11;AIFM1;AVEN;RPL10;SIGMAR1;NAE1;CCAR1;SKP2;API5;RBM25;MTDH;RABGGTB;DDX42;DDX20;APIP;PRDX3;BAK1;ARL6IP1;ANP32A;RPS27A;THOC6;NET1;FAF1;DNAJA3;SHQ1;TFAP4;HSPA5;FLNA
gsea,regulation of intracellular signal transduction (GO:1902531),0.5156258286564953,2.586414391058929,0.0,0.0,0.0,76/234,26.40%,CDK1;TPX2;AURKB;RBBP7;RFC4;RFC5;RPA3;SSRP1;RACGAP1;BRIP1;RBBP4;RFC2;RMI2;BRCA1;TOPBP1;ECT2;EXO1;RPA1;RFC3;HDAC1;PIN1;FAM83D;BARD1;NOC2L;ARHGAP11A;BLM;AURKA;RAD50;CHEK1;MBD3;HDAC2;CDK2;ARHGDIA;RPL5;KMT5A;DDIT4;PRMT5;RPA2;SMYD2;ARHGAP19;AKT1;DEPDC1B;DNA2;TAF15;RBBP8;RPF2;TAF6;NOP2;NBN;EZR;RRS1;BOP1;CCNG1;TAF1;BRD7;PRR5;NET1;MTA2;PTPMT1;CHEK2;TELO2;PIDD1;CHD4;ARHGDIG;ATR;CSNK2A2;EHMT2;OPTN;RAD1;RHNO1;TOP3A;HUS1;TRAF2;RAD9A;PRKAR2A;TAF3
gsea,non-canonical Wnt signaling pathway (GO:0035567),0.6975844001448721,2.5819326196824037,0.0,0.0,0.0,23/59,12.03%,PSMB6;PSMB5;PSMA4;PSMB2;PSMA6;PSMA3;PSMD7;PSMD1;PSMD12;PSMD2;PSMA5;PSMD3;PSMB7;PSMC4;PSMD6;PSMC1;PSMC2;PFN1;PSMD14;PSMD11;PSMC5;PSME2;PSME3
gsea,double-strand break repair via nonhomologous end joining (GO:0006303),0.7037419873546337,2.581380306714389,0.0,0.0,0.0,20/40,16.20%,HMGB2;HMGB1;POLA1;PRPF19;BRCA1;BARD1;NSD2;RAD50;RIF1;UBE2N;PSMD14;RNF168;POLQ;PAXIP1;XRCC6;SMC5;NBN;XRCC5;BRCC3;UBE2V2
gsea,RNA metabolic process (GO:0016070),0.6500095712525367,2.5799184774499992,0.0,0.0,0.0,59/83,27.16%,HNRNPU;HNRNPA3;HNRNPA2B1;HNRNPD;PCBP1;DDX39B;RNASEH2B;HNRNPF;POLR2F;DKC1;HNRNPA1;LSM8;SNRNP40;EXOSC7;POLR2L;DHX9;SYNCRIP;POLR2C;RNASEH2A;HNRNPC;HNRNPA0;HNRNPK;PTBP1;HNRNPR;HNRNPM;PABPC4;WDR74;NCBP2;POLR2E;POLR2H;CELF2;NCBP1;GTF2F2;TBRG4;POLR2B;PRPF4;MPHOSPH10;SND1;DDX20;HNRNPH1;MTREX;GTF2F1;HNRNPUL1;NUFIP1;PPP1R8;PNPT1;POLR2A;MRPL44;DROSHA;NOL9;RNASEH1;DDX54;HNRNPH3;SUPV3L1;RBMX;THOC1;SETX;FASTKD2;PARN
gsea,positive regulation of cell cycle process (GO:0090068),0.7136889796297289,2.577996936945758,0.0,0.0,0.0,30/62,15.14%,RANBP1;AURKB;MAD2L1;NUSAP1;FEN1;CCNB1;CDC6;RACGAP1;CIT;NDC80;KIF23;PLK4;RCC2;KIF20B;RAD21;ECT2;E2F8;SPAG5;KIF14;NUP62;GEN1;E2F7;AURKA;GPSM2;CDC25B;CDC7;DBF4;CEP295;CENPV;NSFL1C
gsea,protein localization to nucleus (GO:0034504),0.6312115992179981,2.5739915259543347,0.0,0.0,0.0,31/69,20.35%,RAN;HNRNPU;PLK1;NUTF2;PHB2;YWHAE;NUP107;IPO5;CALR;NUP85;NUP62;KPNB1;CHCHD10;CSE1L;NUP93;AKT1;NUP133;HIKESHI;NUP88;NUP155;IPO7;RPF2;NXT1;IPO9;RRS1;POM121;TNPO1;IPO11;PINX1;IPO4;NUP188
gsea,protein stabilization (GO:0050821),0.5781709918682431,2.573404628680938,0.0,0.0,0.0,33/99,22.91%,HSP90AB1;TCP1;HSP90AA1;HSPD1;PTGES3;CCT6A;CCT8;GAPDH;CCT3;PHB2;CCT7;CCT5;CCT2;PARK7;PHB;CALR;PIN1;GTSE1;RPL5;CCT4;MCM8;GTPBP4;PFN1;CDKN1A;NAA15;NCLN;TAF1;FLNA;CHEK2;TELO2;ZSWIM7;HCFC1;MT3
gsea,regulation of cell cycle G2/M phase transition (GO:1902749),0.6852079601305947,2.5730578273806133,0.0,0.0,0.0,47/63,25.93%,CDK1;TPX2;CENPF;HMMR;TUBB4B;NPM1;HSP90AA1;PLK1;TUBG1;HAUS4;ATAD5;NEK2;PLK4;YWHAE;KIF14;HAUS1;HAUS5;AURKA;TUBA4A;GTSE1;CDK2;CKAP5;PCNT;TUBA1A;HAUS6;HAUS7;NEDD1;NDE1;CCP110;CNTRL;ODF2;CEP57;CEP192;CEP72;CEP70;ALMS1;CEP135;CEP78;HAUS3;DYNC1H1;DCTN1;CEP76;CENPJ;CLASP1;PCM1;CDK5RAP2;ACTR1A
gsea,post-translational protein modification (GO:0043687),0.560036588588899,2.5727327078545597,0.0,0.0,0.0,49/168,17.07%,RBBP7;ESCO2;HSP90B1;PSMB6;DTL;PDIA6;PSMB5;UCHL3;LRR1;DSCC1;PSMA4;PSMB2;PSMA6;PSMA3;UBE2M;PSMD7;PSMD1;PSMD12;ELOC;PSMD2;CCNF;PSMA5;PSMD3;P4HB;COPS3;PSMB7;PSMC4;PSMD6;DDB1;PSMC1;PSMC2;PSMD14;COPS5;WDR5;PSMD11;PSMC5;PSME2;PSME3;GPS1;SPP1;COPS4;PRKCSH;STT3A;NAE1;SKP2;STT3B;RABGGTB;PSMC6;EPAS1
gsea,positive regulation of cell-cell adhesion (GO:0022409),-0.777030593353492,-2.5688653010101623,0.0,0.0,0.0,9/22,8.65%,CCL5;CD44;IL1B;ADAM19;TNF;SMAD7;FLOT1;CITED2;GCNT2
gsea,mitochondrion organization (GO:0007005),0.5882215009696385,2.5688107344264015,0.0,0.0,0.0,56/102,28.28%,CYCS;HSPD1;PHB2;TIMM23;MTFR2;PARK7;PHB;PARP1;TIMM50;STOML2;TOMM40;TIMM17A;TIMM13;CHCHD10;HIGD1A;TOMM5;BAX;ATAD3A;SAMM50;LONP1;TOMM20;CHCHD4;TFAM;MTX2;TIMM8B;MTX1;HAX1;PITRM1;AIFM1;PRDX3;TIMM9;TMEM70;TIMM10;NRF1;DNAJA3;PNPT1;CLUH;PTCD2;SPG7;HCFC1;ATP23;PPRC1;THG1L;MGME1;TFB1M;MSTO1;FANCG;GABPA;SUPV3L1;TIMM44;NDUFS1;NUBPL;BID;OPA1;ALAS1;IMMP2L
gsea,response to UV (GO:0009411),0.6283364239835619,2.568346861333607,0.0,0.0,0.0,22/65,18.34%,PCLAF;AURKB;FEN1;NPM1;PCNA;EIF2S1;USP1;DTL;POLD1;PARP1;RUVBL2;NOC2L;CDC25A;AKT1;MSH2;MSH6;GPX1;BAK1;ZRANB3;TAF1;NEDD4;POLH
gsea,histone modification (GO:0016570),0.633265796484078,2.5635480792280347,0.0,0.0,0.0,32/68,23.86%,CCNA2;AURKB;UHRF1;EZH2;PRMT1;INCENP;PARK7;PHB;RUVBL2;BAZ1B;HDAC1;RUVBL1;HDAC2;CDK2;NAA50;UBE2N;PARP2;TAF6;SGF29;MORF4L2;PRMT7;RBM14;CARM1;TAF6L;KAT2A;MTA2;MTA1;MT3;SIN3A;BRD8;EHMT2;NTMT1
gsea,recombinational repair (GO:0000725),0.675486986942494,2.560397363563317,0.0,0.0,0.0,34/56,21.67%,RAD51;NUCKS1;FEN1;RPA3;RAD51AP1;AUNIP;BRCA1;PARP1;RPA1;BRCA2;GEN1;BLM;RAD50;MMS22L;NSMCE1;MCM8;RAD54B;SFPQ;RPA2;RFWD3;UBE2N;PSMD14;SMC6;POLQ;RBBP8;SMC5;NBN;RECQL4;PALB2;XRCC1;TONSL;RECQL;ZSWIM7;XRCC2
gsea,postreplication repair (GO:0006301),0.7479394003377892,2.558905657108845,0.0,0.0,0.0,24/35,18.54%,PCLAF;RFC4;RFC5;PCNA;RPA3;DTL;RFC2;BRCA1;POLD1;POLD2;RPA1;RFC3;RFC1;RAD18;NSMCE1;RPA2;UBE2N;POLD3;VCP;MSH2;UBE2V2;POLH;RPS27A;USP10
gsea,"regulation of gene expression, epigenetic (GO:0040029)",0.6587430549479333,2.555779883676456,0.0,0.0,0.0,32/52,25.72%,RBBP7;DNMT1;DEK;EZH2;RBBP4;POLR2F;SUZ12;MYBBP1A;BAZ1B;POLR2L;SMARCA5;DDX21;GPX1;CTCF;POLR2E;ACTB;POLR2H;PRMT7;TAF1D;EED;SMYD5;KAT2A;PHF19;MTF2;TDG;MTA1;PPHLN1;POLR1B;POLR1A;GLMN;POLR1C;POLR1E
gsea,T cell receptor signaling pathway (GO:0050852),0.5950505811528234,2.5540085667632155,0.0,0.0,0.0,28/74,16.76%,PSMB6;PSMB5;PSMA4;STOML2;PSMB2;PSMA6;PSMA3;PSMD7;PSMD1;PSMD12;PSMD2;PSMA5;PSMD3;PSMB7;PSMC4;PSMD6;UBE2N;PSMC1;PSMC2;PSMD14;PSMD11;PSMC5;PSME2;PSME3;EIF2B3;EIF2B1;EIF2B5;PSMC6
gsea,mitotic cytokinesis (GO:0000281),0.8185670806391346,2.5533612334696625,0.0,0.0,0.0,14/29,7.40%,STMN1;NUSAP1;PLK1;CENPA;CEP55;RACGAP1;CIT;INCENP;KIF20A;KIF23;ECT2;ESPL1;CKAP2;ANLN
gsea,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.743729234839647,-2.552803222096932,0.0,0.0,0.0,13/27,12.19%,CCL5;CLCF1;TNFRSF18;TNF;STAT3;PARP14;CD40;IFNG;LYN;CSF1R;IL2;CSF2;TNFRSF1A
gsea,mRNA 3'-end processing (GO:0031124),0.6937593924583123,2.5520863169673014,0.0,0.0,0.0,34/51,20.85%,ALYREF;SRSF2;DDX39B;U2AF1;SLBP;RNPS1;SRSF7;SRSF3;EIF4A3;MAGOH;RBM8A;SRSF9;U2AF2;SRRM1;SRSF6;MAGOHB;SARNP;SRSF1;CPSF2;THOC3;SRSF4;NCBP2;CPSF6;NCBP1;GRSF1;CSTF2;CPSF4;CPSF3;LSM11;THOC6;CPSF1;RPRD1B;LEO1;SYMPK
gsea,protein ubiquitination (GO:0016567),0.5201943195296346,2.5494070006103016,0.0,0.0,0.0,87/216,29.92%,UBE2C;UBE2S;UHRF1;PCNA;PLK1;PSMB6;DTL;PRPF19;PSMB5;UCHL3;BRCA1;PSMA4;PSMB2;PSMA6;PSMA3;TRAIP;BARD1;PSMD7;RAD18;PSMD1;PSMD12;ELOC;PSMD2;CCNF;PSMA5;STUB1;UBE2T;PSMD3;RNF126;PSMB7;PSMC4;THOP1;CDC34;RFWD3;PSMD6;UBE2N;DDB1;VCP;PSMC1;PSMC2;PSMD14;PSMD11;PSMC5;PSME2;RNF168;RACK1;PSME3;DCAF15;BLMH;UBA1;TRIM37;UBE2E3;SKP2;CDC16;USP5;UBE2V2;PSMC6;FANCL;EPAS1;TAF1;NEDD4;RPS27A;CUL1;CAND1;LEO1;CDC27;CDC23;CUL4B;PRKDC;FBXL14;FBXO45;TRAF2;TNFAIP1;KEAP1;HUWE1;NFX1;TRIM35;ASB2;BSPRY;USP7;RBBP6;RNF8;TRIM44;UBA6;ERCC8;HLTF;FBXO31
gsea,modification-dependent protein catabolic process (GO:0019941),0.5736152504159759,2.5471364441992006,0.0,0.0,0.0,47/99,27.99%,AURKB;UBE2C;MAD2L1;UBE2S;UHRF1;CDC20;ANAPC5;PLK1;BUB1B;DTL;BUB3;ANAPC15;AURKA;ELOC;STUB1;PSMD3;COPS3;RNF126;CDC34;DDB1;FZR1;PSMC2;PSMD14;PSMD11;LONP1;RNF168;UBA1;PCYOX1L;CDC16;TAF1;NEDD4;ADRM1;RPS27A;UBQLN1;RNF5;ANAPC1;CDC27;CDC23;ANAPC4;FBXL14;HERPUD1;FBXO45;KEAP1;UBQLN4;ASB2;RBBP6;RNF8
gsea,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.7191727097722934,2.5421873218787794,0.0,0.0,0.0,27/41,18.40%,PSMB6;PSMB5;PSMA4;PSMB2;PSMA6;PSMA3;PSMD7;PSMD1;PSMD12;ELOC;PSMD2;PSMA5;PSMD3;PSMB7;PSMC4;PSMD6;HIGD1A;PSMC1;PSMC2;PSMD14;PSMD11;PSMC5;PSME2;PSME3;PSMC6;EPAS1;RPS27A
gsea,protein modification by small protein conjugation (GO:0032446),0.5367296638596439,2.541990500500462,0.0,0.0,0.0,79/180,28.39%,UBE2C;UBE2S;UHRF1;PCNA;PLK1;SAE1;SUMO2;UCHL3;BRCA1;NUP107;RANGAP1;NUP85;AAAS;TRIM28;NUP62;UBA2;UBE2M;NDC1;TRAIP;BARD1;NUP37;NUP43;RAD18;ELOC;CCNF;STUB1;UBE2T;NUP93;NUP205;CDC34;RFWD3;UBE2N;DDB1;VCP;NUP133;SUMO3;NUP88;RNF168;NUP155;RACK1;NUP160;NUP54;DCAF15;UBA1;UBE2E3;NUP35;POM121;NAE1;CDC16;USP5;UBE2V2;EPAS1;RAE1;NEDD4;NUP210;RPS27A;RANBP2;CUL1;NUP188;CAND1;LEO1;CDC27;CDC23;NUP214;SEH1L;CUL4B;PRKDC;UBA3;FBXO45;TNFAIP1;KEAP1;HUWE1;NFX1;TRIM35;ASB2;BSPRY;USP7;RNF8;TRIM44
gsea,protein import into nucleus (GO:0006606),0.6807363565168651,2.5398523677299303,0.0,0.0,0.0,28/47,20.35%,RAN;NUTF2;KPNA2;PHB2;NUP107;IPO5;NUP85;NUP62;KPNB1;CSE1L;NUP93;AKT1;NUP133;HIKESHI;NUP88;NUP155;IPO7;NUP54;NXT1;IPO9;NUP35;POM121;KPNA3;TNPO1;IPO11;RANBP2;IPO4;NUP188
gsea,positive regulation of binding (GO:0051099),0.6940065657510301,2.5388447160712433,0.0,0.0,0.0,9/49,9.78%,STMN1;HMGB2;RAN;HMGB1;GMNN;NME1;PIN1;DHX9;CDT1
gsea,regulation of primary metabolic process (GO:0080090),0.653332068251878,2.5369715115256617,0.0,0.0,0.0,46/71,25.94%,FDPS;PSMB6;PSMB5;PSMA4;PSMB2;IDI1;PSMA6;ODC1;PSMA3;PSMD7;PSMD1;PSMD12;PSMD2;PSMA5;PSMD3;PSMB7;PSMC4;PSMD6;SQLE;PSMC1;PSMC2;PSMD14;HMGCS1;PSMD11;PSMC5;PSME2;PSME3;HMGCR;FASN;FDFT1;SC5D;PSMC6;PMVK;CARM1;SREBF2;NCOR2;DHCR7;SP1;SIN3A;AZIN1;ROCK2;NFYB;ACACA;LDLR;OPA3;NFYC
gsea,mitotic nuclear division (GO:0140014),0.7310117707713725,2.5331403937112182,0.0,0.0,0.0,30/54,13.81%,RAN;CDCA8;TPX2;UBE2C;KIF11;NUSAP1;UBE2S;PLK1;SMC4;SMC1A;TUBG1;KIFC1;NDC80;NCAPG2;KNSTRN;SMC3;KIF18B;SPAG5;AAAS;NUP62;CENPK;KPNB1;ESPL1;SGO1;DSN1;NSL1;MIS12;KIF18A;ZWINT;NDE1
gsea,regulation of cellular response to heat (GO:1900034),0.6531316715577314,2.5326765914098455,0.0,0.0,0.0,35/62,23.68%,HSP90AB1;RPA3;HSP90AA1;PTGES3;YWHAE;FKBP4;NUP107;RPA1;DNAJC2;NUP85;AAAS;NUP62;NDC1;NUP37;NUP43;NUP93;NUP205;RPA2;NUP133;HIKESHI;HSPA8;NUP88;NUP155;NUP160;NUP54;NUP35;POM121;RAE1;NUP210;RANBP2;DNAJC7;NUP188;ATR;NUP214;SEH1L
gsea,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.767507287066528,2.5286576906406015,0.0,0.0,0.0,25/35,12.03%,AURKB;PSMB6;PSMB5;PSMA4;PSMB2;PSMA6;PSMA3;PSMD7;PSMD1;PSMD12;AURKA;PSMD2;CHEK1;PSMA5;PSMD3;PSMB7;PSMC4;PSMD6;PSMC1;PSMC2;PSMD14;PSMD11;PSMC5;PSME2;PSME3
gsea,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.5093629452587103,2.5285241882877734,0.0,0.0,0.0,78/208,31.25%,CCNA2;GMNN;NUCKS1;YBX1;HINT1;FBXO5;ESCO2;EZH2;HNRNPD;MYBL2;NOLC1;NUP107;PHB;DSCC1;E2F1;SMC3;MYBBP1A;CALR;BRCA2;NONO;NSD2;MYB;SRRT;SRSF10;TCOF1;MLF1;PPIE;HMGN5;SFPQ;FUS;PRMT5;HP1BP3;HMGA1;ZNHIT3;EIF4E;PUM3;SAP30;CNBP;NUP35;RPL10;CCAR1;GEMIN5;TCF3;CARM1;MYCBP;ORC3;ATRX;UTP4;TAF6L;PHF19;MTF2;CHEK2;PSPC1;POLR2A;USP37;HCFC1;TCF7;FOXK2;SP1;EHMT2;NFYB;LIN54;MYBL1;KAT7;METAP1;NFYC;EIF2A;NFX1;RBBP6;NFKB2;EIF2B4;NFYA;ANKRD17;GCFC2;FADS1;ORC5;CCAR2;RABL3
gsea,chromatin remodeling (GO:0006338),0.6263896525964431,2.52851381112506,0.0,0.0,0.0,32/70,23.01%,NPM1;RBBP4;NPM3;CBX3;NUDT5;SMARCC1;RUVBL2;BAZ1B;HDAC1;POLE3;RUVBL1;ACTL6A;MYB;HNRNPC;MBD3;HDAC2;SMARCA5;PIH1D1;SMARCA4;SUV39H2;SMARCB1;ACTB;TADA2A;ATRX;TAF6L;KAT2A;PBRM1;MTA2;SMARCC2;CHD4;HCFC1;CHD1L
gsea,nuclear membrane reassembly (GO:0031468),0.7677420360652656,2.528316670895162,0.0,0.0,0.0,24/32,17.15%,RAN;CDK1;CCNB2;BANF1;CCNB1;RCC1;REEP4;NUP107;RANGAP1;NUP85;KPNB1;NDC1;NUP37;NUP43;LBR;NUP93;NUP205;NUP133;NUP155;NUP160;NSFL1C;NUP35;POM121;VRK1
gsea,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.7124755773727369,2.527989510731749,0.0,0.0,0.0,20/40,13.75%,CDK1;UBE2C;FBXO5;CDK4;DLGAP5;CCNB1;ANAPC5;CDCA5;TFDP1;DTL;PHB2;RCC2;EIF4G1;CDC25C;ESPL1;CDC25A;CDC25B;AKT1;CDC7;RDX
gsea,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.6654852256568722,-2.5265835184393515,0.0,0.0,0.0,18/46,9.86%,GNA15;RGS1;S1PR4;ADGRE5;GABBR1;PTGER4;ADGRG1;ADRB2;GLP1R;ADORA2A;CALCA;S1PR1;ADGRG5;CALCB;CXCL9;S1PR2;RAMP1;LPAR3
gsea,regulation of cellular amine metabolic process (GO:0033238),0.830957264386341,2.526201200659407,0.0,0.0,0.0,23/27,12.03%,PSMB6;PSMB5;PSMA4;PSMB2;PSMA6;ODC1;PSMA3;PSMD7;PSMD1;PSMD12;PSMD2;PSMA5;PSMD3;PSMB7;PSMC4;PSMD6;PSMC1;PSMC2;PSMD14;PSMD11;PSMC5;PSME2;PSME3
gsea,regulation of ATP metabolic process (GO:1903578),0.6905377234592017,2.524601373760602,0.0,0.0,0.0,25/38,23.68%,PGAM1;SHMT2;NUP107;NUP85;AAAS;NUP62;NDC1;NUP37;NUP43;EIF6;NUP93;NUP205;NUP133;NUP88;NUP155;NUP160;NUP54;NUP35;POM121;RAE1;NUP210;RANBP2;NUP188;NUP214;SEH1L
gsea,nuclear-transcribed mRNA catabolic process (GO:0000956),0.6531670013663846,2.5211855516297557,0.0,0.0,0.0,42/78,18.63%,RPS17;EXOSC8;RPS2;RPL14;GSPT1;RNPS1;RPS15;RPS25;RPS6;EIF4A3;RPL31;MAGOH;MRTO4;EIF4G1;RBM8A;RPL41;EXOSC7;RPL4;RPS8;ERI1;THRAP3;RPS18;RPL5;RPL23A;MAGOHB;ETF1;RPL10A;RPL15;RPSA;RPLP0;NCBP2;RPS26;RPL8;EXOSC9;EXOSC5;NCBP1;RPL10;RPL3;RPS27A;EXOSC4;RPLP1;CNOT9
gsea,mitochondrial translation (GO:0032543),0.6718127563095904,2.5201935161126205,0.0,0.0,0.0,54/63,27.85%,MRPL18;MRPL12;MRPL42;CHCHD1;MRPL28;MRPL17;MRPL13;MRPL51;MRPL20;MRPS28;GADD45GIP1;MRPL15;MRPS7;TSFM;MRPL35;TUFM;MRPS5;MRPS10;MRPL40;MRPL2;MRPS12;MRPS18B;MRPL11;MRPL53;MRPL55;MRPS18A;NOA1;MRPL39;MRPL37;DAP3;MRPL49;MRPL22;MRPL3;MRPS22;MRPL16;MRPS25;MRPS35;GFM1;MRPL45;MRPL38;MRPS27;MRPS30;MRPS6;MRPS2;MRPL1;PTCD3;MRPL44;RARS2;MRPL19;MRPL50;QRSL1;FASTKD2;MRPL47;IARS2
gsea,histone exchange (GO:0043486),0.8023932672848174,2.5188521357423563,0.0,0.0,0.0,22/32,10.27%,KNL1;RBBP7;CENPW;ANP32E;NPM1;NASP;CENPA;CENPH;CENPM;RBBP4;CENPS;CENPP;MIS18BP1;HJURP;RUVBL1;CENPK;OIP5;SMARCA5;CENPN;CENPU;CENPI;MIS18A
gsea,translesion synthesis (GO:0019985),0.7305000099364234,2.514178260871804,0.0,0.0,0.0,16/33,10.04%,PCLAF;RFC4;RFC5;PCNA;RPA3;DTL;RFC2;POLD1;POLD2;RPA1;RFC3;RFC1;POLE2;RPA2;POLD3;VCP
gsea,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.7094567377801608,2.51375241863663,0.0,0.0,0.0,26/44,15.95%,NCL;HNRNPU;C1QBP;RNPS1;SRSF7;SRSF3;MAGOH;HNRNPA1;DAZAP1;RBM8A;SRSF9;U2AF2;THRAP3;SRSF10;SRSF6;HNRNPK;PTBP1;RBMXL1;SF3B4;SRSF4;MBNL3;METTL16;SMU1;CELF2;NCBP1;RBM25
gsea,regulation of cytokinesis (GO:0032465),0.6905875236089674,2.5129331097145022,0.0,0.0,0.0,22/45,16.72%,AURKB;PRC1;PLK1;CDC6;RACGAP1;CIT;KIF20A;KIF23;PLK4;KIF20B;ECT2;E2F8;KIF14;PIN1;E2F7;AURKA;CDC25B;PRPF40A;CCP110;CENPV;CALM2;PKP4
gsea,spliceosomal complex assembly (GO:0000245),0.7485703461204405,2.5106880199354022,0.0,0.0,0.0,22/29,18.06%,SNRPD1;SNRPE;DDX39B;PRPF19;SRSF9;DDX1;SRSF10;SRSF6;SF3A3;USP39;SRSF1;SCAF11;SF3A2;SF3A1;LUC7L3;TXNL4A;SMN1;CELF2;LUC7L;NCBP1;SNRNP200;SRPK1
gsea,RNA transport (GO:0050658),0.679196403883387,2.5097750775871406,0.0,0.0,0.0,30/53,15.50%,ALYREF;YBX1;SRSF2;HNRNPA2B1;DDX39B;U2AF1;SLBP;RNPS1;SRSF7;SRSF3;EIF4A3;MAGOH;HNRNPA1;RBM8A;NUP62;SRSF9;U2AF2;CKAP5;SRRM1;SRSF6;MAGOHB;SARNP;SRSF1;EIF4E;THOC3;SRSF4;NUP155;NCBP2;NCBP1;POM121
gsea,mitotic nuclear membrane reassembly (GO:0007084),0.772207919461865,2.50754878024904,0.0,0.0,0.0,23/30,17.15%,RAN;CDK1;CCNB2;BANF1;CCNB1;RCC1;REEP4;NUP107;RANGAP1;NUP85;KPNB1;NDC1;NUP37;NUP43;LBR;NUP93;NUP205;NUP133;NUP155;NUP160;NUP35;POM121;VRK1
gsea,mitotic nuclear membrane organization (GO:0101024),0.772207919461865,2.50754878024904,0.0,0.0,0.0,23/30,17.15%,RAN;CDK1;CCNB2;BANF1;CCNB1;RCC1;REEP4;NUP107;RANGAP1;NUP85;KPNB1;NDC1;NUP37;NUP43;LBR;NUP93;NUP205;NUP133;NUP155;NUP160;NUP35;POM121;VRK1
gsea,organelle assembly (GO:0070925),0.5271898304878637,2.5068581199281477,0.0,0.0,0.0,73/166,32.27%,CENPF;CENPE;CENPW;NPM1;DLGAP5;LSM3;CENPA;G3BP1;EIF2S1;HAUS4;NEK2;PLK4;RCC1;NUP62;HAUS1;DYNLL2;HAUS5;ANLN;E2F4;PCNT;TMEM107;SQLE;CEP83;HAUS6;SAC3D1;TUBGCP2;MIS12;ATP2A2;HAUS7;UBAP2L;CFAP298;MRPL22;NSFL1C;CENPT;PRRC2C;CEP89;RBM14;KIF24;GORASP2;POC1B;WDR90;FLII;SCLT1;UBQLN1;TMEM237;FLNA;CORO1A;SSX2IP;HAUS3;DYNC1H1;DHX29;ABCB6;CENPJ;ATXN2L;PCM1;EIF2A;CCDC61;CEP162;DYNC2H1;EXOC4;TMEM138;HAUS2;CEP290;EHD4;DDX3X;CEP19;ACTR2;BICD1;TUBGCP3;OFD1;HAUS8;IFT74;NEK1
gsea,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.6660940523167568,2.506352286400152,0.0,0.0,0.0,18/46,11.40%,CDK1;RPS27L;PCNA;CCNB1;PRMT1;TFDP1;E2F8;E2F1;CDC25C;E2F7;AURKA;GTSE1;E2F4;CDK2;RPA2;RFWD3;BAX;CDKN1A
gsea,NIK/NF-kappaB signaling (GO:0038061),0.7128779672169376,2.5062436669323542,0.0,0.0,0.0,23/42,12.03%,PSMB6;PSMB5;PSMA4;PSMB2;PSMA6;PSMA3;PSMD7;PSMD1;PSMD12;PSMD2;PSMA5;PSMD3;PSMB7;PSMC4;PSMD6;AKT1;PSMC1;PSMC2;PSMD14;PSMD11;PSMC5;PSME2;PSME3
gsea,negative regulation of cell cycle process (GO:0010948),0.7345790222659551,2.5041442511644005,0.0,0.0,0.0,18/41,7.36%,RRM2;AURKB;RAD51;RBBP7;FBXO5;EZH2;TFDP1;RBBP4;CBX5;NEK2;CBX3;BRCA1;E2F8;E2F1;SUZ12;E2F7;ESPL1;CHEK1
gsea,RNA 3'-end processing (GO:0031123),0.692164976101029,2.5034803966440244,0.0,0.0,0.0,30/45,20.96%,ALYREF;SRSF2;DDX39B;U2AF1;RNPS1;SRSF7;SRSF3;EIF4A3;MAGOH;RBM8A;SRSF9;U2AF2;SRRM1;SRSF6;MAGOHB;SARNP;SRSF1;CPSF2;THOC3;SRSF4;NCBP2;NCBP1;CSTF2;CPSF4;CPSF3;THOC6;CPSF1;RPRD1B;SYMPK;PNPT1
gsea,cell cycle G1/S phase transition (GO:0044843),0.6841741409983245,2.502060454533328,0.0,0.0,0.0,19/44,12.20%,CCNA2;CDK4;NASP;CDKN3;POLE;GSPT1;RCC1;E2F1;CCNE1;CDC25A;CCNE2;CDKN2A;CDK2;CDC34;BCAT1;EIF4E;CDKN1A;CDC7;DBF4
gsea,regulation of generation of precursor metabolites and energy (GO:0043467),0.7126977333826532,2.5003209566608775,0.0,0.0,0.0,26/35,23.68%,PGAM1;NUP107;NUP85;AAAS;NUP62;NDC1;NUP37;NUP43;EIF6;NUP93;NUP205;NUP133;NUP88;NUP155;NUP160;NUP54;NOA1;NUP35;POM121;RAE1;NUP210;RANBP2;NUP188;PNPT1;NUP214;SEH1L
gsea,regulation of calcium ion transport (GO:0051924),-0.7730815897322854,-2.4993923890915086,0.0,0.0,0.0,7/23,6.27%,CCL5;ORAI1;BCL2;IL16;CCL4;F2R;CRACR2A
gsea,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.6318215157323985,2.492977242293566,0.0,0.0,0.0,29/54,25.42%,CDK1;RPS27L;PCNA;CCNB1;PRMT1;TFDP1;E2F8;E2F1;CDC25C;E2F7;AURKA;GTSE1;E2F4;FOXM1;BAX;CDKN1A;PAXIP1;NBN;TFDP2;CARM1;ATRX;USP10;CNOT9;TFAP4;CHEK2;PIDD1;CNOT1;CNOT10;NDRG1
gsea,DNA replication initiation (GO:0006270),0.8427561828217156,2.490497879247265,0.0,0.0,0.0,30/34,12.20%,MCM3;MCM5;GMNN;MCM7;ORC6;MCM4;MCM6;RPA3;CDC45;CDC6;MCM2;PRIM1;POLA1;POLE;PRIM2;TOPBP1;MCM10;RPA1;POLE3;CDK2;POLE2;MCM8;ORC1;POLA2;CDC34;RPA2;CDT1;ORC2;CDC7;DBF4
gsea,centromere complex assembly (GO:0034508),0.8172176659768359,2.486578698198294,0.0,0.0,0.0,25/32,10.27%,CENPF;KNL1;RBBP7;HELLS;CENPE;CENPW;NPM1;DLGAP5;NASP;CENPA;CENPH;CENPM;RBBP4;CENPS;CENPP;MIS18BP1;HJURP;RUVBL1;CENPK;OIP5;SMARCA5;CENPN;CENPU;CENPI;MIS18A
gsea,ciliary basal body-plasma membrane docking (GO:0097711),0.6275785373665479,2.48370317363568,0.0,0.0,0.0,42/67,25.93%,CDK1;TUBB4B;HSP90AA1;PLK1;TUBG1;HAUS4;NEK2;PLK4;YWHAE;HAUS1;HAUS5;TUBA4A;CKAP5;PCNT;TUBA1A;CEP83;HAUS6;HAUS7;NEDD1;NDE1;CCP110;CNTRL;ODF2;CEP89;KIF24;SCLT1;CEP57;CEP192;CEP72;CEP70;ALMS1;CEP135;CEP78;HAUS3;DYNC1H1;DCTN1;CEP76;CENPJ;CLASP1;PCM1;CDK5RAP2;ACTR1A
gsea,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.4975491167711016,2.483601611889061,0.0,0.0,0.0,82/277,25.12%,HMGB2;BIRC5;TYMS;SET;PA2G4;CENPF;GMNN;YBX1;NCL;DBI;EZH2;CDC6;DHFR;GAPDH;CBX5;SHMT1;ENO1;PHB2;CBX3;BRCA1;SUV39H1;PHB;EIF4A3;E2F1;MYBBP1A;HDAC1;CALR;TIMELESS;TRIM28;NONO;MRPL13;SYNCRIP;MYB;CDKN2A;HDAC2;FOXM1;CAPRIN1;KMT5A;SFPQ;HMGA1;GTPBP4;SMARCA4;TNFSF4;HSPA8;CDKN1A;SUV39H2;RACK1;BCLAF1;TNFRSF4;PASK;CTCF;PDS5A;XRCC6;XRCC5;LARP1;TFDP2;EED;BRD7;CNOT9;SAMD1;TFAP4;ILF3;L3MBTL2;PUS7;PHF10;GZMB;PSPC1;SMARCC2;CBY1;NCOR2;ATR;FOXK2;MT3;SIN3A;TLE5;ZC3H8;CNOT1;CNOT10;FMR1;KAT7;PCGF6;BCL7A
gsea,cellular response to interleukin-12 (GO:0071349),0.7543127588730034,2.4802784031139593,0.0,0.0,0.0,16/28,13.18%,PPIA;MIF;LMNB1;TCP1;HNRNPA2B1;SNRPA1;HNRNPF;HSPA9;CFL1;HNRNPDL;P4HB;GSTO1;MTAP;PSME2;RPLP0;LCP1
gsea,interleukin-1-mediated signaling pathway (GO:0070498),0.665772110136069,2.4796015479738425,0.0,0.0,0.0,23/48,12.03%,PSMB6;PSMB5;PSMA4;PSMB2;PSMA6;PSMA3;PSMD7;PSMD1;PSMD12;PSMD2;PSMA5;PSMD3;PSMB7;PSMC4;PSMD6;UBE2N;PSMC1;PSMC2;PSMD14;PSMD11;PSMC5;PSME2;PSME3
gsea,protein sumoylation (GO:0016925),0.72977732354864,2.4791415834624675,0.0,0.0,0.0,26/36,20.35%,SAE1;SUMO2;NUP107;RANGAP1;NUP85;AAAS;TRIM28;NUP62;UBA2;NDC1;NUP37;NUP43;NUP93;NUP205;NUP133;SUMO3;NUP88;NUP155;NUP160;NUP54;NUP35;POM121;RAE1;NUP210;RANBP2;NUP188
gsea,nuclear export (GO:0051168),0.6636012961301242,2.4784712780256664,0.0,0.0,0.0,41/59,23.80%,RAN;ALYREF;SRSF2;NUTF2;DDX39B;U2AF1;RNPS1;SRSF7;SRSF3;EIF4A3;MAGOH;HNRNPA1;CALR;RBM8A;NUP62;SRSF9;U2AF2;SRRM1;CSE1L;SRSF6;MAGOHB;SARNP;ANKLE1;SRSF1;XPO1;EIF4E;THOC3;SRSF4;NUP155;NCBP2;NCBP1;POM121;RAE1;THOC6;NUP188;XPO4;DESI1;THOC5;LSG1;NUP214;CCHCR1
gsea,regulation of gene silencing by RNA (GO:0060966),0.7094826423809902,2.4781849709115558,0.0,0.0,0.0,31/38,24.74%,POLR2F;NUP107;EIF4G1;NUP85;AAAS;NUP62;NDC1;NUP37;NUP43;POLR2L;POLR2C;NUP93;NUP205;NUP133;NUP88;NUP155;NUP160;NUP54;POLR2E;POLR2H;NUP35;POM121;POLR2B;RAE1;NUP210;RANBP2;NUP188;POLR2A;NUP214;SEH1L;FMR1
gsea,regulation of posttranscriptional gene silencing (GO:0060147),0.7094826423809902,2.4781849709115558,0.0,0.0,0.0,31/38,24.74%,POLR2F;NUP107;EIF4G1;NUP85;AAAS;NUP62;NDC1;NUP37;NUP43;POLR2L;POLR2C;NUP93;NUP205;NUP133;NUP88;NUP155;NUP160;NUP54;POLR2E;POLR2H;NUP35;POM121;POLR2B;RAE1;NUP210;RANBP2;NUP188;POLR2A;NUP214;SEH1L;FMR1
gsea,"transcription, DNA-templated (GO:0006351)",0.5373087141490928,2.4682860620883584,0.0,0.0,0.0,61/124,28.82%,PTMA;DEK;SSRP1;PMF1;TRIP13;TFDP1;MRPL12;POLR2F;RNPS1;PARP1;E2F1;POLR3K;POLR2L;ELOC;POLR2C;SMARCA5;MLF1;PRMT5;GTF3A;PPP5C;NELFE;DDX21;TAF15;TFAM;TTF2;NCBP2;TAF6;POLR3H;POLR2E;POLR2H;SMN1;NELFCD;DRG1;NCBP1;GTF2F2;POLR2B;GTF2E2;TAF1;GTF3C5;MED4;PWP1;GTF2F1;IVNS1ABP;UBTF;IWS1;LEO1;POLR2A;GTF2H4;GTF3C2;POLR1C;BTF3;RBMX;TAF3;COPS2;SETX;NFX1;GTF2H3;HSF1;GTF2H1;NFYA;GTF2H2
gsea,regulation of carbohydrate catabolic process (GO:0043470),0.7318980053226684,2.467829390851153,0.0,0.0,0.0,24/30,23.68%,PGAM1;NUP107;NUP85;AAAS;NUP62;NDC1;NUP37;NUP43;EIF6;NUP93;NUP205;NUP133;NUP88;NUP155;NUP160;NUP54;NUP35;POM121;RAE1;NUP210;RANBP2;NUP188;NUP214;SEH1L
gsea,negative regulation of programmed cell death (GO:0043069),0.5192182157761268,2.4677123448175333,0.0,0.0,0.0,51/188,18.48%,BIRC5;PTMA;CDK1;PA2G4;MAD2L1;MIF;NPM1;PLK1;HSP90B1;HSPD1;NME2;TFRC;FIGNL1;PHB2;PARK7;HSPA9;VDAC1;HDAC1;KIF14;STIL;NUP62;BARD1;CFL1;ASNS;PRELID1;HDAC2;FXN;ARHGDIA;CASP3;HMGN5;HNRNPK;HIGD1A;AKT1;MYDGF;ATAD3A;PPIF;CD74;COPS5;PSMC5;DHCR24;HAX1;NAA15;AVEN;RPL10;API5;MTDH;APIP;PRDX3;ARL6IP1;RPS27A;THOC6
gsea,interleukin-12-mediated signaling pathway (GO:0035722),0.7605645498491957,2.4643767098956295,0.0,0.0,0.0,16/27,13.18%,PPIA;MIF;LMNB1;TCP1;HNRNPA2B1;SNRPA1;HNRNPF;HSPA9;CFL1;HNRNPDL;P4HB;GSTO1;MTAP;PSME2;RPLP0;LCP1
gsea,CENP-A containing chromatin organization (GO:0061641),0.8333792528196537,2.463427143809067,0.0,0.0,0.0,21/26,10.27%,KNL1;RBBP7;CENPW;NPM1;NASP;CENPA;CENPH;CENPM;RBBP4;CENPS;CENPP;MIS18BP1;HJURP;RUVBL1;CENPK;OIP5;SMARCA5;CENPN;CENPU;CENPI;MIS18A
gsea,CENP-A containing nucleosome assembly (GO:0034080),0.8333792528196537,2.463427143809067,0.0,0.0,0.0,21/26,10.27%,KNL1;RBBP7;CENPW;NPM1;NASP;CENPA;CENPH;CENPM;RBBP4;CENPS;CENPP;MIS18BP1;HJURP;RUVBL1;CENPK;OIP5;SMARCA5;CENPN;CENPU;CENPI;MIS18A
gsea,DNA replication-independent nucleosome assembly (GO:0006336),0.7959083335873415,2.462076350138974,0.0,0.0,0.0,23/32,10.27%,ASF1B;KNL1;RBBP7;CENPW;NPM1;NASP;CENPA;CENPH;CENPM;RBBP4;CENPS;HAT1;CENPP;MIS18BP1;HJURP;RUVBL1;CENPK;OIP5;SMARCA5;CENPN;CENPU;CENPI;MIS18A
gsea,spliceosomal snRNP assembly (GO:0000387),0.7833911152218486,2.4616811423263187,0.0,0.0,0.0,22/27,16.38%,SNRPD1;LSM2;SNRPE;SNRPF;SNRPB;SNRPD3;PRPF19;GEMIN6;SRSF10;STRAP;PRMT5;CLNS1A;PRPF31;PRPF8;GEMIN2;SART3;SART1;SMN1;WDR77;PRMT7;GEMIN5;DDX20
gsea,protein import (GO:0017038),0.6482921141688103,2.4595372217458875,0.0,0.0,0.0,26/52,20.35%,RAN;HSP90AA1;NUTF2;PHB2;NUP107;IPO5;NUP85;NUP62;KPNB1;CSE1L;HSPA4;NUP93;AKT1;NUP133;HIKESHI;SAMM50;NUP88;NUP155;IPO7;NXT1;IPO9;POM121;TNPO1;IPO11;IPO4;NUP188
gsea,mitotic DNA damage checkpoint signaling (GO:0044773),0.692909596330789,2.457789848914029,0.0,0.0,0.0,18/39,11.40%,CDK1;CLSPN;TIPIN;RPS27L;PLK1;DTL;BRCA1;TOPBP1;BLM;TICRR;CHEK1;EME1;FANCD2;CDK2;RPA2;RFWD3;FZR1;CDKN1A
gsea,nucleosome organization (GO:0034728),0.7182962126591786,2.4531896017629315,0.0,0.0,0.0,19/39,13.88%,HMGB2;ANP32B;SET;NAP1L1;ANP32E;NPM1;NASP;CHAF1A;SMARCC1;POLE3;CHAF1B;SMARCA5;HMGA1;SMARCA4;NAP1L4;GRWD1;SMARCB1;CTCF;SART3
gsea,ncRNA export from nucleus (GO:0097064),0.734888142771862,2.4507401730186,0.0,0.0,0.0,24/31,20.35%,RAN;NPM1;NUP107;NUP85;AAAS;NUP62;SSB;NDC1;NUP37;NUP43;NUP93;NUP205;NUP133;NUP88;NUP155;NCBP2;NUP160;NUP54;NUP35;POM121;RAE1;NUP210;RANBP2;NUP188
gsea,peptide biosynthetic process (GO:0043043),0.7067221567429561,2.449968545434042,0.0,0.0,0.0,46/65,18.62%,RPS17;RPS2;MRPL18;MRPL42;RPL14;GSPT1;RPS15;RPS25;RPS6;RPL31;MRPL28;EIF4G1;RPL41;RPL4;MRPL13;MRPL51;RPS8;RPS18;RPL5;RPL23A;PABPC4;FARSB;MRPS7;MRPL35;ABCF1;MRPS5;RPL10A;RPL15;COPS5;MRPS12;MRPS18B;RPSA;MRPL11;RPLP0;RPS26;MRPL55;RPL8;MRPS18A;MRPL37;MRPL3;RPL10;RSL24D1;RRBP1;RPL3;RPS27A;RPLP1
gsea,regulation of glycolytic process (GO:0006110),0.6651559625226522,2.4493576974798477,0.0,0.0,0.0,24/44,23.68%,PGAM1;NUP107;NUP85;AAAS;NUP62;NDC1;NUP37;NUP43;EIF6;NUP93;NUP205;NUP133;NUP88;NUP155;NUP160;NUP54;NUP35;POM121;RAE1;NUP210;RANBP2;NUP188;NUP214;SEH1L
gsea,regulation of gene silencing by miRNA (GO:0060964),0.6830221321143475,2.4462043433455887,0.0,0.0,0.0,32/43,24.74%,POLR2F;NUP107;EIF4G1;NUP85;AAAS;NUP62;NDC1;NUP37;NUP43;POLR2L;DHX9;POLR2C;NUP93;NUP205;NUP133;NUP88;NUP155;NUP160;NUP54;POLR2E;POLR2H;NUP35;POM121;POLR2B;RAE1;NUP210;RANBP2;NUP188;POLR2A;NUP214;SEH1L;FMR1
gsea,sister chromatid segregation (GO:0000819),0.8275388066992188,2.445754266942325,0.0,0.0,0.0,22/29,13.10%,RAN;TOP2A;CDCA8;NUSAP1;PLK1;SMC4;SMC1A;TUBG1;KIFC1;NDC80;NCAPG2;KNSTRN;KIF18B;SPAG5;CENPK;ESPL1;SGO1;DSN1;NSL1;MIS12;KIF18A;ZWINT
gsea,negative regulation of T cell activation (GO:0050868),-0.7364275701531845,-2.4437119181869704,0.0,0.0,0.0,12/24,8.90%,LGALS3;CD274;CD86;RIPOR2;CEBPB;LAX1;PAG1;TNFAIP8L2;PDCD1LG2;FCGR2B;FOXP3;IL4I1
gsea,telomere maintenance (GO:0000723),0.7001464702400274,2.442504053737104,0.0,0.0,0.0,22/40,15.28%,RAD51;PCNA;RPA3;PTGES3;POLD1;POLD2;PARP1;RPA1;APEX1;BLM;RAD50;RIF1;RPA2;POLD3;DNA2;CTC1;SMC6;XRCC6;SMC5;NBN;RECQL4;XRCC5
gsea,regulation of purine nucleotide metabolic process (GO:1900542),0.7185617557402665,2.4410203759117204,0.0,0.0,0.0,24/31,23.68%,PGAM1;NUP107;NUP85;AAAS;NUP62;NDC1;NUP37;NUP43;EIF6;NUP93;NUP205;NUP133;NUP88;NUP155;NUP160;NUP54;NUP35;POM121;RAE1;NUP210;RANBP2;NUP188;NUP214;SEH1L
gsea,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.7820797060303482,2.440966347708022,0.0,0.0,0.0,27/31,20.29%,PSMB6;PSMB5;PSMA4;PSMB2;PSMA6;PSMA3;PSMD7;PSMD1;PSMD12;AURKA;PSMD2;PSMA5;PSMD3;PSMB7;PSMC4;PSMD6;PSMC1;PSMC2;PSMD14;PSMD11;PSMC5;PSME2;PSME3;AVEN;PSMC6;PINX1;CUL1
gsea,chromatin remodeling at centromere (GO:0031055),0.8209016803093306,2.440099891003818,0.0,0.0,0.0,22/28,10.27%,KNL1;RBBP7;HELLS;CENPW;NPM1;NASP;CENPA;CENPH;CENPM;RBBP4;CENPS;CENPP;MIS18BP1;HJURP;RUVBL1;CENPK;OIP5;SMARCA5;CENPN;CENPU;CENPI;MIS18A
gsea,regulation of mitotic nuclear division (GO:0007088),0.7710913111744322,2.438022487994064,0.0,0.0,0.0,15/31,9.23%,MKI67;NUSAP1;FBXO5;CCNB1;NEK2;PKMYT1;RCC1;KIF20B;ANAPC15;PIN1;NUP62;CDC25C;AURKA;CHEK1;PRMT5
gsea,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.7243971594312917,2.4366083656301987,0.0,0.0,0.0,18/31,16.90%,CCNA2;CCNB2;HSP90AB1;CCNB1;CDC6;CDKN3;PKMYT1;CCNE1;CDC25C;CDC25A;BLM;CCNE2;CCNF;GTPBP4;CDKN1A;ACTB;BCCIP;CCNG1
gsea,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.6163577356401386,2.436375673394898,0.0,0.0,0.0,26/67,12.56%,EIF5A;PSMB6;PSMB5;PSMA4;PSMB2;PSMA6;PSMA3;PSMD7;PSMD1;PSMD12;PSMD2;PSMA5;PSMD3;PSMB7;PSMC4;PSMD6;ACTN4;PSMC1;PSMC2;PSMD14;TNFSF4;PSMD11;PSMC5;PSME2;PSME3;TNFRSF4
gsea,chromosome condensation (GO:0030261),0.8679801153916828,2.434159975982053,0.0,0.0,0.0,17/26,4.74%,TOP2A;SMC2;CDK1;BANF1;SET;NUSAP1;NCAPG;CCNB1;PLK1;SMC4;NCAPD2;CDCA5;NCAPH;INCENP;NCAPG2;NCAPD3;NCAPH2
gsea,ribosomal large subunit biogenesis (GO:0042273),0.751619432733697,2.4302994996762846,0.0,0.0,0.0,38/43,22.14%,NPM1;NHP2;SNU13;RPL14;EBNA1BP2;MRTO4;RSL1D1;NOC2L;NOP16;MRPL20;EIF6;RPL5;RPL23A;BRIX1;RPL10A;GTF3A;WDR12;WDR74;RPLP0;RRP15;RPF2;NOP2;SDAD1;PPAN;NIP7;RRS1;PES1;BOP1;RPL10;RSL24D1;NLE1;MAK16;RPL3;LAS1L;NVL;RPF1;MRPL1;MDN1
gsea,cilium assembly (GO:0060271),0.5255737208155286,2.4297639065455905,0.0,0.0,0.0,69/145,32.27%,CDK1;TUBB4B;HSP90AA1;PLK1;TUBG1;HAUS4;NEK2;PLK4;YWHAE;HAUS1;DYNLL2;HAUS5;TUBA4A;E2F4;CKAP5;PCNT;TMEM107;TUBA1A;CEP83;HAUS6;IFT27;HAUS7;NEDD1;NDE1;CCP110;CFAP298;CNTRL;ODF2;CEP89;KIF24;POC1B;TNPO1;WDR90;SCLT1;CEP57;CEP192;TMEM237;FLNA;SSX2IP;CEP72;CEP70;ALMS1;CEP135;CEP78;HAUS3;IFT57;DYNC1H1;DCTN1;CEP76;CENPJ;CLASP1;PCM1;CDK5RAP2;ACTR1A;CEP162;DYNC2H1;EXOC4;CEP152;TMEM138;HAUS2;CEP290;EHD4;CEP19;ACTR2;C2CD3;OFD1;HAUS8;IFT74;NEK1
gsea,transcription-coupled nucleotide-excision repair (GO:0006283),0.6608390110297423,2.427994791827645,0.0,0.0,0.0,32/53,21.82%,LIG1;RFC4;RFC5;PCNA;RPA3;RFC2;PRPF19;POLD1;POLR2F;POLD2;RPA1;RFC3;RFC1;POLR2L;POLR2C;PPIE;COPS3;HMGN1;RPA2;POLD3;DDB1;COPS5;GPS1;COPS4;POLR2E;POLR2H;POLR2B;XRCC1;RPS27A;COPS7A;POLR2A;GTF2H4
gsea,mitotic metaphase plate congression (GO:0007080),0.7682440481697841,2.4274505559262356,0.0,0.0,0.0,19/30,12.51%,CDCA8;CENPE;NUDC;CCNB1;CEP55;CDCA5;NUF2;KIF22;KIFC1;NDC80;KIF2C;SPDL1;KIF14;NUP62;KPNB1;CDT1;MIS12;MAD1L1;KIF18A
gsea,negative regulation of apoptotic process (GO:0043066),0.4940462453410874,2.424512688107661,0.0,0.0,0.0,76/228,28.11%,BIRC5;PTMA;CDK1;SET;PA2G4;MAD2L1;MIF;NPM1;PLK1;HSP90B1;HSPD1;NME2;TFRC;FIGNL1;PHB2;YWHAE;PARK7;HSPA9;VDAC1;HDAC1;KIF14;STIL;NUP62;BARD1;CFL1;ASNS;PRELID1;HDAC2;FXN;ARHGDIA;CASP3;HMGN5;SFPQ;HNRNPK;MAZ;HIGD1A;AKT1;MYDGF;ATAD3A;PPIF;CD74;MSH2;COPS5;GPX1;DHCR24;HAX1;NAA15;AVEN;RPL10;API5;MTDH;APIP;PRDX3;ARL6IP1;PTRH2;RPS27A;THOC6;HSPA5;FLNA;PIDD1;AATF;MT3;SOD2;NAA35;CSNK2A2;TXNDC5;BHLHB9;PRKDC;NAA16;SUPV3L1;PCID2;MYC;SETX;CDKN2D;BID;OPA1
gsea,chromatin assembly (GO:0031497),0.7631894142270994,2.4230713346912576,0.0,0.0,0.0,14/25,13.88%,HMGB2;ANP32B;NAP1L1;NPM1;RBBP4;CHAF1A;POLE3;NOC2L;CHAF1B;SMARCA5;NAP1L4;GRWD1;CTCF;SART3
gsea,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.7723747768404344,2.422114163762852,0.0,0.0,0.0,8/20,10.29%,UBE2C;UBE2S;CDC20;PLK1;RPS2;PIN1;UBE2N;FZR1
gsea,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.8130830275332386,2.4148825005936536,0.0,0.0,0.0,14/25,9.78%,RRM2;TYMS;FBXO5;PCNA;CDC45;CDC6;DHFR;TFDP1;POLA1;E2F1;CCNE1;E2F7;ORC1;CDT1
gsea,regulation of interleukin-1 beta production (GO:0032651),-0.6938800619581228,-2.413100734511884,0.0,0.0,0.0,19/33,14.15%,TNFAIP3;MALT1;ZC3H12A;EGR1;CX3CR1;TYROBP;TNF;F2R;FOXP1;STAT3;IFNG;SIRPA;APP;NLRP3;F2RL1;MEFV;CD36;CASP1;LPL
gsea,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.6691314285091998,2.413000043075716,0.0,0.0,0.0,19/46,11.23%,RFC4;RFC5;FEN1;PCNA;RPA3;RFC2;POLD1;POLD2;PARP1;RPA1;RFC3;RFC1;RAD50;DDX1;RPA2;POLD3;ANKLE1;DDB1;DNA2
gsea,tRNA transport (GO:0051031),0.7358480241661572,2.4011671354795268,0.0,0.0,0.0,24/30,20.35%,RAN;YBX1;NUP107;NUP85;AAAS;NUP62;SSB;NDC1;NUP37;NUP43;NUP93;NUP205;NUP133;NUP88;TOMM20;NUP155;NUP160;NUP54;NUP35;POM121;RAE1;NUP210;RANBP2;NUP188
gsea,"positive regulation of gene expression, epigenetic (GO:0045815)",0.6737123325544195,2.4009649492418443,0.0,0.0,0.0,23/36,25.72%,DEK;ATAD2;POLR2F;MYBBP1A;BAZ1B;POLR2L;CHEK1;SMARCA5;HMGA1;ELOF1;DDX21;CDCA4;POLR2E;ACTB;POLR2H;TAF1D;KAT2A;ASF1A;POLR1B;ZMIZ2;POLR1A;POLR1C;POLR1E
gsea,"base-excision repair, gap-filling (GO:0006287)",0.7993692549892317,2.397790076610789,0.0,0.0,0.0,18/26,10.86%,LIG1;RFC4;RFC5;FEN1;PCNA;RPA3;POLE;RFC2;POLD1;POLD2;PARP1;RPA1;RFC3;RFC1;APEX1;RPA2;POLD3;UNG
gsea,antigen receptor-mediated signaling pathway (GO:0050851),0.5438926602078229,2.3966337488355016,0.0,0.0,0.0,28/90,16.76%,PSMB6;PSMB5;PSMA4;STOML2;PSMB2;PSMA6;PSMA3;PSMD7;PSMD1;PSMD12;PSMD2;PSMA5;PSMD3;PSMB7;PSMC4;PSMD6;UBE2N;PSMC1;PSMC2;PSMD14;PSMD11;PSMC5;PSME2;PSME3;EIF2B3;EIF2B1;EIF2B5;PSMC6
gsea,"DNA-templated transcription, termination (GO:0006353)",0.655528173269109,2.394010312227237,0.0,0.0,0.0,35/47,28.82%,SNRPE;SNRPF;SNRPB;SNRPD3;POLR2F;SLBP;POLR3K;POLR2L;PRMT5;MAZ;CPSF2;TTF2;NCBP2;POLR2E;POLR2H;SMN1;NCBP1;TAF1D;CSTF2;CPSF4;CPSF3;LSM11;CPSF1;UBTF;SYMPK;POLR2A;GTF2H4;POLR1B;POLR1A;POLR1C;POLR1E;SETX;GTF2H3;GTF2H1;GTF2H2
gsea,negative regulation of DNA recombination (GO:0045910),0.6921623235803175,2.393887496400655,0.0,0.0,0.0,22/31,23.42%,RMI2;POLR2F;PARPBP;BLM;POLR2L;POLR2C;RIF1;SMCHD1;CGAS;MSH2;MSH6;POLQ;POLR2E;POLR2H;POLR2B;ZRANB3;RTEL1;ATRX;TINF2;POLR2A;FANCB;HELB
gsea,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.7319206190461882,2.3929452798314244,0.0,0.0,0.0,33/49,18.62%,RPS17;RPS2;RPL14;GSPT1;RNPS1;RPS15;RPS25;RPS6;EIF4A3;RPL31;MAGOH;EIF4G1;RBM8A;RPL41;RPL4;RPS8;RPS18;RPL5;RPL23A;MAGOHB;ETF1;RPL10A;RPL15;RPSA;RPLP0;NCBP2;RPS26;RPL8;NCBP1;RPL10;RPL3;RPS27A;RPLP1
gsea,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.7294402580402717,2.385731287569719,0.0,0.0,0.0,24/28,23.68%,RAN;NUP107;NUP85;AAAS;NUP62;SSB;NDC1;NUP37;NUP43;NUP93;NUP205;NUP133;NUP88;NUP155;NUP160;NUP54;NUP35;POM121;RAE1;NUP210;RANBP2;NUP188;NUP214;SEH1L
gsea,tRNA export from nucleus (GO:0006409),0.7294402580402717,2.385731287569719,0.0,0.0,0.0,24/28,23.68%,RAN;NUP107;NUP85;AAAS;NUP62;SSB;NDC1;NUP37;NUP43;NUP93;NUP205;NUP133;NUP88;NUP155;NUP160;NUP54;NUP35;POM121;RAE1;NUP210;RANBP2;NUP188;NUP214;SEH1L
gsea,monocyte chemotaxis (GO:0002548),-0.7902271845524791,-2.3850515001007984,0.0,0.0,0.0,11/19,13.09%,CCL5;LGALS3;CCL1;CCL4;ANXA1;FLT1;CALCA;XCL1;CCL2;PDGFB;CCL8
gsea,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.7350586178755025,2.3842247166958392,0.0,0.0,0.0,17/32,11.09%,ALYREF;RAD51;NUCKS1;TIPIN;PCNA;CENPS;POLE;POLD1;TIMELESS;FAM111A;GEN1;TRAIP;BLM;MMS22L;EME1;RFWD3;FANCM
gsea,negative regulation of G0 to G1 transition (GO:0070317),0.7348993459792884,2.38115401529437,0.0,0.0,0.0,18/29,19.75%,RRM2;RAD51;RBBP7;EZH2;TFDP1;RBBP4;CBX5;CBX3;BRCA1;E2F1;SUZ12;CHEK1;CDC7;RBBP8;TFDP2;EED;E2F6;L3MBTL2
gsea,nucleocytoplasmic transport (GO:0006913),0.7140626528091123,2.381139719726531,0.0,0.0,0.0,21/31,18.29%,SNRPD1;NPM1;SNRPE;SNRPF;NUTF2;SNRPB;SNRPD3;HNRNPA1;AAAS;GEMIN6;NUP205;XPO1;NCBP2;NXT1;GEMIN2;SMN1;NCBP1;GEMIN5;DDX20;RSRC1;ANP32A
gsea,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.7681458626992826,2.375587908208238,0.0,0.0,0.0,12/23,8.12%,AURKB;TCP1;HNRNPA2B1;CCT6A;CCT8;CCT3;NEK2;CCT7;CCT5;CCT2;HNRNPA1;CCT4
gsea,cellular response to UV (GO:0034644),0.6315531548914781,2.36922721212749,0.0,0.0,0.0,22/45,27.33%,AURKB;NPM1;PCNA;EIF2S1;POLD1;PARP1;RUVBL2;PPID;NOC2L;CDC25A;CHEK1;DDB1;CDKN1A;BAK1;TAF1;NEDD4;ATR;RHNO1;FMR1;CUL4B;MYC;YY1
gsea,mitotic chromosome condensation (GO:0007076),0.866558032223618,2.3690402814575577,0.0,0.0,0.0,14/22,4.74%,SMC2;CDK1;SET;NUSAP1;NCAPG;CCNB1;PLK1;SMC4;NCAPD2;CDCA5;NCAPH;NCAPG2;NCAPD3;NCAPH2
gsea,spindle assembly (GO:0051225),0.6331036078047163,2.365066539566877,0.0,0.0,0.0,35/46,32.72%,TPX2;KIF11;SMC1A;KIFC1;HAUS4;NEK2;RCC1;SMC3;AAAS;HAUS1;KPNB1;HAUS5;HAUS6;SAC3D1;TUBGCP2;HAUS7;BCCIP;STAG1;NUMA1;CEP192;FLNA;CHEK2;ABRAXAS1;HAUS3;KIF2A;CLASP1;CCDC61;CLASP2;HAUS2;WRAP73;TUBGCP3;OFD1;HAUS8;STAG2;MAP9
gsea,regulation of double-strand break repair via homologous recombination (GO:0010569),0.6731122949639168,2.3609352147043565,0.0,0.0,0.0,14/33,12.26%,RAD51;RAD51AP1;FIGNL1;RMI2;PARP1;PARPBP;TIMELESS;RIF1;CHEK1;SMCHD1;FUS;RPA2;CGAS;POLQ
gsea,regulation of telomere maintenance via telomerase (GO:0032210),0.682199315565042,2.359697899636282,0.0,0.0,0.0,21/34,22.70%,AURKB;TCP1;HNRNPU;CCT6A;CCT8;CCT3;NEK2;CCT7;CCT5;CCT2;HNRNPA1;HNRNPC;CCT4;CTC1;XRCC5;PIF1;PINX1;TINF2;NAF1;EXOSC10;ATR
gsea,replication fork processing (GO:0031297),0.7167408619756357,2.356309791403377,0.0,0.0,0.0,20/29,18.44%,ALYREF;RAD51;NUCKS1;PCNA;CENPS;BRCA2;FAM111A;GEN1;TRAIP;BLM;MMS22L;EME1;RFWD3;FANCM;DNA2;ZGRF1;ZRANB3;ETAA1;RTEL1;ATRX
gsea,establishment of protein localization to organelle (GO:0072594),0.6126269174433636,2.3555508700107644,0.0,0.0,0.0,23/48,20.35%,RAN;NUTF2;PHB2;NUP107;IPO5;NUP85;NUP62;KPNB1;CSE1L;NUP93;AKT1;NUP133;HIKESHI;NUP88;NUP155;IPO7;NXT1;IPO9;POM121;TNPO1;IPO11;IPO4;NUP188
gsea,positive regulation of cellular protein localization (GO:1903829),0.6350655491975766,2.354519905907948,0.0,0.0,0.0,14/39,19.00%,CDK1;HSP90AB1;PLK1;NDC80;TFRC;PARK7;NUP62;GTSE1;CDT1;AKT1;GNL3;CENPQ;NUMA1;RANGRF
gsea,fibroblast growth factor receptor signaling pathway (GO:0008543),0.6977965872681539,2.352961949386164,0.0,0.0,0.0,18/30,21.52%,SHCBP1;HNRNPF;POLR2F;HNRNPA1;POLR2L;POLR2C;PTBP1;HNRNPM;NCBP2;POLR2E;POLR2H;NCBP1;GTF2F2;POLR2B;HNRNPH1;CEP57;GTF2F1;POLR2A
gsea,intracellular protein transport (GO:0006886),0.4865098082204897,2.351833833766965,0.0,0.0,0.0,66/158,34.65%,RAN;NPM1;NUTF2;PHB2;NUP107;IPO5;CALR;NUP85;NUP62;KPNB1;CSE1L;NUP93;ANKLE1;LMAN1;AKT1;NUP133;HIKESHI;TMED2;XPO1;IFT27;CD74;NUP88;NUP155;IPO7;NXT1;IPO9;POM121;ARCN1;TNPO1;VPS35;COX18;RANGRF;COPB2;IPO11;IPO4;NUP188;EIF2D;ADPRH;XPO4;ARL1;DESI1;TBC1D10B;NUP214;CCHCR1;GIPC1;RANBP3;ARFIP2;SIL1;TNPO3;HEATR3;TMED1;XPO6;XPO5;SGSM3;RPAIN;E2F3;XPO7;RABL3;NSF;KATNB1;AP3D1;CLTC;DNAJC27;C2CD5;STRADA;COPA
gsea,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.6393958590076967,2.3512606848472153,0.0,0.0,0.0,13/40,13.27%,CENPE;KIF11;RACGAP1;KIF22;KIF15;KIF2C;KIF23;CANX;DYNLL2;CD74;KIF18A;AP1M1;IFI30
gsea,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.6393958590076967,2.3512606848472153,0.0,0.0,0.0,13/40,13.27%,CENPE;KIF11;RACGAP1;KIF22;KIF15;KIF2C;KIF23;CANX;DYNLL2;CD74;KIF18A;AP1M1;IFI30
gsea,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.647340492425883,2.345416143885859,0.0,0.0,0.0,21/39,24.35%,CDK1;PCNA;CCNB1;PRMT1;TFDP1;E2F8;E2F1;CDC25C;E2F7;AURKA;GTSE1;E2F4;BAX;CDKN1A;TFDP2;CARM1;CNOT9;CHEK2;PIDD1;CNOT1;CNOT10
gsea,mitochondrial transport (GO:0006839),0.6970741216763593,2.3450109714504914,0.0,0.0,0.0,17/29,18.85%,HSP90AA1;SLC25A5;TIMM23;TOMM40;TIMM17A;TIMM13;TOMM5;PPIF;TOMM20;MTX2;TIMM8B;PITRM1;SLC25A13;TIMM9;BAK1;TIMM10;COX18
gsea,negative regulation of cellular amide metabolic process (GO:0034249),0.6275520708285504,2.344761642316271,0.0,0.0,0.0,19/49,19.88%,TYMS;YBX1;NCL;DHFR;GAPDH;SHMT1;EIF4A3;CALR;PIN1;MRPL13;SYNCRIP;CAPRIN1;RACK1;RTN3;LARP1;CNOT9;ILF3;PUS7;GZMB
gsea,telomere maintenance via telomere lengthening (GO:0010833),0.7278976709446469,2.3435493119524065,0.0,0.0,0.0,19/27,21.08%,RAD51;HSP90AB1;HSP90AA1;NHP2;PTGES3;GAR1;DKC1;RPA1;RFC1;RAD50;CDK2;NOP10;CTC1;RTEL1;PIF1;PINX1;SHQ1;TINF2;TELO2
gsea,Ras protein signal transduction (GO:0007265),0.5705779105913188,2.34217329087362,0.0,6.627367732329748e-06,0.001,13/75,11.40%,CCNA2;DNMT1;G3BP1;PARK7;TRIM28;KPNB1;CFL1;CDKN2A;CDK2;ARHGDIA;GPSM2;HRAS;CDKN1A
gsea,interstrand cross-link repair (GO:0036297),0.6517683678590974,2.340056941442878,0.0,6.59751472452646e-06,0.001,23/41,18.40%,RAD51;NUCKS1;RPA3;RAD51AP1;USP1;CENPS;NEIL3;RPA1;EME1;FANCD2;UBE2T;MCM8;RPA2;RFWD3;FANCI;VCP;FANCM;RNF168;MSH6;FANCA;FANCF;FANCL;RPS27A
gsea,mitotic spindle assembly (GO:0090307),0.7050362891803967,2.3380648479755437,0.0,6.567929456703472e-06,0.001,11/31,6.00%,TPX2;AURKB;KIF11;PRC1;SMC1A;RACGAP1;KIFC1;KIF23;SMC3;AAAS;KPNB1
gsea,regulation of DNA replication (GO:0006275),0.6962243736370881,2.3368319343582242,0.0,6.5386083430574736e-06,0.001,16/35,11.24%,CCNA2;GMNN;NUCKS1;FBXO5;ESCO2;PCNA;CDC6;ATAD5;DSCC1;SMC3;BLM;DHX9;CDT1;GTPBP4;DNA2;CTC1
gsea,regulation of G0 to G1 transition (GO:0070316),0.7176210792585307,2.336672764074551,0.0,6.509547861532774e-06,0.001,18/32,19.75%,RRM2;RAD51;RBBP7;EZH2;TFDP1;RBBP4;CBX5;CBX3;BRCA1;E2F1;SUZ12;CHEK1;CDC7;RBBP8;TFDP2;EED;E2F6;L3MBTL2
gsea,positive regulation of telomere maintenance via telomerase (GO:0032212),0.7772843774425635,2.336023054576,0.0,6.480744552410948e-06,0.001,11/21,8.12%,AURKB;TCP1;CCT6A;CCT8;CCT3;NEK2;CCT7;CCT5;CCT2;HNRNPA1;CCT4
gsea,positive regulation of cell population proliferation (GO:0008284),0.5142652177202007,2.335518043491981,0.0,6.452195016937772e-06,0.001,51/205,16.71%,BIRC5;TIPIN;MIF;NAP1L1;FBXO5;CDK4;PRC1;NPM1;NME1;HNRNPU;EZH2;NME2;PRMT1;SLC25A5;PHB;KIF20B;RPS6;SAPCD2;E2F1;HDAC1;CALR;KIF14;DHX9;HDAC2;FXN;CDK2;CDC123;TTK;HMGN5;FOXM1;MAZ;CDC25B;AKT1;COX17;HRAS;CDCA7L;TNFSF4;CD74;CDKN1A;CDC7;SAAL1;SINHCAF;DNAJA2;ASH2L;NOP2;FAM98B;WDR77;CNBP;TBRG4;CCAR1;PRDX3
gsea,small GTPase mediated signal transduction (GO:0007264),0.5942865473221591,2.334248349759968,0.0,6.42389591598629e-06,0.001,9/56,11.40%,CCNA2;DNMT1;G3BP1;PARK7;TRIM28;CDKN2A;CDK2;HRAS;CDKN1A
gsea,regulation of response to DNA damage stimulus (GO:2001020),0.7186763942241737,2.333985551619247,0.0,6.39584396875491e-06,0.001,16/24,19.04%,FBXO5;USP1;NSMCE4A;NSMCE1;WDR76;KMT5A;RPA2;RFWD3;UBE2N;SMYD2;ANKLE1;BCLAF1;UBE2V2;ETAA1;POLH;WRNIP1
gsea,nucleobase-containing small molecule interconversion (GO:0015949),0.8094465801328568,2.3338025538254192,0.0,6.368035951499453e-06,0.001,9/18,7.45%,RRM2;DUT;RRM1;TYMS;NME1;DTYMK;NME2;AK2;AK6
gsea,calcium ion transport (GO:0006816),-0.633556791654038,-2.3291808186799394,0.0,0.0,0.0,15/41,13.31%,CCL5;TPT1;ORAI1;CCR5;ATP2B4;SLC3A2;ORAI2;ATP2A3;RYR1;CRACR2A;ATP2B2;RAMP1;CACNB3;CCL8;TRPV2
gsea,negative regulation of gene expression (GO:0010629),0.5028048468810983,2.3277187403951554,0.0,6.340468696298157e-06,0.001,52/176,24.74%,TYMS;RBBP7;HELLS;YBX1;MIF;LSM2;NCL;DNMT1;EZH2;DHFR;GAPDH;RBBP4;SHMT1;PARK7;EIF4A3;SUZ12;HDAC1;CALR;MRPL13;AURKA;SYNCRIP;TARDBP;CAPRIN1;PTBP1;SLC7A5;RBL1;HRAS;RACK1;RPS26;METTL16;CENPV;LARP1;EED;PTRH2;SMYD5;TAF1;CNOT9;PHF19;SHQ1;MTF2;ILF3;PUS7;GZMB;PNPT1;PPHLN1;NCOR2;SETDB1;TLE5;ROCK2;CNOT1;CNOT10;FMR1
gsea,regulation of protein localization to nucleus (GO:1900180),0.6753913063365198,2.3275394022626243,0.0,6.313139089848595e-06,0.001,8/27,11.13%,CDK1;PLK1;TFRC;PARK7;PIN1;GTSE1;AKT1;SUMO3
gsea,RNA-dependent DNA biosynthetic process (GO:0006278),0.7446946104271407,2.327159317378323,0.0,6.286044072295598e-06,0.001,18/24,21.08%,PPIA;HSP90AB1;HSP90AA1;NHP2;PTGES3;GAR1;DKC1;RPA1;RFC1;RAD50;CDK2;NOP10;RTEL1;PIF1;PINX1;SHQ1;TINF2;TELO2
gsea,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.6318620589615237,2.325849071082012,0.0,6.259180636089206e-06,0.001,13/41,13.27%,CENPE;KIF11;RACGAP1;KIF22;KIF15;KIF2C;KIF23;CANX;DYNLL2;CD74;KIF18A;AP1M1;IFI30
gsea,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.6258310554705767,2.32524067696874,0.0,6.2325458248718055e-06,0.001,16/41,19.34%,CENPE;KIF11;RACGAP1;KIF22;KIF15;KIF2C;KIF23;KDELR2;TMED2;KIF18A;LMAN2;ARCN1;ZW10;ERGIC1;PITPNB;COPB2
gsea,telomere organization (GO:0032200),0.6763017795561732,2.3162284676190064,0.0,1.2412273464787069e-05,0.002,19/35,15.28%,PCNA;RPA3;PTGES3;POLD1;POLD2;PARP1;RPA1;APEX1;BLM;RAD50;RIF1;RPA2;POLD3;DNA2;CTC1;XRCC6;NBN;RECQL4;XRCC5
gsea,positive regulation of cellular process (GO:0048522),0.4842154805986,2.3147979043542954,0.0,1.2359901002910332e-05,0.002,73/277,19.18%,BIRC5;PA2G4;TIPIN;NAP1L1;FBXO5;HSP90AB1;CDK4;PRC1;NPM1;C1QBP;EZH2;CDC6;PRMT1;SLC25A5;LYAR;PHB;KIF20B;RPS6;SAPCD2;HDAC1;SPAG5;CALR;EIF4G1;KIF14;NSMCE4A;RAD18;CHEK1;HDAC2;FXN;CDK2;CDC123;TTK;NSMCE1;HMGN5;FOXM1;P4HB;RAD23A;MAZ;CDC25B;ANKLE1;ACTN4;AKT1;COX17;EXOSC2;HRAS;CDCA7L;TNFSF4;SMC6;BCLAF1;CDC7;HDGFL2;SINHCAF;DNAJA2;ASH2L;NOP2;FAM98B;FASN;EXOSC9;SMC5;LMAN2;WDR77;CNBP;NCBP1;DNPH1;TBRG4;CCAR1;EIF4G2;PRDX3;TPM1;EXOSC4;FAF1;NUMA1;DERL2
gsea,transcription by RNA polymerase II (GO:0006366),0.48414266598948236,2.313837241136142,0.0,1.2307968645755246e-05,0.002,101/172,39.92%,SNRPE;SNRPF;DEK;SSRP1;PMF1;TRIP13;SNRPB;SNRPD3;TFDP1;POLR2F;SLBP;PARP1;HDAC1;POLR2L;ELOC;POLR2C;SRRT;MAZ;INTS11;CPSF2;ELOF1;NELFE;DDX21;TAF15;TTF2;NCBP2;TAF6;POLR2E;POLR2H;NELFCD;E2F2;NCBP1;GTF2F2;POLR2B;GTF2E2;CSTF2;CPSF4;TAF1;CPSF3;LSM11;ELP2;ADRM1;MED4;GTF2F1;CPSF1;INTS7;RPRD1B;IWS1;LEO1;SYMPK;POLR2A;NCOR2;GTF2H4;SP1;INTS10;ZC3H8;BTF3;RBMX;TAF3;PCID2;COPS2;SETX;NFX1;NR2C2AP;GTF2H3;INTS8;ELP4;GTF2H1;NFYA;GTF2H2;MED7;INTS14;E2F3;MED16;INTS1;RNMT;TAF9;GTF2E1;INTS5;INTS3;RPAP1;CDC73;TBP;TBL1X;CSTF3;CTDP1;TAF2;INTS9;ICE2;PKNOX1;MLLT1;INTS2;TAF5;POU2F1;INTS13;MED1;CTR9;INTS4;ERCC3;EAF1;ELOA
gsea,nucleosome assembly (GO:0006334),0.7695237263686531,2.313475416404131,0.0,1.2256470868994765e-05,0.002,14/23,13.88%,HMGB2;ANP32B;ASF1B;NAP1L1;NPM1;NASP;RBBP4;HAT1;CHAF1A;CHAF1B;SMARCA5;NAP1L4;GRWD1;SART3
gsea,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.7629546582830573,2.3125278191397385,0.0,1.2205402240373951e-05,0.002,10/22,6.27%,UBE2C;CENPE;FBXO5;DLGAP5;CCNB1;ANAPC5;PLK1;CDC6;ANAPC15;ESPL1
gsea,regulation of cell population proliferation (GO:0042127),0.46919449890138054,2.3117416355779095,0.0,1.2154757417799787e-05,0.002,77/339,20.57%,HMGB2;BIRC5;TIPIN;NAP1L1;FBXO5;UHRF1;CDK4;PRC1;NPM1;SHCBP1;NME1;EZH2;CDC6;PRMT1;SLC25A5;RBBP4;CDKN3;TFRC;CDCA7;PHB;KIF20B;RPS6;SAPCD2;HDAC1;CALR;KIF14;TIMELESS;NUP62;E2F7;CDKN2A;HDAC2;FXN;CDK2;CDC123;TTK;HMGN5;FOXM1;RNF126;HP1BP3;MAZ;CDC25B;EEF1E1;SMYD2;HMGA1;AKT1;SQLE;GTPBP4;COX17;HRAS;CDCA7L;TNFSF4;CDKN1A;CDC7;SINHCAF;GNL3;DNAJA2;ASH2L;NOP2;CTCF;FAM98B;XRCC6;WDR77;CNBP;UTP20;PDS5B;XRCC5;TBRG4;CCAR1;PRDX3;BRD7;DERL2;DNAJA3;PBRM1;PINX1;TFAP4;RPRD1B;TSPAN31
gsea,cellular response to ionizing radiation (GO:0071479),0.6364249900749002,2.311168635520064,0.0,1.21045311474783e-05,0.002,19/37,25.53%,RAD51;NUCKS1;RAD51AP1;FIGNL1;ECT2;TMEM109;BLM;EEF1D;HRAS;CDKN1A;XRCC6;XRCC5;NET1;INTS7;ATR;RAD1;RHNO1;HUS1;RAD9A
gsea,cellular response to light stimulus (GO:0071482),0.6688686396225373,2.3086959099135105,0.0,1.205471826209773e-05,0.002,9/36,6.41%,AURKB;NPM1;PCNA;EIF2S1;POLD1;PARP1;RUVBL2;NOC2L;CDC25A
gsea,regulation of ubiquitin-protein transferase activity (GO:0051438),0.6727398018287085,2.306012738783347,0.0,1.2005313679056347e-05,0.002,6/23,9.50%,FBXO5;PLK1;RPS2;PARK7;PIN1;UBE2N
gsea,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.8460767404479129,2.306010879592854,0.0,1.1956312398733667e-05,0.002,12/15,12.13%,CDK1;FBXO5;CDK4;NPM1;CCNB1;ATAD5;DTL;RCC2;CDC25C;CDC25A;CDC25B;CDC7
gsea,response to ionizing radiation (GO:0010212),0.5933237768371181,2.3055751606351995,0.0,1.1907709502803856e-05,0.002,27/51,26.62%,RAD51;RAD51AP1;FIGNL1;BRCA1;TOPBP1;ECT2;BLM;TICRR;FANCD2;RFWD3;EEF1D;MSH2;CDKN1A;RNF168;PAXIP1;BRCC3;NET1;MRNIP;INTS7;MTA1;ABRAXAS1;AEN;RAD1;RHNO1;HUS1;RAD9A;MYC
gsea,signal transduction in response to DNA damage (GO:0042770),0.6279514237249593,2.304725840025853,0.0,1.1859500152590074e-05,0.002,21/36,28.77%,CLSPN;BRIP1;PRPF19;E2F1;E2F7;CHEK1;PAXIP1;NBN;ATRX;USP10;INTS7;CHEK2;ATR;RAD1;RHNO1;HUS1;NDRG1;RAD9A;BID;DOT1L;RAD17
gsea,telomere maintenance via telomerase (GO:0007004),0.7378987770080035,2.304003363098954,0.0,1.1811679587458664e-05,0.002,17/23,21.08%,HSP90AB1;HSP90AA1;NHP2;PTGES3;GAR1;DKC1;RPA1;RFC1;RAD50;CDK2;NOP10;RTEL1;PIF1;PINX1;SHQ1;TINF2;TELO2
gsea,cellular component assembly (GO:0022607),0.5320372411567295,2.301891712985626,0.0,1.1764243123252002e-05,0.002,34/110,22.26%,TRIP13;RBBP4;PPIH;CHAF1A;RAD21;KNTC1;SYCE2;PPID;NOC2L;CHCHD10;CHAF1B;CD74;TUBGCP2;NEFH;RTN3;ST13;LCP1;ACTB;NIFK;EZR;KPNA3;GEMIN5;FANCA;CAPZA2;GORASP2;ARL6IP1;ZW10;SPTBN1;TFAP4;TINF2;FLNA;TSPAN4;MDN1;SPG7
gsea,ribonucleoprotein complex biogenesis (GO:0022613),0.6884387482062304,2.301506883511005,0.0,1.1717186150758995e-05,0.002,31/40,24.84%,RPS17;NPM1;RPL14;RPS15;RPS25;EBNA1BP2;RPS6;MRTO4;NOC2L;NOP16;RPL5;EMG1;XPO1;GTF3A;WDR12;WDR74;RPF2;SDAD1;NIP7;RRS1;PES1;BOP1;NOP14;LTV1;SHQ1;NVL;NAF1;BYSL;RIOK2;NOM1;CUL4B
gsea,positive regulation of ATPase activity (GO:0032781),0.7601472361688238,2.2986937418233544,0.0,1.1670504134222105e-05,0.002,10/19,12.63%,UHRF1;HNRNPU;DNAJC9;DYNLL2;DHX9;AHSA1;PFN1;MSH2;MSH6;DNAJB11
gsea,epithelial cell differentiation (GO:0030855),0.6206006195976845,2.2970935673042194,0.0,1.1624192609879954e-05,0.002,14/44,16.75%,CDK1;TAGLN2;PCNA;E2F8;VDAC1;PGK1;HDAC1;E2F7;E2F4;HDAC2;PIH1D1;AKT1;DNPH1;PCK2
gsea,DNA strand elongation involved in DNA replication (GO:0006271),0.9002250732040079,2.2955544870156133,0.0,1.157824718454446e-05,0.002,16/17,9.56%,MCM3;LIG1;MCM7;RFC4;PCNA;MCM4;GINS2;POLA1;POLE;POLD2;RFC3;POLE3;GINS3;GINS4;GINS1;POLD3
gsea,mitotic G2/M transition checkpoint (GO:0044818),0.7003410467518728,2.2952663611538524,0.0,1.1532663534211609e-05,0.002,16/29,16.03%,CDK1;CLSPN;PLK1;CDC6;DTL;BRCA1;TOPBP1;BLM;TICRR;CHEK1;ORC1;FZR1;CDKN1A;NBN;NAE1;BRCC3
gsea,regulation of phosphorylation (GO:0042325),0.5702171470187232,2.2949004118662795,0.0,1.1487437402704895e-05,0.002,35/74,24.91%,MCM7;MIF;PTGES3;PGAM1;NUP107;PIN1;NUP85;AAAS;NUP62;NDC1;BARD1;NUP37;NUP43;EIF6;CDKN2A;NUP93;NUP205;NUP133;CDKN1A;NUP88;NUP155;NUP160;NUP54;NUP35;POM121;CORO1C;RAE1;NUP210;DSCAM;RANBP2;NUP188;PRKRIP1;NUP214;SEH1L;GLMN
gsea,lymphocyte chemotaxis (GO:0048247),-0.6943982497485851,-2.294739728625188,0.0,7.649635231924989e-05,0.002,8/23,13.09%,CCL5;CCL1;PIK3CD;CCL4;XCL1;ADAM8;CCL2;CCL8
gsea,regulation of exit from mitosis (GO:0007096),0.739638512971238,2.294442748600888,0.0,1.1442564600350581e-05,0.002,13/25,7.40%,UBE2C;MAD2L1;UBE2S;CDC20;ANAPC5;CDCA5;BUB1B;PHB2;NEK2;BUB3;KNTC1;ANAPC15;ANLN
gsea,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.6226996725113717,-2.2878471762364367,0.0,0.00010591802628819213,0.003,15/37,9.86%,S1PR4;ADGRE5;PTGER4;ADGRG1;ADRB2;GLP1R;ADORA2A;CALCA;S1PR1;ADGRG5;CALCB;CXCL9;S1PR2;RAMP1;LPAR3
gsea,regulation of DNA recombination (GO:0000018),0.7034449973596979,2.2851047840203957,0.0,1.1398041002683846e-05,0.002,11/24,12.11%,ALYREF;RAD51;RAD51AP1;KPNA2;FIGNL1;BLM;RAD50;CHEK1;RPA2;MSH2;MSH6
gsea,DNA recombination (GO:0006310),0.6821251359514958,2.284261599748079,0.0,1.1353862549185073e-05,0.002,13/32,11.35%,HMGB1;RAD51;HMGB3;RAD21;EXO1;RPA1;GEN1;BLM;RAD50;TSN;RAD54L;RAD54B;MSH2
gsea,protein targeting to mitochondrion (GO:0006626),0.7154929152591925,2.2821388649419783,0.0,1.131002524204536e-05,0.002,20/29,17.50%,HSP90AA1;HSPD1;TIMM23;TIMM50;TOMM40;TIMM17A;TIMM13;HSPA4;TOMM5;SAMM50;GRPEL1;TOMM20;CHCHD4;TIMM8B;PITRM1;AIFM1;PMPCA;TIMM9;TIMM10;PMPCB
gsea,positive regulation of cellular protein metabolic process (GO:0032270),0.5978050526228541,2.279364811718931,0.0,1.1266525144960571e-05,0.002,34/56,29.74%,RPS27L;UHRF1;NPM1;HSP90AA1;PLK1;HNRNPD;EIF4A3;EIF3C;EIF4G1;EIF6;HDAC2;STUB1;RPL5;AKT1;EIF3D;PASK;RDX;EZR;LARP4;BAK1;VPS35;FAF1;LARP4B;NSUN5;FMR1;PRKDC;FADD;METTL5;NAT10;PYM1;FXR2;ZCCHC4;MTOR;DDX3X
gsea,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.8057406625393129,2.2735468638207146,0.0,1.122335838195306e-05,0.002,14/20,9.56%,LIG1;RFC4;RFC5;PCNA;RPA3;POLE;RFC2;POLD1;POLD2;RPA1;RFC3;RFC1;RPA2;POLD3
gsea,negative regulation of nucleic acid-templated transcription (GO:1903507),0.4571113227215755,2.271480582634741,0.0,1.677078170433062e-05,0.003,74/228,32.25%,HMGB2;BIRC5;SET;PA2G4;CENPF;GMNN;EZH2;CBX5;ENO1;PHB2;CBX3;BRCA1;SUV39H1;PHB;E2F1;MYBBP1A;HDAC1;CALR;TIMELESS;TRIM28;NONO;MYB;CDKN2A;HDAC2;FOXM1;KMT5A;SFPQ;HMGA1;SMARCA4;TNFSF4;HSPA8;SUV39H2;BCLAF1;TNFRSF4;CTCF;XRCC6;XRCC5;TFDP2;EED;BRD7;SAMD1;TFAP4;ILF3;L3MBTL2;PHF10;PSPC1;SMARCC2;CBY1;NCOR2;FOXK2;MT3;SIN3A;TLE5;ZC3H8;KAT7;PCGF6;BCL7A;COPS2;SFMBT1;PRDM16;KAT8;DMAP1;KDM8;LBH;RBM15B;GCFC2;BASP1;SETDB2;CCAR2;RIOX1;MEN1;TRERF1;RPS6KA5;PRDM5
gsea,mismatch repair (GO:0006298),0.7237578715999601,2.270738837125621,0.0,1.6707014473515676e-05,0.003,12/24,12.11%,LIG1;PCNA;RPA3;POLD1;POLD2;EXO1;RPA1;RNASEH2A;RPA2;POLD3;MSH2;MSH6
gsea,"DNA-templated transcription, elongation (GO:0006354)",0.6044430540382746,2.270403692996993,0.0,1.6643730327782662e-05,0.003,27/41,28.82%,SSRP1;POLR2F;POLR2L;ELOC;POLR2C;ELOF1;NELFE;NCBP2;POLR2E;POLR2H;NELFCD;NCBP1;GTF2F2;POLR2B;ELP2;ADRM1;GTF2F1;IWS1;LEO1;POLR2A;GTF2H4;POLR1E;PCID2;GTF2H3;ELP4;GTF2H1;GTF2H2
gsea,"nucleotide-excision repair, DNA incision (GO:0033683)",0.703657873866423,2.269160203386783,0.0,1.658092379824386e-05,0.003,14/30,9.84%,RFC4;RFC5;PCNA;RPA3;RFC2;POLD1;POLD2;PARP1;RPA1;RFC3;RFC1;RPA2;POLD3;DDB1
gsea,positive regulation of macromolecule biosynthetic process (GO:0010557),0.5676661122873784,2.2659397216602795,0.0,2.202478599766728e-05,0.004,35/73,31.48%,RPS27L;NPM1;PCNA;HNRNPD;PRMT1;ATAD5;EIF4A3;EIF3C;DHX9;EIF6;RPL5;CDT1;AKT1;EIF3D;DNA2;CTC1;PASK;LARP4;FAF1;LARP4B;NSUN5;FMR1;PRKDC;KAT7;METTL5;NAT10;MYC;PYM1;FXR2;ZCCHC4;MTOR;DDX3X;NAMPT;UPF3B;HSPH1
gsea,positive regulation of DNA metabolic process (GO:0051054),0.6276594886315656,2.265339238007779,0.0,2.1942296162470027e-05,0.004,21/39,27.99%,HMGB1;RAD51;PCNA;BRCA1;TRIM28;DHX9;RAD50;SMCHD1;UBE2N;RNF168;GNL3;NBN;BRCC3;RTEL1;ATRX;ABRAXAS1;APLF;MYC;ZCWPW1;USP7;RNF8
gsea,positive regulation of telomerase activity (GO:0051973),0.7413083300627041,2.261768217852948,0.0,2.1860421923057823e-05,0.004,9/21,8.12%,AURKB;HSP90AB1;TCP1;HSP90AA1;PTGES3;NEK2;CCT2;DKC1;CCT4
gsea,regulation of cell division (GO:0051302),0.6200224379540838,2.260180285012846,0.0,2.1779156414050175e-05,0.004,15/38,17.59%,AURKB;ORC6;PRC1;PLK1;KIF20A;PLK4;KIF18B;PIN1;BLM;AURKA;PRPF40A;RACK1;CCP110;CALM2;SMYD5
gsea,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.7324482376740291,2.2595874030282226,0.0,2.1698492871775915e-05,0.004,13/22,16.03%,CDK1;CLSPN;PLK1;DTL;BRCA1;TOPBP1;BLM;TICRR;CHEK1;FZR1;CDKN1A;NBN;BRCC3
gsea,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.7110180746059273,2.257704404187565,0.0,2.7023030790495833e-05,0.005,14/29,9.84%,RFC4;RFC5;PCNA;RPA3;RFC2;POLD1;POLD2;PARP1;RPA1;RFC3;RFC1;RPA2;POLD3;DDB1
gsea,regulation of RNA splicing (GO:0043484),0.6132841967572047,2.257118221198714,0.0020964360587002098,2.69236814125896e-05,0.005,20/37,21.52%,HNRNPF;SRSF3;SNRNP70;U2AF2;SRSF10;FUS;HNRNPK;PTBP1;RRP1B;RPS26;MBNL3;METTL16;GRSF1;HNRNPH1;SRPK1;LARP7;ZPR1;RBM38;HNRNPLL;POLR2A
gsea,mRNA splice site selection (GO:0006376),0.7334475461868969,2.256340308295436,0.0,2.682505986895374e-05,0.005,11/17,15.10%,PSIP1;SRSF9;SRSF10;SRSF6;SF3A3;SRSF1;SF3A2;SF3A1;LUC7L3;CELF2;LUC7L
gsea,regulation of nucleic acid-templated transcription (GO:1903506),0.46257934565085057,2.254195431117309,0.0,2.672715819059989e-05,0.005,53/177,27.68%,YBX1;HINT1;EZH2;HNRNPD;MYBL2;NUP107;PHB;E2F1;MYBBP1A;CALR;BRCA2;NONO;NSD2;MYB;SRRT;SRSF10;MLF1;PPIE;HMGN5;SFPQ;FUS;PRMT5;HP1BP3;HMGA1;ACTN4;ZNHIT3;SAP30;CNBP;NUP35;CCAR1;TCF3;CARM1;MYCBP;ATRX;UTP4;TAF6L;PHF19;MTF2;CHEK2;PSPC1;POLR2A;HCFC1;TCF7;FOXK2;SP1;NFYB;LIN54;MYBL1;KAT7;NFYC;COPS2;NFX1;NFKB2
gsea,heterochromatin assembly (GO:0031507),0.7601059783508326,2.247840871012975,0.0,3.1955962229342715e-05,0.006,9/15,19.77%,HELLS;SUV39H1;HDAC1;POLE3;CDKN2A;SMCHD1;HMGA1;CENPV;RRP8
gsea,DNA geometric change (GO:0032392),0.7401277108750037,2.244776978467372,0.0,3.1840179757497265e-05,0.006,15/21,20.58%,HMGB2;HMGB1;HNRNPA2B1;HMGB3;BLM;DHX9;RAD50;DDX1;DNA2;NBN;RECQL4;ZRANB3;RTEL1;PIF1;RECQL
gsea,protein localization to chromosome (GO:0034502),0.705037360737418,2.2417738537497285,0.0,3.172523326017778e-05,0.006,15/22,19.67%,PLK1;CENPA;RAD21;RPA1;MCM8;RPA2;MSH2;CTCF;HASPIN;SLF1;XRCC5;ATRX;PINX1;MRNIP;TINF2
gsea,transcription elongation from RNA polymerase II promoter (GO:0006368),0.6023502667121389,2.241368909208658,0.0,3.1611113716076424e-05,0.006,26/40,28.82%,SSRP1;POLR2F;POLR2L;ELOC;POLR2C;ELOF1;NELFE;NCBP2;POLR2E;POLR2H;NELFCD;NCBP1;GTF2F2;POLR2B;ELP2;ADRM1;GTF2F1;IWS1;LEO1;POLR2A;GTF2H4;PCID2;GTF2H3;ELP4;GTF2H1;GTF2H2
gsea,positive regulation of nucleocytoplasmic transport (GO:0046824),0.6419138863080203,2.2408710550634243,0.0,3.1497812233223103e-05,0.006,14/32,21.85%,RAN;ANP32B;YWHAE;ECT2;IPO5;TRIM28;DHX9;GTSE1;NCBP2;CPSF6;NEDD4;FLNA;ZPR1;XPO4
gsea,negative regulation of cellular protein metabolic process (GO:0032269),0.5930394359774328,2.23974242409439,0.0,3.661620672112185e-05,0.007,23/51,24.74%,TYMS;YBX1;NCL;DHFR;GAPDH;SHMT1;EIF4A3;CALR;MRPL13;SYNCRIP;CAPRIN1;SERPINE2;AKT1;RACK1;LARP1;CNOT9;ILF3;PUS7;GZMB;CNOT1;CNOT10;CST3;FMR1
gsea,regulation of DNA metabolic process (GO:0051052),0.6640333764721269,2.2393567346575987,0.0,3.648589993563744e-05,0.007,20/28,26.67%,ALYREF;NUCKS1;HNRNPD;USP1;KPNA2;TICRR;WDR18;UBE2N;CDT1;NBN;XRCC5;UBE2V2;POLH;PIF1;WRNIP1;HELB;YLPM1;KAT7;MYC;THOC1
gsea,nucleic acid-templated transcription (GO:0097659),0.674098852400779,2.2382829511873608,0.0,3.6356517311752194e-05,0.007,14/25,21.52%,PTMA;POLR2F;RNPS1;E2F1;POLR2L;POLR2C;MLF1;PPP5C;POLR2E;POLR2H;DRG1;POLR2B;PWP1;POLR2A
gsea,purine-containing compound biosynthetic process (GO:0072522),0.7691251052722946,2.235435471336753,0.0,4.140348463165722e-05,0.008,12/18,12.37%,SHMT1;SHMT2;MTHFD1;ADSL;DCK;PAICS;GART;PPAT;APRT;GMPS;ADK;PRPS1
gsea,positive regulation of intracellular protein transport (GO:0090316),0.5399810578711952,2.235108117283797,0.0,4.125769771394012e-05,0.008,28/71,29.25%,RAN;ANP32B;TFDP1;SAE1;YWHAE;KIF20B;ECT2;E2F1;IPO5;TRIM28;GTSE1;PCNT;ZDHHC2;HRAS;HTRA2;TFDP2;GZMB;FLNA;ZPR1;NMT1;SREBF2;XPO4;CSNK2A2;PCM1;HUWE1;BID;DMAP1;CEP290
gsea,protein K63-linked ubiquitination (GO:0070534),0.6781624708945418,2.2345351613962956,0.0,4.111293386231226e-05,0.008,12/23,19.17%,UBE2S;PRPF19;STUB1;UBE2T;RNF126;UBE2N;RNF168;UBE2E3;UBE2V2;NEDD4;ZFP91;RNF5
gsea,neutrophil degranulation (GO:0043312),0.4716585851015033,2.23299188744198,0.0,4.0969182345311167e-05,0.008,44/219,15.39%,PPIA;HMGB1;PA2G4;IMPDH2;FABP5;MIF;HSP90AB1;TUBB4B;HSP90AA1;NME2;PGAM1;CCT8;PKM;CCT2;PDAP1;DDOST;KPNB1;PSMD7;GLIPR1;ILF2;PSMD1;PSMD12;PSMD2;PSMA5;APRT;PSMD3;PPIE;PSMB7;ALAD;PSMD6;PRDX4;DSN1;VCP;PSMC2;PSMD14;HSPA8;PSMD11;GUSB;AP1M1;XRCC6;MAGT1;PFKL;XRCC5;MLEC
gsea,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.8296076027160375,2.2324942067367197,0.0,4.0826432581041786e-05,0.008,13/17,8.51%,TCP1;NHP2;CCT6A;CCT8;CCT3;CCT7;CCT5;CCT2;DKC1;RUVBL2;RUVBL1;CCT4;NOP10
gsea,positive regulation of ion transport (GO:0043270),-0.6730544080827982,-2.231794563169747,0.0,0.0003934098119275708,0.012,6/22,7.65%,CCL5;ORAI1;CCL4;F2R;CRACR2A;ACTN2
gsea,regulation of programmed cell death (GO:0043067),0.4958276924914248,2.2308036999773715,0.0,4.068467413457984e-05,0.008,33/101,27.95%,BIRC5;ANP32B;ANP32E;NME1;HSP90AA1;NME2;PHB;CALR;NUP62;RSL1D1;APEX1;PRELID1;TARDBP;ACTN4;AKT1;VCP;BAX;PSMC5;HAX1;NAE1;SKP2;RBM25;RABGGTB;DDX42;ANP32A;DNAJA3;PIDD1;IFT57;TRAF2;NDRG1;LRP8;PTPN6;BID
gsea,neutrophil mediated immunity (GO:0002446),0.4701115356385173,2.227598917478291,0.0,4.0543896715429044e-05,0.008,44/220,15.39%,PPIA;HMGB1;PA2G4;IMPDH2;FABP5;MIF;HSP90AB1;TUBB4B;HSP90AA1;NME2;PGAM1;CCT8;PKM;CCT2;PDAP1;DDOST;KPNB1;PSMD7;GLIPR1;ILF2;PSMD1;PSMD12;PSMD2;PSMA5;APRT;PSMD3;PPIE;PSMB7;ALAD;PSMD6;PRDX4;DSN1;VCP;PSMC2;PSMD14;HSPA8;PSMD11;GUSB;AP1M1;XRCC6;MAGT1;PFKL;XRCC5;MLEC
gsea,regulation of microtubule polymerization or depolymerization (GO:0031110),0.7575157657679658,2.2273316999848083,0.0,4.040409017503101e-05,0.008,5/16,8.39%,STMN1;SKA1;FKBP4;SKA2;SKA3
gsea,regulation of telomerase activity (GO:0051972),0.6740189658442948,2.226572520363222,0.0,4.529840006736724e-05,0.009,9/27,8.12%,AURKB;HSP90AB1;TCP1;HSP90AA1;PTGES3;NEK2;CCT2;DKC1;CCT4
gsea,mRNA stabilization (GO:0048255),0.7306843400590426,2.22564065887653,0.0,4.514326856028721e-05,0.009,12/22,11.92%,YBX1;HNRNPU;E2F1;YBX3;DHX9;SYNCRIP;HNRNPC;THRAP3;HNRNPA0;TARDBP;FUS;TAF15
gsea,neutrophil activation involved in immune response (GO:0002283),0.4701054613561621,2.222234664450152,0.0,4.998799552371584e-05,0.01,44/221,15.39%,PPIA;HMGB1;PA2G4;IMPDH2;FABP5;MIF;HSP90AB1;TUBB4B;HSP90AA1;NME2;PGAM1;CCT8;PKM;CCT2;PDAP1;DDOST;KPNB1;PSMD7;GLIPR1;ILF2;PSMD1;PSMD12;PSMD2;PSMA5;APRT;PSMD3;PPIE;PSMB7;ALAD;PSMD6;PRDX4;DSN1;VCP;PSMC2;PSMD14;HSPA8;PSMD11;GUSB;AP1M1;XRCC6;MAGT1;PFKL;XRCC5;MLEC
gsea,positive regulation of DNA repair (GO:0045739),0.6533112084308468,2.221514657080714,0.0,4.981796832805695e-05,0.01,14/31,17.78%,HMGB1;PCNA;BRCA1;PARP1;TIMELESS;TRIM28;DHX9;SMCHD1;FOXM1;UBE2N;RNF168;SLF1;BRCC3;XRCC1
gsea,negative regulation of B cell activation (GO:0050869),-0.7746195326045306,-2.221070252563168,0.0,0.0004283795729877993,0.014,8/15,8.50%,TNFAIP3;CTLA4;TYROBP;CD300A;TNFRSF13B;FCGR2B;LYN;PARP3
gsea,regulation of cellular component organization (GO:0051128),0.5225466631115089,2.2194796687628635,0.0,5.46140032450631e-05,0.011,17/75,18.76%,MKI67;HSP90AA1;HNRNPU;SSRP1;TMEM97;TFRC;PARK7;HJURP;NUBP1;KIF14;AURKA;ATAD3A;HSPA8;NCLN;NEDD4;URI1;NET1
gsea,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.8226584165355294,2.2193380272751706,0.0,5.44294964773433e-05,0.011,13/17,13.10%,MAD2L1;CENPF;FBXO5;CDC20;PLK1;BUB1;TRIP13;BUB1B;BUB3;KNTC1;TTK;MAD1L1;ZWINT
gsea,termination of RNA polymerase II transcription (GO:0006369),0.7366592839224964,2.2187136259242966,0.0,5.4246232179439786e-05,0.011,16/21,20.85%,SNRPE;SNRPF;SNRPB;SNRPD3;SLBP;MAZ;CPSF2;TTF2;NCBP2;NCBP1;CSTF2;CPSF4;CPSF3;LSM11;CPSF1;SYMPK
gsea,negative regulation of translation (GO:0017148),0.5865940588710676,2.2183708952901937,0.0,5.406419784326717e-05,0.011,22/50,24.74%,TYMS;YBX1;NCL;DHFR;GAPDH;SHMT1;EIF4A3;CALR;MRPL13;SYNCRIP;CAPRIN1;RACK1;METTL16;LARP1;CNOT9;ILF3;PUS7;GZMB;ROCK2;CNOT1;CNOT10;FMR1
gsea,cellular response to heat (GO:0034605),0.7574734097975596,2.2152637128739205,0.0,5.38833811280723e-05,0.011,9/19,13.09%,RBBP7;HSP90AB1;HSP90AA1;YWHAE;STUB1;VCP;HIKESHI;HTRA2;CLPB
gsea,ribosome assembly (GO:0042255),0.7022001417935928,2.213842936545163,0.0,5.370376985764538e-05,0.011,25/32,22.14%,RPS27L;NPM1;C1QBP;RPS15;MRPL20;EIF6;RPL5;RPL23A;BRIX1;MRPS7;RPSA;RPLP0;RPF2;NOP2;PPAN;MRPL22;RRS1;BOP1;RPL10;RSL24D1;NLE1;RPL3;RRP7A;MRPS2;MDN1
gsea,ATP-dependent chromatin remodeling (GO:0043044),0.6633827667619351,2.2127323619644996,0.0,5.3525352017586765e-05,0.011,17/30,22.18%,ANP32E;NASP;RBBP4;SMARCC1;HDAC1;ACTL6A;HNRNPC;MBD3;HDAC2;SMARCA5;SMARCA4;SMARCB1;ACTB;PBRM1;MTA2;SMARCC2;CHD4
gsea,organelle organization (GO:0006996),0.4438393343897032,2.212155520517903,0.0,5.334811575262787e-05,0.011,97/211,39.84%,CDCA8;PPIA;CENPW;CYCS;DIAPH3;CEP55;PHB2;MTFR2;PARK7;PHB;PARP1;STOML2;PPID;CHCHD10;CFL1;MNS1;LMAN1;PRPF40A;TMED2;ATAD3A;LONP1;TFAM;MTX2;MTX1;HAX1;LMAN2;LARP4;NSFL1C;CENPT;ODF2;PRDX3;GORASP2;ZW10;LNPK;PITPNB;TPM1;NRF1;NUMA1;DNAJA3;MREG;CLUH;PTCD2;ARL1;HCFC1;PPRC1;TFB1M;MAST2;OPTN;CEP78;MSTO1;FANCG;GABPA;CLASP1;PEX7;MYC;HUWE1;DYNC2H1;TMED1;PI4K2B;OPA1;ALAS1;CLASP2;DYRK3;DPYSL2;NPLOC4;BNIP1;WDR73;PHIP;SMPD4;RHOT2;POLRMT;PACSIN2;PEX3;HSD17B10;FBXW8;YME1L1;TRAPPC12;AGTPBP1;ABCD3;MTFR1;ABI2;TICAM2;SEC23IP;PDZD8;CAMSAP1;EPS15;DYM;UBXN2B;BCS1L;BAG5;PRKCI;KIFAP3;SYNE3;ARHGAP21;ATP8B4;PIKFYVE;HTT
gsea,positive regulation of response to DNA damage stimulus (GO:2001022),0.6261232775792286,2.210543885065236,0.0,5.800587203346036e-05,0.012,22/34,31.20%,PCNA;BRCA1;TRIM28;NSMCE4A;DHX9;NSMCE1;SMCHD1;UBE2N;EEF1E1;ANKLE1;RNF168;BCLAF1;BRCC3;ABRAXAS1;ATR;FMR1;MYC;FXR2;RNF8;ERCC8;CCAR2;WRAP53
gsea,DNA duplex unwinding (GO:0032508),0.6318206823211966,2.2085285231810823,0.0,6.263298518086634e-05,0.013,28/38,28.82%,RAD51;MCM7;MCM4;MCM6;MCM2;PARP1;RPA1;BLM;DHX9;RAD50;DDX1;HMGA1;DDB1;RAD23B;NBN;RECQL4;RTEL1;RPS27A;PIF1;RECQL;GTF2H4;CHD1L;CUL4B;SUPV3L1;GTF2H3;DDX11;GTF2H1;GTF2H2
gsea,DNA strand elongation (GO:0022616),0.859978795146646,2.2081391078296244,0.0,6.2427631131093e-05,0.013,13/15,9.56%,MCM3;MCM7;RFC4;MCM4;GINS2;POLA1;POLD2;RFC3;GINS3;RAD50;GINS4;GINS1;POLD3
gsea,DNA integrity checkpoint signaling (GO:0031570),0.6747788029511804,2.2068243369362457,0.0,6.222361926465152e-05,0.013,19/28,25.53%,CLSPN;TIPIN;CDC45;CDC6;BRIP1;PRPF19;E2F1;TIMELESS;CHEK1;CDT1;DNA2;NBN;INTS7;CHEK2;ATR;RAD1;RHNO1;HUS1;RAD9A
gsea,protein-containing complex subunit organization (GO:0043933),0.562437852361792,2.206297379035903,0.0,6.202093646574385e-05,0.013,24/58,25.32%,PPIH;KNTC1;NDC1;PPID;CHCHD10;NUP205;NUP133;CD74;TUBGCP2;ST13;NUP54;NIFK;NUP35;KPNA3;GEMIN5;FANCA;CAPZA2;ZW10;TFAP4;TSPAN4;MDN1;SPG7;SEH1L;TRAF2
gsea,regulation of endothelial cell apoptotic process (GO:2000351),-0.6546286582296745,-2.2053035159049745,0.0,0.00048766424603521793,0.017,10/26,12.52%,TNFAIP3;PDCD4;ICAM1;PLCG1;TNF;CD40;CD40LG;THBS1;NFE2L2;CCL2
gsea,"RNA splicing, via transesterification reactions (GO:0000375)",0.7414106433886226,2.203239623528536,0.0,6.181956978890703e-05,0.013,15/18,18.11%,SNRNP40;SRSF10;SRRM1;SF3B3;SF3A3;SF3B4;SCAF11;KHSRP;PRPF8;SRSF4;GEMIN2;TXNL4A;PRPF4;MPHOSPH10;DBR1
gsea,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.7093434237984191,-2.202487318012411,0.0,0.0004859768264987639,0.018,10/18,11.79%,ZC3H12A;PDCD4;PER1;TNF;HIF1A;STAT3;SIRPA;IL17RA;PLD4;MEFV
gsea,regulation of protein binding (GO:0043393),0.5373894102571104,2.2018172257925337,0.0,6.161950645625685e-05,0.013,18/64,23.10%,RAN;AURKB;PLK1;PARK7;PIN1;AURKA;AKT1;BAX;CDKN1A;RACK1;ACTB;PRMT7;TAF1;GTF2F1;NVL;SYMPK;CTSZ;TLE5
gsea,maturation of SSU-rRNA (GO:0030490),0.6761985336244478,2.197426556163457,0.0,7.087007752475198e-05,0.015,22/24,29.69%,SNU13;RPS8;NOL11;HEATR1;WDR3;NOP14;NOL10;UTP3;TSR1;UTP6;NOB1;UTP4;DCAF13;BMS1;WDR46;TSR2;HELB;RIOK2;PWP2;NAT10;TSR3;SRFBP1
gsea,interferon-gamma-mediated signaling pathway (GO:0060333),-0.637678461482372,-2.196829509879507,0.0,0.0005354744662347491,0.021,17/30,11.92%,STAT1;IRF1;SP100;IRF4;IRF7;CD44;IRF9;ICAM1;GBP2;IRF2;IFNG;PTAFR;CAMK2D;HCK;OAS3;TRIM8;TRIM5
gsea,histone methylation (GO:0016571),0.7245958063739879,2.1963976682320467,0.0,7.064219946197141e-05,0.015,12/18,23.86%,EZH2;PRMT1;FBL;SUV39H1;PRMT5;SMYD2;SUV39H2;PRMT7;CARM1;SETD6;EHMT2;NTMT1
gsea,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.6964798517016093,2.1961193189072703,0.0,7.041578215600356e-05,0.015,19/21,26.09%,RPS8;HEATR1;RRS1;NOP9;TBL3;UTP20;NOP14;NOL10;UTP3;TSR1;RPP40;UTP6;UTP4;DCAF13;BMS1;WDR46;TSR2;HELB;PWP2
gsea,regulation of peptidyl-serine phosphorylation (GO:0033135),0.574574592573513,2.195739602323015,0.0,7.019081160598438e-05,0.015,10/47,14.15%,MIF;HSP90AB1;HSP90AA1;TFRC;PARK7;EIF4G1;DDIT4;AKT1;RACK1;HAX1
gsea,positive regulation of cellular amide metabolic process (GO:0034250),0.5795366804759082,2.195367057785295,0.0,6.996727398940482e-05,0.015,26/47,31.10%,RPS27L;NPM1;HNRNPD;EIF4A3;EIF3C;EIF6;RPL5;CASP3;EIF3D;RACK1;PASK;LARP4;LARP4B;NSUN5;SP1;ROCK2;FMR1;PRKDC;METTL5;NAT10;PYM1;FXR2;ZCCHC4;MTOR;DDX3X;UPF3B
gsea,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.7259508058260694,2.1953427830378582,0.0,6.974515565927971e-05,0.015,3/17,3.91%,STMN1;TPX2;FKBP4
gsea,cellular macromolecule catabolic process (GO:0044265),0.6474740820454438,2.1951919604073864,0.0,6.95244431413706e-05,0.015,16/26,26.01%,HNRNPD;RNASEH2B;EXOSC7;RNASEH2A;PABPC4;HTRA2;NCBP1;STT3B;SND1;MTREX;RNF5;PPP1R8;CHEK2;PNPT1;RNASEH1;SUPV3L1
gsea,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.7432204290226154,2.19345471563766,0.0,6.930512313146092e-05,0.015,11/18,14.61%,LSM2;LSM3;EXOSC8;LSM7;EXOSC7;DIS3;EXOSC3;EXOSC2;EXOSC1;EXOSC9;EXOSC5
gsea,protein homooligomerization (GO:0051260),0.5433636815866703,2.189987436021911,0.0,7.829880682504045e-05,0.016,22/57,26.39%,TK1;MIF;PRMT1;SHMT1;SHMT2;ECT2;BLM;FUS;ALAD;POLQ;ALDH9A1;SIGMAR1;APIP;LETM1;ALDOA;PNPT1;CBY1;THG1L;SOD2;ACACA;MLKL;RBMX
gsea,mitotic spindle checkpoint signaling (GO:0071174),0.8174340866237947,2.1892776557182794,0.0,7.75670422752737e-05,0.016,12/16,13.10%,MAD2L1;CENPF;CDC20;PLK1;BUB1;TRIP13;BUB1B;BUB3;KNTC1;TTK;MAD1L1;ZWINT
gsea,mitotic spindle assembly checkpoint signaling (GO:0007094),0.8174340866237947,2.1892776557182794,0.0,7.75670422752737e-05,0.016,12/16,13.10%,MAD2L1;CENPF;CDC20;PLK1;BUB1;TRIP13;BUB1B;BUB3;KNTC1;TTK;MAD1L1;ZWINT
gsea,spindle assembly checkpoint signaling (GO:0071173),0.8174340866237947,2.1892776557182794,0.0,7.75670422752737e-05,0.016,12/16,13.10%,MAD2L1;CENPF;CDC20;PLK1;BUB1;TRIP13;BUB1B;BUB3;KNTC1;TTK;MAD1L1;ZWINT
gsea,carbohydrate catabolic process (GO:0016052),0.753009309534715,2.1854804649651833,0.0,8.642334505606401e-05,0.018,8/20,5.01%,LDHA;TPI1;PGAM1;GAPDH;ENO3;ENO1;PKM;PGK1
gsea,carbohydrate derivative biosynthetic process (GO:1901137),0.760448063944522,2.1848511746526653,0.0,8.615578052028671e-05,0.018,5/15,8.62%,RRM2;RRM1;TPI1;TKT;ALG8
gsea,maturation of LSU-rRNA (GO:0000470),0.7298878146537009,2.1843852740600638,0.0,8.588986761744633e-05,0.018,20/24,21.92%,NHP2;SNU13;RSL1D1;EIF6;FTSJ3;ZNHIT3;RPL10A;DDX18;WDR12;RRP15;RPF2;NOP2;NIFK;RPL7L1;PES1;BOP1;MAK16;LAS1L;RPF1;MRPL1
gsea,tRNA processing (GO:0008033),0.5811530425935254,2.1839610010346373,0.0,8.562559110170035e-05,0.018,29/42,31.34%,SSB;NSUN2;RPP30;DDX1;POP5;TRMT6;WDR4;FAM98B;METTL1;CSTF2;CPSF4;RPP40;POP1;CPSF1;TRUB1;ELP5;CTU2;THUMPD1;THG1L;TSEN15;TSEN54;ELAC2;DTWD1;FTSJ1;TSEN34;ADAT2;TRMT61A;TRMT10A;FARS2
gsea,negative regulation of lymphocyte proliferation (GO:0050672),-0.6633248395546589,-2.1821137627919587,0.0,0.000652232056616762,0.025,12/23,8.90%,CTLA4;CD274;CD86;CEBPB;TYROBP;PDCD1LG2;CD300A;TNFRSF13B;FCGR2B;LYN;FOXP3;IL4I1
gsea,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.8670133482869421,2.1795793054557904,0.0,9.884129421652525e-05,0.019,13/15,8.51%,TCP1;NHP2;CCT6A;CCT8;CCT3;CCT7;CCT5;CCT2;DKC1;RUVBL2;RUVBL1;CCT4;NOP10
gsea,cellular response to radiation (GO:0071478),0.6565924339256003,2.1786848261091936,0.0,9.853902726173466e-05,0.019,13/24,25.53%,RAD51;RAD51AP1;FIGNL1;ECT2;BLM;EEF1D;CDKN1A;NET1;INTS7;RAD1;RHNO1;HUS1;RAD9A
gsea,protein methylation (GO:0006479),0.671976408139621,2.1776848524779937,0.0,9.823860339813181e-05,0.019,15/23,25.33%,EZH2;PRMT1;SNRPB;SNRPD3;GSPT1;PRMT5;ETF1;FAM98B;PRMT7;PRMT3;CARM1;FAM98A;EHMT2;NTMT1;ATPSCKMT
gsea,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.6820175812869518,2.1742088168741693,0.0,0.00010239182426575109,0.02,12/23,15.95%,HNRNPU;RNPS1;MAGOH;HNRNPA1;RBM8A;THRAP3;SRSF6;PTBP1;MBNL3;SMU1;CELF2;RBM25
gsea,positive regulation of proteasomal protein catabolic process (GO:1901800),0.5720759121079602,2.1741740083687,0.0,0.0001020815460104003,0.02,12/42,17.62%,PLK1;SUMO2;STUB1;RAD23A;VCP;PSMC2;PSMC5;RACK1;HSPBP1;USP5;PSMC6;TAF1
gsea,cellular protein modification process (GO:0006464),0.3995591138584565,2.1734090450617325,0.0,0.00010177314254813324,0.02,181/480,39.45%,BIRC5;CDK1;AURKB;RBBP7;UBE2S;CDK4;PLK1;HSP90B1;MELK;PSMB6;DTL;PDIA6;NEK2;PSMB5;PLK4;UCHL3;METAP2;LRR1;PARK7;PARP1;TIMM50;PSMA4;PSMB2;RPN2;PSMA6;DDOST;PSMA3;CCNE1;PPM1G;UBE2M;PSMD7;RPN1;PSMD1;PSMD12;AURKA;ELOC;PSMD2;CHEK1;CCNF;CDK2;PSMA5;PSMD3;P4HB;COPS3;PSMB7;PSMC4;CDC34;CDC25B;PSMD6;BCKDK;DDB1;AKT1;PSMC1;PSMC2;PPP5C;PSMD14;PARP2;COPS5;WDR5;PSMD11;PSMC5;PSME2;STK39;PSME3;GPS1;PASK;SPP1;COPS4;PRKCSH;STT3A;HASPIN;SEPHS1;NAE1;SKP2;STT3B;RABGGTB;PSMC6;EPAS1;VRK1;TAF1;SRPK1;DCAF13;SERP1;ZDHHC6;ILF3;COPS7A;ALG3;CUL1;CAND1;CHEK2;BMP2K;PRKCE;ADPRH;PTPN7;PDXP;MT3;PIGU;MAST2;ROCK2;PPP2R5D;CDK6;OARD1;CALU;CST3;CUL4B;PRKDC;UBA3;FBXL14;METAP1;PPP1CB;DCAF7;KEAP1;MCRS1;CAMKK2;COPS2;RYK;ASB2;PTPN6;SUMF2;GMFB;NUS1;DYRK3;BRD2;RCN1;SLC35A1;PPP2CB;GRK2;MTOR;ERCC8;LGALS1;DUSP12;FBXO31;FNTB;CUL3;MEN1;COPS7B;CUL5;RPS6KA5;NEK1;RBBP5;CREB1;PPP3CB;BIRC6;MAP4K1;MAPK6;CDK8;KTN1;B4GALT5;MPI;STRADA;ATM;DDB2;FBXW8;CUL4A;TRIOBP;RUNX3;MAPKAPK2;PPP2R3A;CTDP1;UFL1;STK3;DCUN1D1;KLHL5;PTAR1;KLHL9;PLOD2;CHUK;DCAF4;DCLK1;PDK1;TAB1;ROCK1;BAP1;PRKCI;MAP4K4;MAPK8;PHKA2;SERP2;FEM1B;UBXN7;PPP2R1B
gsea,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.568135192648668,2.172868985181158,0.0,0.0001014665969380485,0.02,26/46,33.69%,CDK4;TFDP1;E2F1;EIF4G1;KIF14;E2F7;CDKN2A;AKT1;RBL1;CDKN1A;PSME2;PSME3;RDX;WEE1;LSM11;BRD7;CDK6;CDKN2D;PTPN6;TM4SF5;RBL2;DDX3X;ANKRD17;CDKN2C;JADE1;CDC73
gsea,positive regulation of transcription by RNA polymerase I (GO:0045943),0.7022706791524521,2.169425658359672,0.0,0.00010116189244273906,0.02,12/20,20.66%,NCL;LYAR;WDR75;PIH1D1;WDR43;SMARCA4;NOL11;SMARCB1;HEATR1;PWP1;UTP15;UBTF
gsea,histone mRNA metabolic process (GO:0008334),0.7291126752252375,2.169367986899247,0.0,0.00010085901252524582,0.02,13/19,18.50%,SNRPE;SNRPF;SNRPB;SNRPD3;SLBP;SSB;ERI1;CPSF2;NCBP2;NCBP1;CPSF3;LSM11;EXOSC4
gsea,response to unfolded protein (GO:0006986),0.6233908900685438,2.167959233868294,0.0,0.00010493002523067756,0.02,16/35,27.74%,HSP90AB1;HSP90AA1;HSPD1;HSPA9;HSPE1;HSPA4;BAX;HSPA8;STT3B;HSPA14;BAK1;HSPA5;OPTN;HERPUD1;HSPA13;HSF1
gsea,positive regulation of cell cycle (GO:0045787),0.577099738133143,2.1670439835150055,0.0,0.00010461773348891959,0.02,9/39,10.91%,CDK4;CCNB1;CALR;ASNS;CHEK1;RAD23A;CDC25B;AKT1;EIF4E
gsea,positive regulation of cytokinesis (GO:0032467),0.7358928347951044,2.164703577437538,0.0,0.0001126652514496057,0.021,11/19,16.72%,AURKB;CDC6;RACGAP1;CIT;KIF23;KIF20B;ECT2;KIF14;CDC25B;CENPV;PKP4
gsea,positive regulation of cell division (GO:0051781),0.7358928347951044,2.164703577437538,0.0,0.0001126652514496057,0.021,11/19,16.72%,AURKB;CDC6;RACGAP1;CIT;KIF23;KIF20B;ECT2;KIF14;CDC25B;CENPV;PKP4
gsea,lymphocyte migration (GO:0072676),-0.6785693714483585,-2.16456036389964,0.0,0.0009638540392225485,0.039,12/21,16.14%,CCL5;TBX21;CCL1;CCL4;CRTAM;S1PR1;XCL1;ADAM8;CCL2;CCL8;RET;CCL7
gsea,activation of protein kinase activity (GO:0032147),0.5584281184059091,2.1636935560381367,0.0,0.00011665340194339706,0.022,9/54,10.02%,PPIA;TPX2;CLSPN;PHB2;PARK7;PHB;ECT2;KIF14;AKT1
gsea,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.7488946093771282,2.162026761787255,0.0,0.00011631030370238708,0.022,11/17,14.61%,LSM2;LSM3;EXOSC8;LSM7;EXOSC7;DIS3;EXOSC3;EXOSC2;EXOSC1;EXOSC9;EXOSC5
gsea,regulation of endopeptidase activity (GO:0052548),0.6639712416141541,2.1619348028538066,0.0,0.00011596921776777598,0.022,8/25,12.03%,GAPDH;HDAC1;PSMA3;PRELID1;SERPINE2;AKT1;PSME2;PSME3
gsea,positive regulation of establishment of protein localization (GO:1904951),0.7729181919285706,2.160370765124976,0.0,0.00011563012648775322,0.022,9/16,8.12%,TCP1;CCT6A;CCT8;CCT3;CCT7;CCT5;CCT2;DKC1;CCT4
gsea,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.5846157513642581,2.1600647503084685,0.0,0.00011956312398733667,0.022,9/38,18.63%,MIF;HSP90AB1;HSP90AA1;TFRC;PARK7;EIF4G1;AKT1;HAX1;CNOT9
gsea,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.538753474814874,2.15605851640219,0.0,0.00013198865213427647,0.022,24/53,31.47%,HSP90AB1;PLK1;UCHL5;SUMO2;PARK7;STUB1;RAD23A;VCP;XPO1;RACK1;RAD23B;HSPBP1;USP5;TAF1;DESI1;GLMN;HERPUD1;GIPC1;KEAP1;UBQLN4;USP7;BAG2;CCAR2;TAF9
gsea,cellular response to tumor necrosis factor (GO:0071356),0.5023624490598712,2.1526009047139425,0.0,0.00013585143363198832,0.023,30/104,12.56%,EIF5A;PSMB6;PSMB5;BRCA1;PSMA4;PSMB2;PSMA6;PSMA3;YBX3;PSMD7;PSMD1;PSMD12;DHX9;PSMD2;PSMA5;PSMD3;PSMB7;PSMC4;PSMD6;ACTN4;AKT1;PSMC1;PSMC2;PSMD14;TNFSF4;PSMD11;PSMC5;PSME2;PSME3;TNFRSF4
gsea,cellular response to chemokine (GO:1990869),-0.6423843386294508,-2.151520741834438,0.0,0.0011365172344574266,0.046,16/31,16.15%,CCL5;DUSP1;RIPOR2;ZC3H12A;CCL1;CCR2;CCL4;XCL1;PTK2B;CXCL9;CXCL2;CCL2;CCL8;PF4;CCL7;GPR35
gsea,positive regulation of interleukin-1 beta production (GO:0032731),-0.7100044057325187,-2.1485590340119236,0.0021598272138228943,0.0011891705678719752,0.05,13/19,16.67%,MALT1;EGR1;TYROBP;TNF;STAT3;IFNG;APP;NLRP3;F2RL1;CD36;CASP1;LPL;JAK2
gsea,establishment of mitotic spindle localization (GO:0040001),0.7087537556484009,2.1472260007220516,0.0,0.0001566242368417929,0.027,14/22,18.97%,MAD2L1;NUSAP1;PLK1;CENPA;NDC80;SAPCD2;SPDL1;KPNB1;ESPL1;GPSM2;NDE1;NSFL1C;ZW10;NUMA1
gsea,'de novo' posttranslational protein folding (GO:0051084),0.6630998433121398,2.147221652373591,0.0,0.00015617287016501542,0.027,11/24,20.13%,PTGES3;SDF2L1;CCT2;HSPA9;HSPE1;HSPA8;CHCHD4;ST13;HSPA14;HSPA5;DNAJC7
gsea,regulation of cellular protein localization (GO:1903827),0.6232020688755519,2.146813181598467,0.0,0.0001557240975495987,0.027,7/27,13.18%,HSP90AB1;HSP90AA1;PARP1;PIN1;VCP;SUMO3;LCP1
gsea,response to light stimulus (GO:0009416),0.614029144690436,2.14580138965885,0.0,0.00015527789669702105,0.027,6/32,12.11%,PCLAF;USP1;DTL;POLD1;COPS3;MSH6
gsea,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.5698713642178687,2.144856724371672,0.0,0.00015901895490315777,0.027,12/42,19.15%,CDC20;PLK1;SUMO2;STUB1;RAD23A;VCP;FZR1;RACK1;HSPBP1;USP5;TAF1;UBQLN1
gsea,ribosomal small subunit biogenesis (GO:0042274),0.696821927368908,2.143401242369711,0.0,0.00016273869653831935,0.028,17/25,19.21%,RPS27L;RPS17;NPM1;SNU13;RPS15;RPS25;RPS6;EMG1;MRPS7;RPSA;NOL11;WDR3;NOP14;LTV1;NOB1;UTP4;RRP7A
gsea,error-prone translesion synthesis (GO:0042276),0.750787044571259,2.143177329140747,0.0,0.00016227637069588096,0.028,10/18,9.35%,RFC4;RFC5;PCNA;RPA3;RFC2;RPA1;RFC3;RFC1;POLE2;RPA2
gsea,establishment of protein localization to mitochondrion (GO:0072655),0.6823906609441688,2.1423608749850716,0.0,0.0001618166642633147,0.028,16/25,17.42%,HSPD1;TIMM23;TIMM50;TOMM40;TIMM17A;TIMM13;AKT1;TOMM5;GRPEL1;TOMM20;CHCHD4;TIMM8B;PITRM1;AIFM1;TIMM9;TIMM10
gsea,glucose metabolic process (GO:0006006),0.6295827304484474,2.1407244674440156,0.0,0.0001613595550422319,0.028,14/32,22.41%,TPI1;PGAM1;GAPDH;ENO3;ENO1;MDH2;PGK1;GOT2;SLC25A10;SLC25A13;PCK2;ALDOA;ADPGK;PGM1
gsea,regulation of cell cycle G1/S phase transition (GO:1902806),0.6760304778657515,2.1395522754224015,0.0,0.00016503079085576047,0.029,8/20,12.03%,EZH2;PHB2;E2F1;KIF14;FAM83D;CDKN1A;PSME2;PSME3
gsea,negative regulation of cell death (GO:0060548),0.575659425837524,2.137211155924893,0.0,0.0001645672212185252,0.029,9/38,12.08%,PARK7;EIF4G1;NUP62;RAD18;TMEM109;SRSF6;AKT1;PSMC5;HTRA2
gsea,regulation of protein localization (GO:0032880),0.5952523148748772,2.1315521586159174,0.0,0.0001887221859015804,0.032,6/30,16.39%,HSP90AB1;HSP90AA1;PARP1;RSL1D1;RACK1;BORA
gsea,regulation of cell growth (GO:0001558),0.4717698862997056,2.1311879722263822,0.0,0.00018819502895772125,0.032,29/104,23.24%,RBBP7;TMEM97;TFRC;ENO1;PHB;EIF4G1;NUBP1;KIF14;CDKN2A;FXN;AKT1;SMARCA4;ATAD3A;EXOSC2;CDKN1A;RACK1;HDGFL2;EXOSC9;NCBP1;DNPH1;EIF4G2;URI1;EXOSC4;NET1;DERL2;NME6;OSGIN2;MT3;ING1
gsea,positive regulation of cellular biosynthetic process (GO:0031328),0.5054628639967625,2.128992501121301,0.0,0.0001876708088213488,0.032,42/95,29.74%,RPS27L;HSP90AB1;NPM1;PCNA;HSP90AA1;HNRNPD;PRMT1;ATAD5;PARK7;EIF4A3;EIF3C;DHX9;EIF6;RPL5;CDT1;DDB1;AKT1;EIF3D;DNA2;CTC1;PASK;LARP4;STARD4;FAF1;LARP4B;NSUN5;SP1;SCARB1;FMR1;PRKDC;KAT7;GIPC1;LDLR;MID1IP1;METTL5;NAT10;MYC;PYM1;FXR2;ZCCHC4;MTOR;DDX3X
gsea,cytoplasmic translation (GO:0002181),0.7596610089453628,2.1262057985855023,0.0,0.00019528643584598325,0.034,30/35,20.06%,RPS17;EIF4A1;RPS2;RPL14;GSPT1;RPS15;RPS25;RPS6;RPL31;RPL41;RPL4;RPS8;RPL22L1;RPS18;RPL5;RPL23A;ETF1;RPL10A;RPL15;RPSA;RPLP0;RPS26;RPL8;EIF2B3;DRG1;RPL10;RPL3;RPS27A;RPLP1;DRG2
gsea,protein N-linked glycosylation via asparagine (GO:0018279),0.7439076878056508,2.1257480491396334,0.0,0.0001942075052611988,0.034,8/15,16.08%,RPN2;DDOST;RPN1;ALG8;LMAN1;STT3A;MAGT1;STT3B
gsea,peptidyl-asparagine modification (GO:0018196),0.7439076878056508,2.1257480491396334,0.0,0.0001942075052611988,0.034,8/15,16.08%,RPN2;DDOST;RPN1;ALG8;LMAN1;STT3A;MAGT1;STT3B
gsea,peptidyl-serine modification (GO:0018209),0.4832792986398791,2.1233378140274666,0.0,0.0001977073420754789,0.034,39/89,38.75%,CDK1;CLSPN;PLK1;HPF1;PARP1;MASTL;AURKA;CDK2;TTK;AKT1;PARP2;STK39;CDC7;GALNT1;NAA10;VRK1;TAF1;PRKCE;ATR;CSNK2A2;MAST2;ROCK2;NTMT1;PRKDC;VRK3;DYRK3;GRK2;MTOR;POGLUT2;RPS6KA5;MAP4K1;ATM;MAPKAPK2;CHUK;POGLUT3;ROCK1;PRKCI;POGLUT1;MAPK8
gsea,dicarboxylic acid metabolic process (GO:0043648),0.6093485563040727,2.1224816005822005,0.0,0.00019716419003680996,0.034,19/35,30.78%,DHFR;MTHFD2;SHMT1;SHMT2;MDH2;MTHFD1;GOT2;MTHFD1L;ME2;SDHA;DLST;SLC19A1;FPGS;ALDH18A1;OGDH;ACLY;IDH2;L2HGDH;NIT2
gsea,regulation of protein export from nucleus (GO:0046825),0.7423646060402365,2.121381258759878,0.0,0.00019662401417369543,0.034,6/15,7.37%,ANP32B;YWHAE;PARK7;RANGAP1;BARD1;GTSE1
gsea,positive regulation of protein phosphorylation (GO:0001934),0.45942287798362025,2.121085831860745,0.0,0.00019608679009125364,0.034,27/159,19.56%,PPIA;CENPE;MIF;HSP90AB1;HSP90AA1;PLK1;TFRC;PARK7;EIF4G1;PIN1;CDK2AP1;RAD50;TTK;AKT1;MYDGF;HRAS;CD74;CDKN1A;RACK1;XRCC6;HAX1;NBN;XRCC5;CALM2;VEGFB;CNOT9;MRNIP
gsea,"negative regulation of transcription, DNA-templated (GO:0045892)",0.40326144784277435,2.1196120377703607,0.0,0.00019954336087804825,0.035,127/427,32.81%,HMGB2;BIRC5;HMGB1;AURKB;SET;PA2G4;CENPF;GMNN;UHRF1;HDGF;HNRNPU;PLK1;C1QBP;EZH2;LYAR;CBX5;ENO1;PHB2;CBX3;BRCA1;SUV39H1;PHB;PARP1;E2F8;E2F1;MYBBP1A;HDAC1;CALR;TIMELESS;TRIM28;NONO;PPID;E2F7;NOC2L;TCERG1;MYB;RIF1;CDKN2A;HDAC2;FOXM1;KMT5A;SFPQ;MAZ;SMYD2;HMGA1;SMARCA4;TNFSF4;ORC2;HSPA8;SUV39H2;BCLAF1;TNFRSF4;CTCF;XRCC6;SAP30;EZR;CNBP;TRIM37;XRCC5;RPL10;MTDH;DDX20;TFDP2;EED;TCF3;TAF1;URI1;BRD7;RPS27A;SAMD1;MCPH1;DNAJA3;E2F6;TFAP4;MTF2;ILF3;L3MBTL2;PHF10;MTA2;FLNA;LARP7;PSPC1;MTA1;SMARCC2;CBY1;SREBF2;NCOR2;HCFC1;EOMES;FOXK2;MT3;SIN3A;TLE5;ZC3H8;EHMT2;DCAF1;CNOT1;KAT7;PCGF6;BCL7A;PTCH1;TAF3;MYC;SFMBT1;NFX1;YY1;HSF1;PRDM16;KAT8;DMAP1;KDM8;LBH;RBM15B;DICER1;GCFC2;BASP1;SETDB2;CCAR2;RIOX1;MEN1;TRERF1;RPS6KA5;GLIS1;PRDM5;RIPPLY3;CREB1;NAB1
gsea,regulation of DNA binding (GO:0051101),0.6720190314001329,2.1180564378079216,0.0,0.00019900112348435786,0.035,7/24,11.13%,HMGB2;HMGB1;NME1;HJURP;E2F1;CDT1;SUMO3
gsea,endoderm formation (GO:0001706),-0.7013733302978014,-2.116907088173128,0.0,0.0018758235960024754,0.076,4/16,1.44%,DUSP2;DUSP5;DUSP4;DUSP1
gsea,regulation of DNA repair (GO:0006282),0.6627003969625047,2.1163520093105266,0.0,0.00021036953454953475,0.038,13/26,19.04%,PCNA;DEK;USP1;BRCA1;TRIM28;DHX9;SMCHD1;UBE2N;RNF168;BRCC3;UBE2V2;POLH;WRNIP1
gsea,"protein localization to chromosome, centromeric region (GO:0071459)",0.8048665953836952,2.114931973762829,0.0,0.00020980096823994143,0.038,12/15,14.49%,CDK1;AURKB;KNL1;CENPA;BUB3;SPDL1;ZWILCH;TTK;MTBP;MIS12;CTCF;HASPIN
gsea,regulation of mitotic spindle organization (GO:0060236),0.6847299886231,2.109175866037354,0.0,0.00022897466197574853,0.042,11/21,18.97%,TACC3;TPX2;HNRNPU;PLK1;NUP62;GPSM2;DRG1;BORA;RAE1;CCSAP;NUMA1
gsea,negative regulation of protein metabolic process (GO:0051248),0.6576570502036689,2.108619364691583,0.0,0.00022835913869086747,0.042,12/24,25.56%,MAD2L1;HSP90AB1;PHB;PFDN6;PIN1;SF3B3;HMGCR;PFDN4;FLNA;AZIN1;VBP1;LDLR
gsea,regulation of macromolecule metabolic process (GO:0060255),0.4984852886422272,2.1086121472652106,0.0,0.00022774691579893484,0.042,18/83,15.49%,HNRNPAB;YBX1;CDK4;HNRNPD;PCBP1;TCF19;PIN1;YBX3;CDK2;HNRNPDL;TARDBP;HNRNPK;FUBP1;COQ7;KHSRP;CTCF;SART3;UBAP2
gsea,cellular response to interferon-gamma (GO:0071346),-0.546674742189949,-2.108435649860815,0.0,0.0021036496887793716,0.086,37/57,18.79%,CCL5;STAT1;IRF1;SP100;GBP6;IRF4;IRF7;CD44;IRF9;CCL1;GBP4;ICAM1;GBP2;IRF2;CCL4;IFNG;SIRPA;PTAFR;XCL1;CAMK2D;HCK;AIF1;OAS3;TLR2;TRIM8;TRIM5;CCL2;CCL8;DAPK1;CASP1;ACOD1;CCL7;JAK2;IFNGR2;TRIM21;GBP7;CCL22
gsea,regulation of double-strand break repair (GO:2000779),0.6146420014444054,2.105957393350076,0.002044989775051125,0.00023497031050987284,0.042,11/28,19.56%,RAD51;DEK;RAD51AP1;FIGNL1;TIMELESS;CHEK1;FOXM1;RPA2;SLF1;RTEL1;MRNIP
gsea,cellular response to oxidative stress (GO:0034599),0.4961897662474622,2.105818704521378,0.0,0.00023434372301517987,0.042,23/70,26.85%,PPIA;CYCS;EIF2S1;PRDX1;PARK7;PARP1;AKT1;LONP1;HTRA2;GPX1;GSR;PYCR2;PRDX3;TXNRD1;TPM1;PNPT1;MT3;SOD2;VKORC1L1;KEAP1;CAMKK2;ERCC6L2;SETX
gsea,glycolytic process (GO:0006096),0.7711392224855939,2.1050889065104013,0.002105263157894737,0.00023761580957323754,0.043,8/17,5.01%,LDHA;TPI1;PGAM1;GAPDH;ENO3;ENO1;PKM;PGK1
gsea,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.5708699614648305,2.1040791710463593,0.0,0.00024087053758191566,0.044,9/37,12.01%,CDK1;CDK4;CCNB1;TRIM28;MED30;CDKN2A;BAX;CDKN1A;BCLAF1
gsea,mitochondrial membrane organization (GO:0007006),0.6488728189023838,2.102812067725844,0.0,0.00024410804480747903,0.045,13/21,22.26%,SLC25A5;HSPA9;TIMM50;IMMT;PPIF;SAMM50;APOO;MTX2;MTX1;BAK1;DNAJC11;CHCHD6;SPG7
gsea,histone lysine methylation (GO:0034968),0.6482449126106639,2.10223056026,0.002150537634408602,0.00024346396025653582,0.045,16/22,32.55%,EZH2;DPY30;SUV39H1;SMYD2;WDR5;SUV39H2;ASH2L;PAXIP1;SETDB1;SETD6;EHMT2;DOT1L;SETDB2;MEN1;PRDM5;RBBP5
gsea,ncRNA catabolic process (GO:0034661),0.6790581408197228,2.1015279093626056,0.0020964360587002098,0.00024282326562428174,0.045,14/19,27.16%,EXOSC8;EXOSC7;DIS3;EXOSC3;EXOSC2;EXOSC9;EXOSC5;SND1;MTREX;EXOSC4;POP1;EXOSC10;ZCCHC8;PARN
gsea,regulation of cellular senescence (GO:2000772),0.6369707995433878,2.1005863705682986,0.0,0.00024218593421844375,0.045,8/21,10.81%,YBX1;FBXO5;RSL1D1;CDKN2A;EEF1E1;HMGA1;RBL1;CGAS
gsea,protein N-linked glycosylation (GO:0006487),0.5744864213945515,2.100040664788727,0.0,0.0002492202551699393,0.045,15/36,23.21%,RPN2;DDOST;RPN1;ALG8;LMAN1;MOGS;STT3A;MAGT1;PMM1;STT3B;DPAGT1;ALG6;MPDU1;ALG3;ALG13
gsea,pyruvate metabolic process (GO:0006090),0.6438691860832794,2.09984814653593,0.0041841004184100415,0.0002485695495428637,0.045,14/30,16.75%,LDHA;TPI1;PGAM1;GAPDH;ENO3;ENO1;PKM;VDAC1;PGK1;BSG;ME2;DLAT;PFKL;PCK2
gsea,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.7037031119501872,2.09950114760327,0.0,0.0002479222330075959,0.045,16/19,23.64%,EXOSC8;EXOSC7;ERI1;EXOSC3;FTSJ3;EXOSC2;WDR12;EXOSC9;RRS1;PES1;NOP9;UTP20;NOP14;RPP40;EXOSC10;NOL9
gsea,positive regulation of double-strand break repair (GO:2000781),0.5759340995830107,2.099494574951111,0.0,0.0002472782791556281,0.045,20/32,34.26%,RAD51AP1;PARP1;TIMELESS;RIF1;SMCHD1;FOXM1;FUS;SLF1;MRNIP;FANCB;PRKDC;ZCWPW1;DDX11;ACTR2;SPIDR;WDR48;SLF2;WRAP53;KMT5C;SPIRE1
gsea,error-free translesion synthesis (GO:0070987),0.7326479311122639,2.098279870082053,0.0,0.0002542265129860274,0.047,14/18,18.40%,RFC4;RFC5;PCNA;RPA3;RFC2;POLD1;RPA1;RFC3;RFC1;RPA2;VCP;POLDIP2;POLH;RPS27A
gsea,regulation of centriole replication (GO:0046599),0.7123217033440858,2.09823744073786,0.002061855670103093,0.00025356959693179987,0.047,14/17,25.89%,NPM1;PLK4;BRCA1;STIL;NUP62;CEP295;TRIM37;RBM14;KAT2A;MDM1;ALMS1;CEP76;CENPJ;CDK5RAP2
gsea,maturation of 5.8S rRNA (GO:0000460),0.7291170846469058,2.0970477981501223,0.0,0.00026424066705964223,0.05,14/15,24.93%,EIF6;FTSJ3;WDR12;RRP15;PES1;MAK16;MTREX;EXOSC4;LAS1L;RPF1;EXOSC10;NOL9;MPHOSPH6;PRKDC
gsea,negative regulation of protein binding (GO:0032091),0.5496810369124421,2.096353750495616,0.0,0.00027109171042887127,0.052,14/43,23.10%,AURKB;PARK7;PIN1;AURKA;AKT1;BAX;CDKN1A;RACK1;ATP2A2;ACTB;GTF2F1;SYMPK;CTSZ;TLE5
gsea,nucleus organization (GO:0006997),0.663704636204133,2.095812835484662,0.0,0.0002703966034790537,0.052,11/21,18.97%,CEP55;REEP4;NDC1;NUP93;NUP205;NUP133;NUP155;NUP54;NUP35;PITPNB;NUMA1
gsea,establishment of spindle orientation (GO:0051294),0.6985215280935279,2.095540085573956,0.0,0.00027345095556438826,0.052,15/20,25.89%,MAD2L1;PLK1;CENPA;NDC80;SAPCD2;SPDL1;GPSM2;NDE1;NSFL1C;ZW10;NUMA1;MAP4;DCTN1;CLASP1;CDK5RAP2
gsea,peptidyl-threonine modification (GO:0018210),0.571730480667548,2.0949556242155327,0.0,0.00027648972422071605,0.053,11/32,24.93%,CDK1;CIT;CHEK1;CAD;AKT1;STK39;GALNT1;TAF1;CSNK2A2;ROCK2;PRKDC
gsea,protein depolymerization (GO:0051261),0.6974501103907279,2.092112951405307,0.0,0.0002869667091629906,0.056,8/18,16.79%,STMN1;KIF2C;KIF18B;KIF14;CFL1;CKAP5;KIF18A;KIF24
gsea,receptor signaling pathway via STAT (GO:0097696),-0.6923961805333448,-2.0907215304323414,0.0020161290322580645,0.0025702774379267957,0.107,10/17,12.52%,STAT1;CLCF1;STAT4;CCR2;STAT3;IFNG;STAT2;IFNAR2;SOCS2;CCL2
gsea,water-soluble vitamin metabolic process (GO:0006767),0.548641670245539,2.0905449172363926,0.0,0.000289955748654569,0.056,20/40,32.82%,DHFR;MTHFD2;SHMT1;SHMT2;MTHFD1;MTHFD1L;GSTO1;SLC19A1;PDZD11;FPGS;SLC25A19;MMADHC;AASDHPPT;CD320;MMAB;MMACHC;ABCC1;MTR;MCCC2;SLC2A1
gsea,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.6487621073920123,2.0899452991089067,0.0,0.0002929296537689748,0.056,16/25,24.35%,LSM2;LSM3;EXOSC8;LSM7;EXOSC7;DIS3;EXOSC3;EXOSC2;EXOSC1;EXOSC9;EXOSC5;EXOSC4;CNOT9;HBS1L;CNOT1;CNOT10
gsea,positive regulation of telomere maintenance (GO:0032206),0.6852692534092929,2.088939644367353,0.0,0.0002921899324210734,0.056,10/19,21.74%,AURKB;HNRNPA2B1;HNRNPD;NEK2;RAD50;GNL3;NBN;RTEL1;ATRX;NAF1
gsea,cellular amide metabolic process (GO:0043603),0.543138930579148,2.086889304045051,0.0,0.00029514322797881594,0.057,8/51,9.83%,DBI;DHFR;MTHFD2;SHMT1;SHMT2;MTHFD1;THOP1;MTHFD1L
gsea,regulation of microtubule cytoskeleton organization (GO:0070507),0.7125640112819096,2.0864495648147754,0.0,0.00030544172440734817,0.059,4/18,8.39%,STMN1;SKA1;SKA2;SKA3
gsea,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.7818563029000402,2.0860155646750815,0.0,0.0003039145157853114,0.059,10/15,13.54%,CYCS;NDUFAB1;CYC1;NDUFA5;NDUFA12;UQCRC1;NDUFA4;SDHD;NDUFV1;SDHA
gsea,aerobic electron transport chain (GO:0019646),0.7818563029000402,2.0860155646750815,0.0,0.0003039145157853114,0.059,10/15,13.54%,CYCS;NDUFAB1;CYC1;NDUFA5;NDUFA12;UQCRC1;NDUFA4;SDHD;NDUFV1;SDHA
gsea,negative regulation of supramolecular fiber organization (GO:1902904),0.5705339144744803,2.0839376669620395,0.0,0.0003214190714672043,0.062,15/34,33.43%,STMN1;TPX2;PFDN6;PFN1;HSPA8;PFDN4;CORO1A;VBP1;CLASP1;LDLR;MID1IP1;CLASP2;FGF13;KATNB1;HDGFL3
gsea,DNA damage checkpoint signaling (GO:0000077),0.6429795484779768,2.0829812242975447,0.0,0.0003206195215381814,0.062,15/22,28.77%,CLSPN;BRIP1;PRPF19;E2F1;CHEK1;NBN;INTS7;CHEK2;ATR;RAD1;RHNO1;HUS1;RAD9A;DOT1L;RAD17
gsea,positive regulation of protein import (GO:1904591),0.647590214046253,2.082796577670797,0.0,0.0003198239395988807,0.062,4/19,5.71%,RAN;ECT2;IPO5;TRIM28
gsea,RNA modification (GO:0009451),0.5528168831630272,2.081313004556193,0.0,0.0003335337641923971,0.065,28/42,34.83%,SSB;NSUN2;NOP10;FTSJ3;TRMT6;WDR4;NOP2;METTL1;PUS7;TRUB1;ELP5;CTU2;THUMPD1;NSUN5;THG1L;TFB1M;NAT10;DTWD1;PARN;FTSJ1;TSR3;ADAT2;RBM15B;TRMT61A;PUS7L;TYW5;QTRT2;RBM15
gsea,regulation of histone acetylation (GO:0035065),0.6528692815536467,2.0812585041641753,0.0,0.00033271022403389734,0.065,10/21,20.72%,SET;BRCA1;PARK7;RUVBL2;NOC2L;CHEK1;PAXIP1;TADA2A;BRD7;IWS1
gsea,regulation of insulin secretion (GO:0050796),-0.5417131787057453,-2.080441272733837,0.0,0.0027715216878743607,0.117,8/38,6.98%,CCL5;ITPR2;IL1B;TNF;PRKCA;GLP1R;IFNG;IRS2
gsea,protein phosphorylation (GO:0006468),0.4228736469624231,2.0784916482964046,0.0,0.0003391057568261531,0.066,79/229,38.75%,BIRC5;CCNA2;CDK1;AURKB;CLSPN;CDK4;PLK1;CIT;INCENP;MELK;NEK2;PLK4;MASTL;BAZ1B;CCNE1;AURKA;CHEK1;CDK2;TTK;CDC25B;CAD;BCKDK;PRDX4;AKT1;STK39;CDC7;PASK;HASPIN;VRK1;TAF1;SRPK1;ILF3;CHEK2;BMP2K;PRKCE;GTF2H4;ATR;CSNK2A2;MAST2;ROCK2;CDK6;RIOK2;PRKDC;CAMKK2;COPS2;GTF2H3;RYK;PTPN6;GMFB;VRK3;DYRK3;GTF2H1;BRD2;GRK2;MTOR;USP15;RPS6KA5;NEK1;CREB1;PPP3CB;BIRC6;MAP4K1;MAPK6;CDK8;KIT;STRADA;ATM;RUNX3;MAPKAPK2;STK3;ABI2;ERC1;CHUK;DCLK1;PDK1;ROCK1;PRKCI;MAP4K4;MAPK8
gsea,negative regulation of mitochondrion organization (GO:0010823),0.6679745498646235,2.078209440197763,0.0,0.00033827257314844757,0.066,7/19,12.57%,SLC25A5;TFRC;PRELID1;FXN;AKT1;PPIF;GPX1
gsea,protein targeting to ER (GO:0045047),0.7292593031635328,2.077620100291071,0.0021598272138228943,0.0003410332978928016,0.067,25/34,18.62%,RPS17;RPS2;RPL14;RPS15;RPS25;RPS6;RPL31;RPL41;RPL4;RPS8;RPS18;RPL5;RPL23A;RPL10A;RPL15;RPSA;RPLP0;SPCS3;RPS26;RPL8;RPL10;EDEM1;RPL3;RPS27A;RPLP1
gsea,DNA modification (GO:0006304),0.6710828799462313,2.076178577274061,0.0,0.0003473615698727452,0.068,10/17,20.12%,NEIL3;PARP1;EXOSC3;UNG;PARP2;MBD4;EXOSC5;EXOSC4;TINF2;TDG
gsea,regulation of gene expression (GO:0010468),0.3998352817582677,2.0734854769649154,0.0,0.0003608035979349568,0.071,140/453,32.81%,HNRNPAB;YBX1;MIF;HINT1;CDK4;DNMT1;EZH2;HNRNPD;MYBL2;PCBP1;TFRC;TCF19;HNRNPF;BRCA1;PARK7;NUP107;PHB;E2F1;MYBBP1A;HDAC1;CALR;BRCA2;PIN1;SNRNP70;NONO;YBX3;NSD2;AURKA;MYB;SRRT;SRSF10;CDK2;HNRNPDL;RPL5;MLF1;TARDBP;PPIE;HMGN5;SFPQ;FUS;HNRNPK;PTBP1;PRMT5;HP1BP3;MAZ;FUBP1;COQ7;HMGA1;AKT1;ZNHIT3;SLC7A5;RBL1;HRAS;CD74;KHSRP;RACK1;RRP1B;GPX1;CTCF;FAM98B;MBNL3;RDX;SART3;METTL16;SAP30;EZR;CNBP;LARP4;NUP35;UBAP2;CCAR1;LARP1;GRSF1;HNRNPH1;TCF3;CPSF4;PTRH2;TAF1;CARM1;MYCBP;ATRX;UTP4;VPS35;TAF6L;PHF19;MTF2;TDG;CHEK2;PSPC1;ZPR1;MTA1;RBM38;HNRNPLL;POLR2A;SETDB1;FAM98A;HCFC1;TCF7;CACTIN;FOXK2;SP1;MT3;TLE5;ROCK2;NFYB;LIN54;CDK6;MYBL1;GLMN;KAT7;GABPA;HNRNPH3;NFYC;AFF3;MYC;NFX1;YY1;NFKB2;RBL2;TNRC6A;TRIM44;NFYA;TESC;TTN;NPAT;MTOR;DDX3X;DICER1;GCFC2;RAB27A;FADS1;SETDB2;CCAR2;PUM2;SPOUT1;ACTG1;RPS6KA5;PRDM5;ASCC2;NAB1
gsea,metal ion transport (GO:0030001),-0.5753757752938873,-2.0733850769551347,0.0,0.0028218654411101066,0.124,11/34,10.23%,CCL5;TPT1;CCR5;SLC3A2;NIPAL3;SLC30A1;ATP2A3;RYR1;ATP2B2;RAMP1;CACNB3
gsea,nucleobase-containing compound catabolic process (GO:0034655),0.6274401106883223,2.0709259019991246,0.0,0.0003741802146683985,0.073,14/23,26.01%,HNRNPD;RNASEH2B;NUDT5;EXOSC7;RNASEH2A;PABPC4;NUDT1;NCBP1;SND1;MTREX;PPP1R8;PNPT1;RNASEH1;SUPV3L1
gsea,positive regulation of protein-containing complex assembly (GO:0031334),0.48641428468222075,2.0705552333531245,0.0,0.00037327201026386356,0.073,35/74,31.30%,RPA3;HSP90AA1;TFRC;PARK7;PARP1;RPA1;EIF4G1;STUB1;PSMC4;PIH1D1;RPA2;CDT1;DDB1;VCP;BAX;PSMC2;PSMC5;RACK1;LCP1;SLF1;PSMC6;BAK1;FAF1;GTF2H4;ATR;CHD1L;CUL4B;GTF2H3;BID;GTF2H1;GTF2H2;DDX3X;SPIDR;SLF2;GNL3L
gsea,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.5578784868661211,2.070376815103641,0.0,0.0003723682039436121,0.073,9/36,17.62%,PLK1;SUMO2;STUB1;RAD23A;VCP;RACK1;HSPBP1;USP5;TAF1
gsea,negative regulation of protein catabolic process (GO:0042177),0.6769642866325342,2.068520841878645,0.0,0.0003820821570899672,0.076,9/19,24.69%,MAD2L1;PHB;PIN1;SNRNP70;SF3B3;HMGCR;FLNA;AZIN1;CST3
gsea,cellular response to unfolded protein (GO:0034620),0.6556706671007858,2.068404149579221,0.0021141649048625794,0.0003811614771933648,0.076,10/20,27.74%,HSPD1;HSPA9;BAX;HSPA8;HSPA14;BAK1;HSPA5;OPTN;HSPA13;HSF1
gsea,chaperone cofactor-dependent protein refolding (GO:0051085),0.6704539867104843,2.0676140224965085,0.0,0.0003908075909658198,0.077,9/20,20.13%,PTGES3;SDF2L1;HSPA9;HSPE1;HSPA8;ST13;HSPA14;HSPA5;DNAJC7
gsea,positive regulation of RNA metabolic process (GO:0051254),0.5906056827859422,2.0663252085147037,0.0,0.0003968950944351817,0.079,18/28,29.55%,U2AF2;WDR75;WDR43;HRAS;HEATR1;BUD23;GRSF1;ZC3H18;UTP15;ZPR1;PNPT1;HNRNPLL;POLR2A;DIMT1;RIOK2;SUPV3L1;SETX;DXO
gsea,cellular response to chemical stress (GO:0062197),0.4995927217132246,2.0647289457696063,0.0,0.0003994495278667839,0.08,22/60,30.70%,PPIA;CYCS;EIF2S1;PRDX1;PARK7;PARP1;LONP1;HTRA2;GPX1;GSR;PYCR2;PRDX3;TXNRD1;PNPT1;MT3;SOD2;VKORC1L1;KEAP1;SETX;FANCC;DDX3X;TXNRD2
gsea,ribosomal large subunit assembly (GO:0000027),0.7296766769613292,2.0645340132419228,0.0,0.00039849618770481065,0.08,14/17,18.28%,MRPL20;RPL5;RPL23A;BRIX1;RPLP0;RPF2;NOP2;PPAN;RRS1;BOP1;RPL10;RSL24D1;NLE1;RPL3
gsea,establishment of mitotic spindle orientation (GO:0000132),0.7193217055054065,2.062828582905882,0.0,0.0004045219028238224,0.082,11/17,18.97%,MAD2L1;PLK1;CENPA;NDC80;SAPCD2;SPDL1;GPSM2;NDE1;NSFL1C;ZW10;NUMA1
gsea,positive regulation of translation (GO:0045727),0.5470660217721726,2.0615329554977135,0.0,0.00040704001770748284,0.083,35/52,31.10%,EIF5A;RPS27L;NPM1;C1QBP;HNRNPD;PKM;EIF4A3;EIF3C;YBX3;DHX9;EIF6;CDC123;RPL5;EIF3D;PASK;EIF2B5;CNBP;LARP4;LARP1;MRPS27;LARP4B;NSUN5;FMR1;PRKDC;METTL5;NAT10;FASTKD2;PYM1;FXR2;ZCCHC4;RCC1L;MTOR;DDX3X;EIF5A2;UPF3B
gsea,inner mitochondrial membrane organization (GO:0007007),0.6819226916710853,2.058246958266731,0.0,0.0004303705813667403,0.085,14/19,22.26%,HSPA9;TIMM13;IMMT;SAMM50;APOO;MTX2;TIMM8B;MTX1;TIMM9;LETM1;TIMM10;DNAJC11;CHCHD6;SPG7
gsea,RNA biosynthetic process (GO:0032774),0.6871591504143063,2.0572423902724433,0.0,0.0004466657841158127,0.088,9/17,14.46%,PRIM1;POLA1;PRIM2;SMARCA5;POLA2;PRMT5;TTF2;TAF6;SMN1
gsea,positive regulation of protein modification process (GO:0031401),0.46329871809953693,2.0571897355985658,0.0,0.0004456123270778037,0.088,23/98,27.46%,PPIA;HSP90AA1;TFRC;CDCA2;PIN1;CDK2AP1;PTBP1;UBE2N;AKT1;MYDGF;HRAS;CD74;RACK1;CEP295;PPP1R7;CALM2;VEGFB;SYMPK;MT3;ROCK2;FMR1;CAMKK2;FXR2
gsea,cotranslational protein targeting to membrane (GO:0006613),0.7373051252136157,2.0570582430878512,0.00423728813559322,0.00044456382748467944,0.088,25/32,18.62%,RPS17;RPS2;RPL14;RPS15;RPS25;RPS6;RPL31;RPL41;SSR2;RPL4;RPS8;RPS18;RPL5;RPL23A;RPL10A;RPL15;RPSA;RPLP0;RPS26;RPL8;RPL10;ARL6IP1;RPL3;RPS27A;RPLP1
gsea,hexose biosynthetic process (GO:0019319),0.6648106249917967,2.0556280283332318,0.002074688796680498,0.00045039653337717965,0.089,13/24,22.41%,TPI1;PGAM1;GAPDH;ENO3;ENO1;MDH2;PGK1;GOT2;SLC25A10;SLC25A13;PCK2;ALDOA;PGM1
gsea,RNA catabolic process (GO:0006401),0.5889809281676078,2.055440470533801,0.0,0.0004493417405589661,0.089,18/31,26.01%,LSM2;FEN1;HNRNPD;RNASEH2B;EXOSC7;RNASEH2A;PABPC4;DNA2;METTL16;NCBP1;SND1;MTREX;PPP1R8;ZPR1;PNPT1;CNOT10;RNASEH1;SUPV3L1
gsea,microtubule polymerization or depolymerization (GO:0031109),0.7008934721090055,2.054176045032389,0.0,0.0004585581028626475,0.092,8/16,16.79%,STMN1;KIF2C;KIF18B;KIF14;PIN1;CKAP5;KIF18A;KIF24
gsea,ERAD pathway (GO:0036503),0.5199273200237001,2.051989130142447,0.0,0.0004677314984423024,0.094,17/45,26.54%,HSP90B1;GET4;STUB1;VCP;STT3B;PSMC6;EDEM1;UBQLN1;RNF5;DERL2;HSPA5;DNAJC10;CCDC47;ECPAS;HERPUD1;FOXRED2;ERLIN1
gsea,peptidyl-threonine phosphorylation (GO:0018107),0.5665133331901849,2.051462284743962,0.0,0.00047345606830101743,0.095,10/30,24.93%,CDK1;CIT;CHEK1;CAD;AKT1;STK39;TAF1;CSNK2A2;ROCK2;PRKDC
gsea,erythrocyte differentiation (GO:0030218),0.6299269381381676,2.049700919924718,0.0,0.00047915407403045774,0.097,4/24,8.38%,SLC25A5;LYAR;HSPA9;CASP3
gsea,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.5600971135988523,2.0494295709976886,0.0,0.00047804492108131317,0.097,17/42,27.95%,ANP32B;RPS27L;CYCS;HSPD1;HSPE1;VCP;BAX;RACK1;FAM162A;CASP8AP2;AIFM1;SENP1;PIDD1;IFT57;TRAF2;FADD;BID
gsea,"negative regulation of gene expression, epigenetic (GO:0045814)",0.6863671469120899,2.0486114617868343,0.0,0.00048370601026516625,0.098,10/17,21.40%,RBBP7;DNMT1;EZH2;RBBP4;SUZ12;EED;SMYD5;PHF19;MTF2;PPHLN1
gsea,gluconeogenesis (GO:0006094),0.6754892849537469,2.046475884085437,0.0021645021645021645,0.0005163391362517644,0.106,13/22,22.41%,TPI1;PGAM1;GAPDH;ENO3;ENO1;MDH2;PGK1;GOT2;SLC25A10;SLC25A13;PCK2;ALDOA;PGM1
gsea,RNA stabilization (GO:0043489),0.6820982938680673,2.0461539969466878,0.0,0.0005185191572462313,0.106,9/19,15.98%,YBX1;HNRNPU;DKC1;E2F1;NSUN2;THRAP3;FUS;TAF15;LARP1
gsea,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.5954781681507425,-2.045679392186758,0.0,0.0040324505722576015,0.166,9/25,12.57%,TNFAIP3;CD274;VSIR;ZC3H12A;RARA;SLAMF1;SIRPA;HAVCR2;SYT11
gsea,positive regulation of protein import into nucleus (GO:0042307),0.6482832239096175,2.0452137482651778,0.0,0.0005274077481849662,0.108,4/18,5.71%,RAN;ECT2;IPO5;TRIM28
gsea,peptidyl-proline modification (GO:0018208),0.7151536454070652,2.0452060518850885,0.0,0.0005262008654660073,0.108,9/18,14.76%,PPIA;PPIL1;PPIH;FKBP4;PIN1;PPID;PPIE;PPIF;PPIG
gsea,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.645960776949979,2.044227594046853,0.0,0.0005417192227234466,0.111,9/20,24.41%,RPS27L;HINT1;MYBBP1A;TMEM109;DDIT4;MSH2;RRP8;AEN;PHLDA3
gsea,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.5549407412527685,2.042582259607261,0.0,0.0005538305526839388,0.111,11/35,19.02%,CDK1;CDK4;CCNB1;TRIM28;MED30;CDKN2A;BAX;CDKN1A;PAXIP1;MED8;MED4
gsea,tRNA modification (GO:0006400),0.5268401740742787,2.0424248443241115,0.0,0.0005525718468823844,0.111,33/45,41.97%,SSB;NSUN2;TRMT6;PUSL1;WDR4;METTL1;PUS1;PUS7;TRUB1;ELP5;CTU2;THUMPD1;TYW1;THG1L;DTWD1;FTSJ1;ADAT2;TRMT61A;TRMT10A;TYW5;QTRT2;TYW3;TRMT5;MTO1;PUS10;TRMO;GTPBP3;TRMT1;TRDMT1;DUS2;WDR6;QTRT1;TARBP1
gsea,protein targeting (GO:0006605),0.514729307721862,2.0405527383158866,0.0,0.0005579612452742377,0.112,17/47,26.05%,TIMM23;TOMM40;TIMM17A;TIMM13;TOMM5;ZDHHC2;TOMM20;SPCS3;TIMM8B;PITRM1;TIMM9;TIMM10;EDEM1;ZDHHC6;SRPRB;GIPC1;TIMM44
gsea,mitochondrial respiratory chain complex I assembly (GO:0032981),0.6490015752760291,2.040338462723365,0.0,0.0005587484366473674,0.113,15/19,28.05%,NDUFAB1;NDUFA5;NDUFA12;NDUFV1;NDUFAF2;NDUFAF4;NDUFAF6;TIMMDC1;ACAD9;ECSIT;NDUFS1;FOXRED1;TIMM21;NUBPL;NDUFAF5
gsea,NADH dehydrogenase complex assembly (GO:0010257),0.6490015752760291,2.040338462723365,0.0,0.0005587484366473674,0.113,15/19,28.05%,NDUFAB1;NDUFA5;NDUFA12;NDUFV1;NDUFAF2;NDUFAF4;NDUFAF6;TIMMDC1;ACAD9;ECSIT;NDUFS1;FOXRED1;TIMM21;NUBPL;NDUFAF5
gsea,positive regulation of organelle assembly (GO:1902117),0.5874213540067386,2.039207754100801,0.0,0.0005805812957583285,0.116,10/28,24.60%,G3BP1;PLK4;SPAG5;NUP62;GPSM2;LCP1;CCP110;NUMA1;CNOT1;DYNC1H1
gsea,epithelium development (GO:0060429),0.5713208145055575,2.038448607357184,0.0,0.0005825679631135791,0.116,9/44,9.33%,CDK1;TAGLN2;PCNA;MTHFD1;VDAC1;PGK1;TIMELESS;STIL;PIH1D1
gsea,snRNA transcription (GO:0009301),0.5191586003415323,2.0367874305767133,0.0,0.0005911136511033124,0.119,40/48,43.03%,POLR2F;POLR2L;POLR2C;SRRT;INTS11;NCBP2;TAF6;POLR2E;POLR2H;NCBP1;GTF2F2;POLR2B;GTF2E2;GTF2F1;INTS7;RPRD1B;POLR2A;SP1;INTS10;ZC3H8;INTS8;INTS14;INTS1;TAF9;GTF2E1;INTS5;INTS3;TBP;INTS9;ICE2;INTS2;TAF5;POU2F1;USPL1;INTS13;INTS4;CDK7;INTS6;CCNK;SNAPC4
gsea,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.6200653899299886,-2.0367377206396386,0.0,0.0045264738130976825,0.191,14/24,16.44%,GNA15;CX3CR1;F2R;F2RL2;GPR174;TGM2;CALCA;ACTN2;F2RL1;C3AR1;HOMER1;GPR55;GPR35;P2RY6
gsea,cellular respiration (GO:0045333),0.6613505522081184,2.0360104953201943,0.0,0.0005996211033525995,0.121,8/18,15.73%,CYCS;ETFB;MDH2;NDUFA5;MTFR2;UQCRC1;SDHA;SLC25A13
gsea,ubiquitin-dependent ERAD pathway (GO:0030433),0.5380641832045631,2.0353388230818505,0.002053388090349076,0.0006015519675612876,0.122,17/37,31.35%,HSP90B1;STUB1;VCP;STT3B;PSMC6;EDEM1;UBQLN1;RNF5;DERL2;HSPA5;DNAJC10;ECPAS;HERPUD1;FOXRED2;ERLIN1;NPLOC4;TMEM129
gsea,protein acetylation (GO:0006473),0.641771140945596,2.0342094070875687,0.0,0.0006230463682614052,0.124,10/20,26.51%,ESCO2;HAT1;DSCC1;NAA50;NAA15;NAA10;NAA40;NAA35;NAA16;NAT10
gsea,purine ribonucleotide metabolic process (GO:0009150),0.5915858900601216,2.0336969166189935,0.0,0.0006281713686379127,0.125,3/29,1.39%,RAN;HINT1;DBI
gsea,mitochondrial respiratory chain complex assembly (GO:0033108),0.5784977059159173,2.0334550477639337,0.0,0.0006300260846028949,0.125,22/34,28.28%,NDUFAB1;NDUFA5;NDUFA12;NDUFV1;COX17;SAMM50;CHCHD4;NDUFAF2;NDUFAF4;AIFM1;SDHAF1;NDUFAF6;COX18;TIMMDC1;ACAD9;ECSIT;NDUFS1;FOXRED1;TIMM21;NUBPL;NDUFAF5;IMMP2L
gsea,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.6643983988959411,-2.032760795828717,0.0,0.004605080409618842,0.198,8/16,14.99%,FURIN;IL1B;TNF;IFNG;ADAM8;SNX9;APOE;TIMP2
gsea,regulation of lipid metabolic process (GO:0019216),0.5235868657618166,2.03227423937165,0.0,0.0006448340829648892,0.129,27/45,35.46%,FDPS;IDI1;SQLE;HMGCS1;HMGCR;FASN;FDFT1;SC5D;PMVK;CARM1;SREBF2;NCOR2;DHCR7;SP1;SIN3A;NFYB;ACACA;OPA3;NFYC;MID1IP1;NFYA;LSS;TM7SF2;MVD;MVK;PLPP1;TBL1X
gsea,chaperone-mediated protein complex assembly (GO:0051131),0.7421387347285279,2.0321451228012144,0.0,0.0006466438273045801,0.13,10/15,11.68%,HSP90AB1;HSP90AA1;HSPD1;PTGES3;CCT2;PFDN6;HSPA4;PSMG2;PSMG1;LONP1
gsea,7-methylguanosine RNA capping (GO:0009452),0.6534333203452599,2.0311891556378874,0.002232142857142857,0.0006502394512234388,0.132,17/20,30.46%,POLR2F;POLR2L;POLR2C;NCBP2;POLR2E;POLR2H;NCBP1;GTF2F2;POLR2B;GTF2F1;POLR2A;GTF2H4;GTF2H3;GTF2H1;GTF2H2;CMTR1;RNMT
gsea,7-methylguanosine mRNA capping (GO:0006370),0.6534333203452599,2.0311891556378874,0.002232142857142857,0.0006502394512234388,0.132,17/20,30.46%,POLR2F;POLR2L;POLR2C;NCBP2;POLR2E;POLR2H;NCBP1;GTF2F2;POLR2B;GTF2F1;POLR2A;GTF2H4;GTF2H3;GTF2H1;GTF2H2;CMTR1;RNMT
gsea,mitochondrial gene expression (GO:0140053),0.6002020584763343,2.030021932869438,0.0,0.0006520254354726084,0.132,19/27,27.85%,MRPL12;MRPL51;MRPS28;MRPS7;MRPL2;MRPS12;MRPS18B;TFAM;MRPS18A;NOA1;MRPL16;MRPS6;MRPS2;PTCD3;RARS2;QRSL1;FASTKD2;MRPL47;IARS2
gsea,protein catabolic process (GO:0030163),0.5760230460963369,2.0290469945428815,0.0,0.0006634183624745929,0.135,10/32,20.59%,HSP90AA1;PRPF19;UCHL3;DDB1;VCP;HSPA8;HTRA2;STT3B;RNF5;CHEK2
gsea,regulation of protein import into nucleus (GO:0042306),0.6167435931651093,2.027904060026355,0.0,0.0006779594606880203,0.139,4/20,5.71%,RAN;ECT2;IPO5;TRIM28
gsea,protein polymerization (GO:0051258),0.6340995337356292,2.0276470591365245,0.0,0.000676482424825955,0.139,5/24,7.77%,UBE2C;UBE2S;DIAPH3;PIN1;CKAP5
gsea,organic hydroxy compound biosynthetic process (GO:1901617),0.6612258502166576,2.0274012480644656,0.0,0.0006781958288346917,0.14,10/20,22.02%,PSAT1;PARK7;LBR;SQLE;HMGCR;MSMO1;SC5D;INSIG1;PMVK;DHCR7
gsea,phospholipid biosynthetic process (GO:0008654),0.5912154137702549,2.0272522778105877,0.0,0.0006767246882081523,0.14,16/25,33.20%,FDPS;IDI1;AGPAT5;DPAGT1;CRLS1;LPCAT1;MBOAT1;PCYT2;DHDDS;FAR1;GNPAT;NUS1;FADS1;MVD;DOLPP1;AGK
gsea,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.5135743369566356,2.0271932405239435,0.0,0.0006752599161557537,0.14,20/59,27.95%,HMGB1;ANP32B;RPS27L;CYCS;HSPD1;HSPE1;VCP;BAX;RACK1;HTRA2;FAM162A;CASP8AP2;AIFM1;SENP1;PIDD1;IFT57;TRAF2;FADD;MYC;BID
gsea,positive regulation of apoptotic process (GO:0043065),0.42129537051013294,2.026896792453175,0.0,0.0006738014714124368,0.14,32/160,19.62%,TOP2A;HMGB1;C1QBP;HSPD1;MELK;RNPS1;RPS6;ECT2;E2F1;MYBBP1A;PPID;BARD1;CASP3;MTCH2;EEF1E1;BAX;RACK1;BCLAF1;HTRA2;RRP1B;FAM162A;UTP11;AIFM1;CCAR1;DDX20;BAK1;PTRH2;RPS27A;NET1;FAF1;SHQ1;TFAP4
gsea,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.5673537621166911,2.025418274644023,0.0,0.0006818190217036483,0.143,14/31,24.93%,RPS27L;BRCA1;E2F1;TMEM109;DDIT4;BAX;MSH2;HTRA2;MSH6;BAK1;CHEK2;AEN;PHLDA3;PRKDC
gsea,regulation of protein catabolic process (GO:0042176),0.5120067370065674,2.0246573311717517,0.0,0.0006835025254609413,0.144,17/45,20.59%,MAD2L1;DTL;PHB;ODC1;PIN1;FAM83D;BARD1;SF3B3;DDB1;VCP;FZR1;ZDHHC2;HMGCR;NEDD4;FAF1;FLNA;CHEK2
gsea,snRNA transcription by RNA polymerase II (GO:0042795),0.5180539062288504,2.024200681171729,0.0,0.0006851788038802201,0.144,39/47,43.03%,POLR2F;POLR2L;POLR2C;SRRT;INTS11;NCBP2;TAF6;POLR2E;POLR2H;NCBP1;GTF2F2;POLR2B;GTF2E2;GTF2F1;INTS7;RPRD1B;POLR2A;SP1;INTS10;ZC3H8;INTS8;INTS14;INTS1;TAF9;GTF2E1;INTS5;INTS3;TBP;INTS9;ICE2;INTS2;TAF5;POU2F1;INTS13;INTS4;CDK7;INTS6;CCNK;SNAPC4
gsea,positive regulation of nucleic acid-templated transcription (GO:1903508),0.401076507389054,2.0235625319858146,0.0,0.0006868479033769324,0.144,95/258,37.72%,HMGB2;HNRNPAB;NPM1;HNRNPD;NME2;ATAD2;MRPL12;BRCA1;PHB;SMARCC1;E2F1;DNAJC2;HDAC1;BRCA2;PHF5A;NUP85;TRIM28;NUP62;MED30;ILF2;BLM;MYB;THRAP3;HDAC2;HMGN5;FOXM1;MAZ;HMGA1;AKT1;SMARCA4;CD74;PSMC5;TAF15;TFAM;CTCF;SPP1;XRCC6;NAA15;CNBP;SNX5;TCF3;BRD7;KAT2A;MED4;TFAP4;PITHD1;ILF3;CHEK2;SMARCC2;HCFC1;EOMES;FOXK2;SP1;MT3;ING1;MYBL1;NAA16;CDK5RAP2;PCID2;MYC;CAMKK2;ANKRD49;PRDM16;KAT8;TRIM44;GTF2H1;NFYA;KDM8;TASP1;TESC;LBH;TCF4;NPAT;CEP290;MED14;MED16;PHIP;TRERF1;BRPF1;CREB1;PPP3CB;MED24;ING5;TADA3;TBL1X;SHC1;RUNX3;CHD8;PSRC1;OSR2;MAP2K3;CHUK;LEF1;JMJD6;FUBP3
gsea,positive regulation of developmental process (GO:0051094),0.485542111593505,2.0227256082369216,0.0,0.0006853802796517681,0.144,27/73,34.26%,PA2G4;FBXO5;HSP90AB1;CDC20;C1QBP;TFRC;AURKA;CFL1;RIF1;LLPH;PAXIP1;CORO1C;VPS35;NUMA1;ZDHHC6;ZBED3;FMR1;CLASP1;RALA;LRP8;RBM19;CLASP2;BASP1;SRF;KMT5C;B4GALT5;SPIRE1
gsea,regulation of proteasomal protein catabolic process (GO:0061136),0.6008909377151818,2.0225883234732613,0.0,0.0006839189144499519,0.144,18/28,26.48%,HSP90AB1;UCHL5;RAD23A;ALAD;USP14;XPO1;PSMC2;PSMD14;PSMC5;PSME2;RAD23B;PSME3;GPX1;PSMC6;DESI1;FMR1;GLMN;UBQLN4
gsea,regulation of neurogenesis (GO:0050767),0.5994079236125581,2.022376313247318,0.0017211703958691911,0.0006824637678234627,0.144,2/26,0.96%,HMGB2;NAP1L1
gsea,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.6202126195005071,2.0219654450879885,0.0,0.0006841244567852915,0.145,8/21,17.74%,EZH2;TFDP1;PHB2;EIF4G1;FAM83D;AKT1;RDX;LSM11
gsea,positive regulation of histone methylation (GO:0031062),0.7116063373535926,2.0178445385239887,0.0,0.0007416333395210274,0.159,8/15,19.72%,DNMT1;BRCA1;MYB;RIF1;WDR5;PAXIP1;PHF19;MTF2
gsea,positive regulation of cytoskeleton organization (GO:0051495),0.545085505929653,2.0173026575990396,0.0,0.000740065404342336,0.159,12/41,24.60%,PLK4;SPAG5;NUP62;GPSM2;PFN1;HRAS;HAX1;NUMA1;SYNPO2;PRKCE;PDXP;DYNC1H1
gsea,negative regulation of GTPase activity (GO:0034260),0.6765807603534122,2.0150825448710963,0.0,0.0007663138621804406,0.166,5/16,13.75%,RCC2;TMED2;HRAS;RRP1B;RDX
gsea,regulation of megakaryocyte differentiation (GO:0045652),0.5850071210438639,2.01115720112611,0.0,0.0008109526204341092,0.177,7/32,13.07%,HMGB2;PRMT1;DPY30;HDAC1;EIF6;WDR5;ASH2L
gsea,negative regulation of binding (GO:0051100),0.5117398838684684,2.0103301465370502,0.0,0.0008184799149427238,0.178,17/50,23.10%,AURKB;PARK7;E2F1;PIN1;AURKA;AKT1;GTPBP4;BAX;SUMO3;CDKN1A;RACK1;ACTB;GTF2F1;TFAP4;SYMPK;CTSZ;TLE5
gsea,cellular senescence (GO:0090398),0.6772047783305513,2.0097607458101083,0.0,0.0008198345655798352,0.179,7/18,14.02%,CALR;CDKN2A;HMGA1;HRAS;CDKN1A;SMC6;SMC5
gsea,epidermis development (GO:0008544),0.6462996990522888,2.009054379145779,0.0,0.0008181194305054005,0.179,5/22,12.79%,FABP5;YBX1;HDAC1;HDAC2;ATP2A2
gsea,regulation of telomere maintenance (GO:0032204),0.6224347338204295,2.008871295017271,0.003992015968063872,0.0008225268983700859,0.181,12/20,27.58%,HNRNPD;RAD50;GNL3;NBN;XRCC5;RTEL1;ATRX;PIF1;TINF2;YLPM1;MYC;USP7
gsea,positive regulation of viral process (GO:0048524),0.5761604456341101,2.008443482538358,0.0,0.0008238646512252417,0.182,22/35,23.20%,PPIA;KPNA2;PPIH;POLR2F;PPID;POLR2L;DHX9;POLR2C;PPIE;RAD23A;DDB1;NELFE;POLR2E;POLR2H;NELFCD;GTF2F2;POLR2B;LARP1;SRPK1;GTF2F1;POLR2A;TARBP2
gsea,sterol biosynthetic process (GO:0016126),0.6429216911275861,2.0077126323018994,0.0,0.0008221518349025282,0.182,20/24,33.50%,FDPS;IDI1;LBR;SQLE;HMGCS1;HMGCR;DHCR24;FDFT1;MSMO1;SC5D;INSIG1;PMVK;HSD17B7;DHCR7;ACAT2;ACLY;LSS;TM7SF2;MVD;MVK
gsea,positive regulation of programmed cell death (GO:0043068),0.41720065109597654,2.005117680015946,0.0,0.0008629877766637849,0.19,30/154,19.62%,TOP2A;HMGB1;C1QBP;HSPD1;MELK;RNPS1;RPS6;ECT2;E2F1;PPID;BARD1;CASP3;MTCH2;EEF1E1;BAX;RACK1;BCLAF1;HTRA2;RRP1B;FAM162A;UTP11;AIFM1;CCAR1;DDX20;BAK1;RPS27A;NET1;FAF1;SHQ1;TFAP4
gsea,rRNA modification (GO:0000154),0.6841493533498825,2.0041590600540804,0.0021008403361344537,0.0008763630428492104,0.194,14/17,29.02%,NHP2;GAR1;FBL;DKC1;NOP10;FTSJ3;BUD23;THUMPD1;DIMT1;TFB1M;METTL5;NAT10;ZCCHC4;TSR3
gsea,MAPK cascade (GO:0000165),0.4393740953779148,1.9978765410896966,0.0,0.0009229704999952202,0.203,40/142,27.74%,CDK1;PSMB6;PSMB5;YWHAE;PEBP1;PSMA4;PSMB2;PSMA6;PSMA3;PSMD7;PSMD1;PSMD12;PSMD2;PSMA5;PSMD3;PSMB7;PSMC4;PSMD6;PSMC1;PSMC2;PPP5C;PSMD14;HRAS;PSMD11;PSMC5;PSME2;PSME3;PSMC6;RPS27A;SPTBN1;CUL1;PTPN7;MT3;PPP1CB;MYC;CAMKK2;SETX;ARL2;NRAS;HSF1
gsea,positive regulation of protein kinase activity (GO:0045860),0.48800842375903475,1.9975959746612215,0.0,0.0009210674680364672,0.203,18/74,21.08%,TPX2;CLSPN;CENPE;HSP90AB1;HSP90AA1;EZH2;INCENP;ECT2;KIF14;PIH1D1;CDKN1A;XRCC6;XRCC5;CALM2;BORA;ETAA1;MRNIP;TELO2
gsea,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.7410390366398321,1.9973167375428862,0.00425531914893617,0.0009221859470504763,0.203,23/30,18.62%,RPS17;RPS2;RPL14;RPS15;RPS25;RPS6;RPL31;RPL41;RPL4;RPS8;RPS18;RPL5;RPL23A;RPL10A;RPL15;RPSA;RPLP0;RPS26;RPL8;RPL10;RPL3;RPS27A;RPLP1
gsea,transcription by RNA polymerase I (GO:0006360),0.612173859300731,1.9958018754096012,0.004081632653061225,0.0009443522719040872,0.206,17/25,28.82%,POLR2F;POLR2L;TCOF1;POLR2E;POLR2H;TAF1D;TAF1;UBTF;GTF2H4;POLR1B;POLR1A;RRN3;POLR1C;POLR1E;GTF2H3;GTF2H1;GTF2H2
gsea,internal peptidyl-lysine acetylation (GO:0018393),0.6460487504262966,1.9955246814862817,0.0020876826722338203,0.0009424171238059231,0.206,11/18,28.18%,RUVBL2;RUVBL1;NAA50;TAF6;SGF29;MORF4L2;TAF6L;KAT2A;BRD8;KAT7;KAT8
gsea,positive regulation of gene expression (GO:0010628),0.4213577935365665,1.9952659868177933,0.0,0.0009524706533592434,0.208,72/227,29.74%,MIF;RPS27L;DNMT1;NPM1;DEK;HNRNPD;GAPDH;TFRC;BRCA1;POLR2F;PARK7;PHB;EIF4A3;E2F1;EIF3C;MYBBP1A;BAZ1B;U2AF2;POLR2L;EIF6;SMARCA5;RPL5;HMGN5;MAZ;FUBP1;AKT1;EIF3D;TNFSF4;CD74;DDX21;PASK;CTCF;FAM98B;POLR2E;ACTB;POLR2H;RDX;EZR;LARP4;TAF1D;VPS35;KAT2A;LARP4B;ZPR1;HNRNPLL;POLR2A;POLR1B;FAM98A;HCFC1;NSUN5;SP1;MT3;POLR1A;ROCK2;FMR1;GLMN;PRKDC;GABPA;POLR1C;POLR1E;METTL5;NAT10;MYC;SETX;PYM1;FXR2;TNRC6A;ZCCHC4;TESC;TTN;MTOR;DDX3X
gsea,positive regulation of RNA splicing (GO:0033120),0.6418444187976685,1.995113005567878,0.0,0.0009505268356993265,0.208,12/20,26.85%,NCL;DAZAP1;U2AF2;THRAP3;RBMXL1;SF3B4;NCBP1;ZPR1;HNRNPLL;POLR2A;RBMX;SETX
gsea,histone acetylation (GO:0016573),0.5113536969056217,1.994567107189085,0.0,0.000963505887651516,0.213,29/46,37.64%,HAT1;RUVBL2;POLE3;BRCA2;RUVBL1;ACTL6A;NAA50;WDR5;TAF6;SGF29;MORF4L2;NAA40;TADA2A;TAF6L;KAT2A;BRD8;KAT7;KAT8;DMAP1;EP400;ZZZ3;TAF9;BRPF1;JADE1;ING5;TADA3;JADE2;LEF1;TAF5
gsea,regulation of inflammatory response (GO:0050727),-0.4566172372885408,-1.9933980468433212,0.0,0.007284426840207279,0.293,53/101,18.23%,CCL5;TNFAIP3;TMSB4X;NFKBIA;ETS1;NFKBIZ;CCL1;ZBP1;PDCD4;CCR2;IL16;SEMA7A;PIK3AP1;IL1B;TNF;TNFAIP8L2;FOXP1;PTGER4;USP18;ANXA1;NINJ1;IFNG;SIRPA;AREL1;SBNO2;IL17RA;PTGS2;CASP4;XCL1;APP;HCK;RORA;IL2;NLRP3;TLR2;BCL6;MEFV;TNFRSF1A;CASP1;APOE;SPATA2;ACOD1;LPL;METRNL;CD200R1;TLR7;NLRC3;PLA2G7;JAK2;MMP9;GATA3;MGST2;GRN
gsea,cellular response to interleukin-1 (GO:0071347),0.4973759972909891,1.9930274691479162,0.0,0.000979409106605617,0.217,27/75,20.29%,PSMB6;PSMB5;PSMA4;PSMB2;PSMA6;PSMA3;PSMD7;PSMD1;PSMD12;PSMD2;PSMA5;PSMD3;PSMB7;PSMC4;PSMD6;UBE2N;PSMC1;PSMC2;PSMD14;PSMD11;PSMC5;PSME2;PSME3;PSMC6;RPS27A;USP10;CUL1
gsea,protein transmembrane import into intracellular organelle (GO:0044743),0.6706726059135198,1.9847486730279278,0.0020876826722338203,0.0010487238111607314,0.225,9/18,14.72%,HSPD1;TIMM23;TIMM50;TOMM40;TIMM17A;GRPEL1;TOMM20;CHCHD4;AIFM1
gsea,regulation of peptide hormone secretion (GO:0090276),-0.5772590702808298,-1.9830659018441794,0.0029585798816568047,0.008146861522000112,0.323,8/27,8.29%,CCL5;ITPR2;IL1B;TNF;PRKCA;GLP1R;IFNG;HFE
gsea,regulation of protein dephosphorylation (GO:0035304),0.6188320815555789,1.9792146041628533,0.0,0.001120722764419762,0.237,9/21,20.85%,PPIA;HSP90B1;CDCA2;PIN1;PTBP1;PPP1R7;CALM2;PPP1R8;SYMPK
gsea,cilium organization (GO:0044782),0.4431500757642756,1.9790466556540036,0.0,0.001118458678026995,0.237,48/92,40.84%,PLK4;DYNLL2;MNS1;PCNT;TMEM107;CEP83;CCP110;CFAP298;ODF2;CEP89;KIF24;POC1B;WDR90;SCLT1;TMEM237;FLNA;RTTN;SSX2IP;CEP78;CENPJ;PCM1;CEP162;DYNC2H1;EXOC4;TMEM138;CEP290;EHD4;CEP19;ACTR2;OFD1;IFT74;NEK1;CEP164;CCDC66;RP2;IQCB1;TMEM216;RAB23;CEP250;IFT140;RAB3IP;CEP41;HDAC6;IFT88;KIFAP3;IFT46;SNX10;AHI1
gsea,neuron development (GO:0048666),0.48162710503934997,1.9782787650983584,0.0,0.001122109560808573,0.239,4/60,4.90%,STMN1;HMGB1;PRMT1;MANF
gsea,protein tetramerization (GO:0051262),0.5608661207675005,1.9780324740574005,0.0,0.0011198517950926604,0.239,13/30,24.52%,TK1;SHMT1;SHMT2;FARSB;ALDH9A1;CPSF6;FARSA;APIP;ALDOA;CBY1;THG1L;SOD2;ACACA
gsea,negative regulation of cellular process (GO:0048523),0.39591345075171563,1.9749099453898944,0.0,0.0011734832515443872,0.248,57/250,24.91%,ANP32B;GMNN;RBBP7;MIF;ORC6;FBXO5;NPM1;NME1;CDC6;RBBP4;CDKN3;ENO1;PARK7;PHB;SUZ12;NUP62;E2F7;RAD18;TMEM109;BLM;CDKN2A;ARHGDIA;SRSF6;FOXM1;EEF1E1;SMYD2;HMGA1;GTPBP4;SMARCA4;HRAS;CDKN1A;RACK1;HTRA2;SINHCAF;TAF6;CTCF;UTP20;PDS5B;SMYD5;BRD7;VPS35;DNAJA3;PBRM1;PINX1;TFAP4;DSCAM;NME6;ARHGDIG;OSGIN2;MT3;SOD2;ING1;CHERP;CDK6;THAP12;MYBL1;GLMN
gsea,regulation of viral transcription (GO:0046782),0.600728019956592,1.9742915014192521,0.0,0.0011975480835445063,0.255,14/22,23.20%,POLR2F;POLR2L;DHX9;POLR2C;NELFE;POLR2E;POLR2H;NELFCD;GTF2F2;POLR2B;GTF2F1;LARP7;POLR2A;TARBP2
gsea,negative regulation of double-strand break repair (GO:2000780),0.6274310960947671,1.9729972976278924,0.0,0.0012332338423673842,0.261,7/20,12.26%,AUNIP;RMI2;PARPBP;RIF1;SMCHD1;CGAS;POLQ
gsea,receptor signaling pathway via JAK-STAT (GO:0007259),-0.6416966446275523,-1.9698302033743509,0.008064516129032258,0.009040478001365895,0.355,10/18,12.52%,STAT1;CLCF1;STAT4;CCR2;STAT3;IFNG;STAT2;IFNAR2;SOCS2;CCL2
gsea,lipid biosynthetic process (GO:0008610),0.5212675351815461,1.969797583861064,0.002044989775051125,0.001289241290540099,0.27,24/37,38.92%,NDUFAB1;ACSL5;HMGCR;AGPAT5;FDFT1;PDSS1;LPCAT1;MBOAT1;ACACA;PCYT2;ACLY;GNPAT;FDXR;FADS1;LSS;MVD;DOLPP1;MCAT;MVK;GPAT4;CBR4;ABCD3;ACSL1;PDSS2
gsea,RNA methylation (GO:0001510),0.5043509563869809,1.966940251825367,0.0,0.0013275198452677645,0.277,31/45,41.97%,FBL;NSUN2;FTSJ3;TRMT6;NOP2;METTL1;METTL16;BUD23;DIMT1;VIRMA;NSUN5;TFB1M;METTL5;FTSJ1;ZCCHC4;RBM15B;TRMT61A;CMTR1;TRMT10A;METTL14;TYW3;RBM15;TRMT5;MTO1;TRMO;GTPBP3;TRDMT1;TRMT10C;ZC3H13;WDR6;TARBP1
gsea,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.6359861536757069,-1.9653324808729395,0.0,0.009031069359102029,0.366,7/19,9.23%,CCL5;IL10RA;SOCS1;TNF;F2R;NLK;NOTCH1
gsea,response to interferon-gamma (GO:0034341),-0.5407808065621945,-1.9649161329370286,0.0,0.008786152466382414,0.366,23/46,14.07%,CCL5;GCH1;STAT1;SP100;GBP6;IFITM1;IFITM2;CCL1;GBP4;IFITM3;GBP2;CCL4;CD40;SIRPA;XCL1;AIF1;TLR2;MEFV;CCL2;CCL8;DAPK1;CASP1;ACOD1
gsea,cytoskeleton-dependent intracellular transport (GO:0030705),0.6787382101208934,1.9645098444533007,0.0,0.0013656461989825963,0.28,3/17,9.52%,TUBA1B;TUBA1C;TUBA1A
gsea,positive regulation of response to external stimulus (GO:0032103),-0.48258883142665315,-1.9637976803828232,0.0,0.008631338420022026,0.367,36/66,18.23%,CCL5;NFKBIA;ETS1;NFKBIZ;CCL1;ZBP1;PDCD4;CCR2;IL16;IL1B;TNF;PRKCA;PTGER4;NINJ1;IFNG;IL17RA;CD180;THBS1;APP;DHX58;AIF1;ADAM8;DDX60;IL2;SCIMP;TLR2;F2RL1;TNFRSF1A;LY86;PDGFB;ACOD1;LPL;TLR7;PLA2G7;MGST2;GRN
gsea,protein export from nucleus (GO:0006611),0.6524389384308604,1.9636284192042872,0.0,0.0013832789205757146,0.284,14/17,30.07%,RAN;NUTF2;CALR;CSE1L;ANKLE1;XPO1;XPO4;DESI1;NUP214;CCHCR1;RANBP3;XPO6;XPO5;XPO7
gsea,intracellular protein transmembrane transport (GO:0065002),0.6290890711203977,1.962819955513,0.0,0.0013950412224047217,0.286,14/22,27.60%,HSPD1;TIMM23;TIMM50;TOMM40;TIMM17A;GRPEL1;TOMM20;CHCHD4;AIFM1;HSPA5;DNAJC15;PEX7;TIMM44;TIMM21
gsea,chemokine-mediated signaling pathway (GO:0070098),-0.6063991150268755,-1.9594293268506853,0.005277044854881266,0.008732988978284093,0.374,15/26,18.79%,CCL5;CCL1;CCR2;CCL4;XCL1;PTK2B;CXCL9;CXCL2;CCL2;CCL8;PF4;CCL7;GPR35;SH2B3;CCL22
gsea,cytokine-mediated signaling pathway (GO:0019221),0.39506974389766825,1.9590361484593237,0.0,0.001458859145252602,0.299,68/311,27.72%,BIRC5;PPIA;EIF5A;MIF;LMNB1;TCP1;HSP90AA1;HSP90B1;HNRNPA2B1;PSMB6;SNRPA1;HNRNPF;PSMB5;HSPA9;PSMA4;PSMB2;PSMA6;PSMA3;CANX;PSMD7;PSMD1;PSMD12;CFL1;PSMD2;PSMA5;HNRNPDL;PSMD3;CASP3;P4HB;PSMB7;PSMC4;PSMD6;UBE2N;ACTN4;AKT1;PSMC1;GSTO1;SMARCA4;MTAP;PSMC2;PSMD14;TNFSF4;HSPA8;CDKN1A;PSMD11;PSMC5;PSME2;PSME3;RPLP0;TNFRSF4;LCP1;IFI30;PLP2;TXLNA;PSMC6;RPS27A;CUL1;MID1;MT3;SOD2;JAGN1;TRAF2;IL9R;RALA;LRP8;MYC;PTPN6;ANXA2
gsea,protein-containing complex assembly (GO:0065003),0.4290868854044456,1.9578113906854948,0.0,0.001470425974047418,0.303,64/134,41.68%,PPIH;KNTC1;STOML2;HDAC1;RUVBL1;PPID;BLM;DHX9;CHCHD10;CDC123;LMAN1;TMED2;SMARCA4;SAMM50;CD74;TUBGCP2;ST13;ASH2L;NIFK;KPNA3;GEMIN5;FANCA;CAPZA2;ZW10;TFAP4;CUL1;CAND1;LEO1;PDZD11;TSPAN4;CTSZ;MDN1;SPG7;TCF7;TRAF2;FADD;MYC;ZNHIT6;HSF1;OPA1;FANCC;AFG3L2;CD2AP;NSF;CUL3;MEN1;WDCP;RBBP5;SLC2A1;CDC73;SEC23IP;SEC24D;TUBGCP4;LEF1;AREG;MDM2;DNAJB12;NDUFAF1;KIFAP3;CTNNB1;ANKRD28;AXIN1;TRRAP;PPP6R3
gsea,negative regulation of oxidative stress-induced cell death (GO:1903202),0.6538757021100686,1.957256161635977,0.00202020202020202,0.0014819472641461916,0.304,4/15,12.08%,PPIA;PARK7;AKT1;HTRA2
gsea,enzyme linked receptor protein signaling pathway (GO:0007167),-0.5070160586591538,-1.9571542161799662,0.0,0.008780976021488631,0.378,21/42,18.58%,CSF1;STYK1;SLA;CD7;NEDD9;LCP2;FLT1;SYK;FES;LYN;PTK2B;HCK;CASS4;CSF1R;RAPGEF1;FGR;CD4;RET;JAK2;BLNK;LIFR
gsea,cholesterol biosynthetic process (GO:0006695),0.6482917760486052,1.9562003710237574,0.00211864406779661,0.001499178286970883,0.306,20/22,33.50%,FDPS;IDI1;LBR;SQLE;HMGCS1;HMGCR;DHCR24;FDFT1;MSMO1;SC5D;INSIG1;PMVK;HSD17B7;DHCR7;ACAT2;ACLY;LSS;TM7SF2;MVD;MVK
gsea,positive regulation of protein ubiquitination (GO:0031398),0.5352129725217659,1.954112252698628,0.0022172949002217295,0.0015249573152090747,0.31,14/37,20.74%,PLK1;RPS2;CENPS;BRCA1;PIN1;STUB1;UBE2N;FANCI;FANCM;HSPBP1;PAXIP1;UBQLN1;TBC1D7;MTA1
gsea,transcription initiation from RNA polymerase I promoter (GO:0006361),0.6131281370375655,1.9502068012352258,0.002004008016032064,0.0015936290361599804,0.322,16/23,28.82%,POLR2F;POLR2L;POLR2E;POLR2H;TAF1D;TAF1;UBTF;GTF2H4;POLR1B;POLR1A;RRN3;POLR1C;POLR1E;GTF2H3;GTF2H1;GTF2H2
gsea,negative regulation of mRNA catabolic process (GO:1902373),0.6556577070319043,1.9501641297213481,0.0,0.0015905164794487307,0.322,7/17,15.98%,YBX1;HNRNPU;E2F1;THRAP3;FUS;TAF15;LARP1
gsea,positive regulation of mitotic nuclear division (GO:0045840),0.6572312905755997,1.9501556815141077,0.0033277870216306157,0.001587416057461501,0.322,10/21,22.15%,NUSAP1;DLGAP5;ANAPC5;NUP62;ESPL1;AURKA;CDC16;CDC27;CDC23;ANAPC4
gsea,protein ADP-ribosylation (GO:0006471),0.6451120272066473,1.9493617307877198,0.002074688796680498,0.001612822801879764,0.324,3/16,11.37%,HPF1;PARP1;PARP2
gsea,regulation of immune response (GO:0050776),-0.4825462624592924,-1.9470436230717907,0.0,0.009720921079338522,0.412,34/70,17.40%,SAMHD1;IRF1;CLEC2D;JAML;SLAMF7;IFITM1;IRF4;IRF7;TYROBP;ICAM1;CRTAM;RSAD2;FOXP1;CD226;CD300A;CD40;CD40LG;SYK;FCGR2B;PVR;LYN;FOXP3;IL4I1;ITGB7;CD300LF;DHX58;BCL6;FGR;CD300LD;AHR;CD200R1;COL1A1;NCR1;ITGB1
gsea,leukocyte cell-cell adhesion (GO:0007159),-0.653211105018351,-1.9466103941655533,0.004415011037527594,0.009546744769442384,0.413,5/15,7.38%,CCL5;ICAM1;NT5E;CD40LG;SYK
gsea,ncRNA metabolic process (GO:0034660),0.6106970871474917,1.9465085417116414,0.00398406374501992,0.0016438188337715286,0.33,12/19,29.94%,RAN;KHSRP;NIFK;DGCR8;DROSHA;TARBP2;DTD2;DTD1;ZCCHC8;PARN;XPO5;DICER1
gsea,positive regulation of type I interferon production (GO:0032481),0.4830489062297922,1.9426356963823994,0.0,0.0017570102294863898,0.342,14/54,15.28%,HSP90AA1;HSPD1;G3BP1;GAPDH;POLR2F;POLR3K;POLR2L;DHX9;CGAS;POLR3H;POLR2E;POLR2H;XRCC6;XRCC5
gsea,signal transduction by p53 class mediator (GO:0072331),0.6328731257719751,1.9420380342825159,0.0,0.0017621106832137556,0.344,8/18,19.77%,HINT1;MYBBP1A;E2F7;PAXIP1;NBN;ATRX;USP10;RRP8
gsea,positive regulation of defense response (GO:0031349),-0.4951894352439858,-1.9417314861955783,0.002347417840375587,0.00978407003810113,0.42,25/52,18.23%,CCL5;NFKBIA;ETS1;NFKBIZ;CCL1;ZBP1;PDCD4;CCR2;IL16;IL1B;TNF;PTGER4;NINJ1;IFNG;IL17RA;APP;ADAM8;IL2;TLR2;TNFRSF1A;LPL;TLR7;PLA2G7;MGST2;GRN
gsea,positive regulation of erythrocyte differentiation (GO:0045648),0.656273217798228,1.939376776633744,0.001976284584980237,0.001812431545037769,0.355,2/15,2.20%,HMGB2;PRMT1
gsea,glucose homeostasis (GO:0042593),0.567644541488431,1.9392895651275768,0.0,0.001811761442386145,0.355,3/29,4.62%,NUCKS1;PARK7;RPS6
gsea,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.632680012539072,1.9390791361743485,0.0020876826722338203,0.0018110939170524118,0.356,9/19,21.29%,TFDP1;YWHAE;E2F1;CHCHD10;BAX;TFDP2;BAK1;GZMB;NMT1
gsea,"DNA-templated transcription, initiation (GO:0006352)",0.4432214902002362,1.9358730151411958,0.0,0.0018975769318047794,0.37,43/86,36.21%,POLR2F;HDAC1;POLR2L;POLR2C;SMARCA5;MAZ;TAF15;TFAM;TAF6;POLR3H;POLR2E;POLR2H;E2F2;GTF2F2;POLR2B;GTF2E2;TAF1D;TAF1;GTF2F1;UBTF;POLR2A;NCOR2;GTF2H4;POLR1B;POLR1A;TFB1M;RRN3;POLR1C;POLR1E;TAF3;NR2C2AP;GTF2H3;GTF2H1;GTF2H2;MED7;E2F3;TAF9;GTF2E1;POLRMT;GTF3C1;TBP;TBL1X;TAF2
gsea,neuron projection development (GO:0031175),0.4643045339548083,1.9355930742397638,0.0,0.0019023592457410434,0.373,9/75,20.73%,STMN1;HMGB1;PRMT1;KIF20B;MANF;NEFH;NEDD4;MAP4;ZPR1
gsea,secondary alcohol biosynthetic process (GO:1902653),0.6473259218581504,1.9355733855158475,0.0,0.0018987218475656302,0.373,19/21,33.50%,FDPS;IDI1;LBR;SQLE;HMGCS1;HMGCR;DHCR24;FDFT1;MSMO1;INSIG1;PMVK;HSD17B7;DHCR7;ACAT2;ACLY;LSS;TM7SF2;MVD;MVK
gsea,negative regulation of epithelial cell apoptotic process (GO:1904036),-0.6260886165690036,-1.9351849852241534,0.0029154518950437317,0.010184942908791555,0.437,6/17,17.67%,TNFAIP3;ICAM1;NUPR1;NFE2L2;TCF7L2;GATA3
gsea,protein modification process (GO:0036211),0.5399514613191294,1.931786820729707,0.0,0.0019901327622472336,0.383,15/34,29.84%,UBE2S;PARP1;RPN2;UBE2M;RPN1;CDC34;SEPHS1;RABGGTB;SERP1;ADPRH;PRKDC;UBA3;MCRS1;SLC35A1;DUSP12
gsea,regulation of RNA metabolic process (GO:0051252),0.5526473904232521,1.9310141477856717,0.0,0.0020002910643081425,0.384,11/28,21.48%,PCBP1;HNRNPF;SNRNP70;FUS;PTBP1;RRP1B;MBNL3;GRSF1;HNRNPH1;RBM38;HNRNPLL
gsea,protein complex oligomerization (GO:0051259),0.5077240054948573,1.9304891475947061,0.0,0.0020104107416463865,0.385,16/43,29.48%,PRMT1;SHMT2;ECT2;STOML2;BLM;FUS;ALAD;POLQ;CPSF6;LETM1;PNPT1;MAT2A;RBMX;ZNHIT6;OPA1;EHD4
gsea,protein maturation (GO:0051604),0.5199587379194381,1.9301610180236397,0.0,0.002012154357957664,0.385,19/46,28.91%,HSPD1;NDUFAB1;METAP2;STUB1;GLRX3;NAA50;GCSH;DNAJB11;PITRM1;NAA15;NAA10;NAA40;LMF2;TYSND1;NAA35;NAA16;PTCH1;TASP1;TESC
gsea,plasma membrane bounded cell projection organization (GO:0120036),0.4825386980029163,1.929970487435831,0.0,0.002019439279770963,0.388,13/59,27.37%,STMN1;HMGB1;PRMT1;MANF;MNS1;ODF2;NEDD4;TPM1;MAP4;CEP78;BLOC1S2;ARFIP2;RYK
gsea,cellular response to topologically incorrect protein (GO:0035967),0.5809143439400091,1.92952387918265,0.0,0.002026696659346782,0.391,10/23,27.74%,HSPA9;STUB1;BAX;HSPA8;HSPA14;BAK1;HSPA5;OPTN;HSPA13;HSF1
gsea,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.6317635888836285,1.9281463498404032,0.0017985611510791368,0.002050507576382824,0.395,8/20,24.33%,BRCA1;PHB;HDAC1;CALR;SMARCA4;CNOT9;NCOR2;CNOT1
gsea,glucose catabolic process to pyruvate (GO:0061718),0.722794599406253,1.9262110517994628,0.0021929824561403508,0.002081342276779558,0.399,7/16,5.01%,TPI1;PGAM1;GAPDH;ENO3;ENO1;PKM;PGK1
gsea,canonical glycolysis (GO:0061621),0.722794599406253,1.9262110517994628,0.0021929824561403508,0.002081342276779558,0.399,7/16,5.01%,TPI1;PGAM1;GAPDH;ENO3;ENO1;PKM;PGK1
gsea,regulation of lipid storage (GO:0010883),-0.6464801014590796,-1.9201421147717876,0.007194244604316547,0.011623887582650667,0.49,5/15,4.07%,NFKBIA;ZC3H12A;HILPDA;NFKB1;TNF
gsea,IRE1-mediated unfolded protein response (GO:0036498),0.5596567086408206,1.9200720725035456,0.002008032128514056,0.002225825699370259,0.421,11/26,28.30%,HDGF;PDIA6;MYDGF;DNAJB11;HYOU1;EDEM1;SERP1;HSPA5;SRPRB;DCTN1;DDX11
gsea,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.654328580742512,1.9146092661106648,0.0,0.0023697679855467627,0.443,8/15,20.81%,HNRNPU;TCERG1;WDR43;NELFE;RNF168;NELFCD;LARP7;LEO1
gsea,regulation of T cell proliferation (GO:0042129),-0.5121309011580255,-1.9128872599018334,0.0,0.01219421398107315,0.514,13/36,10.08%,CCL5;LGALS3;CD274;CD86;CEBPB;IL1B;PDCD1LG2;ANXA1;CD40LG;FOXP3;IL4I1;TNFSF9;AIF1
gsea,regulation of macrophage activation (GO:0043030),0.6897535036487195,1.9118340606005428,0.0,0.002447468322144519,0.453,3/16,11.33%,MIF;HSPD1;CD74
gsea,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.6472329771493059,1.9113262801816868,0.0,0.002464762571824769,0.456,9/16,21.79%,HNRNPU;PARP1;HNRNPA1;HNRNPC;CTC1;PIF1;PINX1;TINF2;EXOSC10
gsea,cholesterol metabolic process (GO:0008203),0.5545682603909802,1.9097245798021378,0.0,0.002514721981145203,0.458,24/35,36.87%,FDPS;IDI1;FDX1;LBR;SQLE;HMGCS1;HMGCR;DHCR24;FDFT1;MSMO1;INSIG1;PMVK;HSD17B7;DHCR7;MT3;ACAT2;ACLY;LSS;TM7SF2;MVD;MVK;SCAP;NSDHL;CLN6
gsea,Golgi organization (GO:0007030),0.46207259142148943,1.9065993140509996,0.001953125,0.002597164402375483,0.466,31/58,41.86%,CDK1;PRMT5;LMAN1;TMED2;LMAN2;NSFL1C;GORASP2;VRK1;ZW10;ARL1;OPTN;CLASP1;HUWE1;DYNC2H1;TMED1;PI4K2B;CLASP2;GCC2;NPLOC4;FBXW8;TRAPPC12;TICAM2;SEC23IP;DYM;UBXN2B;BAG5;ARHGAP21;ATP8B4;HTT;GAK;ATL3
gsea,regulation of mRNA processing (GO:0050684),0.6289111245507105,1.9064990619218212,0.0,0.0025977806029975877,0.467,13/18,22.68%,SRSF3;DHX9;SRSF10;HNRNPK;METTL16;NCBP1;CPSF4;SRPK1;SAFB;LARP7;IWS1;PTCD2;SLTM
gsea,histone H4 acetylation (GO:0043967),0.5332056380157039,1.9057412818291137,0.0022522522522522522,0.0026092437678310533,0.47,22/32,37.57%,HAT1;RUVBL2;BRCA2;RUVBL1;ACTL6A;WDR5;MORF4L2;NAA40;HCFC1;BRD8;KAT7;MCRS1;KAT8;KANSL2;DMAP1;EP400;ZZZ3;JADE1;ING5;TADA3;JADE2;LEF1
gsea,negative regulation of tumor necrosis factor production (GO:0032720),-0.56576531845382,-1.9052738424395415,0.002976190476190476,0.013004379894272479,0.535,8/23,12.57%,TNFAIP3;VSIR;ZC3H12A;RARA;SLAMF1;SIRPA;HAVCR2;SYT11
gsea,regulation of cellular localization (GO:0060341),0.5772040376358369,1.9042319240558176,0.0039603960396039604,0.002650444834009486,0.473,6/23,18.97%,HSP90AB1;HSP90AA1;PARP1;SPAG5;MAD1L1;NUMA1
gsea,positive regulation of epithelial cell proliferation (GO:0050679),0.533838791271051,1.904214615711865,0.0,0.0026455547143895424,0.473,7/46,11.03%,HMGB2;NME1;NME2;SRSF6;AKT1;MYDGF;HRAS
gsea,peptidyl-serine phosphorylation (GO:0018105),0.4431875201853954,1.9038353770649954,0.0,0.002656866565031678,0.474,30/81,38.75%,CDK1;CLSPN;PLK1;MASTL;AURKA;CDK2;TTK;AKT1;STK39;CDC7;VRK1;TAF1;PRKCE;ATR;CSNK2A2;MAST2;ROCK2;PRKDC;VRK3;DYRK3;GRK2;MTOR;RPS6KA5;MAP4K1;ATM;MAPKAPK2;CHUK;ROCK1;PRKCI;MAPK8
gsea,regulation of protein ubiquitination (GO:0031396),0.4819129993001805,1.902036145050809,0.0,0.002695060509400219,0.477,18/51,20.16%,HSP90AB1;HSP90AA1;CENPS;BRCA1;PARK7;U2AF2;STUB1;UBE2N;FANCI;AKT1;GTPBP4;HSPBP1;PAXIP1;PRMT3;UBQLN1;PINX1;IVNS1ABP;TBC1D7
gsea,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.6231498301425309,1.9019384463270235,0.006,0.002690115444245356,0.477,5/18,11.33%,MIF;KMT5A;EEF1E1;SMYD2;CD74
gsea,negative regulation of protein kinase activity (GO:0006469),0.4723444624173441,1.9013197989674055,0.002028397565922921,0.0027066485407774322,0.479,8/42,23.20%,PPIA;NPM1;PARK7;AKT1;CDKN1A;CORO1C;PRKRIP1;TARBP2
gsea,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.6075919513127924,1.9003872036970337,0.0,0.002731153993092818,0.481,7/18,17.74%,CDC6;TFDP1;EIF4G1;AKT1;MTBP;RDX;LSM11
gsea,glycolytic process through glucose-6-phosphate (GO:0061620),0.699151045403966,1.8983857788305134,0.002207505518763797,0.0028116970416511085,0.491,12/17,22.80%,TPI1;PGAM1;GAPDH;ENO3;ENO1;PKM;PGK1;PFKL;PFKP;ALDOA;ADPGK;FOXK2
gsea,positive regulation of DNA recombination (GO:0045911),0.5999306594820735,1.8976168896221135,0.004347826086956522,0.0028305861807730627,0.493,13/21,31.20%,RAD51AP1;TFRC;PARP1;TIMELESS;RIF1;FUS;PAXIP1;MRNIP;FANCB;ZCWPW1;ACTR2;WDR48;WRAP53
gsea,regulation of chromosome organization (GO:0033044),0.6412799330425941,1.896552820283723,0.0020408163265306124,0.002865384613231063,0.498,9/15,26.62%,HNRNPD;BUB1;RMI2;CDT1;CENPV;XRCC5;PIF1;YLPM1;MYC
gsea,regulation of type I interferon production (GO:0032479),0.4613701147431325,1.8946507043100878,0.0,0.0029106893908986153,0.503,20/54,29.18%,G3BP1;GAPDH;POLA1;POLR2F;PIN1;POLR3K;POLR2L;DHX9;CGAS;POLR3H;POLR2E;POLR2H;XRCC6;XRCC5;PRKDC;POLR3D;POLR1C;NFKB2;DDX41;NPLOC4
gsea,microtubule polymerization (GO:0046785),0.603771272513894,1.8930135336338982,0.004405286343612335,0.0029531766725078715,0.509,15/18,37.54%,TPX2;TUBG1;PIN1;CKAP5;TUBGCP2;NDE1;CENPJ;CLASP1;CLASP2;FGF13;TUBGCP3;HDGFL3;TUBGCP4;TUBGCP6;TUBGCP5
gsea,DNA methylation (GO:0006306),0.6019653651111465,1.8884536671778822,0.0,0.0031014523016588565,0.525,2/17,1.18%,HELLS;DNMT1
gsea,tRNA aminoacylation for protein translation (GO:0006418),0.5638225714523726,1.8869562680189762,0.0,0.0031434418621959486,0.529,15/22,31.34%,PPA1;AIMP2;FARSB;EEF1E1;FARSA;PPA2;YARS2;SARS2;TARS2;DARS2;RARS2;IARS2;CARS2;EARS2;FARS2
gsea,rRNA methylation (GO:0031167),0.6074490591893991,1.8836234848671947,0.006276150627615063,0.0032406992326873972,0.541,12/18,30.50%,FBL;EMG1;FTSJ3;NOP2;METTL16;BUD23;DIMT1;NSUN5;TFB1M;METTL5;ZCCHC4;MRM3
gsea,positive regulation of immunoglobulin production (GO:0002639),0.6256339266133369,1.8809818482125034,0.0038095238095238095,0.003334972497046062,0.55,7/18,13.35%,TFRC;PHB2;PHB;RIF1;TNFSF4;TNFRSF4;PAXIP1
gsea,regulation of cellular amide metabolic process (GO:0034248),0.5540900199704435,1.8805421724477929,0.0040650406504065045,0.0033526508846987695,0.552,10/24,28.56%,PGAM1;NOLC1;TCOF1;EIF4E;PUM3;RPL10;GEMIN5;METAP1;EIF2A;EIF2B4
gsea,positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.45768645228959565,-1.8765971786077718,0.0,0.017171768131490746,0.626,30/53,19.47%,CXCR6;GNA15;S1PR4;CCR5;CX3CR1;CXCR3;CCL1;CCR2;CCR8;F2R;CIB2;F2RL2;GPR174;PTGER4;GLP1R;CALCA;LPAR3;CACNB3;CYSLTR1;F2RL1;C3AR1;CD36;CCR4;GPR55;GPR35;SLC8A1;CCR3;JPH3;CCR9;C5AR1
gsea,carbohydrate homeostasis (GO:0033500),0.6241127882021154,1.8706713471307712,0.0016286644951140066,0.003753489291125753,0.583,2/20,4.62%,PARK7;RPS6
gsea,regulation of microtubule polymerization (GO:0031113),0.5838618312404411,1.869449365087838,0.0019011406844106464,0.0038070374501459787,0.589,8/21,27.41%,STMN1;DRG1;NUMA1;CLIP1;DCTN1;CLASP1;CDK5RAP2;ARL2
gsea,positive regulation of protein transport (GO:0051222),0.5120880078977144,1.8674137359579768,0.0,0.0038839333557761395,0.596,11/39,31.19%,PPIA;KIF20B;PPID;PCNT;RACK1;EZR;PCM1;TTN;ACSL3;CEP290;CD2AP
gsea,termination of RNA polymerase I transcription (GO:0006363),0.5900756384340454,1.8658243087227449,0.00199203187250996,0.003942279654110089,0.599,14/22,28.82%,POLR2F;POLR2L;POLR2E;POLR2H;TAF1D;UBTF;GTF2H4;POLR1B;POLR1A;POLR1C;POLR1E;GTF2H3;GTF2H1;GTF2H2
gsea,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.6200502414080821,1.8656915918075931,0.0,0.003938681135046428,0.601,11/17,28.82%,RPA3;PARP1;RPA1;RPA2;DDB1;GTF2H4;CHD1L;CUL4B;GTF2H3;GTF2H1;GTF2H2
gsea,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.6200502414080821,1.8656915918075931,0.0,0.003938681135046428,0.601,11/17,28.82%,RPA3;PARP1;RPA1;RPA2;DDB1;GTF2H4;CHD1L;CUL4B;GTF2H3;GTF2H1;GTF2H2
gsea,negative regulation of peptidase activity (GO:0010466),0.6422429983674305,1.8654953939374934,0.004838709677419355,0.00393948834013772,0.603,4/18,10.02%,GAPDH;PARK7;SERPINE2;AKT1
gsea,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.49922521752212196,-1.8653459964869006,0.005571030640668524,0.018691151277324798,0.652,12/31,12.82%,ATP2B4;SPRY1;SMAD7;CRIM1;SKIL;CREB3L1;SULF2;HHEX;THBS1;NOTCH1;SKI;WNT1
gsea,tRNA aminoacylation (GO:0043039),0.5866740946452306,1.8653228660210572,0.0,0.003940292687865856,0.603,14/19,31.82%,PPA1;AIMP2;FARSB;EEF1E1;FARSA;PPA2;YARS2;SARS2;DARS2;RARS2;QRSL1;IARS2;FARS2;GATB
gsea,negative regulation of DNA biosynthetic process (GO:2000279),0.621810504198857,1.863143353568224,0.0038684719535783366,0.004010962573691793,0.608,12/17,31.85%,HNRNPU;HNRNPA1;HNRNPC;CTC1;CDKN1A;PIF1;PINX1;TINF2;EXOSC10;NAT10;GNL3L;MEN1
gsea,primary neural tube formation (GO:0014020),0.62539565609041,1.8608263387779256,0.0018148820326678765,0.004092247892001436,0.614,3/17,9.83%,MTHFD1;STIL;MTHFD1L
gsea,tube closure (GO:0060606),0.62539565609041,1.8608263387779256,0.0018148820326678765,0.004092247892001436,0.614,3/17,9.83%,MTHFD1;STIL;MTHFD1L
gsea,cellular transition metal ion homeostasis (GO:0046916),0.4947706923187058,1.8591428300287014,0.004098360655737705,0.004154555897918501,0.621,20/36,34.92%,TFRC;NUBP1;FXN;GLRX3;CUL1;CAND1;SLC31A1;MT3;CCDC115;ABCB6;HMOX2;MYC;ATP6V0A2;SLC39A10;ABCG2;COX19;SLC39A6;TMEM199;SLC39A7;ABCB7
gsea,regulation of erythrocyte differentiation (GO:0045646),0.5588013323222836,1.8571492027245635,0.0019455252918287938,0.004260327771482108,0.627,3/23,4.18%,HMGB2;PRMT1;HSPA9
gsea,regulation of T cell activation (GO:0050863),-0.5552645088788024,-1.855574755324171,0.0,0.019936861823204498,0.678,13/24,13.02%,CCL5;LGALS3;TBX21;LAX1;PAG1;CCR2;TNFAIP8L2;CRTAM;SIRPA;IL4I1;TNFSF9;CCL2;CD4
gsea,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.5884811499086608,1.855551485839817,0.00375234521575985,0.004314428000345146,0.631,13/22,33.69%,CDK4;E2F7;CDKN2A;RBL1;CDKN1A;WEE1;BRD7;CDK6;CDKN2D;RBL2;CDKN2C;JADE1;CDC73
gsea,negative regulation of kinase activity (GO:0033673),0.5056510989464006,1.8519241608451646,0.0,0.0044553985800525895,0.642,7/31,23.20%,PPIA;HNRNPU;PARK7;AKT1;PRDX3;PRKRIP1;TARBP2
gsea,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.469222065693296,-1.851807912162058,0.0,0.020176303211713986,0.685,21/50,17.43%,UBB;ZFP36L2;ZFP36L1;PRKCZ;FURIN;NR3C1;SMAD7;OVOL2;ARHGEF18;TGFBR3;NLK;GCNT2;XCL1;ACVRL1;SMAD3;SKI;FOS;PTPRK;TWSG1;ITGB1;CLEC3B
gsea,positive regulation of nitric oxide metabolic process (GO:1904407),0.630035098917388,1.8514217894474148,0.0017211703958691911,0.004475740172333987,0.645,3/18,10.02%,HSP90AB1;HSP90AA1;AKT1
gsea,monocarboxylic acid metabolic process (GO:0032787),0.49678050819081454,1.8508982970054275,0.0,0.004493459235950912,0.646,23/61,31.92%,LDHA;VDAC1;GOT2;MTHFD1L;BSG;ME2;DLAT;FASN;MECR;MSMO1;GATM;PDZD11;GRHPR;SCPEP1;SLC16A3;AASDHPPT;DLD;GNPAT;CKM;PDHA1;ACSL3;ALKBH7;MCCC2
gsea,negative regulation of interleukin-6 production (GO:0032715),-0.6064949674052208,-1.8502750935942145,0.0,0.020112420951777177,0.688,8/18,16.21%,TNFAIP3;ZC3H12A;SLAMF1;TNF;SIRPA;SYT11;CD200R1;NLRC3
gsea,positive regulation of mitotic cell cycle (GO:0045931),0.6071472734319092,1.8498761563759651,0.003861003861003861,0.0045314943830870105,0.646,4/18,10.91%,CCNB1;ASNS;CDC25B;EIF4E
gsea,negative regulation of transcription by RNA polymerase II (GO:0000122),0.36419595178456826,1.8490250466389295,0.0,0.004569397463739998,0.647,105/295,41.57%,HMGB1;AURKB;UHRF1;HDGF;HNRNPU;PLK1;C1QBP;EZH2;LYAR;CBX5;ENO1;SUV39H1;PHB;PARP1;E2F8;E2F1;HDAC1;CALR;PPID;E2F7;NOC2L;TCERG1;MYB;RIF1;HDAC2;FOXM1;KMT5A;SFPQ;MAZ;SMYD2;SMARCA4;ORC2;SUV39H2;CTCF;SAP30;EZR;CNBP;TRIM37;RPL10;MTDH;DDX20;EED;TCF3;TAF1;NEDD4;URI1;RPS27A;ATRX;MCPH1;DNAJA3;E2F6;MTF2;MTA2;LARP7;MTA1;SREBF2;NCOR2;HCFC1;EOMES;SIN3A;TLE5;EHMT2;DCAF1;CNOT1;PTCH1;TAF3;MYC;NFX1;YY1;HSF1;PRDM16;DMAP1;DICER1;MEN1;SRF;GLIS1;PRDM5;RIPPLY3;WWOX;CDC73;GATAD2B;SP2;TBL1X;RUNX3;USP9X;CHD8;DNMT3A;OSR2;IRF8;TRIM33;BMI1;MDM2;MED1;CTR9;BPTF;MIER2;SPEN;IRF2BP1;CBX6;YEATS2;HIVEP1;THAP1;RITA1;BRMS1L;RB1
gsea,defense response to Gram-negative bacterium (GO:0050829),0.6872725157257639,1.8468732337837068,0.0015220700152207,0.00464524494278357,0.651,1/15,0.04%,HMGB2
gsea,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.6411811411010178,1.8466517617471423,0.0017301038062283738,0.0046498781545507685,0.653,3/17,10.02%,HSP90AB1;HSP90AA1;AKT1
gsea,negative regulation of response to stimulus (GO:0048585),0.5617314915620212,1.846295125216326,0.0,0.004672202681444702,0.655,3/26,10.71%,YBX1;FBXO5;RBL1
gsea,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.5815688657783015,1.8456033662125892,0.0038095238095238095,0.004707076505391113,0.658,13/22,33.69%,CDK4;E2F7;CDKN2A;RBL1;CDKN1A;WEE1;BRD7;CDK6;CDKN2D;RBL2;CDKN2C;JADE1;CDC73
gsea,positive regulation of tumor necrosis factor production (GO:0032760),0.519948137708178,1.8454064648253048,0.0,0.0047141002801031244,0.662,3/39,6.70%,HMGB1;MIF;DHX9
gsea,positive regulation of mitochondrion organization (GO:0010822),0.5135776033992312,1.8444314526739378,0.00196078431372549,0.004761365162636601,0.665,13/32,27.95%,PARK7;AURKA;CHCHD10;BAX;PPIF;HTRA2;FAM162A;BAK1;VPS35;ZDHHC6;RALA;CAMKK2;BID
gsea,transcription by RNA polymerase III (GO:0006383),0.5887756940938649,1.8438428528684394,0.0,0.004790882073219854,0.666,14/19,36.67%,POLR3K;POLR2L;GTF3A;POLR3H;GTF3C5;IVNS1ABP;ZC3H8;GTF3C2;GTF3C3;POLR3G;GTF3C1;TBP;GTF3C4;ICE2
gsea,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.5430031863198561,1.8430272976265638,0.0020408163265306124,0.0048228058578573514,0.666,12/24,27.95%,TFDP1;SAE1;YWHAE;E2F1;HTRA2;TFDP2;GZMB;NMT1;SREBF2;CSNK2A2;HUWE1;BID
gsea,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.5864123536538105,1.8418488073119346,0.004310344827586207,0.004879657223895145,0.667,9/19,26.48%,RPL5;RAD23A;XPO1;RAD23B;TAF1;DESI1;CSNK2A2;GLMN;UBQLN4
gsea,positive regulation of transcription by RNA polymerase II (GO:0045944),0.3521251774695693,1.841474435119579,0.0,0.0049038223608765235,0.667,137/442,34.55%,HMGB2;HMGB1;EIF5A;YBX1;UHRF1;NPM1;DLGAP5;HNRNPU;NME2;MYBL2;ATAD2;TFDP1;PCBP1;BRCA1;PARK7;PARP1;E2F8;RUVBL2;E2F1;HDAC1;PIN1;MED30;E2F7;APEX1;TCERG1;DHX9;CKAP2;MYB;THRAP3;E2F4;HDAC2;SMARCA5;FOXM1;SFPQ;PELP1;HMGA1;SMARCA4;MYDGF;RBL1;HRAS;COPS5;SMARCB1;BCLAF1;RRP1B;GNL3;TAF6;PAXIP1;XRCC6;HAX1;CNBP;E2F2;RBM14;TFDP2;EPAS1;TCF3;ETV4;RPS27A;ATRX;TAF6L;NRF1;KAT2A;MED4;SENP1;ATF1;GTF2F1;MTF2;PHF10;LARP7;NUFIP1;RPRD1B;GCN1;LEO1;SREBF2;NFATC2IP;ECD;HCFC1;EOMES;AATF;PPRC1;FOXK2;SP1;ZMIZ2;SIN3A;BRD8;SS18L2;NFYB;ZBED3;MYBL1;PRKDC;KAT7;GABPA;FADD;RBMX;MCRS1;ASXL1;MYC;SETX;CEBPZ;GLYR1;YY1;ZBED4;NFKB2;HSF1;KAT8;DOT1L;PAXBP1;PRPF6;GABPB2;TCF4;NPAT;BCLAF3;DDX3X;MED14;E2F3;MED16;ACTR2;PHIP;PLXND1;SSBP3;NAMPT;HSF2;PCGF5;TAF9;MEN1;TRERF1;SRF;RPS6KA5;GLIS1;CREB1;PPP3CB;MED24;WWOX;CDK8;CDC73;UTF1;ATM;TCF20
gsea,negative regulation of hydrolase activity (GO:0051346),0.5326404419815278,1.8382004334955409,0.0018796992481203006,0.005072623391076029,0.674,10/29,27.41%,RCC2;TMED2;HRAS;RRP1B;RDX;URI1;PPP1R35;EGLN1;CST3;ARL2
gsea,protein localization to organelle (GO:0033365),0.4544862220585715,1.8376800758608238,0.001949317738791423,0.005101359956793032,0.676,31/61,41.40%,YBX1;YWHAE;RPA1;GET4;CALR;SSB;DHX9;DDX1;MTCH2;RPA2;VPS35;SERP1;CNTLN;CCDC47;ARL1;OPTN;GCC2;DDX3X;CEP68;BICD1;PACSIN2;TTC21B;CEP250;IFT140;BICD2;BANP;MDM2;PAQR3;PIKFYVE;SNX10;GAK
gsea,positive regulation of histone acetylation (GO:0035066),0.5883297689086179,1.8354025603353474,0.003929273084479371,0.0052269790511238114,0.682,9/18,27.27%,BRCA1;RUVBL2;PIH1D1;SMARCB1;PAXIP1;TADA2A;BRD7;KAT7;GLYR1
gsea,protein autoubiquitination (GO:0051865),0.5578507134011299,1.8316426485136617,0.0019230769230769232,0.00545147050573448,0.692,13/22,34.44%,UHRF1;BRCA1;RAD18;STUB1;UBE2T;TRIM37;TRAF2;NFX1;RNF8;ERCC8;CUL3;RNF141;DDB2
gsea,positive regulation of growth (GO:0045927),0.5091133643335575,1.8313489894703492,0.0056179775280898875,0.0054472028678866895,0.692,12/35,20.73%,EIF4G1;FXN;AKT1;EXOSC2;HDGFL2;EXOSC9;NCBP1;DNPH1;EIF4G2;EXOSC4;DERL2;ZPR1
gsea,regulation of intracellular transport (GO:0032386),0.5686216174639864,1.8277304220134272,0.007434944237918215,0.005660667633643703,0.699,8/21,25.33%,SPAG5;AAAS;NEFH;LCP1;NUMA1;NUP214;DYNC1H1;ATPSCKMT
gsea,regulation of interleukin-2 production (GO:0032663),-0.5341610763573358,-1.8268005834920427,0.0,0.024424835316993434,0.754,16/27,13.02%,TNFAIP3;ZFP36;MALT1;IRF4;CD86;TBX21;CCR2;PDE4B;IL1B;RUNX1;ANXA1;CARD11;FOXP3;XCL1;HAVCR2;CD4
gsea,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.5953894444225355,1.8267610364819393,0.01092896174863388,0.005712869217265082,0.703,4/19,16.05%,PLK1;EIF4G1;DDIT4;CALM2
gsea,calcium ion homeostasis (GO:0055074),-0.4726269651634685,-1.8264377927008517,0.005305039787798408,0.024016912460847566,0.755,18/38,16.47%,CCL5;TPT1;ATP2B4;CCL1;CCR2;CIB2;SLC30A1;FAM20A;ATP2A3;ATP2B2;CD40;CALCB;ATP13A2;ATP1B1;CCL8;SELENON;CCL7;SLC8A1
gsea,B cell receptor signaling pathway (GO:0050853),-0.5547770644210245,-1.8250793800477236,0.005050505050505051,0.023832222065951963,0.757,13/22,14.30%,CTLA4;CD38;BCL2;PIK3CD;LAT2;SYK;NFAM1;RFTN1;TEC;NFATC2;BTK;CD79A;CD79B
gsea,iron ion homeostasis (GO:0055072),0.532093534795727,1.8234198240338064,0.004024144869215292,0.00590790783190626,0.712,14/26,34.92%,TFRC;NUBP1;FXN;GLRX3;CUL1;CAND1;CCDC115;ABCB6;HMOX2;MYC;ATP6V0A2;ABCG2;TMEM199;ABCB7
gsea,regulation of endocytosis (GO:0030100),-0.5110974280419203,-1.8224964045955492,0.002457002457002457,0.023917859491818794,0.765,13/30,17.83%,LGALS3;HIP1;FLOT1;PACSIN1;ABCA7;RAB5B;LRP1;RUFY2;DAB2;SYT11;APOE;RAB4A;CD151
gsea,chordate embryonic development (GO:0043009),0.6033549809024475,1.8221528081507634,0.001763668430335097,0.005979211168107898,0.718,2/19,5.70%,BRCA1;STIL
gsea,cytoplasmic microtubule organization (GO:0031122),0.5187217196792587,1.8210065681880236,0.004132231404958678,0.006057647621984253,0.724,18/29,37.54%,FIGNL1;KPNB1;TUBGCP2;EZR;NUMA1;HOOK1;CLIP1;DYNC1H1;DCTN1;CLASP1;PCM1;WDR73;TUBGCP3;HOOK2;TUBGCP4;CAMSAP1;TUBGCP6;TUBGCP5
gsea,response to interleukin-1 (GO:0070555),-0.510488682817588,-1.820650690963816,0.0,0.023858516866989313,0.771,22/39,19.51%,CCL5;ZC3H12A;CCL1;GBP2;NFKB1;CCL4;IL1B;PRKCA;HIF1A;ANXA1;CD40;SIRPA;XCL1;APP;CCL2;CCL8;ACOD1;CCL7;HDAC4;IRAK3;CCL22;MAPK13
gsea,regulation of protein metabolic process (GO:0051246),0.5471689692063517,1.818522101916985,0.006060606060606061,0.006219235111426727,0.734,10/25,25.56%,HSP90AB1;ODC1;FAM83D;ZDHHC2;VPS35;FAF1;PARL;CHEK2;ROCK2;LDLR
gsea,positive regulation of protein dephosphorylation (GO:0035307),0.6180253965897103,1.8160948823675616,0.008247422680412371,0.006365586706902723,0.738,8/15,20.85%,PPIA;HSP90AB1;CDCA2;PIN1;PTBP1;PPP1R7;CALM2;SYMPK
gsea,protein homotetramerization (GO:0051289),0.5487491408820682,1.8157164956135714,0.0,0.006391637019633557,0.742,10/23,24.52%,TK1;SHMT1;SHMT2;ALDH9A1;APIP;ALDOA;CBY1;THG1L;SOD2;ACACA
gsea,snRNA 3'-end processing (GO:0034472),0.6096771121870941,1.8149451845245268,0.008695652173913044,0.00645665778515782,0.747,13/17,32.43%,EXOSC8;EXOSC7;EXOSC3;EXOSC2;EXOSC9;EXOSC5;EXOSC4;INTS7;TOE1;INTS8;INTS14;INTS1;INTS5
gsea,regulation of complement activation (GO:0030449),0.7256330352430422,1.8123257205874488,0.002894356005788712,0.006636002056679854,0.754,3/16,4.27%,C1QBP;PHB2;PHB
gsea,regulation of neurotransmitter receptor activity (GO:0099601),-0.6067979301162967,-1.8085523165056558,0.008264462809917356,0.02632567324815328,0.805,7/16,13.37%,CNIH2;DLG2;ACTN2;PTK2B;APP;DLGAP4;DAPK1
gsea,negative regulation of T cell proliferation (GO:0042130),-0.5777088325201785,-1.8076694143725835,0.006787330316742082,0.026040968778995168,0.806,7/18,8.90%,CD274;CD86;CEBPB;CRTAM;PDCD1LG2;FOXP3;IL4I1
gsea,endomembrane system organization (GO:0010256),0.40504408454761426,1.806401427595412,0.0,0.007011821114303866,0.771,59/97,49.76%,REEP4;NUP93;LMAN1;TMED2;NUP155;LMAN2;NSFL1C;GORASP2;ZW10;LNPK;SERP1;SPTBN1;ARL1;HOOK1;OPTN;CLASP1;HUWE1;SYNGR2;DYNC2H1;TMED1;PI4K2B;CLASP2;NPLOC4;BNIP1;SYNGR1;SMPD4;AP3D1;SUN2;FBXW8;TRAPPC12;HOOK2;TICAM2;SEC23IP;DYM;UBXN2B;BAG5;ARHGAP21;ATP8B4;HTT;DNAJC13;SNX10;TLCD2;GAK;ATL3;SEC61A1;USP8;TLCD1;CTDNEP1;HACE1;REEP6;VPS33B;SPAG4;ARFGEF1;ATL2;FAM174B;CAV2;MIA3;COG7;STX17
gsea,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.5936063118066569,1.8058973035207089,0.006289308176100629,0.0070293401161477045,0.772,10/17,31.47%,HSP90AB1;UCHL5;PARK7;RPL5;TAF1;CSNK2A2;GIPC1;USP7;CCAR2;TAF9
gsea,negative regulation of DNA metabolic process (GO:0051053),0.6229776678356322,1.8052054831877473,0.0076045627376425855,0.007061350594166017,0.773,7/15,18.39%,BLM;MSH2;CDKN1A;MSH6;XRCC5;ZRANB3;RTEL1
gsea,positive regulation of endothelial cell proliferation (GO:0001938),0.5186109056929749,1.805029090319671,0.0034129692832764505,0.007054520752750353,0.773,7/37,22.81%,HMGB2;HMGB1;AKT1;MYDGF;VEGFB;EGFL7;SP1
gsea,negative regulation of Ras protein signal transduction (GO:0046580),0.5899124180187897,1.8050132938377303,0.0031007751937984496,0.007042879629395979,0.773,1/22,0.02%,STMN1
gsea,regulation of translational initiation (GO:0006446),0.497293985918321,1.804539258011178,0.0,0.007060232017528998,0.773,15/34,18.57%,NPM1;EIF3B;EIF4G1;DDX1;CDC123;EIF4H;EIF5B;NCBP2;GLE1;EIF2B5;NCBP1;LARP1;EIF4G2;EIF4B;EIF5
gsea,protein deacetylation (GO:0006476),0.5102939640560735,1.8042719319656304,0.002079002079002079,0.007072709403500905,0.773,9/29,22.97%,PHB;HDAC1;HDAC2;MORF4L2;RBM14;MTA2;FLNA;MTA1;SIN3A
gsea,regulation of protein kinase activity (GO:0045859),0.4358128880354603,1.8031417161575203,0.0,0.007130840914819461,0.778,14/59,29.07%,PPIA;CENPE;PARK7;ECT2;AKT1;CDKN1A;XRCC6;XRCC5;MRNIP;PRKRIP1;TARBP2;CAMKK2;CEP85;TTN
gsea,positive regulation of protein metabolic process (GO:0051247),0.4652321327599233,1.8020923690310147,0.0,0.00720799033290543,0.783,9/49,10.29%,UHRF1;PRMT1;DTL;EIF4G1;BARD1;DDB1;AKT1;VCP;FZR1
gsea,cellular response to alcohol (GO:0097306),0.5720223658035801,1.8020449740750966,0.0018115942028985507,0.007198590427726935,0.783,5/21,15.98%,RAD51;BRCA1;BLM;TNFSF4;LARP1
gsea,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.4001974059940466,1.8008813814095914,0.0,0.0072705905894619735,0.787,41/162,35.74%,STMN1;SHCBP1;HSP90AA1;HNRNPF;POLR2F;HNRNPA1;POLR2L;POLR2C;CASP3;PTBP1;HNRNPM;DDIT4;AKT1;HRAS;NCBP2;POLR2E;ACTB;POLR2H;NCBP1;GTF2F2;POLR2B;HNRNPH1;VEGFB;CEP57;GTF2F1;POLR2A;ROCK2;SETX;RYK;AP3S1;NUS1;ATP6V0A2;ACTR2;PHIP;NAMPT;ACTG1;ELMO1;KIT;PTPN11;SHC1;MAPKAPK2
gsea,positive regulation of myeloid cell differentiation (GO:0045639),0.5592463479993567,1.8008561406604862,0.001876172607879925,0.007261119231679564,0.787,2/21,2.20%,HMGB2;PRMT1
gsea,response to endoplasmic reticulum stress (GO:0034976),0.4370180644128801,1.7999459761257997,0.0,0.007294616296624796,0.789,20/61,25.32%,HSP90B1;EIF2S1;PDIA3;P4HB;PDIA4;VCP;BAX;ATP2A2;EIF2B5;AIFM1;GORASP2;HYOU1;BAK1;UBQLN1;RNF5;HSPA5;DNAJC10;CCDC47;HERPUD1;TRAF2
gsea,positive regulation of inflammatory response (GO:0050729),-0.4665494772612074,-1.7991339535500723,0.00477326968973747,0.027601994160987266,0.815,27/49,20.50%,NFKBIA;ETS1;NFKBIZ;CCL1;ZBP1;PDCD4;CCR2;IL16;IL1B;TNF;PTGER4;NINJ1;IFNG;IL17RA;NUPR1;APP;ADAM8;IL2;TLR2;TNFRSF1A;LPL;TLR7;PLA2G7;MGST2;GRN;MAPK13;C2CD4A
gsea,negative regulation of transferase activity (GO:0051348),0.5994721368392038,1.7991315220583255,0.006185567010309278,0.007325622886124931,0.789,6/16,19.50%,FBXO5;HNRNPU;PARK7;PRDX3;PIF1;PINX1
gsea,regulation of ion transmembrane transporter activity (GO:0032412),0.5936308238712791,1.7952916567301747,0.006622516556291391,0.007556253568813327,0.799,6/20,19.00%,PHB2;YWHAE;PPIF;STK39;NEDD4;RANGRF
gsea,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.5995173311232515,-1.7945710760961464,0.008213552361396304,0.028534435963424594,0.829,5/18,2.94%,TNFAIP3;STAT1;ZC3H12A;TNIP3;PER1
gsea,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.5448527788608485,-1.7943957489276046,0.00946969696969697,0.02808181093639663,0.83,7/23,10.51%,CISH;PIK3R1;SOCS1;ITPKB;PIK3CD;SOCS5;SOCS2
gsea,neural tube closure (GO:0001843),0.5728033772863979,1.7903426235058464,0.0037735849056603774,0.0079261921712691,0.814,3/20,9.83%,MTHFD1;STIL;MTHFD1L
gsea,mesenchymal cell differentiation (GO:0048762),0.5655638372168075,1.7855306882268143,0.005199306759098787,0.008299673523454287,0.832,3/22,5.89%,HNRNPAB;TRIM28;FAM83D
gsea,regulation of interleukin-12 production (GO:0032655),0.5589106690877479,1.7807951002230678,0.003316749585406302,0.008664849693877107,0.836,4/26,11.27%,HMGB1;C1QBP;HSPD1;TNFSF4
gsea,positive regulation of response to stimulus (GO:0048584),0.5141775130887986,1.7805742549624726,0.0018315018315018315,0.008681584496782118,0.838,9/28,12.01%,NSMCE4A;DHX9;CDKN2A;NSMCE1;EEF1E1;HMGA1;ANKLE1;CGAS;BCLAF1
gsea,neutrophil migration (GO:1990266),-0.5042161808143583,-1.776851551066945,0.01808785529715762,0.03221875875059292,0.862,17/32,18.79%,CCL5;LGALS3;JAML;CCL1;PIK3CD;PDE4B;CCL4;SYK;XCL1;CXCL9;CXCL2;CCL2;CCL8;PF4;CCL7;PIP5K1C;CCL22
gsea,positive regulation of chemotaxis (GO:0050921),-0.5528197215628755,-1.775862096516381,0.005154639175257732,0.03200261913639844,0.863,9/20,14.55%,TMSB4X;CCR2;NRP1;XCL1;THBS1;AIF1;F2RL1;PDGFB;LGMN
gsea,neutrophil chemotaxis (GO:0030593),-0.5088291330174181,-1.7758553021940222,0.01808785529715762,0.03149464105486831,0.863,17/31,18.79%,CCL5;LGALS3;JAML;CCL1;PIK3CD;PDE4B;CCL4;SYK;XCL1;CXCL9;CXCL2;CCL2;CCL8;PF4;CCL7;PIP5K1C;CCL22
gsea,prostaglandin metabolic process (GO:0006693),0.647178822467151,1.773372266359965,0.0015723270440251573,0.009259595979846984,0.851,3/15,11.33%,MIF;PTGES3;CD74
gsea,protein monoubiquitination (GO:0006513),0.5736957766986748,1.7730509428159453,0.007009345794392523,0.009275320789356847,0.851,5/19,8.72%,UHRF1;DTL;RAD18;UBE2T;RNF126
gsea,positive regulation of B cell activation (GO:0050871),0.506770943372882,1.772291951841842,0.007407407407407408,0.009316855681271646,0.852,7/33,13.35%,MIF;TFRC;RIF1;TNFSF4;CD74;TNFRSF4;PAXIP1
gsea,negative regulation of catabolic process (GO:0009895),0.5667941264042698,1.7700585823703396,0.006791171477079796,0.009494394627367814,0.858,8/23,24.69%,MAD2L1;PHB;PIN1;SF3B3;HMGCR;FLNA;AZIN1;CST3
gsea,cellular iron ion homeostasis (GO:0006879),0.5357349206883363,1.7699354423673541,0.008456659619450317,0.009493264219344936,0.858,14/24,34.92%,TFRC;NUBP1;FXN;GLRX3;CUL1;CAND1;CCDC115;ABCB6;HMOX2;MYC;ATP6V0A2;ABCG2;TMEM199;ABCB7
gsea,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.5927682016277245,1.768916715525892,0.005190311418685121,0.00956934731561587,0.86,7/19,20.18%,C1QBP;RCC2;CALR;P4HB;ACTN4;CORO1C;FLNA
gsea,negative regulation of neuron death (GO:1901215),0.4597709856990115,1.7680557608774443,0.0019723865877712033,0.009628835987525633,0.862,12/43,25.32%,SET;PARK7;EIF4G1;KIF14;AKT1;MSH2;HTRA2;VPS35;MT3;SOD2;BHLHB9;TRAF2
gsea,steroid biosynthetic process (GO:0006694),0.5369166196312181,1.767912585302899,0.0038535645472061657,0.009634493628341045,0.862,13/23,33.80%,LBR;SQLE;HMGCR;FDFT1;MSMO1;SC5D;INSIG1;PMVK;DHCR7;FDXR;LSS;TM7SF2;HSD17B10
gsea,regulation of T cell receptor signaling pathway (GO:0050856),-0.5627110338456476,-1.7669516954430087,0.010526315789473684,0.03358428917916067,0.885,6/20,7.33%,LGALS3;PVRIG;CD226;CD300A;PTPRJ;CARD11
gsea,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.47099205330593613,1.766151019524188,0.002109704641350211,0.009793816564008809,0.864,17/38,31.02%,PPIA;ENO1;PARK7;YBX3;NOC2L;AKT1;DDIAS;PPIF;HTRA2;HYOU1;URI1;SOD2;HERPUD1;CDKN2D;OPA1;DDX3X;CCAR2
gsea,regulation of release of cytochrome c from mitochondria (GO:0090199),0.5498712193476831,1.7644393208385978,0.005376344086021506,0.009968907582233047,0.868,7/22,12.57%,PRELID1;FXN;AKT1;BAX;PPIF;FAM162A;GPX1
gsea,positive regulation of histone modification (GO:0031058),0.5867884530051463,1.7633173166335652,0.00202020202020202,0.010078451320640957,0.87,11/17,32.18%,BRCA1;RUVBL2;UBE2N;PAXIP1;SART3;TADA2A;BRD7;FMR1;GLYR1;AKAP8;RPS6KA5
gsea,fatty acid beta-oxidation (GO:0006635),0.5118606522084302,1.762059927387269,0.006185567010309278,0.010189965883086885,0.872,18/28,39.25%,ETFB;ACADL;MECR;HADH;ACAT2;ECHDC2;ECHDC1;DECR1;GCDH;ECI1;ETFDH;SLC25A17;IVD;MCAT;HSD17B10;ABCD3;MTLN;CPT2
gsea,anion transmembrane transport (GO:0098656),0.497847671514777,1.7615424279716114,0.00816326530612245,0.010224772037954974,0.872,16/31,35.33%,SLC25A5;SFXN1;SLC25A10;SLC7A5;SLC25A13;SLC7A1;SLC19A1;SLC35B1;SLC25A19;SLC35A1;SLC25A1;SFXN2;ABCC1;SLC35A3;LRRC8B;SLC7A3
gsea,posttranscriptional regulation of gene expression (GO:0010608),0.48752035433666663,1.7611367339586828,0.0021321961620469083,0.01025022771114307,0.872,14/32,32.08%,NOLC1;TCOF1;EIF4E;PUM3;METTL16;LARP4;RPL10;LARP1;GEMIN5;METAP1;EIF2A;EIF2B4;PUM2;SPOUT1
gsea,toll-like receptor signaling pathway (GO:0002224),0.4676414852237764,1.7607183046434516,0.0037174721189591076,0.010261764012741488,0.872,3/44,1.81%,HMGB1;HSP90B1;HSPD1
gsea,positive regulation of protein catabolic process (GO:0045732),0.46330245370150075,1.7568144598401922,0.003766478342749529,0.010595670888294445,0.883,11/41,18.79%,HSP90AA1;DTL;BARD1;DDB1;VCP;FZR1;RDX;EZR;NEDD4;VPS35;FAF1
gsea,granulocyte chemotaxis (GO:0071621),-0.5029572778581414,-1.7565920529049046,0.020618556701030927,0.03622396499056171,0.898,18/32,18.79%,CCL5;LGALS3;JAML;CCL1;PIK3CD;PDE4B;CCL4;ANXA1;SYK;XCL1;CXCL9;CXCL2;CCL2;CCL8;PF4;CCL7;PIP5K1C;CCL22
gsea,regulation of androgen receptor signaling pathway (GO:0060765),0.6004456698081153,1.7544417831034864,0.011928429423459244,0.010820462720853968,0.885,4/16,10.60%,PARK7;PHB;HDAC1;SMARCA4
gsea,regulation of organelle organization (GO:0033043),0.47925813259071665,1.7533900313001476,0.004166666666666667,0.010909104347258372,0.886,10/34,21.63%,CDT1;LMAN1;RDX;EZR;CENPV;ARL6IP1;MYO5A;VPS35;PARL;CLIC4
gsea,organelle disassembly (GO:1903008),0.5347334051959837,1.7532776390255238,0.012958963282937365,0.010903492668067396,0.886,13/21,37.52%,CDK1;VCP;DENR;VRK1;EIF2D;PELO;DYRK3;MRRF;KIF5B;KLC1;MTIF2;UFL1;GFM2
gsea,negative regulation of cell cycle (GO:0045786),0.48225145154012233,1.7511689307327007,0.001876172607879925,0.011074114020219291,0.887,8/39,12.98%,MAD2L1;GMNN;PLK1;IPO5;CDKN2A;IPO7;HTRA2;TAF6
gsea,apoptotic process (GO:0006915),0.3729389302176497,1.7490058294299433,0.0,0.011317321178765462,0.891,52/126,39.62%,PPIA;HSPD1;MCM2;CIT;MELK;GAPDH;PARP1;VDAC1;TRAIP;ESPL1;CHEK1;CASP3;DDIT4;AKT1;BAX;BCLAF1;FAM162A;DHCR24;AIFM1;NAE1;BAK1;GZMB;MRPS30;PRKCE;PIDD1;IFT57;FADD;TNFAIP1;MYC;THOC1;FASTKD2;NDUFS1;BID;AKAP1;DDX41;MTOR;AHCYL1;BNIP1;CASP7;BBC3;JADE1;ELMO1;HK2;TNFRSF10B;BCL2L13;AIFM2;STK3;MAGI3;MDM2;FEM1B;DAP;ERCC3
gsea,regulation of epidermal cell differentiation (GO:0045604),-0.5749208868741005,-1.747431013129364,0.006880733944954129,0.03825513037347215,0.912,7/16,15.33%,ZFP36;ZFP36L1;SULT2B1;ERRFI1;RUNX1;AQP3;MAFF
gsea,regulation of embryonic development (GO:0045995),0.6253046746261776,1.7470237851267323,0.005964214711729622,0.011516424394281815,0.896,9/15,28.47%,CDK1;RACGAP1;CFL1;CCSAP;TDG;ZBED3;CLASP1;RBM19;CLASP2
gsea,cellular response to fibroblast growth factor stimulus (GO:0044344),0.47250168481704874,1.7467852716784906,0.001949317738791423,0.01152129229209545,0.896,18/41,21.52%,SHCBP1;HNRNPF;POLR2F;HNRNPA1;POLR2L;POLR2C;PTBP1;HNRNPM;NCBP2;POLR2E;POLR2H;NCBP1;GTF2F2;POLR2B;HNRNPH1;CEP57;GTF2F1;POLR2A
gsea,organophosphate biosynthetic process (GO:0090407),0.541569740590362,1.7457009848200609,0.004310344827586207,0.011610294118715968,0.897,10/19,32.77%,TPI1;TKT;AGPAT5;GK;LPCAT1;MBOAT1;PCYT2;GNPAT;FADS1;PPIP5K1
gsea,positive regulation of microtubule polymerization (GO:0031116),0.6060549992637126,1.745441233490614,0.0150093808630394,0.011605918297776978,0.897,8/15,27.41%,CKAP5;DRG1;NUMA1;CLIP1;DCTN1;CLASP1;CDK5RAP2;ARL2
gsea,homotypic cell-cell adhesion (GO:0034109),0.5549246308381699,1.7442661451180823,0.00998003992015968,0.01170584986384843,0.899,10/20,39.01%,PPIA;CSRP1;ACTB;FLNA;METAP1;TJP2;ACTG1;MYH9;ACTN1;PIK3CG
gsea,proteolysis (GO:0006508),0.4081755992733408,1.7433226948298908,0.0,0.011810000028691975,0.901,40/104,36.65%,PSMB5;METAP2;PSMA6;FAM111A;CASP3;PSMC4;THOP1;PSMD6;LAP3;LONP1;HTRA2;CLPP;SPCS3;PITRM1;RNPEP;ERAP1;SENP1;PARL;DPP3;GZMB;MIPEP;CTSZ;DESI1;SPG7;TYSND1;ZMPSTE24;UBA3;LRP8;PTCH1;UFSP2;ST14;TASP1;CASP7;AFG3L2;YME1L1;NLN;TBL1X;CLPX;DPP4;ADAM17
gsea,regulation of cellular protein metabolic process (GO:0032268),0.5146607491838632,1.7427427760202154,0.0017699115044247787,0.011868623548926597,0.902,13/33,28.56%,UHRF1;NOLC1;EIF4G1;TCOF1;AKT1;EIF4E;PUM3;RPL10;GEMIN5;VPS35;METAP1;EIF2A;EIF2B4
gsea,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.48487534426722784,1.739946047996478,0.009242144177449169,0.01213243311758096,0.907,3/41,6.70%,HMGB1;MIF;DHX9
gsea,regulation of cellular component biogenesis (GO:0044087),0.5156499705786523,1.739007343738342,0.0038314176245210726,0.012208406647079275,0.909,9/26,25.32%,HSP90AA1;HJURP;HSPA8;RDX;EZR;NCLN;HCFC1;ROCK2;TRAF2
gsea,histone deacetylation (GO:0016575),0.5014794447180216,1.738598466824878,0.006198347107438017,0.01224364958380001,0.911,9/28,22.97%,PHB;HDAC1;HDAC2;SFPQ;MORF4L2;RBM14;MTA2;MTA1;SIN3A
gsea,neuron projection extension (GO:1990138),0.5401970631009352,1.734520645286473,0.009328358208955223,0.012662917624967109,0.92,3/20,12.22%,HSP90AB1;HSP90AA1;LLPH
gsea,microtubule bundle formation (GO:0001578),0.5766551933269585,1.734413764237992,0.015789473684210527,0.01265025457317778,0.92,7/19,25.89%,PLK1;KIF20A;AAAS;NUMA1;CLIP1;CLASP1;CDK5RAP2
gsea,regulation of protein phosphorylation (GO:0001932),0.38179567741887865,1.7343961544305637,0.0,0.012633151199623754,0.92,33/126,34.42%,PPIA;NPM1;HSP90AA1;TFRC;PARK7;ECT2;PIN1;CDK2AP1;TARDBP;AKT1;MYDGF;HRAS;CD74;RACK1;CORO1C;VEGFB;DNAJC10;CACTIN;MT3;ROCK2;PPP2R5D;ZBED3;FMR1;PRKDC;CAMKK2;FXR2;TTN;AKAP8;PHIP;MEN1;C9ORF72;IBTK;RAP2A
gsea,regulation of smoothened signaling pathway (GO:0008589),0.555780581239406,1.7316399721602467,0.0017825311942959,0.01293139074615253,0.924,6/21,26.32%,UCHL5;VCP;TEDC1;RACK1;TEDC2;PTCH1
gsea,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.5793201701333861,1.730963360254455,0.010395010395010396,0.012980891821744053,0.926,5/16,18.45%,PDIA3;CALR;CANX;IFI30;ERAP1
gsea,mRNA modification (GO:0016556),0.563835695084303,1.7264227208071619,0.012320328542094456,0.013571961431853264,0.93,11/18,33.48%,DKC1;NSUN2;TRMT6;METTL16;PUS1;PUS7;TRUB1;VIRMA;TRMT61A;CMTR1;METTL14
gsea,negative regulation of inflammatory response (GO:0050728),-0.4081611968844832,-1.725905747332487,0.004166666666666667,0.04548678621490918,0.937,37/73,23.79%,TNFAIP3;FURIN;PLCG1;TNFAIP8L2;PTGER4;ADRB2;GLP1R;ADORA2A;CALCA;SIRPA;SYK;LYN;CALCB;PLK2;RAMP1;HCK;RORA;NLRP3;CYSLTR1;FGR;MEFV;TNFRSF1A;CYSLTR2;APOE;ACOD1;METRNL;CD200R1;HTR7;SLAMF8;NLRC3;GATA3;GRN;RLN3;NR1H3;IGF1;ADM;PPARG
gsea,sterol metabolic process (GO:0016125),0.5226499789190933,1.7237452970464928,0.0036231884057971015,0.013887447643348283,0.936,15/26,36.87%,FDX1;LBR;SQLE;HMGCR;FDX2;MSMO1;SC5D;INSIG1;PMVK;DHCR7;FDXR;TM7SF2;SCAP;NSDHL;CLN6
gsea,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.5339840073750324,1.7236323560547284,0.012684989429175475,0.013877486784017292,0.936,13/21,28.82%,RPA3;PARP1;RPA1;RPA2;DDB1;RAD23B;RPS27A;GTF2H4;CHD1L;CUL4B;GTF2H3;GTF2H1;GTF2H2
gsea,endoplasmic reticulum organization (GO:0007029),0.48865395732781447,1.7230865529561166,0.009765625,0.013934131030419641,0.936,12/33,31.96%,REEP4;GET4;LMAN1;RTN3;LMAN2;LNPK;SERP1;CCDC47;ZBED3;TMEM33;BNIP1;SMPD4
gsea,regulation of humoral immune response (GO:0002920),0.6795314955913481,1.7224671713818909,0.008571428571428572,0.013986172273750144,0.936,2/17,3.56%,C1QBP;PHB2
gsea,regulation of nervous system development (GO:0051960),0.5969359027836008,1.722436173091949,0.014084507042253521,0.013967257584920982,0.936,2/16,5.58%,HMGB2;KIF14
gsea,sensory perception of mechanical stimulus (GO:0050954),0.517622031427675,1.7222269416828104,0.008333333333333333,0.01397270030232855,0.936,5/27,17.42%,BIRC5;TIMM13;TIMM8B;TIMM9;TIMM10
gsea,snRNA processing (GO:0016180),0.571959788910911,1.7214972480510455,0.016666666666666666,0.014026654128892401,0.936,14/15,42.47%,INTS11;INTS7;INTS10;TOE1;INTS8;INTS14;INTS1;INTS5;INTS3;TUT1;INTS9;INTS2;INTS4;INTS6
gsea,regulation of regulatory T cell differentiation (GO:0045589),-0.5940866781923397,-1.7205556474336898,0.022774327122153208,0.04669427341275623,0.941,14/17,11.20%,CTLA4;IRF1;VSIR;TNFRSF18;SOCS1;DUSP10;RUNX1;IL2RA;IFNG;FOXP3;IL4I1;IL2;NFATC2;BCL6
gsea,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.453387320346351,1.718757899737136,0.01171875,0.014302896026885132,0.938,11/38,20.16%,CENPS;SAE1;BRCA1;UBA2;STUB1;FANCI;HSPBP1;GNL3;PAXIP1;UBQLN1;TBC1D7
gsea,intrinsic apoptotic signaling pathway (GO:0097193),0.4197239627520181,1.717810341672171,0.004246284501061571,0.01440017547206642,0.94,24/56,35.18%,HINT1;C1QBP;BRCA1;E2F1;MYBBP1A;BAX;CDKN1A;HTRA2;MSH6;AIFM1;BAK1;RRP8;CUL1;CHEK2;DNAJC10;PRKDC;TRAF2;DDX3X;CUL3;CUL5;BBC3;ATM;CUL4A;TNFRSF10B
gsea,negative regulation of MAP kinase activity (GO:0043407),-0.4853740388390496,-1.71757666972667,0.017130620985010708,0.047115101171934515,0.943,13/28,21.01%,DUSP1;SPRY1;PDCD4;DUSP10;IL1B;CD300A;DNAJA1;PTPRJ;LYN;APOE;IRAK3;SH2B3;SPRY2
gsea,positive regulation of intracellular signal transduction (GO:1902533),0.35411492459464233,1.7163880315397742,0.0,0.014554255960875298,0.941,63/233,40.24%,HMGB1;MIF;HSP90AB1;HSP90AA1;C1QBP;GAPDH;TFRC;PHB2;PARK7;PHB;RPS15;ECT2;NUP62;DDX1;MAZ;UBE2N;ACTN4;EEF1D;BAX;MYDGF;CGAS;PPP5C;HRAS;CD74;DDX21;RACK1;BCLAF1;HAX1;MTDH;NEDD4;FLNA;ROCK2;SEH1L;TMEM101;TRAF2;FADD;RYK;PTPN6;BID;TRIM44;LGALS1;DDX3X;ANKRD17;SLC20A1;PUM2;ZDHHC13;USP15;BBC3;TSPAN6;KIT;GSDME;TNFRSF10B;PTPN11;SHC1;TICAM2;CHUK;AREG;ROCK1;CBL;PIK3CG;MID2;RIPK2;JCAD
gsea,heme biosynthetic process (GO:0006783),0.583129614107301,1.716047199032726,0.01160541586073501,0.01454796374659819,0.941,10/15,35.98%,HMBS;FXN;ALAD;CPOX;PGRMC1;ABCB6;ALAS1;COX10;ABCG2;COX15
gsea,porphyrin-containing compound biosynthetic process (GO:0006779),0.583129614107301,1.716047199032726,0.01160541586073501,0.01454796374659819,0.941,10/15,35.98%,HMBS;FXN;ALAD;CPOX;PGRMC1;ABCB6;ALAS1;COX10;ABCG2;COX15
gsea,alpha-amino acid metabolic process (GO:1901605),0.5355090688694321,1.7132602321439998,0.0234375,0.014851970654525483,0.942,8/21,25.73%,MTHFD1;GOT2;ASNS;OAT;PYCR2;SLC25A13;ALDH18A1;KYAT3
gsea,generation of neurons (GO:0048699),0.4630495195962675,1.7132200668488626,0.0027137042062415195,0.014832019354397794,0.942,7/65,11.36%,HMGB2;RACGAP1;CIT;PIN1;CASP3;DDIT4;TUBGCP2
gsea,transcription initiation from RNA polymerase II promoter (GO:0006367),0.40658078484321697,1.708964499360663,0.0038461538461538464,0.015394063575671649,0.948,33/68,39.62%,POLR2F;HDAC1;POLR2L;POLR2C;MAZ;TAF15;TAF6;POLR2E;POLR2H;E2F2;GTF2F2;POLR2B;GTF2E2;TAF1;GTF2F1;POLR2A;NCOR2;GTF2H4;TAF3;NR2C2AP;GTF2H3;GTF2H1;GTF2H2;MED7;E2F3;TAF9;GTF2E1;TBP;TBL1X;TAF2;TAF5;MED1;ERCC3
gsea,phosphorylation (GO:0016310),0.34694177607246157,1.7073164062318325,0.0,0.015599701026864872,0.949,80/196,45.39%,BIRC5;CDK1;AURKB;CDK4;PLK1;MELK;NEK2;PLK4;PGK1;CCNE1;AURKA;CHEK1;CDK2;CDC25B;BCKDK;AKT1;STK39;PASK;HASPIN;VRK1;TAF1;SRPK1;ILF3;CHEK2;BMP2K;PRKCE;GK;MAST2;ROCK2;CDK6;PRKDC;CAMKK2;COPS2;RYK;GMFB;DYRK3;BRD2;GRK2;MTOR;RPS6KA5;NEK1;TKFC;CREB1;PPP3CB;BIRC6;MAP4K1;AGK;MAPK6;CDK8;STRADA;ATM;NADK;RUNX3;MAPKAPK2;STK3;CHUK;DCLK1;PDK1;ROCK1;PRKCI;MAP4K4;MAPK8;POMK;HK1;PIK3CG;CLK2;ACVR1;CDK7;NEK4;MAP3K20;CDK16;CDKL3;TLK2;GNPTAB;PANK3;FAM20B;CERKL;EIF2AK4;PI4KA;PIK3R4
gsea,negative regulation of mitotic cell cycle (GO:0045930),0.5340861252366181,1.7070238244104134,0.0037313432835820895,0.015622190511462613,0.949,9/24,21.06%,MAD2L1;BUB1;BUB1B;ZWILCH;CHEK1;ZWINT;WEE1;ZW10;NME6
gsea,actomyosin structure organization (GO:0031032),0.5055951453488013,1.7065009241768787,0.012915129151291513,0.015670651551996564,0.949,14/27,38.24%,CIT;CSRP1;TPM1;FLII;EPB41L2;CSRP2;ROCK2;TNFAIP1;TTN;CUL3;KCTD13;MYH9;TNNT1;ROCK1
gsea,regulation of cell development (GO:0060284),0.5643045345366685,1.7058279427518204,0.008012820512820512,0.015721135856121903,0.949,2/21,10.02%,HMGB2;AKT1
gsea,myeloid leukocyte differentiation (GO:0002573),0.4804631592439137,1.705798526428442,0.006700167504187605,0.015704404407008776,0.949,6/39,11.40%,CDK4;DEK;PARP1;E2F1;CDK2;CDKN1A
gsea,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.43392811650389096,1.7051183367292728,0.0055147058823529415,0.01577845273693652,0.95,31/65,37.79%,DYNLL2;KDELR2;LMAN1;TMED2;BCAP29;LMAN2;CAPZA2;ARCN1;HYOU1;MIA2;ZW10;ERGIC1;CNIH4;RANGRF;SPTBN1;COPB2;CTSZ;DYNC1H1;DCTN1;ACTR1A;COPG1;TMED1;CD55;NSF;CUL3;COPA;COPG2;TRAPPC12;TICAM2;SEC24D;AREG
gsea,regulation of protein kinase B signaling (GO:0051896),0.4056784573347158,1.7047200635169775,0.003169572107765452,0.015800513356831667,0.95,11/84,15.97%,HSP90AB1;HSP90AA1;C1QBP;PARK7;PHB;MAZ;AKT1;MYDGF;RACK1;HAX1;MTDH
gsea,cellular response to growth factor stimulus (GO:0071363),-0.3973220324446232,-1.7046307849890427,0.002364066193853428,0.051608810494698495,0.956,29/73,21.01%,CCL5;EEF1A1;ZFP36;ZFP36L2;CD44;ZFP36L1;NR4A1;PLCG1;NR3C1;SMAD7;OVOL2;RUNX2;ANXA1;NRP1;FLT1;XCL1;ACVRL1;SMAD3;NOTCH1;RAPGEF1;KIDINS220;EGR3;CCL2;PDGFB;LGMN;CLEC3B;DLL4;VSTM2A;SPRY2
gsea,positive regulation of phosphorylation (GO:0042327),0.39422458389610054,1.701845613635068,0.003110419906687403,0.016201594526839915,0.954,23/107,27.46%,PPIA;MIF;HSP90AA1;PTGES3;TFRC;PIN1;CDK2AP1;RAD50;AKT1;MYDGF;HRAS;CD74;RACK1;NBN;VEGFB;DSCAM;MT3;ROCK2;FMR1;GLMN;CAMKK2;RYK;FXR2
gsea,negative regulation of growth (GO:0045926),0.42709796065499445,1.7005280775029228,0.0,0.016367068026298816,0.955,19/55,34.22%,RBBP7;ENO1;PHB;CDKN2A;SMARCA4;CDKN1A;RACK1;PNPT1;NME6;OSGIN2;MT3;ING1;CDKN2D;DDX3X;CCAR2;CDKN2C;JADE1;ING5;DCBLD2
gsea,negative regulation of neuron projection development (GO:0010977),0.5632642557172418,1.7002178255135665,0.0033500837520938024,0.016366692752004086,0.956,3/19,7.73%,FKBP4;HDAC2;ARHGDIA
gsea,mRNA catabolic process (GO:0006402),0.48803456938066764,1.6993430529942695,0.015053763440860216,0.0164542403614154,0.957,11/25,29.55%,LSM2;MRTO4;THRAP3;EXOSC9;METTL16;EXOSC4;PNPT1;EXOSC10;CNOT10;SUPV3L1;DXO
gsea,response to gamma radiation (GO:0010332),0.5359229360690543,1.6986988867296542,0.008316008316008316,0.016515836400000754,0.958,10/19,34.33%,TMEM109;FANCD2;HRAS;XRCC6;XRCC5;ATR;MYC;HSF1;MEN1;ATM
gsea,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.6028634384232022,1.698454592946437,0.007936507936507936,0.016525936452411724,0.958,1/18,0.33%,HMGB1
gsea,regulation of fibroblast proliferation (GO:0048145),0.5365891772701149,1.6981875600768783,0.006493506493506494,0.0165466823375332,0.958,6/27,11.40%,MIF;CDK4;E2F1;DHX9;CD74;CDKN1A
gsea,regulation of phosphoprotein phosphatase activity (GO:0043666),0.565653089608674,1.6977429553068994,0.006198347107438017,0.01658868730696065,0.958,4/16,16.05%,HSP90AB1;HSP90B1;MASTL;CALM2
gsea,negative regulation of cell growth (GO:0030308),0.41423205013809994,1.694286176273766,0.001841620626151013,0.017018020728409775,0.96,18/58,34.22%,RBBP7;ENO1;PHB;CDKN2A;SMARCA4;CDKN1A;RACK1;NME6;OSGIN2;MT3;ING1;CDKN2D;FGF13;DDX3X;CCAR2;CDKN2C;JADE1;DCBLD2
gsea,cellular response to decreased oxygen levels (GO:0036294),0.43512393799005583,1.6937960868226536,0.012295081967213115,0.01706134543650067,0.96,16/45,31.58%,SUV39H1;PGK1;STUB1;P4HB;HP1BP3;SUV39H2;FAM162A;EPAS1;HYOU1;UBQLN1;EGLN1;MT3;NDRG1;MYC;MTOR;TBL2
gsea,regulation of smooth muscle cell proliferation (GO:0048660),-0.4871134914825341,-1.6937509372520454,0.0,0.05532948840848956,0.961,11/27,14.93%,CCL5;TNFAIP3;STAT1;NR4A3;TNF;FOXP1;IFNG;THBS1;AIF1;PDGFB;TCF7L2
gsea,platelet aggregation (GO:0070527),0.5573518413029542,1.693473666693986,0.010101010101010102,0.01708119510057203,0.96,9/17,39.01%,PPIA;CSRP1;ACTB;FLNA;METAP1;ACTG1;MYH9;ACTN1;PIK3CG
gsea,positive regulation of intracellular transport (GO:0032388),0.5362760706042603,1.68836538807891,0.01867219917012448,0.017806816362613297,0.965,8/18,29.25%,KIF20B;SPAG5;PCNT;NEDD4;NUMA1;DYNC1H1;PCM1;CEP290
gsea,fatty acid oxidation (GO:0019395),0.48905958920323056,1.6857976862726884,0.011538461538461539,0.018204392717246765,0.968,16/26,39.25%,ACADL;ADH5;MECR;HADH;ACAT2;ECHDC2;ECHDC1;DECR1;ECI1;SLC25A17;MCAT;HSD17B10;PECR;ABCD3;MTLN;CPT2
gsea,lymphocyte proliferation (GO:0046651),0.5845490040696257,1.6849553231436294,0.01073345259391771,0.018313387084474508,0.969,3/16,12.56%,HELLS;HSPD1;TNFRSF4
gsea,negative regulation of phosphorylation (GO:0042326),0.431791182424065,1.6837643055178226,0.0035714285714285713,0.018451613565577427,0.97,24/52,41.26%,PPIA;HNRNPU;PARK7;CDKN2A;TARDBP;CDKN1A;CORO1C;PRDX3;DNAJC10;PRKRIP1;CACTIN;ZBED3;PRKDC;CDKN2D;CDKN2C;MEN1;C9ORF72;IBTK;ROCK1;FBLN1;PAQR3;XDH;PFKFB1;ANKLE2
gsea,sensory perception of sound (GO:0007605),0.497549500385443,1.6818792860802592,0.009868421052631578,0.018688490428944382,0.97,5/28,17.42%,BIRC5;TIMM13;TIMM8B;TIMM9;TIMM10
gsea,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.4691046744915159,1.680801763074209,0.0,0.018806841348658968,0.97,13/38,29.74%,HMGB1;CYCS;YWHAE;AKT1;HTRA2;GPX1;DHCR24;ARL6IP1;DELE1;MT3;MYC;CDKN2D;DDX3X
gsea,histone H3-K4 methylation (GO:0051568),0.563762007512691,1.6791578248425052,0.016913319238900635,0.01901731252947792,0.971,4/16,13.35%,DPY30;WDR5;ASH2L;PAXIP1
gsea,regulation of protein polymerization (GO:0032271),0.5480038173964821,1.676671675866105,0.009861932938856016,0.019416032136993725,0.971,3/18,14.15%,HSP90AA1;PFN1;HAX1
gsea,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.41906540143511983,-1.6764693399754518,0.010025062656641603,0.06310949066338115,0.969,24/55,19.43%,CCL5;CLCF1;CD44;TNFRSF18;TNF;NEDD9;STAT3;NRP1;PARP14;CD40;IFNG;PTPRJ;LYN;PTK2B;CASS4;CSF1R;TEC;IL2;CSF2;TNFRSF1A;ITGA5;PDGFB;JAK2;PARP9
gsea,epithelial to mesenchymal transition (GO:0001837),0.5273563792056191,1.6758394276379172,0.008576329331046312,0.019522357540526024,0.971,3/23,5.89%,HNRNPAB;TRIM28;FAM83D
gsea,positive regulation of viral genome replication (GO:0045070),0.555236296471623,1.6746943653968778,0.011695906432748537,0.01968068802393555,0.973,13/19,30.06%,TOP2A;PPIA;PPIH;PPID;PPIE;RAD23A;DDB1;LARP1;SRPK1;TARBP2;HACD3;DDX3X;TMEM39A
gsea,negative regulation of MAPK cascade (GO:0043409),0.42900193206998927,1.6745482948737753,0.0036429872495446266,0.0196839534105386,0.973,6/46,14.69%,PPIA;PEBP1;PHB;PIN1;FOXM1;EZR
gsea,positive regulation of interleukin-8 production (GO:0032757),0.5267235274244633,1.673661610146073,0.01001669449081803,0.01979152917131407,0.973,3/26,11.33%,HMGB1;PARK7;CD74
gsea,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.5779813085121694,1.6717850337339393,0.018518518518518517,0.02002797127795985,0.973,11/15,33.30%,MED30;PSMC4;PSMC2;PSMC5;PAXIP1;PSMC6;MED4;MED14;MED16;SRF;MED24
gsea,positive regulation of fibroblast proliferation (GO:0048146),0.6040816718243706,1.6715626091411535,0.013157894736842105,0.020036970848359353,0.973,6/18,11.40%,MIF;CDK4;E2F1;DHX9;CD74;CDKN1A
gsea,positive regulation of interleukin-12 production (GO:0032735),0.5604285817790012,1.66954543644311,0.0150093808630394,0.02037419230150593,0.975,3/17,11.27%,HMGB1;HSPD1;TNFSF4
gsea,cellular amino acid catabolic process (GO:0009063),0.4644564314211295,1.6687385678001585,0.0045662100456621,0.020463584311453027,0.975,20/47,33.80%,SHMT1;SHMT2;GOT2;BCKDK;GCSH;BCAT1;BLMH;CARNMT1;DLST;BCAT2;GSTZ1;GLDC;OGDH;DLD;GCDH;ALDH7A1;BCKDHB;MCCC2;IVD;HSD17B10
gsea,negative regulation of immune response (GO:0050777),-0.4129408288235402,-1.6663786181705789,0.006289308176100629,0.06702966674593339,0.98,32/58,19.05%,LGALS3;TNFAIP3;CCR2;FURIN;PLCG1;SPI1;PTGER4;ADRB2;CD300A;GLP1R;ADORA2A;CALCA;TRAFD1;SYK;FCGR2B;LYN;FOXP3;CALCB;PLK2;RAMP1;HCK;DHX58;CYSLTR1;FGR;CYSLTR2;HAVCR2;ACOD1;HTR7;NLRC3;TRIM21;IRAK3;RLN3
gsea,gene silencing by miRNA (GO:0035195),0.5232168375208919,1.6659871155198018,0.027559055118110236,0.020919403421210098,0.979,9/17,32.08%,RAN;EIF6;TARBP2;CNOT1;TNRC6A;XPO5;DICER1;PUM2;SPOUT1
gsea,receptor-mediated endocytosis (GO:0006898),0.4194010580179763,1.65891269455342,0.0066555740432612314,0.022246931473386692,0.981,13/68,25.56%,HSP90AA1;HSP90B1;TFRC;CALR;CANX;CLTB;M6PR;HYOU1;NEDD4;RABEPK;SCARB1;AP1G2;LDLR
gsea,positive regulation of protein binding (GO:0032092),0.4655013212695474,1.6587702003771703,0.014545454545454545,0.022238277311868927,0.981,4/32,19.78%,RAN;PIN1;TAF1;NVL
gsea,peptide metabolic process (GO:0006518),0.4823875095930121,1.6568791708429238,0.01436265709156194,0.022547331800668275,0.981,9/30,22.08%,THOP1;GPX1;SPCS3;GSR;CARNMT1;ERAP1;PARL;MIPEP;GSTZ1
gsea,negative regulation of developmental process (GO:0051093),0.4842168267080371,1.6564414052481544,0.00463678516228748,0.02259595901682057,0.981,12/36,26.99%,ANP32B;MIF;TFRC;SUZ12;FOXM1;SINHCAF;WDR77;ROCK2;CDK6;CST3;HUWE1;SFMBT1
gsea,purine ribonucleotide biosynthetic process (GO:0009152),0.5656186077401977,1.655595144328528,0.020676691729323307,0.022718504889217405,0.981,6/15,24.72%,IMPDH2;ADSL;GMPS;AMPD2;GUCY1B1;DCAKD
gsea,supramolecular fiber organization (GO:0097435),0.3698093349611218,1.655160650744286,0.0,0.022779080860057234,0.981,56/149,38.83%,STMN1;HSP90AB1;KIF2C;FIGNL1;KIF18B;KIF14;PIN1;TPM3;CKAP5;P4HB;TPM4;TUBGCP2;KIF18A;CORO1C;KIF24;COLGALT1;MYO5A;TPM1;RPS27A;FLII;ALDOA;CORO1A;MARCKSL1;HOOK1;CLIP1;ZBED3;DYNC1H1;CST3;DCTN1;KIF2A;SH3BP1;CENPJ;PCM1;MPRIP;FGF13;ERMN;WDR73;CD2AP;TUBGCP3;KATNB1;ELMO1;HDGFL3;RUFY3;TRIOBP;HOOK2;USP9X;ACTN1;TUBGCP4;PLOD2;CAMSAP1;TUBGCP6;TUBGCP5;CORO7;CRTAP;MDM2;GGA2
gsea,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.35252344737885916,1.654458629527434,0.0,0.022868205743813246,0.981,38/126,39.98%,PPIA;NPM1;TFDP1;TFRC;PHB2;PARK7;PSMA6;DHX9;UBE2N;AKT1;SMARCA4;COPS5;SMARCB1;TRIM37;MTDH;PRDX3;TCF3;TAF1;RPS27A;PIDD1;PPRC1;BUD31;TRAF2;LRP8;NFKB2;HSF1;RHEBL1;SRF;RPS6KA5;KIT;STK3;ERC1;CHUK;TAB1;PRKCI;CTNNB1;MID2;RIPK2
gsea,regulation of organelle assembly (GO:1902115),0.4523292067603278,1.6540172996199554,0.008281573498964804,0.022907918308380737,0.981,17/36,39.82%,NPM1;STIL;CEP295;RDX;EZR;ADPRH;TBC1D10B;ALMS1;CEP76;CENPJ;ATXN2L;SGSM3;C9ORF72;TRAPPC12;IFT140;IFT88;PIKFYVE
gsea,positive regulation of interleukin-6 production (GO:0032755),0.4745014043469091,1.6539492058578273,0.005110732538330494,0.022892288794194117,0.981,5/41,11.33%,HMGB1;HSPD1;DHX9;TNFSF4;CD74
gsea,regulation of stress-activated MAPK cascade (GO:0032872),0.5008874123943078,1.6517083962385635,0.013725490196078431,0.02330567935739354,0.981,5/22,26.62%,PPIA;FOXM1;COPS5;MID1;MYC
gsea,glial cell development (GO:0021782),0.5662340913571557,1.6512176712305657,0.020036429872495445,0.023350736397586735,0.981,7/15,28.56%,EIF2B3;EIF2B1;EIF2B5;NSUN5;MT3;CDK6;EIF2B4
gsea,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.5566227906342838,1.6468723310087652,0.015717092337917484,0.024198270911833464,0.985,5/15,18.10%,BRCA1;RUVBL2;PAXIP1;TADA2A;BRD7
gsea,regulation of protein targeting to mitochondrion (GO:1903214),0.5422036193595826,1.646632169174259,0.01859504132231405,0.024211449577488466,0.985,8/16,26.83%,SAE1;LMAN1;HTRA2;HAX1;PARL;SREBF2;CSNK2A2;HUWE1
gsea,histone H3 acetylation (GO:0043966),0.47507958031502195,1.6379136054669512,0.018633540372670808,0.025900506834635427,0.987,19/26,41.70%,POLE3;BRCA2;WDR5;SGF29;TADA2A;TAF6L;KAT2A;KAT7;TAF9;BRPF1;JADE1;ING5;TADA3;JADE2;LEF1;TAF5;YEATS2;KAT14;JADE3
gsea,regulation of cation channel activity (GO:2001257),-0.46768730552779314,-1.6376724660830957,0.005390835579514825,0.08153684169639396,0.988,15/29,18.33%,CNIH2;AHNAK;CTSS;DLG2;ACTN2;PTK2B;APP;CAMK2D;CACNB3;HOMER1;DAPK1;SELENON;MMP9;ITGB1;JPH3
gsea,phospholipid metabolic process (GO:0006644),0.4708067749405973,1.636564743012482,0.012844036697247707,0.02613240858623223,0.987,14/29,35.82%,PGP;AGPAT5;FDFT1;GDE1;PDXP;LPCAT1;MBOAT1;PLAA;PCYT2;GNPAT;FADS1;ACP6;PLPP1;SMPD1
gsea,regulation of mitochondrial membrane potential (GO:0051881),0.49752212117637207,1.6355301900401855,0.018281535648994516,0.026280611330186103,0.987,9/23,18.73%,PARK7;STOML2;PRELID1;AKT1;VCP;BAX;PRDX3;BAK1;PPA2
gsea,response to organonitrogen compound (GO:0010243),0.557289121641313,1.6343986755410822,0.010238907849829351,0.026497186499074808,0.988,6/17,29.39%,DHFR;VCP;RNF5;CCDC47;KAT7;MTOR
gsea,selective autophagy (GO:0061912),0.4512077526440305,1.6325121382874987,0.017278617710583154,0.026818214853676834,0.989,8/29,24.60%,PHB2;PARK7;DYNLL2;PCNT;UBE2N;RPS27A;UBQLN1;DYNC1H1
gsea,positive regulation of protein kinase B signaling (GO:0051897),0.41207126396859384,1.6298848646304183,0.0015748031496062992,0.027364310080732607,0.989,9/68,15.97%,HSP90AB1;HSP90AA1;C1QBP;PARK7;PHB;MAZ;MYDGF;HAX1;MTDH
gsea,regulation of angiogenesis (GO:0045765),-0.3607219147579066,-1.6292051137546237,0.0057306590257879654,0.08574935109578634,0.99,95/95,96.14%,TNFAIP3;STAT1;ITGAX;SP100;ETS1;ZC3H12A;ATP2B4;CCR2;PIK3CD;PLCG1;IL1B;PRKCA;HIF1A;RUNX1;CTSH;NINJ1;FLT1;CD40;GTF2I;GLUL;HHEX;THBS1;ATF2;FOXJ2;ECM1;PGF;PF4;CEACAM1;TNFSF12;ITGB1;CCR3;GRN;ADGRA2;GPNMB;SPRY2;FOXO4;SIRT1;JUP;TGFB2;PPARG;RGCC;HSPB1;PRKD2;FGF2;ITGB8;VEGFA;CXCL10;CXCL13;SPHK1;ANXA3;STAB1;HMOX1;PDE3B;HIPK1;AGO1;SPARC;HGS;ALOX5;AMOT;PTPRM;KLF4;CD160;PML;VASH2;SERPINE1;F3;NF1;PAK4;DAB2IP;CEMIP2;HIPK2;XBP1;RAMP2;PRKCB;SPRED1;PDPK1;AGO2;VASH1;SERPINF1;TWIST1;RHOB;PIK3R6;CTNNB1;ROCK1;ANGPTL4;HK2;PLXND1;ROCK2;SP1;EGLN1;VEGFB;MTDH;MYDGF;PGK1;BRCA1
gsea,positive regulation of kinase activity (GO:0033674),0.44605363299343903,1.627859329806622,0.014802631578947368,0.0278162292268792,0.989,8/41,19.56%,CENPE;RAD50;CD74;CDKN1A;XRCC6;NBN;XRCC5;MRNIP
gsea,negative regulation of protein modification process (GO:0031400),0.41162462707273756,1.625563498093721,0.013333333333333334,0.028301108788242917,0.989,21/46,42.98%,PPIA;DBI;PARK7;TARDBP;CORO1C;XRCC1;TINF2;PPP1R8;DNAJC10;CACTIN;ZBED3;PRKDC;MEN1;C9ORF72;IBTK;CRTAP;FBLN1;PAQR3;XDH;CDYL;TRAF3IP1
gsea,protein processing (GO:0016485),0.43914818019929086,1.625497120604844,0.007104795737122558,0.028270323444329525,0.989,14/43,26.32%,METAP2;STOML2;FAM111A;FXN;HTRA2;SPCS3;PITRM1;PARL;PIDD1;SPG7;ATP23;TYSND1;ZMPSTE24;PTCH1
gsea,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.41775576465969144,-1.6251619380275433,0.006779661016949152,0.0870488228155001,0.991,19/42,19.05%,FURIN;PLCG1;PTGER4;ADRB2;GLP1R;ADORA2A;CALCA;SYK;FCGR2B;LYN;CALCB;PLK2;RAMP1;HCK;CYSLTR1;FGR;CYSLTR2;HTR7;RLN3
gsea,inflammatory response (GO:0006954),-0.4018809272835809,-1.6247020991855832,0.014450867052023121,0.08622231711412594,0.991,53/95,19.47%,CCL5;CD44;CEBPB;CCR5;GPR68;REL;CCL1;CCR2;ADGRE5;PIK3CD;NFKB1;CCL4;IL1B;TNF;F2R;PTGER4;ANXA1;IL2RA;STAT3;ADORA2A;CYBB;CD40;IFNG;CD40LG;NFAM1;FCGR2B;XCL1;CXCL9;THBS1;IL1RN;CSF1R;AIF1;ADAM8;NLRP3;FOS;TLR2;C3AR1;MEFV;TNFRSF1A;CXCL2;CCL2;CCL8;FUT7;HDAC5;OLR1;PF4;CCL7;HDAC4;CD14;CCR3;BLNK;CCL22;C5AR1
gsea,positive regulation of production of molecular mediator of immune response (GO:0002702),0.5640978150188074,1.6235315940288906,0.025134649910233394,0.028604781327289545,0.989,5/16,12.56%,PHB2;PHB;SLC7A5;TNFSF4;TNFRSF4
gsea,liver development (GO:0001889),0.5381875336074561,1.6230711917677347,0.019197207678883072,0.028661824194016312,0.991,6/18,17.54%,E2F8;E2F7;AURKA;PRKCSH;PCK2;GFER
gsea,regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.4219876160262921,-1.6215346412507192,0.0035211267605633804,0.08705284893930636,0.991,18/41,19.05%,FURIN;PLCG1;PTGER4;ADRB2;GLP1R;ADORA2A;CALCA;SYK;LYN;CALCB;PLK2;RAMP1;HCK;CYSLTR1;FGR;CYSLTR2;HTR7;RLN3
gsea,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.5221132923257391,1.621471427516452,0.017094017094017096,0.028982828106855194,0.991,10/24,29.74%,YWHAE;PARK7;PIH1D1;AKT1;GPX1;DHCR24;ARL6IP1;MT3;CDKN2D;DDX3X
gsea,regulation of proteolysis (GO:0030162),0.5166269109984495,1.6201000954516867,0.02462121212121212,0.02924900594727322,0.991,9/20,26.03%,PLK1;HDAC2;STUB1;SERPINE2;AKT1;BAK1;PARL;CST3;FADD
gsea,defense response to Gram-positive bacterium (GO:0050830),0.5736762373202563,1.6178090326066998,0.0205761316872428,0.029741937938873093,0.991,1/15,0.04%,HMGB2
gsea,negative regulation of organelle assembly (GO:1902116),0.5035382088211413,1.6166078680916982,0.022813688212927757,0.029936613527695978,0.991,10/22,30.06%,BRCA1;CCP110;TRIM37;RBM14;KAT2A;TBC1D7;MDM1;ODF2L;CDK5RAP2;TMEM39A
gsea,protein K48-linked ubiquitination (GO:0070936),0.48978778054557504,1.6166049621950063,0.014799154334038054,0.029895938781055082,0.991,7/21,19.17%,UBE2C;UBE2T;RNF126;CDC34;UBE2E3;SKP2;RNF5
gsea,negative regulation of apoptotic signaling pathway (GO:2001234),0.43216765954828934,1.6161768620935404,0.019891500904159132,0.029952752656757044,0.991,19/43,33.66%,SLC25A5;PARK7;NOC2L;PRELID1;FXN;MAZ;PIH1D1;AKT1;PPIF;PSME3;GPX1;URI1;CSNK2A2;HERPUD1;OPA1;DDX3X;PHIP;BIRC6;CAAP1
gsea,snRNA metabolic process (GO:0016073),0.5504682571296846,1.6135294546406462,0.026373626373626374,0.030523428692187212,0.991,14/15,42.47%,INTS11;MTREX;INTS7;INTS10;ZCCHC8;INTS8;INTS1;INTS5;INTS3;TUT1;INTS9;INTS2;INTS4;INTS6
gsea,response to hydrogen peroxide (GO:0042542),0.4638115619853592,1.6127271543457784,0.013671875,0.03070608339541764,0.992,7/28,18.76%,PARK7;ECT2;FXN;PPIF;GPX1;PRDX3;NET1
gsea,negative regulation of protein-containing complex assembly (GO:0031333),0.4795139950335745,1.6121972679863803,0.013986013986013986,0.030799177988506878,0.992,11/26,39.19%,HMGB1;PARK7;KIF14;HSPA5;AIDA;HSF1;DDX3X;CPTP;SVIP;HDAC6;TFIP11
gsea,macrophage activation (GO:0042116),-0.5353545725426806,-1.6088906118289916,0.03855421686746988,0.093759351928713,0.991,12/18,20.98%,TNF;FOXP1;IFNG;SYK;SBNO2;APP;AIF1;ITGAM;C1QA;JAK2;C5AR1;CD93
gsea,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.5426275640624324,1.6059715671983155,0.03512396694214876,0.032190636580847,0.994,14/16,34.70%,PARP1;COPS3;DDB1;COPS5;RAD23B;GPS1;COPS4;RPS27A;COPS7A;CUL4B;COPS2;COPS7B;DDB2;CUL4A
gsea,Notch signaling pathway (GO:0007219),0.46497997474920894,1.605935768266694,0.01675977653631285,0.03215514865159434,0.994,4/26,17.00%,YBX1;DLGAP5;GMDS;NLE1
gsea,plasma membrane bounded cell projection assembly (GO:0120031),0.3453958442705065,1.60523526561911,0.0037243947858473,0.032273514747682745,0.994,49/119,40.84%,PLK4;DYNLL2;PCNT;TMEM107;CEP83;CFAP298;EZR;CEP89;KIF24;POC1B;WDR90;SCLT1;TMEM237;FLNA;SSX2IP;EMP3;CENPJ;PCM1;ARFIP2;CEP162;DYNC2H1;EXOC4;TMEM138;CEP290;EHD4;CEP19;ACTR2;CD2AP;OFD1;IFT74;NEK1;KIT;RAP2A;CEP164;CCDC66;RP2;IQCB1;TMEM216;RAB23;CEP250;IFT140;MAP4K4;RAB3IP;CEP41;HDAC6;IFT88;IFT46;SNX10;AHI1
gsea,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.5054273503499823,1.597747290478541,0.03829787234042553,0.034141659847549265,0.997,9/18,32.08%,HNRNPA2B1;SRRT;DGCR8;MRPL44;DROSHA;TARBP2;DICER1;PUM2;SPOUT1
gsea,fatty acid catabolic process (GO:0009062),0.4560041841956791,1.5948173543626405,0.020703933747412008,0.03474853443199081,0.999,17/31,39.25%,ACADL;MECR;NUDT19;AIG1;HADH;ACAT2;ECHDC2;ECHDC1;DECR1;ECI1;SLC25A17;MCAT;HSD17B10;PECR;ABCD3;MTLN;CPT2
gsea,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.5532589366536802,1.5946566565958298,0.039473684210526314,0.03477459803992012,0.999,4/15,19.15%,HSP90AB1;HSP90AA1;EPAS1;UBQLN1
gsea,negative regulation of macromolecule metabolic process (GO:0010605),0.37214536339078896,1.5937273130509113,0.004658385093167702,0.034994701877300284,0.999,27/97,36.29%,MIF;HSP90AB1;DNMT1;PARK7;HDAC1;AURKA;TARDBP;SLC7A5;RBL1;HRAS;RACK1;PTRH2;TAF1;SETDB1;TLE5;ROCK2;OPTN;LDLR;YY1;RBL2;TNRC6A;DICER1;SETDB2;WDR54;CELF1;TERF2;ANXA7
gsea,regulation of reactive oxygen species metabolic process (GO:2000377),0.4831772696055758,1.591477638623883,0.020442930153321975,0.035594085870403906,0.999,8/25,22.91%,BRCA1;EIF6;FOXM1;COQ7;CDKN1A;PARL;AATF;MT3
gsea,calcium ion transmembrane transport (GO:0070588),0.46075363044342843,1.5890929423974116,0.008417508417508417,0.03620360220212818,1.0,9/33,22.26%,PHB2;PHB;STOML2;ATP2A2;PMPCA;LETM1;PMPCB;PARL;SPG7
gsea,activation of protein kinase B activity (GO:0032148),0.5742451348267291,1.5881704441049185,0.02875399361022364,0.0363955330486159,1.0,5/16,22.91%,PPIA;PARK7;AKT1;PRR5;MT3
gsea,negative regulation of cell population proliferation (GO:0008285),0.33303307232766355,1.5876146273197242,0.005076142131979695,0.03650504167275413,1.0,48/163,38.91%,NPM1;NME1;CDC6;TFDP1;RBBP4;CDKN3;PHB;E2F1;NUP62;E2F7;CDKN2A;EEF1E1;SMYD2;HMGA1;GTPBP4;HRAS;CDKN1A;CTCF;UTP20;PDS5B;BRD7;DNAJA3;PBRM1;PINX1;TFAP4;TINF2;SOD2;CHERP;CDK6;THAP12;GLMN;MYC;CDKN2D;PTPN6;TESC;E2F3;CDKN2C;MEN1;CDC73;ING5;GSDME;PLPP1;CELF1;RUNX3;FRZB;DLL1;BAP1;FBLN1
gsea,membrane organization (GO:0061024),0.3612254505677088,1.5871935793524918,0.001838235294117647,0.036569462627435316,1.0,54/101,46.39%,CEP55;TFRC;KIF20A;REEP4;TIMM50;NUP93;HSPA8;CLTB;M6PR;NUP155;ACTB;NSFL1C;CORO1C;RPS27A;COX18;SERP1;SPTBN1;NEMP1;LDLR;HUWE1;SYNGR2;OPA1;TMEM33;ACTR2;SYNGR1;ACTG1;AP3D1;SUN2;CLTC;PACSIN2;GCA;CPTP;PLEKHA8;TMEM43;EPS15;AREG;UBXN2B;GAPVD1;PRKCI;CBL;TLCD2;GAK;VAMP8;AP2B1;TLCD1;STAM2;DVL2;CTDNEP1;HACE1;USO1;AP2A2;STON2;VPS33B;SPAG4
gsea,negative regulation of interferon-gamma production (GO:0032689),0.5252549990263166,1.5864306734484912,0.03317535545023697,0.036701790418106145,1.0,3/19,11.27%,HMGB1;C1QBP;TNFSF4
gsea,regulation of epithelial cell proliferation (GO:0050678),0.45475133045586735,1.5850186886887458,0.029950083194675542,0.03699111005784209,1.0,10/37,26.62%,UHRF1;NME1;NME2;SRSF6;HRAS;GPX1;TINF2;CDK6;PRKDC;MYC
gsea,negative regulation of cell projection organization (GO:0031345),0.5103258645560251,1.5846909921665082,0.019963702359346643,0.03700807288046843,1.0,2/18,7.64%,FKBP4;HDAC2
gsea,acyl-CoA metabolic process (GO:0006637),0.5599635664526339,1.5840159573952655,0.03278688524590164,0.03711992173421665,1.0,6/15,24.87%,DBI;HMGCS1;DLST;SUCLG2;ACACA;OGDH
gsea,tRNA methylation (GO:0030488),0.4610494719607584,1.5836076241855093,0.01882845188284519,0.03719664857139063,1.0,19/27,46.24%,NSUN2;METTL1;FTSJ1;TRMT61A;TRMT10A;HSD17B10;TYW3;TRMT5;MTO1;TRMO;GTPBP3;TRMT1;TRDMT1;TRMT10C;WDR6;DALRD3;TARBP1;PRORP;ALKBH8
gsea,positive regulation of cell adhesion (GO:0045785),-0.42819548765717147,-1.5831512317618275,0.018867924528301886,0.11047029479303673,0.997,16/35,16.67%,CCL5;TNFRSF18;TNF;SMAD7;PRKCA;ADGRG1;CITED2;TGM2;PTPRJ;SYK;PRSS2;ADAM8;PDGFB;FUT7;RET;JAK2
gsea,carboxylic acid metabolic process (GO:0019752),0.5586056326520296,1.583057556676986,0.01800327332242226,0.037336937333627314,1.0,5/17,23.44%,MIF;GSTO1;CARNMT1;LIAS;GRHPR
gsea,intraciliary transport involved in cilium assembly (GO:0035735),0.48546811472273704,1.5802217172167883,0.020637898686679174,0.038038401416956726,1.0,16/22,43.61%,DYNLL2;IFT27;TNPO1;SSX2IP;IFT57;PCM1;DYNC2H1;IFT74;TTC21B;IFT140;IFT88;KIFAP3;IFT46;IFT22;TRAF3IP1;IFT80
gsea,positive regulation of cell growth (GO:0030307),0.4302929584843026,1.579254913339691,0.012965964343598054,0.03828513488009509,1.0,23/47,41.65%,EIF4G1;FXN;AKT1;EXOSC2;HDGFL2;EXOSC9;NCBP1;DNPH1;EIF4G2;EXOSC4;DERL2;PLAA;GOLGA4;SUPV3L1;DDX3X;DDX49;RUFY3;ADAM17;MFSD2A;UNC13A;KLHL22;SLC25A33;USP47
gsea,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.4953448485190683,1.5771340938380543,0.025157232704402517,0.0388122168062099,1.0,9/19,33.89%,AUNIP;RIF1;SMCHD1;MRNIP;PRKDC;HSF1;ACTR2;WRAP53;KMT5C
gsea,negative regulation of protein ubiquitination (GO:0031397),0.4468248852528429,1.5766674342287275,0.02494802494802495,0.03885738766793698,1.0,12/28,31.30%,FBXO5;PARK7;U2AF2;AKT1;GTPBP4;PRMT3;TAF1;PINX1;IVNS1ABP;NXN;BAG2;GNL3L
gsea,pattern recognition receptor signaling pathway (GO:0002221),0.48147776487854876,1.5763595085143416,0.026833631484794274,0.03891011849211743,1.0,7/27,38.40%,HMGB1;HSP90B1;RPS27A;LACC1;MAPKAPK2;TAB1;TRAF3
gsea,regulation of viral genome replication (GO:0045069),0.42776757935377363,1.5746395347267677,0.017408123791102514,0.039332707502474196,1.0,15/40,30.06%,PPIA;BANF1;PPIH;FAM111A;PPID;PPIE;RAD23A;DDB1;LARP1;SRPK1;ILF3;TARBP2;HACD3;DDX3X;TMEM39A
gsea,brain development (GO:0007420),0.40125898155328765,1.5730826318184956,0.005253940455341506,0.03971972939275263,1.0,20/54,39.74%,PHGDH;CENPF;DDIT4;TUBGCP2;UTP3;EOMES;ABCB6;CDK5RAP2;PTCH1;PAFAH1B3;SETD1A;SPATA5;PTPN11;CHD8;ROGDI;DHX37;POMK;MFSD2A;PBX4;BPTF
gsea,macroautophagy (GO:0016236),0.40426787384742463,1.5730628963768603,0.011135857461024499,0.03966978803358303,1.0,10/44,25.49%,VDAC1;TOMM40;DYNLL2;VCP;TOMM5;TOMM20;UBQLN1;CSNK2A2;PLAA;VPS16
gsea,protein glycosylation (GO:0006486),0.36884073497021064,1.5701244935128718,0.004081632653061225,0.04041818156241279,1.0,42/72,50.93%,RPN2;DDOST;RPN1;ALG8;MOGS;STT3A;MAGT1;GALNT1;PMM1;STT3B;DPAGT1;ALG6;SERP1;ALG3;NUS1;DOLPP1;ENTPD5;B4GALT5;MPI;ALG9;PGM3;GALNT7;PLOD2;POGLUT1;POMK;POMT2;SERP2;GALNT18;EOGT;FUT4;B3GNT3;ST3GAL5;B4GAT1;POFUT1;POMT1;ALG10B;OGA;POMGNT1;B3GALNT2;COG7;ALG12;GFPT1
gsea,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.4800044120442953,-1.5697881700129974,0.034261241970021415,0.11952130070147687,0.999,11/24,16.76%,LGALS3;TNFAIP3;SP100;BCL2L1;ICAM1;TMC8;TNFSF10;THBS1;MADD;TMBIM1;PMAIP1
gsea,regulation of small GTPase mediated signal transduction (GO:0051056),0.39220719569393764,1.5695545906518693,0.009819967266775777,0.040548634755442334,1.0,23/68,47.55%,RACGAP1;ECT2;NUP62;ARHGAP11A;ARHGDIA;FOXM1;ARHGAP19;DEPDC1B;NET1;ARHGDIG;SH3BP1;CD2AP;RABL3;RHOT2;INPP5B;ARHGAP21;ARHGAP24;ARHGAP10;ARHGAP35;RHOB;TIAM1;VAV2;SRGAP2
gsea,heterotypic cell-cell adhesion (GO:0034113),-0.5197745752630132,-1.5693656990973706,0.03617571059431524,0.1183995615079824,0.999,7/17,17.40%,ITGAX;NINJ1;ITGB7;ITGA5;CD200R1;DSG2;ITGB1
gsea,positive regulation of cellular component biogenesis (GO:0044089),0.37875111500722214,1.5672517137574133,0.015810276679841896,0.04121775446823397,1.0,16/50,31.30%,TFRC;PARK7;PIH1D1;CDT1;VCP;BAX;PFN1;RACK1;SLF1;BAK1;FAF1;SYNPO2;BID;SPIDR;SLF2;GNL3L
gsea,regulation of cellular metabolic process (GO:0031323),0.5038548636955946,1.5658494510574898,0.038834951456310676,0.04155035946058108,1.0,10/19,26.92%,EIF6;STUB1;FOXM1;COQ7;FASN;VPS35;PARL;NCOR2;ACACA;ACLY
gsea,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.5032399003721765,1.5642500053396078,0.031578947368421054,0.04190109839936627,1.0,7/21,24.93%,C1QBP;CALR;P4HB;CAPRIN1;FLNA;SS18L2;PRKDC
gsea,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.418754346574781,-1.5637659097945402,0.022727272727272728,0.12171214803951973,0.999,19/36,22.63%,CCL5;PIK3R1;PIK3CD;PIK3AP1;TNF;F2R;FLT1;IRS2;LYN;PIK3R5;F2RL1;FGR;PDGFB;FN1;JAK2;NCF1;SIRT1;IGF1;TGFB2
gsea,RNA polyadenylation (GO:0043631),0.5457960573084426,1.5620200204088472,0.05625,0.04252974779106345,1.0,11/15,35.78%,CPSF2;GRSF1;CPSF3;CPSF1;LEO1;SYMPK;PNPT1;AHCYL1;CDC73;CSTF3;TUT1
gsea,mRNA polyadenylation (GO:0006378),0.5457960573084426,1.5620200204088472,0.05625,0.04252974779106345,1.0,11/15,35.78%,CPSF2;GRSF1;CPSF3;CPSF1;LEO1;SYMPK;PNPT1;AHCYL1;CDC73;CSTF3;TUT1
gsea,sterol homeostasis (GO:0055092),0.49763047526032755,1.56105033954964,0.028523489932885907,0.04278135408532934,1.0,5/23,25.56%,TMEM97;CNBP;INSIG1;SCARB1;LDLR
gsea,positive regulation of B cell proliferation (GO:0030890),0.4997123592120637,1.5580047325393318,0.030418250950570342,0.043610610905631376,1.0,4/20,12.56%,MIF;TFRC;CD74;TNFRSF4
gsea,cholesterol homeostasis (GO:0042632),0.506472697760123,1.557193815031126,0.026936026936026935,0.04378656596511886,1.0,5/22,25.56%,TMEM97;CNBP;INSIG1;SCARB1;LDLR
gsea,positive regulation of cellular component organization (GO:0051130),0.3807408631023292,1.5570313401762255,0.009784735812133072,0.043771682690922555,1.0,25/59,41.57%,CDC20;TFRC;PARK7;PIH1D1;CDT1;LMAN1;VCP;BAX;RACK1;GPX1;SLF1;BAK1;FAF1;DCTN1;BID;SPIDR;SLF2;GNL3L;ABCB7;SMPD1;MTLN;DLL1;ADD1;CLIP3;RB1
gsea,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.4994177707529972,1.5568453272044667,0.03925619834710744,0.04376625058368334,1.0,9/17,33.30%,MED30;BCLAF1;PAXIP1;MED4;SETX;MED14;MED16;SRF;MED24
gsea,regulation of neuron apoptotic process (GO:0043523),0.4071390443996045,1.5561251410377857,0.024208566108007448,0.043943208394662904,1.0,10/43,24.75%,SET;PARK7;KIF14;BAX;MSH2;SIGMAR1;NAE1;MT3;SOD2;BHLHB9
gsea,negative regulation of cytokine production (GO:0001818),-0.3528958716198068,-1.5555537688889876,0.008264462809917356,0.12691837654796687,0.999,52/89,25.43%,TNFAIP3;TMSB4X;CD274;VSIR;ISG15;ZFP36;TBX21;ZC3H12A;RARA;PDCD4;SLAMF1;TYROBP;TNF;PTGER4;PDCD1LG2;ANXA1;DDX58;DDIT3;IFNG;SIRPA;FCGR2B;FOXP3;UBE2L6;XCL1;THBS1;DHX58;F2RL1;MEFV;IKBKE;HAVCR2;SYT11;ACOD1;CD200R1;FN1;SIGIRR;ANXA4;NLRC3;CEACAM1;TWSG1;INHBA;BCL3;IRAK3;GPNMB;INHA;ZFPM1;APPL2;RGCC;AXL;TLR4;ARRB1;IL10;TRIB2
gsea,negative regulation of neuron apoptotic process (GO:0043524),0.43013449538797516,1.5554392154397996,0.04296875,0.04410281267994816,1.0,9/32,24.75%,SET;PARK7;KIF14;NONO;MSH2;ZPR1;MT3;SOD2;BHLHB9
gsea,protein transport (GO:0015031),0.3318572017367272,1.555236210249599,0.0017574692442882249,0.044106354206098076,1.0,46/144,39.23%,CENPF;NPM1;HSP90B1;TFRC;CANX;NDC1;PDIA4;HIKESHI;TMED2;IFT27;CD74;ARCN1;MIA2;VPS35;SPTBN1;COPB2;EIF2D;ADPRH;ARL1;TBC1D10B;OPTN;GOLGA4;COPG1;ARFIP2;SIL1;TMED1;SGSM3;GCC2;CEP290;ATP6V0A2;RABL3;NSF;SCAMP4;AP3D1;MYH9;CLTC;DNAJC27;COPA;COPG2;TICAM2;SEC23IP;RAB23;SNX27;GGA2;HDAC6;AP3B1
gsea,extrinsic apoptotic signaling pathway (GO:0097191),0.42882403100433136,1.5550060465819073,0.020036429872495445,0.04411737848163812,1.0,12/35,29.74%,SIVA1;CASP3;BAX;CASP8AP2;BAK1;DDX47;DELE1;TRAF2;BLOC1S2;FADD;BID;DDX3X
gsea,branched-chain amino acid metabolic process (GO:0009081),0.5295234772848816,1.5546816997164852,0.04048582995951417,0.04410758370845341,1.0,12/15,42.13%,BCKDK;BCAT1;BCAT2;DLD;BCKDHB;MCCC2;IVD;HSD17B10;HIBADH;HIBCH;ACAD8;DBT
gsea,branched-chain amino acid catabolic process (GO:0009083),0.5295234772848816,1.5546816997164852,0.04048582995951417,0.04410758370845341,1.0,12/15,42.13%,BCKDK;BCAT1;BCAT2;DLD;BCKDHB;MCCC2;IVD;HSD17B10;HIBADH;HIBCH;ACAD8;DBT
gsea,histone monoubiquitination (GO:0010390),0.5310395018439741,1.5544983386354305,0.04319654427645788,0.04412043008073215,1.0,9/15,34.44%,UHRF1;DDB1;RNF168;TRIM37;LEO1;CUL4B;RNF40;CDC73;DDB2
gsea,actin filament bundle assembly (GO:0051017),0.49765762287014487,1.5540555253978618,0.03793103448275862,0.04420405373223677,1.0,4/20,21.91%,HSP90B1;LCP1;EZR;PDXP
gsea,protein autophosphorylation (GO:0046777),0.3619215554727726,1.5528523224036923,0.00992063492063492,0.04452009642605728,1.0,19/76,35.74%,AURKB;MELK;NEK2;AURKA;CAD;AKT1;STK39;PASK;VRK1;TAF1;CHEK2;ATR;RIOK2;CAMKK2;MTOR;MAP4K1;KIT;ATM;MAPKAPK2
gsea,apoptotic mitochondrial changes (GO:0008637),0.4722893876507187,1.5527249448125762,0.027196652719665274,0.04451192479986935,1.0,13/21,37.97%,HSPD1;TIMM50;BAX;BAK1;VPS35;SOD2;NDUFS1;BID;CCAR2;BBC3;HK2;AIFM2;GGCT
gsea,regulation of kinase activity (GO:0043549),0.4479118229301867,1.5512496833546552,0.018835616438356163,0.04489174789033661,1.0,12/32,30.17%,HNRNPU;ECT2;RAD50;RBL1;CD74;NBN;PRDX3;CAMKK2;RYK;RBL2;TTN;VAC14
gsea,lipid transport (GO:0006869),0.4066454045050099,1.5504696584661646,0.027422303473491772,0.04511858262102387,1.0,18/43,38.81%,FABP5;PRELID3B;GOT2;PRELID1;PITPNB;SCARB1;LDLR;NME4;SLC25A17;PRELID2;PEX3;CPTP;PLEKHA8;ABCD3;PRELID3A;ACSL1;OSBP;MFSD2A
gsea,second-messenger-mediated signaling (GO:0019932),-0.3926894255634649,-1.5496968955912456,0.014005602240896359,0.13045777920233484,0.999,21/48,24.31%,CXCR6;CCR5;CX3CR1;CXCR3;CCR2;CCR8;PLCG1;LAT2;MCTP2;PPP1R9B;CD36;APOE;CCR4;BTK;DGKD;CCR3;CCR9;CCL3;EDNRB;NOS2;CCR1
gsea,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.5052810897183095,-1.548312299200715,0.04119850187265917,0.13010428443060512,0.999,8/19,13.55%,DUSP2;DUSP5;DUSP4;DUSP1;DUSP10;PTPRJ;DUSP16;PTPN13
gsea,glutamine family amino acid metabolic process (GO:0009064),0.5029078781199166,1.5479501822785782,0.03861788617886179,0.045833677115950905,1.0,9/17,36.37%,GOT2;CAD;OAT;PYCR2;FPGS;ALDH18A1;NIT2;PYCR1;DDAH2
gsea,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.5164890081970265,-1.5466420886662504,0.03765690376569038,0.1298644281855624,0.999,9/16,18.24%,PIK3R1;FLT1;WDR81;PTK2B;PIK3IP1;FGR;PDGFB;AMBRA1;ATG14
gsea,negative regulation of viral genome replication (GO:0045071),-0.4527713799421193,-1.5465129111971982,0.0507399577167019,0.1284982249151836,0.999,14/28,16.81%,CCL5;ISG15;IFITM1;ISG20;IFITM2;IFITM3;IFIT1;TNF;RSAD2;RNASEL;RESF1;OAS3;SLPI;TASOR
gsea,regulation of interleukin-4 production (GO:0032673),-0.4972512796874351,-1.5450008409297569,0.031578947368421054,0.12846745837920226,0.999,11/17,12.46%,IRF4;CD86;CEBPB;PRKCZ;RARA;DDIT3;CD40LG;SYK;FOXP3;NLRP3;HAVCR2
gsea,regulation of supramolecular fiber organization (GO:1902903),0.5308450608182512,1.544273411999546,0.043824701195219126,0.047005593052397744,1.0,3/15,12.57%,PARK7;HSPA8;GPX1
gsea,regulation of cytosolic calcium ion concentration (GO:0051480),-0.38307106228203136,-1.5440063296632414,0.023121387283236993,0.12797839743010506,0.999,31/52,19.83%,CXCR6;S1PR4;CCR5;ATP2B4;CX3CR1;CXCR3;CCL1;CCR2;CCR8;F2R;CIB2;PTGER4;RYR1;GLP1R;ATP2B2;CALCA;CALCB;SMAD3;LPAR3;CYSLTR1;F2RL1;C3AR1;CD36;CCR4;GPR35;SLC8A1;CCR3;ATP1A2;CCR9;C5AR1;CLN3
gsea,cellular metal ion homeostasis (GO:0006875),-0.3968314158540451,-1.543497470185048,0.0158311345646438,0.12698058237292978,0.999,20/41,24.31%,CCL5;TPT1;ATP2B4;CCL1;CCR2;SLC30A1;ATP2A3;ATP2B2;CD40;CALCB;ATP13A2;ATP1B1;CCL8;SLC41A1;CCL7;SLC8A1;ATP1A2;STIM2;CCL3;CCR1
gsea,cellular divalent inorganic cation homeostasis (GO:0072503),-0.393440795224884,-1.540515732302287,0.03007518796992481,0.12788527143597728,0.999,20/42,24.31%,CCL5;TPT1;ATP2B4;CCL1;CCR2;SLC30A1;ATP2A3;ATP2B2;CD40;CALCB;SLC39A13;ATP13A2;ATP1B1;CCL8;SLC41A1;CCL7;SLC8A1;STIM2;CCL3;CCR1
gsea,defense response to symbiont (GO:0140546),-0.37987419266297595,-1.5374642131446568,0.02564102564102564,0.1291307779634305,0.999,35/64,21.07%,STAT1;SAMHD1;IRF1;ISG15;IFITM1;IRF7;ISG20;RTP4;IFITM2;ZBP1;LYST;BCL2L1;IFITM3;BCL2;IRF2;IFIT1;IFI27;RSAD2;DDX58;RNASEL;IFIT3;CD40;RNASE6;STAT2;MAP3K14;IFNAR2;OAS3;TLR2;F2RL1;TRIM56;TRIM5;ACOD1;TLR7;PMAIP1;PLSCR1
gsea,non-motile cilium assembly (GO:1905515),0.48514727147472825,1.5367961070671152,0.04201680672268908,0.0493566149916035,1.0,13/19,47.89%,TMEM107;CEP89;IFT57;DCTN1;PCM1;CEP290;C2CD3;TMEM216;CEP250;IFT88;TMEM80;RPGRIP1L;GORAB
gsea,positive regulation of multicellular organismal process (GO:0051240),0.35754195594993066,1.5366321712255402,0.002840909090909091,0.0493497923632329,1.0,51/149,43.72%,FABP5;MIF;FBXO5;C1QBP;EZH2;NME2;GAPDH;TFRC;ENO1;CFL1;RIF1;TNFSF4;PAXIP1;ACADL;EPAS1;ETV4;GATM;KAT2A;NUMA1;HADH;ALMS1;ZBED3;DYNC1H1;GLMN;DECR1;RBM19;HSF1;PRDM16;MTOR;KMT5C;B4GALT5;EHMT1;IL21;PTPN11;LEF1;ACSL1;ROCK1;MED1;PIK3CG;CPT2;CTNNB1;AGPAT1;ACVR1;OMA1;ADRB1;SLC11A1;VAMP8;ELOVL6;TWIST1;CCDC88B;BATF
gsea,positive regulation of protein polymerization (GO:0032273),0.4467283431488087,1.5360079699583287,0.030303030303030304,0.04949589986262439,1.0,10/32,27.41%,HSP90AA1;PFN1;DRG1;NUMA1;PRKCE;CLIP1;DCTN1;CLASP1;CDK5RAP2;ARL2
gsea,positive regulation of interleukin-10 production (GO:0032733),0.5170478318721969,1.5337227620812084,0.034926470588235295,0.05022308354035281,1.0,3/17,11.27%,HMGB1;HSPD1;TNFSF4
gsea,regulation of osteoclast differentiation (GO:0045670),-0.5206297104425748,-1.5336940565360015,0.0507399577167019,0.13088688640020077,0.999,10/15,24.76%,CEBPB;CSF1;TNF;IFNG;GPR55;MAFB;TCTA;CCL3;CCR1;TLR4
gsea,fat cell differentiation (GO:0045444),-0.44571556791044775,-1.5326770139288803,0.02997275204359673,0.13043191727764983,0.999,12/27,21.20%,NR4A2;NR4A3;SDF4;NR4A1;FOXO1;EGR2;PID1;EP300;METRNL;TCF7L2;MAFB;SIRT1
gsea,positive regulation of protein secretion (GO:0050714),0.4398263071771961,1.5326657116390556,0.028662420382165606,0.05052577102085442,1.0,3/38,14.69%,PPIA;PPID;EZR
gsea,"retrograde transport, endosome to Golgi (GO:0042147)",0.42271913156102514,1.5312837005026048,0.017543859649122806,0.05095434240560325,1.0,16/35,41.01%,RNF126;LMAN1;SNX5;VPS52;VPS35;ARL1;TBC1D10B;DCTN1;GCC2;CLTC;VPS50;ERC1;UBE2O;PIKFYVE;ANKFY1;HEATR5A
gsea,beta-catenin-TCF complex assembly (GO:1904837),0.463304217939235,1.5311465576789987,0.033707865168539325,0.05093639730462143,1.0,13/23,41.44%,HDAC1;RUVBL1;SMARCA4;ASH2L;LEO1;TCF7;MYC;MEN1;RBBP5;CDC73;LEF1;CTNNB1;TRRAP
gsea,aggrephagy (GO:0035973),0.5135332976710023,1.5304586086544854,0.04666666666666667,0.05109608566898949,1.0,7/15,24.60%,PARK7;DYNLL2;PCNT;UBE2N;RPS27A;UBQLN1;DYNC1H1
gsea,negative regulation of cell-substrate adhesion (GO:0010812),0.5639879257306883,1.5283492922296051,0.03609022556390978,0.05180758976427193,1.0,4/18,16.60%,RCC2;CDKN2A;ACTN4;CORO1C
gsea,regulation of nitric oxide biosynthetic process (GO:0045428),0.48109424898535835,1.528339127330152,0.045936395759717315,0.051752122995668386,1.0,4/25,11.45%,HSP90AB1;HSP90AA1;AKT1;KHSRP
gsea,cellular response to organonitrogen compound (GO:0071417),0.44623407938457516,1.526154363345299,0.01951219512195122,0.05246103799317095,1.0,8/38,21.91%,HSP90B1;BRCA1;IPO5;ACTB;EZR;LARP1;TAF1;PDXP
gsea,positive regulation of supramolecular fiber organization (GO:1902905),0.4047074136986182,1.5248674741382118,0.022727272727272728,0.052885825737357645,1.0,13/45,27.41%,PFN1;GPX1;DRG1;COLGALT1;NUMA1;SYNPO2;PRKCE;PDXP;CLIP1;DCTN1;CLASP1;CDK5RAP2;ARL2
gsea,regulation of activated T cell proliferation (GO:0046006),0.5365869234927081,1.5246373618698965,0.05362776025236593,0.052898364929684305,1.0,1/16,0.33%,HMGB1
gsea,cellular response to glucose starvation (GO:0042149),0.4475941625617088,1.5223631058032001,0.043478260869565216,0.05365773459361221,1.0,5/26,19.90%,MYBBP1A;HNRNPA1;ASNS;RRP8;HSPA5
gsea,regulation of protein-containing complex assembly (GO:0043254),0.3577279668731972,1.5222486556682202,0.01651376146788991,0.05364206224780558,1.0,29/67,39.19%,HSP90AA1;TFRC;PARK7;HJURP;PIH1D1;CDT1;VCP;BAX;HSPA8;RACK1;SLF1;NCLN;BAK1;FAF1;HSPA5;HCFC1;TRAF2;AIDA;HSF1;BID;DDX3X;SPIDR;SLF2;GNL3L;PTPN11;SVIP;MTLN;HDAC6;TFIP11
gsea,negative regulation of BMP signaling pathway (GO:0030514),-0.4811451201254659,-1.5221332150525324,0.04656862745098039,0.1378846750554479,1.0,8/16,19.84%,SMAD7;CRIM1;SKIL;NOTCH1;SKI;WNT1;FSTL1;HTRA3
gsea,regulation of immune effector process (GO:0002697),0.6102466882342098,1.5199541323808514,0.03918722786647315,0.05442219675189314,1.0,2/16,3.56%,C1QBP;PHB2
gsea,cellular response to amyloid-beta (GO:1904646),-0.4942429618927385,-1.5192603945755732,0.07336956521739131,0.13877226932900788,1.0,12/19,24.76%,ICAM1;ADRB2;FCGR2B;CASP4;APP;LRP1;CD36;LGMN;IGF1;GSK3B;ITGA4;TLR4
gsea,glycosaminoglycan catabolic process (GO:0006027),0.4920722292558376,1.5179031620493728,0.025793650793650792,0.055066429845717794,1.0,2/19,12.42%,HMMR;GUSB
gsea,regulation of monocyte chemotaxis (GO:0090025),-0.5130457639337378,-1.5167006502388438,0.0684931506849315,0.13969326738528157,1.0,9/16,16.51%,CCL5;DUSP1;CCL1;CCR2;LYN;AIF1;LGMN;SLAMF8;PLA2G7
gsea,regulation of actin cytoskeleton reorganization (GO:2000249),0.4976786272741571,1.5151143260468725,0.04307116104868914,0.056011042933010895,1.0,3/17,14.15%,ARHGDIA;HRAS;HAX1
gsea,regulation of macroautophagy (GO:0016241),0.3870649963820453,1.5149085865412777,0.022964509394572025,0.05602685973412397,1.0,16/45,39.06%,GAPDH;CASP3;AKT1;LARP1;SNX5;NEDD4;VPS35;UBQLN1;EXOC4;MTOR;ATP6V0A2;SCOC;C9ORF72;UCHL1;MAPK8;HDAC6
gsea,monocarboxylic acid biosynthetic process (GO:0072330),0.46404427357927824,1.5144367773200764,0.045936395759717315,0.05612200275472833,1.0,10/23,38.29%,NDUFAB1;PARK7;GATM;ACACA;ACLY;MCAT;HSD17B10;CBR4;ABCD3;OSBP
gsea,positive regulation of immune effector process (GO:0002699),0.5091538637012222,1.5144006020850878,0.05162523900573614,0.05607098735489281,1.0,3/18,11.27%,PHB;MYB;TNFSF4
gsea,cellular response to starvation (GO:0009267),0.3553857657429998,1.510154652527969,0.015655577299412915,0.057614296767091976,1.0,30/71,48.72%,EIF2S1;MYBBP1A;HNRNPA1;ASNS;DAPL1;HSPA8;CDKN1A;RRP8;HSPA5;GCN1;SREBF2;EHMT2;SEH1L;MTOR;FADS1;TBL2;ITFG2;DEPDC5;MAPK8;MFSD2A;DAP;TCIRG1;ATG7;NPRL3;EIF2AK4;PIK3R4;PRKAA1;MIOS;MLST8;WDR24
gsea,positive regulation of neurogenesis (GO:0050769),0.45352745474055756,1.5075639130347096,0.03125,0.058596713440436765,1.0,14/28,45.85%,NAP1L1;ARHGDIA;CAPRIN1;METRN;SS18L2;BHLHB9;PLXND1;FBXW8;CTNNB1;SPEN;CDKL3;CX3CL1;SERPINF1;TIAM1
gsea,neurogenesis (GO:0022008),0.47770228848204155,1.5061411872396917,0.05588822355289421,0.05900773509592554,1.0,8/19,36.85%,CIT;WDR62;CDK6;CDK5RAP2;RYK;METTL14;THOC2;ROGDI
gsea,regulation of Rho protein signal transduction (GO:0035023),0.4284926730425475,1.505409494797201,0.0224,0.05924923535535262,1.0,6/39,31.75%,STMN1;ARHGDIA;NET1;TNFAIP1;CUL3;KCTD13
gsea,cellular response to lipopolysaccharide (GO:0071222),-0.3760706254766436,-1.4979802710646346,0.0364963503649635,0.154587537680792,1.0,62/62,99.99%,CCL5;TNFAIP3;CD274;ZFP36;CD86;CCR5;ZC3H12A;TNIP3;CX3CR1;PDCD4;NFKB1;PDE4B;CD68;IL1B;TNF;PDCD1LG2;SIRPA;SBNO2;LYN;CD180;CXCL9;HCK;NLRP3;CXCL2;CCL2;CASP1;ACOD1;PF4;CD14;NR1H3;CCL3;AXL;TLR4;IL10;ADAM9;CXCL10;CXCL13;TRIM41;TNIP2;RELA;VIM;SERPINE1;GFI1;MEF2C;DAB2IP;XBP1;CTSG;CD80;NFKBIB;CTR9;MAPK8;TICAM2;SELENOS;UPF1;CDC73;PLAA;CACTIN;PRKCE;MTDH;TNFSF4;HMGB1;HMGB2
gsea,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.370836373138181,-1.4973943382184585,0.027586206896551724,0.1536383338520742,1.0,24/49,22.63%,CCL5;PIK3R1;PIK3CD;PIK3AP1;TNF;F2R;FLT1;IRS2;LYN;PIK3IP1;PIK3R5;F2RL1;FGR;PDGFB;PTPN13;FN1;NLRC3;CEACAM1;JAK2;PIP5K1C;NCF1;SIRT1;IGF1;TGFB2
gsea,regulation of Ras protein signal transduction (GO:0046578),0.41588825169409577,1.4967477315047495,0.04012841091492777,0.06260923718422826,1.0,6/45,13.75%,KIF14;NUP62;LRRC59;ARHGDIA;FOXM1;RDX
gsea,regulation of MAPK cascade (GO:0043408),0.363083152179194,1.4967253734504842,0.023688663282571912,0.06253636790382956,1.0,19/70,40.24%,HMGB1;PEBP1;FAM83D;MYDGF;HRAS;CD74;APIP;ROCK2;RYK;PTPN6;LBH;KIT;GSDME;WDR54;SHC1;STK3;ROCK1;MAP4K4;JCAD
gsea,positive regulation of cellular metabolic process (GO:0031325),0.4058699410599281,1.4964352970746455,0.02809917355371901,0.06256548726963201,1.0,14/49,27.72%,CDK1;UHRF1;CCNB1;EIF4G1;PRELID1;AKT1;CDKN1A;FASN;STARD4;MT3;ACACA;FMR1;ACLY;ANXA2
gsea,negative regulation of endopeptidase activity (GO:0010951),0.5078388613705099,1.4953107227882008,0.05509181969949917,0.06294776390522702,1.0,3/18,10.02%,GAPDH;SERPINE2;AKT1
gsea,external encapsulating structure organization (GO:0045229),-0.3517645362963403,-1.4952330315244269,0.0163265306122449,0.15413939253366157,1.0,28/68,22.07%,ITGAX;ITGA1;CD44;ICAM1;FURIN;ADAM19;TGFBI;CDH1;ITGA6;ADAMTS6;THBS1;ITGB7;APP;LAMC2;APLP1;ITGA5;ITGAE;PDGFB;COL1A1;FN1;ITGAM;MMP9;JAM2;ITGB1;MMP14;COL5A3;LAMC1;SH3PXD2A
gsea,cellular response to hydrogen peroxide (GO:0070301),0.45093216785071005,1.493431787138987,0.040229885057471264,0.06361063649362775,1.0,6/24,18.76%,PARK7;ECT2;FXN;PPIF;SIGMAR1;NET1
gsea,glutathione metabolic process (GO:0006749),0.482961693374276,1.4929575579124599,0.05263157894736842,0.06373088597278712,1.0,6/17,31.53%,PARK7;GPX1;GSR;GSTZ1;GSS;MMACHC
gsea,myeloid cell differentiation (GO:0030099),0.4508627976185161,1.4928305634414227,0.05132743362831858,0.06371575466627835,1.0,8/26,36.01%,SLC25A5;HSPA9;CASP3;PRDX3;KAT8;DYRK3;KIT;UFL1
gsea,positive regulation of cytokine production (GO:0001819),0.32135326441266804,1.491134925667636,0.011784511784511785,0.06432735196766687,1.0,53/179,43.72%,HMGB1;MIF;HSPD1;G3BP1;GAPDH;BRCA1;POLR2F;PARK7;PHB;STOML2;POLR3K;POLR2L;DHX9;SLC7A5;CGAS;TNFSF4;CD74;POLR3H;POLR2E;POLR2H;XRCC6;XRCC5;KAT2A;SPTBN1;ROCK2;GLMN;PRKDC;POLR3D;TRAF2;POLR1C;FADD;NFKB2;DDX41;LACC1;POLR3G;POLR3E;IL21;PTPN11;SCRIB;LY9;ADAM17;SLAMF6;PIK3CG;POU2AF1;CTNNB1;RIPK2;AGPAT1;SLC11A1;POLR3B;TWIST1;POLR3F;CCDC88B;BATF
gsea,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.4846019914065022,-1.4906156945840123,0.07424593967517401,0.15672752654585137,1.0,11/19,19.94%,TNFAIP3;CD300A;LYN;RAB7B;CD300LF;F2RL1;GRAMD4;ACOD1;CD14;IRAK3;PTPRS
gsea,extracellular structure organization (GO:0043062),-0.34837315430799304,-1.4905249838791823,0.01652892561983471,0.15527719764562609,1.0,28/69,22.07%,ITGAX;ITGA1;CD44;ICAM1;FURIN;ADAM19;TGFBI;CDH1;ITGA6;ADAMTS6;THBS1;ITGB7;APP;LAMC2;APLP1;ITGA5;ITGAE;PDGFB;COL1A1;FN1;ITGAM;MMP9;JAM2;ITGB1;MMP14;COL5A3;LAMC1;SH3PXD2A
gsea,regulation of protein modification process (GO:0031399),0.4140840154441102,1.4876543969749874,0.02529182879377432,0.0657389466333594,1.0,8/31,31.25%,HPF1;PIN1;PUM3;CORO1C;MT3;PHIP;CCAR2;RABL3
gsea,response to growth factor (GO:0070848),0.4853999946957006,1.4862827289984084,0.04868913857677903,0.06622795890381386,1.0,11/18,42.14%,AKT1;RACK1;HTRA2;URI1;TBC1D7;MYC;SHC1;HDAC6;CTNNB1;ACVR1;CPNE3
gsea,positive regulation of innate immune response (GO:0045089),-0.5032133956111078,-1.485562761119545,0.07597535934291581,0.15818857226141494,1.0,4/15,10.28%,CCL5;ZBP1;SPI1;ADAM8
gsea,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.39802123361789893,-1.484868859625153,0.033542976939203356,0.15720656084625728,1.0,19/39,23.41%,UBB;PRKCZ;FURIN;SMAD7;ARHGEF18;TGFBR3;NLK;GCNT2;ACVRL1;SMAD3;SKI;FOS;PTPRK;TWSG1;ITGB1;SIRT1;ZMIZ1;TGFB2;APPL2
gsea,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.4879143563469114,1.483343594288089,0.04047217537942664,0.06731367780510004,1.0,9/21,29.74%,YWHAE;AKT1;GPX1;DHCR24;ARL6IP1;MT3;PCID2;CDKN2D;DDX3X
gsea,extracellular matrix organization (GO:0030198),-0.32173652272830705,-1.4799669216578817,0.009174311926605505,0.1602483114896105,1.0,49/105,26.09%,ITGAX;ITGA1;CD44;GSN;CAPG;ICAM1;GPM6B;CTSS;FURIN;ADAM19;FLOT1;TGFBI;CREB3L1;CDH1;ITGA6;ADAMTS6;PLEC;PRSS2;THBS1;PLOD1;ITGB7;APP;ADAM8;LAMC2;APLP1;ITGA5;ITGAE;PDGFB;COL1A1;FN1;ITGAM;TIMP2;MMP9;JAM2;ITGB1;MMP14;CD151;COL5A3;DST;P3H2;LAMC1;CTSL;SH3PXD2A;EXOC8;TGFB2;TIMP1;CAPN2;ITGA4;SERPINH1
gsea,regulation of neuron death (GO:1901214),0.37810210255839677,1.4798182463164071,0.04024144869215292,0.06877839862227034,1.0,13/43,25.32%,EIF2S1;PARK7;EIF4G1;KIF14;DDIT4;AKT1;HTRA2;DHCR24;SIGMAR1;NAE1;VPS35;CTSZ;TRAF2
gsea,positive regulation of biosynthetic process (GO:0009891),-0.4448242763918295,-1.4790095710878968,0.049886621315192746,0.1597715683085103,1.0,7/22,14.32%,CCL5;F2R;RUNX1;CREB3L1;CD36;APOE;SLC5A3
gsea,calcium-mediated signaling (GO:0019722),-0.3665280933349627,-1.4788872262777428,0.02710027100271003,0.15841969585581542,1.0,22/52,25.99%,CXCR6;CCR5;CX3CR1;CXCR3;CCR2;CCR8;PLCG1;LAT2;MCTP2;PTPRJ;PPP1R9B;ATP1B1;CCR4;BTK;SLC8A1;CCR3;DMTN;CCR9;CCL3;EDNRB;CCR1;PLA2G4B
gsea,regulation of TORC1 signaling (GO:1903432),0.4913240749110839,1.4769452033648653,0.08167330677290836,0.06996783597554128,1.0,9/17,40.79%,PIH1D1;TELO2;SEH1L;DYRK3;C9ORF72;ITFG2;ATM;DEPDC5;KLHL22
gsea,regulation of autophagy (GO:0010506),0.3252896811492191,1.4753345700380873,0.005671077504725898,0.07056925636134767,1.0,45/112,43.34%,HMGB1;GAPDH;VDAC1;EIF4G1;CASP3;AKT1;DAPL1;EIF4E;HTRA2;HAX1;MTDH;EIF4G2;SNX5;NEDD4;USP10;VPS35;UBQLN1;SREBF2;FOXK2;MT3;CSNK2A2;OPTN;KEAP1;KAT8;EXOC4;MTOR;ATP6V0A2;C9ORF72;ATM;CPTP;SVIP;UFL1;UCHL1;DEPDC5;ROCK1;MAPK8;RAB39B;HDAC6;DAP;MID2;KLHL22;WDR6;MTMR4;EIF4G3;TLK2
gsea,response to cytokine (GO:0034097),-0.339845350082879,-1.4751272754747493,0.03667481662591687,0.1603475832835065,1.0,84/84,96.58%,GCH1;STAT1;SP100;CD274;ISG15;IFITM1;IFITM2;REL;BCL2L1;IFITM3;BCL2;XAF1;IL1B;PRKCA;MAPKAPK3;ANXA1;STAT3;NFAT5;CD40;IL18R1;PID1;SMAD3;APP;IFNAR2;CSF1R;MEFV;TRIM56;IKBKE;CASP1;PTPN13;TIMP2;SIGIRR;HDAC4;JAK2;ADAR;TRIM21;LIFR;IRAK3;PLSCR1;CXCL16;TIMP1;IL6ST;ADAM9;FLT3;CXCR4;PTPN5;SPHK1;CIITA;SELP;RIPK1;RELA;EIF2AK2;OSMR;CCR7;PML;KYNU;RELB;PTPN23;PTPN12;NUB1;PTPN9;BST2;SHFL;KLHL20;SLC11A1;SETD2;MAPK8;LEF1;YTHDC2;SMPD1;MAPKAPK2;PTPN11;SRF;TAF9;PTPN6;AFF3;TLE5;PTPN7;HAX1;KHSRP;CD74;CASP3;DDOST;SHMT2
gsea,cellular response to reactive oxygen species (GO:0034614),0.4044068400957944,1.4744230304041497,0.03171641791044776,0.07089108868555659,1.0,11/36,26.85%,PARK7;ECT2;FXN;AKT1;PPIF;PRDX3;TPM1;NET1;CAMKK2;ERCC6L2;SETX
gsea,negative regulation of response to DNA damage stimulus (GO:2001021),0.4802382466005701,1.4735810688353568,0.062370062370062374,0.07121039002186964,1.0,10/17,31.02%,MIF;FBXO5;DDX39B;DDIAS;CD74;RTEL1;THOC5;THOC1;CDKN2D;CCAR2
gsea,response to glucose (GO:0009749),0.48326228204602784,1.4734661399479398,0.05852842809364549,0.07116364166682493,1.0,8/22,28.56%,RACK1;EIF2B3;EIF2B1;EIF2B5;PFKL;PCK2;ZBED3;EIF2B4
gsea,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.5222759465204959,1.4730539376660796,0.06896551724137931,0.07123277388956926,1.0,5/16,26.56%,BRCA1;CARM1;CNOT9;CNOT1;UFSP2
gsea,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.44163061499504197,-1.4712275843928369,0.061274509803921566,0.1624532171562368,1.0,15/24,23.79%,ETS1;EGR1;NR3C1;TNF;SPI1;HIF1A;STAT3;FOXO3;SMAD3;FOS;PDGFB;GATA3;FOSL1;TGFB2;PPARG
gsea,positive regulation of cell-matrix adhesion (GO:0001954),-0.4600537103943525,-1.4709123861390236,0.05454545454545454,0.16129152513064757,1.0,8/21,16.00%,CSF1;S100A10;UTRN;NRP1;PTPRJ;PTK2B;CD36;RIN2
gsea,substantia nigra development (GO:0021762),0.5114139408196183,1.4705471822832732,0.06470588235294118,0.07232489214647618,1.0,8/15,34.60%,YWHAE;ACTB;CALM2;HSPA5;RAD1;CCDC14;BASP1;GNB4
gsea,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.4154854002450254,-1.4689011658209912,0.0581039755351682,0.16163406043799217,1.0,13/26,22.48%,CCL5;STAT1;NR4A3;TNF;FOXP1;THBS1;AIF1;FOXJ2;PDGFB;P2RY6;MMP9;ID2;IGF1
gsea,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.48423517367742336,1.4684368390265876,0.04743833017077799,0.07327091076830654,1.0,5/18,12.01%,EIF5A;SFPQ;BAX;RACK1;BCLAF1
gsea,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.4513828597431911,1.4679155499618137,0.05730129390018484,0.07342991374579916,1.0,9/23,39.36%,RDX;TBC1D10B;MYO10;FMR1;FXR2;SGSM3;ABITRAM;IFT140;IFT88
gsea,positive regulation of transport (GO:0051050),0.3921684611791447,1.4677199323043304,0.04830053667262969,0.07342618693192401,1.0,22/49,42.58%,LYAR;SPAG5;CALR;CHCHD10;BAX;ACTB;LMAN2;BAK1;NUMA1;PLAA;DYNC1H1;FMR1;ANXA2;BID;ACSL3;RAB27A;C2CD5;SMPD1;DLL1;CLIP3;SLC11A1;IL15RA
gsea,regulation of TOR signaling (GO:0032006),0.40675248354674814,1.4670405203616983,0.046966731898238745,0.07363344808728457,1.0,17/35,49.49%,FAM83D;DDIT4;PIH1D1;TBC1D7;TELO2;SEH1L;DYRK3;TTI1;C9ORF72;ITFG2;DEPDC5;NPRL3;PRKAA1;MIOS;MLST8;WDR24;TSC2
gsea,response to insulin (GO:0032868),0.37671157500234587,1.4643565351405097,0.03625954198473282,0.07488863282829779,1.0,9/44,24.93%,PKM;PARP1;EIF6;AKT1;PCK2;INSIG1;MYO5A;ZBED3;PRKDC
gsea,cellular response to cytokine stimulus (GO:0071345),-0.29948068769955616,-1.462423553646178,0.01928374655647383,0.16646283223538855,1.0,236/236,99.95%,CCL5;UBB;STAT1;ITGAX;IRF1;JUNB;GBP6;PIM1;ZFP36;CLCF1;IRF4;CD86;ZFP36L2;DUSP1;RIPOR2;ZFP36L1;CCR5;CSF1;ZC3H12A;IL12RB2;BCL2L11;EGR1;SLA;IFITM2;CCL1;BCL2L1;STAT4;GBP4;IL10RA;BCL2;PIK3R1;CCR2;ICAM1;SOCS1;GBP2;PIK3CD;GRAP2;IFIT1;FOXO1;IL16;NFKB1;CCL4;IL1B;TNF;HIF1A;ANXA1;IL2RA;STAT3;NFAT5;S1PR1;CD40;PTPRJ;IL18R1;FOXO3;SIRPA;SYK;SBNO2;PID1;PTGS2;PTAFR;STAT2;XCL1;CSF2RB;SMAD3;IL1RN;IFNAR2;HCK;SOCS5;CSF1R;AIF1;RORA;SOCS2;RAPGEF1;TEC;IL2;CEBPD;NFE2L2;FOS;TLR2;BCL6;CSF2;ERBIN;IL13RA1;TNFRSF1A;ST3GAL6;CXCL2;CCL2;CD36;CD4;CCL8;DAPK1;CASP1;PTPN13;CCND1;ACOD1;FN1;ITGAM;PF4;RO60;SIGIRR;CCL7;JAK2;F13A1;MMP9;ITGB1;GATA3;IFNGR2;GBP7;LIFR;STAT6;IRAK3;SH2B3;CCL22;MAPK13;MUC1;LRCH1;SIRT1;FSCN1;CCL3;TIMP1;GSK3B;NOS2;CCR1;AXL;TLR4;IL6ST;IL10;PIK3CA;SDC1;EBI3;FGF2;FLT3;CXCR4;VEGFA;CXCL10;PTPN5;SOCS3;WNK1;TYK2;HMOX1;RIPK1;CSF2RA;RELA;IL12RB1;CCL17;CCL25;MAOA;ARHGEF2;IL23A;ALOX5;STAT5B;SOS1;OSMR;LIF;SOCS6;CCR7;GAS6;VIM;OSM;F3;IL22RA2;GBP5;PTPN23;IRF5;IL13;PTPN12;IL3;HYAL2;DAB2IP;VCAM1;PTPN9;XBP1;GRB10;OXSR1;CTSG;PIK3CB;CD80;INPPL1;ZEB1;STAT5A;DOCK8;BATF;CX3CL1;TWIST1;TNFRSF21;TNFSF11;CBL;MAPK8;POU2F1;LEF1;CHUK;IRF8;SHC1;PTPN11;TANK;GSDME;KIT;UPF1;NPNT;SLC12A2;BAG4;SMPD4;IL1R2;PTPN6;GBP3;MYC;RBMX;LRP8;CACTIN;TCF7;PTPN7;PNPT1;USP10;RPS27A;TXLNA;PLP2;HAX1;HTRA2;STK39;KHSRP;CDKN1A;HSPA8;AKT1;CDC34;CASP3;SYNCRIP;DHX9;YBX3;PHB;BRCA1;SHMT1;GAPDH;HSP90B1;HNRNPU;HSP90AA1;BIRC5
gsea,regulation of interferon-gamma production (GO:0032649),0.3955231330997055,1.4605762152183286,0.05149501661129568,0.07658092640842706,1.0,10/46,42.08%,HMGB1;C1QBP;HSPD1;SLC7A5;TNFSF4;FADD;IL21;SCRIB;SLAMF6;SLC11A1
gsea,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.3796743044418638,1.459887755562856,0.03859060402684564,0.07684625495967827,1.0,15/47,42.83%,EZH2;INCENP;PIH1D1;AKT1;HRAS;CALM2;ETAA1;TELO2;DDX3X;KIT;ADAM17;PSRC1;PIK3CG;PIK3R6;TNFSF11
gsea,positive regulation of cell death (GO:0010942),0.4089665605003195,1.4561466491609178,0.06076388888888889,0.07840900797537671,1.0,6/35,22.91%,EIF2S1;PHB;EIF4G1;DDIT4;FAF1;MT3
gsea,response to estrogen (GO:0043627),0.4643841479545743,1.455740154586385,0.07157894736842105,0.07851554707944983,1.0,3/17,13.07%,BRCA1;PELP1;ASH2L
gsea,regulation of myeloid cell differentiation (GO:0045637),0.39870138059342264,1.452919396874828,0.05217391304347826,0.0797765865583591,1.0,15/42,34.83%,PRMT1;DPY30;HSPA9;HDAC1;EIF6;WDR5;ASH2L;LEO1;SIN3A;CDK6;TNRC6A;SETD1A;RBBP5;CDC73;RBM15
gsea,response to interferon-beta (GO:0035456),-0.5055569675855949,-1.4528027953081415,0.07515657620041753,0.17425466445944493,1.0,9/15,14.07%,STAT1;IRF1;IFITM1;IFITM2;IFITM3;XAF1;IFNAR2;IKBKE;ACOD1
gsea,negative regulation of cell-cell adhesion (GO:0022408),0.45909558639644665,1.4526336438739238,0.052434456928838954,0.07982073682394261,1.0,3/22,13.75%,AKT1;GTPBP4;RDX
gsea,negative regulation of endothelial cell proliferation (GO:0001937),-0.4896281429710424,-1.4518694038230042,0.06685236768802229,0.1736493805073866,1.0,8/16,23.88%,STAT1;FLT1;THBS1;CCL2;APOE;DLL4;PPARG;RGCC
gsea,regulation of actin filament bundle assembly (GO:0032231),0.4705090072273688,1.4518193955942253,0.07194244604316546,0.08017222092363369,1.0,7/19,38.24%,PFN1;RDX;SYNPO2;ROCK2;ALMS1;ACTG1;ROCK1
gsea,positive regulation of autophagy (GO:0010508),0.366487223539495,1.4504785245480825,0.04477611940298507,0.08073161959615262,1.0,21/50,50.69%,HMGB1;PHB2;PARK7;MTDH;LARP1;OPTN;CAMKK2;SCOC;C9ORF72;SVIP;UFL1;ROCK1;HTT;MID2;EIF2AK4;PRKAA1;PIK3CB;GPSM1;TSC2;MAP3K7;TFEB
gsea,fatty-acyl-CoA biosynthetic process (GO:0046949),0.4944831556710704,1.4496798747674895,0.06985294117647059,0.0810743125852002,1.0,13/17,43.26%,ACSL5;FASN;HSD17B12;ACACA;ACLY;GCDH;ACSL3;HACD2;SLC25A1;CBR4;ACSL1;ACSL6;ELOVL6
gsea,platelet degranulation (GO:0002576),0.3899813080959261,1.4496706054427817,0.02877697841726619,0.08098248530429832,1.0,15/57,32.98%,TAGLN2;MANF;TUBA4A;FAM3C;ACTN4;PCYOX1L;VEGFB;OLA1;FLNA;ALDOA;SCCPDH;TTN;CYB5R1;NHLRC2;CHID1
gsea,amino acid transmembrane transport (GO:0003333),0.48355581627318894,1.4473799837423573,0.07297830374753451,0.08200139327719407,1.0,7/17,30.20%,SFXN1;SLC7A5;SLC25A13;SLC7A1;SLC38A1;SLC7A6;SFXN2
gsea,cellular defense response (GO:0006968),-0.4278178046161364,-1.447314980013069,0.05491990846681922,0.17654830554232395,1.0,15/25,20.52%,CCR5;CX3CR1;TYROBP;LGALS3BP;ADORA2A;PTK2B;CXCL9;NCR1;NCF2;ITGB1;CCR3;CCR9;C5AR1;FOSL1;NCF1
gsea,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.40289652207987814,1.4463373193760967,0.059813084112149535,0.08239977230198905,1.0,15/36,48.56%,HSP90AB1;HSP90AA1;ACTB;PRKCE;MYO10;ACTR2;ACTG1;ELMO1;MYO1G;CYFIP1;VAV2;PLA2G6;NCKIPSD;WIPF3;PIK3CB
gsea,kidney development (GO:0001822),0.4825413248485694,1.4460280119765987,0.04806201550387597,0.08245420939257028,1.0,2/20,11.05%,CENPF;IFT27
gsea,ERBB2 signaling pathway (GO:0038128),0.47962819922320665,1.4458236930877437,0.06390977443609022,0.0824725453277984,1.0,2/15,7.90%,HSP90AA1;STUB1
gsea,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.4294072817712719,-1.4457122626203829,0.06403940886699508,0.17652612092379105,1.0,15/25,23.79%,ETS1;EGR1;NR3C1;TNF;SPI1;HIF1A;STAT3;FOXO3;SMAD3;FOS;PDGFB;GATA3;FOSL1;TGFB2;PPARG
gsea,negative regulation of transport (GO:0051051),-0.4596216997847758,-1.4429025630413184,0.08396946564885496,0.17767898511576277,1.0,6/19,12.57%,LGALS3;SIRPA;FCGR2B;ABCA7;TLR2;SYT11
gsea,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.437811570058404,1.4426477496876888,0.047957371225577264,0.08402906131188291,1.0,7/28,29.74%,HMGB1;CYCS;HTRA2;BAK1;FADD;MYC;DDX3X
gsea,cellular response to BMP stimulus (GO:0071773),-0.42944637472706754,-1.442072427051763,0.06367924528301887,0.1769958457780022,1.0,10/22,22.63%,PDCD4;SMAD7;RUNX2;TGFBR3;HFE;ACVRL1;SMAD3;RGMB;VSTM2A;TGFB2
gsea,negative regulation of endothelial cell migration (GO:0010596),0.5119497472077025,1.441084649470827,0.06349206349206349,0.08468982533761832,1.0,1/19,0.33%,HMGB1
gsea,phospholipid transport (GO:0015914),0.43091672832552397,1.4391409193070992,0.06589147286821706,0.08553853158921655,1.0,12/25,39.73%,PRELID3B;PRELID1;PITPNB;SCARB1;LDLR;ABCC1;ATP11C;PRELID2;CPTP;PRELID3A;MFSD2A;ATP8B4
gsea,response to tumor necrosis factor (GO:0034612),-0.365777649116399,-1.4377419199059585,0.04186046511627907,0.17990029656679588,1.0,52/52,96.14%,CCL5;GCH1;ZFP36;ZFP36L2;ZFP36L1;ZC3H12A;CCL1;GBP2;CCL4;CD40;PID1;XCL1;NFE2L2;ERBIN;CCL2;CCL8;ACOD1;CCL7;JAK2;GATA3;CCL22;SIRT1;CCL3;CXCL16;ADAM9;SPHK1;RIPK1;RELA;CCL17;CCL25;ARHGEF2;HYAL2;DAB2IP;NUB1;CX3CL1;TNFRSF21;CHUK;YTHDC2;SMPD1;TANK;GSDME;NPNT;BAG4;SMPD4;GBP3;AFF3;CACTIN;AKT1;CASP3;DHX9;YBX3;BRCA1
gsea,cellular response to epidermal growth factor stimulus (GO:0071364),-0.4658889940700537,-1.4373156344483986,0.0745697896749522,0.17885732254002995,1.0,5/17,3.71%,EEF1A1;ZFP36;ZFP36L2;ZFP36L1;PLCG1
gsea,transport across blood-brain barrier (GO:0150104),0.3867304637579786,1.435405912888666,0.04363001745200698,0.08746456606162457,1.0,18/42,42.00%,FABP5;TFRC;SLC29A1;SLC7A5;SLC7A1;SLC19A1;SLC38A1;SLC1A4;ABCC1;ABCG2;SLC2A1;SLC12A2;SLC7A3;SLC16A1;SLC4A8;MFSD2A;SLC6A9;ABCC4
gsea,regulation of mitochondrion organization (GO:0010821),0.4238271995346324,1.4348314892789824,0.05511811023622047,0.08766090196974809,1.0,12/24,42.24%,VDAC1;HTRA2;HAX1;VPS35;PARL;SREBF2;CSNK2A2;INF2;RHOT2;HDAC6;OMA1;PISD
gsea,regulation of cell differentiation (GO:0045595),0.34821151180714516,1.4338173266818925,0.03564727954971857,0.08809833820581554,1.0,31/63,51.50%,ANP32B;PA2G4;HSP90AB1;SUZ12;NSUN2;PTBP1;SINHCAF;SMYD5;CDK6;CLASP1;CDK5RAP2;ST7;CLASP2;FADS1;SRF;RUNX3;DLL1;ROCK1;TRPS1;HEMGN;TIAM1;SMOC1;PRKCB;SCIN;REST;EPHA3;SLC6A6;FLOT2;BIRC2;CDK5RAP1;SPOCK2
gsea,amyloid fibril formation (GO:1990000),-0.4405651762077821,-1.4337846812900463,0.08314606741573034,0.1807734209160136,1.0,9/21,12.80%,UBB;GSN;FURIN;TGFBI;CALCA;UBE2L6;APP;TSPAN5;CD36
gsea,B cell activation (GO:0042113),0.3853859236926567,1.4327773734547313,0.03877221324717286,0.0885534499157637,1.0,11/45,36.65%,HSPD1;SLC25A5;PHB2;PHB;MSH2;TCF3;DCAF1;RABL3;KIT;CD70;ADAM17
gsea,hippo signaling (GO:0035329),0.5036356742373529,1.4323524590119485,0.08664259927797834,0.08867995520704794,1.0,2/15,8.38%,YWHAE;CASP3
gsea,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.42575212498284115,1.4321457581404362,0.050314465408805034,0.08868750402911724,1.0,9/32,40.21%,HSP90AB1;TTK;NUP93;NUMA1;GIPC1;MEN1;ADAM17;UBE2O;ACVR1
gsea,extracellular matrix disassembly (GO:0022617),-0.4366559095211775,-1.4306148148528643,0.07027027027027027,0.18228147875331888,1.0,16/22,24.13%,CD44;GSN;CAPG;CTSS;FURIN;FLOT1;PRSS2;ADAM8;TIMP2;MMP9;MMP14;LAMC1;CTSL;EXOC8;TIMP1;CAPN2
gsea,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.415863225855459,1.4292843870870362,0.06060606060606061,0.09013936484619292,1.0,14/27,34.48%,NOC2L;P4HB;BAX;PPIF;RACK1;BCLAF1;URI1;UBQLN1;PTPMT1;HERPUD1;BID;DDX3X;BBC3;GSDME
gsea,positive regulation of secretion by cell (GO:1903532),0.4139489430215249,1.4291060762701688,0.06393442622950819,0.0901147679683517,1.0,10/35,33.09%,PPIA;PPID;EZR;CLASP1;CLASP2;TTN;GRK2;RAB27A;CD2AP;SLC12A2
gsea,regulation of p38MAPK cascade (GO:1900744),-0.4314629751392627,-1.4285058805888886,0.07142857142857142,0.18292128557733917,1.0,11/23,21.85%,GADD45B;DUSP1;ZC3H12A;PER1;DUSP10;IL1B;SPI1;RELL1;GADD45A;NCF1;MINK1
gsea,positive regulation of neuron death (GO:1901216),0.4273462159039305,1.4281030264613634,0.06405693950177936,0.09056999727517905,1.0,3/28,10.55%,EIF2S1;DDIT4;BAX
gsea,BMP signaling pathway (GO:0030509),-0.4360206874469412,-1.4280839291044738,0.07142857142857142,0.181905877931902,1.0,10/21,25.66%,PDCD4;SMAD7;RUNX2;TGFBR3;HFE;ACVRL1;SMAD3;RGMB;TGFB2;AMH
gsea,response to organic cyclic compound (GO:0014070),-0.4187015963632027,-1.4279094889102093,0.061381074168797956,0.18063338660985537,1.0,14/26,22.20%,CCL5;IL1B;TNF;ANXA1;STAT3;PAQR7;ABCB4;SOCS2;TIPARP;CCL2;AQP3;PMAIP1;ABCA2;CCL3
gsea,response to metal ion (GO:0010038),0.4135538861850817,1.4278514335476329,0.041044776119402986,0.09058377075622047,1.0,10/29,29.73%,FXN;PPP5C;SLC25A13;CALM2;NEDD4;MT3;NDRG1;TTN;PPP2CB;AHCYL1
gsea,secondary alcohol metabolic process (GO:1902652),0.47942811740190866,1.4277186954004977,0.077834179357022,0.09054526386522938,1.0,7/18,36.87%,IDH3A;FDX1;SQLE;IDH2;SCAP;NSDHL;CLN6
gsea,long-chain fatty acid transport (GO:0015909),0.4863819469807626,1.426788349537442,0.08153078202995008,0.09091930391636355,1.0,8/17,39.25%,FABP5;ACACA;MID1IP1;ACSL3;ABCD3;ACSL1;MFSD2A;CPT2
gsea,phosphatidylcholine metabolic process (GO:0046470),0.4261594139666359,1.4261853150715806,0.062193126022913256,0.09113946213906238,1.0,7/30,25.88%,DBI;PLA2G12A;LPCAT1;STARD7;CSNK2A2;MBOAT1;PCYT1A
gsea,protein secretion (GO:0009306),0.4467288268999048,1.4261462194277172,0.09266409266409266,0.09105845940239353,1.0,4/21,17.55%,PARK7;CANX;PDIA4;MIA2
gsea,response to amyloid-beta (GO:1904645),-0.4431200114585755,-1.4241257036131274,0.07792207792207792,0.18294795340653863,1.0,13/22,24.76%,ICAM1;ADRB2;FCGR2B;CASP4;APP;LRP1;CD36;LGMN;MMP9;IGF1;GSK3B;ITGA4;TLR4
gsea,Fc-gamma receptor signaling pathway (GO:0038094),0.3969605409954834,1.4216920442737455,0.07528957528957529,0.09329289379800335,1.0,16/37,48.56%,HSP90AB1;HSP90AA1;ACTB;PRKCE;MYO10;ACTR2;ACTG1;ELMO1;MYO1G;CYFIP1;FCER1G;VAV2;PLA2G6;NCKIPSD;WIPF3;PIK3CB
gsea,regulation of amyloid-beta formation (GO:1902003),0.44900860776035917,1.4215268007705544,0.07704918032786885,0.09327832029799014,1.0,5/21,23.53%,PIN1;CASP3;RTN3;SP1;ROCK2
gsea,T cell activation (GO:0042110),0.39404534286320475,1.421126000151144,0.05415860735009671,0.09336086536551183,1.0,12/35,40.80%,HSPD1;DDOST;TNFSF4;CD74;TNFRSF4;LCP1;PPP3CB;KIT;SCRIB;DPP4;PIK3CG;ADA
gsea,regulation of axonogenesis (GO:0050770),0.4995612384492363,1.4208311445815711,0.09375,0.0934365340823367,1.0,2/15,11.66%,ARHGDIA;METRN
gsea,RNA phosphodiester bond hydrolysis (GO:0090501),0.45300499457251087,1.4208231780095626,0.088659793814433,0.0933333331273257,1.0,10/19,36.99%,NHP2;RPP30;CPSF3;POP1;RNASEH1;TOE1;PARN;DICER1;CSTF3;ZC3H12D
gsea,negative regulation of cell motility (GO:2000146),0.362455506597554,1.4189469660548149,0.04954128440366973,0.09425962463676495,1.0,7/48,21.63%,MIF;PIN1;GTPBP4;CD74;SINHCAF;TPM1;CLIC4
gsea,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.360938638564164,-1.418570614608633,0.05240174672489083,0.18712322558344005,1.0,26/50,25.66%,UBB;PRKCZ;PDCD4;FURIN;SMAD7;RUNX2;ARHGEF18;TGFBR3;HFE;NLK;GCNT2;ACVRL1;SMAD3;SKI;FOS;PTPRK;TWSG1;ITGB1;INHBA;RGMB;SIRT1;ZMIZ1;TGFB2;APPL2;ADAM9;AMH
gsea,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.37495370379585086,-1.4170630243012756,0.060041407867494824,0.18712075168251116,1.0,21/38,25.23%,TNFAIP3;TMSB4X;NFKBIA;ZC3H12A;SPI1;MTURN;DDIT3;FOXP3;NLRP3;ERBIN;HAVCR2;ACOD1;ANXA4;NLRC3;TRIM21;IRAK3;SIRT1;PARP10;PRMT2;ARRB1;IL10
gsea,positive regulation of stress fiber assembly (GO:0051496),-0.42617355703195603,-1.4165876703367768,0.07083333333333333,0.18612621699536375,1.0,10/22,27.20%,RHOC;S100A10;EVL;NRP1;ARHGEF10L;RGCC;LIMK1;LIMCH1;FHOD1;PAK1
gsea,positive regulation of macroautophagy (GO:0016239),0.41124574625078103,1.4148920542539123,0.079002079002079,0.09642351083221296,1.0,6/26,33.55%,SLC25A5;VDAC1;LARP1;OPTN;SCOC;C9ORF72
gsea,calcium ion transmembrane import into cytosol (GO:0097553),-0.4530639023137994,-1.4107658642221972,0.08997429305912596,0.19060905596446492,1.0,7/17,16.47%,ATP2B4;ITPR2;F2R;RYR1;XCL1;TRPV2;SLC8A1
gsea,regulation of endothelial cell proliferation (GO:0001936),0.40569662694620473,1.4085599109974807,0.04430379746835443,0.0997991357914504,1.0,6/39,27.71%,HMGB2;AKT1;MYDGF;VEGFB;EGFL7;NRAS
gsea,positive regulation of interleukin-2 production (GO:0032743),-0.4544608090059862,-1.407897128475782,0.08835341365461848,0.19214840570518488,1.0,10/18,13.02%,MALT1;IRF4;CD86;CCR2;PDE4B;IL1B;RUNX1;ANXA1;CARD11;CD4
gsea,peptidyl-lysine trimethylation (GO:0018023),0.45003584283140174,1.4078164288014567,0.10429447852760736,0.10011643972543377,1.0,9/17,40.49%,SUV39H1;SUV39H2;SMYD5;ATPSCKMT;SETD1A;KMT5C;EEF2KMT;CTR9;SETD2
gsea,import into cell (GO:0098657),0.46734414313441275,1.407565294931935,0.09210526315789473,0.10013909813622726,1.0,5/18,22.17%,SLC29A1;SLC7A5;SLC7A1;SLC19A1;SLC38A1
gsea,fatty acid derivative biosynthetic process (GO:1901570),0.4996723844172783,1.4070123059860347,0.08392857142857142,0.10035079911307591,1.0,9/16,34.84%,FASN;ACACA;FAR1;ACLY;GCDH;BDH1;SLC25A1;AACS;CBR4
gsea,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.3205211643973999,1.4066772920389674,0.04602510460251046,0.10041456219639416,1.0,25/76,39.98%,GAPDH;TFRC;ECT2;NUP62;DDX1;UBE2N;EEF1D;PPP5C;CD74;DDX21;MTDH;FLNA;TMEM101;TRAF2;FADD;LGALS1;ANKRD17;SLC20A1;ZDHHC13;TSPAN6;TNFRSF10B;TICAM2;CHUK;MID2;RIPK2
gsea,fatty acid biosynthetic process (GO:0006633),0.43670869395046197,1.4033105205585268,0.07768595041322314,0.10228375322902668,1.0,10/26,36.05%,NDUFAB1;LIAS;ACACA;HACD3;ACLY;HACD2;FADS1;MCAT;CBR4;ABCD3
gsea,phosphate-containing compound metabolic process (GO:0006796),0.31010724765272735,1.4029314115116922,0.030612244897959183,0.10239147756657185,1.0,46/97,45.16%,PPA1;NUDT5;PGP;PGK1;BCKDK;AKT1;PSPH;NUDT4;PFKL;ISYNA1;GPD2;GDE1;PFKP;PPA2;ALDOA;PDXP;GK;PLAA;HDHD2;FRA10AC1;ACYP1;MTOR;DUSP12;SLC20A1;PPP3CB;PPIP5K1;AGK;HK2;G6PC3;ACP6;PLPP1;NADK;NUDT10;INPP5B;HK1;PIK3CG;AGPAT1;LHPP;NUDT11;PFKFB1;IPMK;PFKM;PANK3;TIGAR;CERKL;PI4KA
gsea,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.4696035912115569,1.4028388752266934,0.08847736625514403,0.1023453938571298,1.0,12/16,34.70%,PARP1;DDB1;RAD23B;RPS27A;GTF2H4;CHD1L;CUL4B;GTF2H3;GTF2H1;GTF2H2;DDB2;CUL4A
gsea,negative regulation of autophagy (GO:0010507),0.38632816564838246,1.4027302420343677,0.07400379506641366,0.1022911670464205,1.0,16/35,43.66%,EIF4G1;SNRNP70;AKT1;DAPL1;EIF4E;EIF4G2;FOXK2;MT3;MTOR;CPTP;DAP;KLHL22;WDR6;EIF4G3;TLK2;ATG7
gsea,cellular protein localization (GO:0034613),0.3054678631009806,1.4022452773705918,0.028622540250447227,0.10247760064164231,1.0,44/131,40.84%,NPM1;PRPF19;TMED2;IFT27;CD74;ARCN1;VPS35;COX18;COPB2;CNTLN;MESD;FLNA;EIF2D;ADPRH;ARL1;TBC1D10B;PIGU;ARFIP2;SIL1;TMED1;SGSM3;CEP68;BICD1;RABL3;NSF;AP3D1;CLTC;DNAJC27;RAP2A;COPA;TICAM2;SEC23IP;ATG9B;TM9SF4;RAB23;SNX27;CEP250;BICD2;GGA2;HDAC6;AP3B1;CTNNB1;IFT22;AHI1
gsea,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.36910758864822407,1.4021845575176233,0.04770992366412214,0.10238878802552981,1.0,14/45,41.57%,PLK1;IPO5;CDKN2A;AKT1;IPO7;PKIG;TFAP4;PRKAR2A;MEN1;SMPD1;UCHL1;PRKAR2B;PAQR3;RB1
gsea,positive regulation of osteoblast differentiation (GO:0045669),0.5057609770005644,1.4000027278505456,0.09,0.10362509788968802,1.0,1/18,0.97%,FBXO5
gsea,global genome nucleotide-excision repair (GO:0070911),0.4531236538648527,1.398967929005083,0.10323886639676114,0.10410496585347838,1.0,12/18,34.70%,PARP1;DDB1;RAD23B;RPS27A;GTF2H4;CHD1L;CUL4B;GTF2H3;GTF2H1;GTF2H2;DDB2;CUL4A
gsea,positive regulation of cell differentiation (GO:0045597),0.3443754439429286,1.3985664964558562,0.04155124653739612,0.1042229274845997,1.0,37/96,54.59%,PA2G4;FBXO5;HSP90AB1;EZH2;ECT2;AKT1;TCF3;CARM1;SIN3A;TCF4;MTOR;SRF;CTNNA1;CREB1;NPNT;LEF1;FRZB;CTNNB1;ACVR1;TWIST1;ZBTB16;GPC1;TIAM1;LTF;NOCT;ZEB1;MMD;CPNE1;REST;SLC6A6;XBP1;BAMBI;TMEM119;MEF2C;CCN4;RPS6KA3;WDFY2
gsea,cellular response to organic cyclic compound (GO:0071407),0.35713453033419973,1.3978185402425127,0.049403747870528106,0.10457981833718534,1.0,19/63,32.57%,RAD51;HSP90B1;BRCA1;RUVBL2;BLM;CASP3;SPP1;ACTB;EZR;LARP1;INSIG1;TAF1;URI1;PDXP;ROCK2;ATP1A1;CASP7;SPIDR;CTNNA1
gsea,skin development (GO:0043588),0.4242737597125933,1.3974474807538353,0.0770440251572327,0.1046724386277719,1.0,6/31,27.56%,STMN1;CASP3;DHCR24;CLIC4;ABCB6;ST14
gsea,negative regulation of protein phosphorylation (GO:0001933),0.3229040627270543,1.3920327920286557,0.04609218436873747,0.10786578718333338,1.0,43/78,54.06%,PPIA;PARK7;EIF4G1;TARDBP;DDIT4;AKT1;RACK1;CALM2;CORO1C;DNAJC10;PRKRIP1;CACTIN;TARBP2;ZBED3;PRKDC;CEP85;PTPN6;MEN1;C9ORF72;IBTK;SNX25;TAB1;FBLN1;PAQR3;GPD1L;XDH;RB1;TRAF3IP1;TWIST1;TRIB3;DUSP19;PDPK1;PPM1F;SPRED1;MVP;TSC2;SPRED2;ENG;AKT1S1;DAB2IP;DVL1;YWHAG;LRP6
gsea,protein destabilization (GO:0031648),0.4541793168531808,1.3919126004935913,0.09297520661157024,0.10782554412646612,1.0,7/18,39.84%,PLK1;RAD23A;KDM8;CUL3;CDC73;MDM2;HTT
gsea,protein lipidation (GO:0006497),0.39607863278439126,1.390876380691454,0.0859538784067086,0.10828121817410062,1.0,14/27,43.66%,ZDHHC2;PIGF;ZDHHC6;PIGU;ZDHHC16;PIGQ;PIGA;ZDHHC12;ZDHHC13;ZDHHC21;PIGH;HHAT;PIGB;ATG7
gsea,inorganic anion transport (GO:0015698),0.46229294244895247,1.390053893263133,0.0888529886914378,0.10870329454267819,1.0,3/21,21.63%,RACGAP1;SLC25A10;CLIC4
gsea,positive regulation of interleukin-1 production (GO:0032732),0.4486926648940922,1.3884919422007496,0.09297912713472485,0.10947594854829282,1.0,4/21,56.73%,HMGB1;RIPK2;TMEM106A;GBP5
gsea,positive regulation of chemokine production (GO:0032722),0.4252781428325355,1.3867283994993032,0.1063063063063063,0.11044683388471396,1.0,3/28,11.33%,HMGB1;TNFSF4;CD74
gsea,positive regulation of T cell activation (GO:0050870),-0.3917974788279065,-1.3841017770098079,0.08016877637130802,0.21583704629121042,1.0,33/33,98.21%,CCL5;CD274;CD86;CCR2;IL1B;PDCD1LG2;ANXA1;ZBTB1;CD40LG;SIRPA;AIF1;CCL2;GATA3;ZMIZ1;IL6ST;IL23A;CCR7;CD81;NCK2;VCAM1;XBP1;FLOT2;TNFRSF13C;CD80;DOCK8;CCDC88B;TNFSF11;CD70;IL21;SLC7A1;TNFSF4;TFRC;HSPD1
gsea,modulation by host of symbiont process (GO:0051851),0.43169602029805093,1.3837895749243243,0.1160337552742616,0.11214301928074673,1.0,9/19,22.81%,NUCKS1;HDAC1;TARDBP;SMARCA4;SMARCB1;RRP1B;SAP30;TFAP4;SP1
gsea,fatty acid metabolic process (GO:0006631),0.3672317591510517,1.3817520627978868,0.05597579425113464,0.11325640090848525,1.0,27/55,47.25%,NDUFAB1;ACSL5;GPX1;FASN;MECR;MSMO1;NUDT19;ACAD9;ACACA;ACLY;GNPAT;ACSL3;ALKBH7;MCAT;CBR4;ABCD3;ACSL1;ACSF2;CPT2;THEM4;ACSL6;ELOVL4;PEX2;HACL1;ECHDC3;AOAH;ACSL4
gsea,protein targeting to membrane (GO:0006612),0.3833231899055177,1.3814203813939732,0.07306889352818371,0.11331905887118163,1.0,17/31,41.94%,SSR2;ZDHHC2;ARL6IP1;ZDHHC6;SIL1;PXMP2;ZDHHC12;SLC25A17;PEX3;ABCD3;PRKCI;RAB3IP;PIKFYVE;ZDHHC24;ICMT;ZDHHC21;SEC61A1
gsea,regulation of neuron differentiation (GO:0045664),0.3953061749002567,1.3805915926395,0.0873015873015873,0.11376675658201024,1.0,19/28,53.71%,ECT2;CALR;TCF3;SIN3A;CDK5RAP2;TCF4;DLL1;ROCK1;MED1;NEPRO;EIF2AK4;TIAM1;ZEB1;MMD;CPNE1;REST;CDK5RAP1;YWHAG;MEF2C
gsea,positive regulation of stress-activated MAPK cascade (GO:0032874),0.35974734838761036,1.380340874718552,0.06620209059233449,0.11378344785251393,1.0,16/52,52.98%,HMGB1;PRMT1;HRAS;MID1;TRAF2;MAP3K4;TRAF3;XDH;AXIN1;DUSP22;DUSP19;TAOK2;SEMA4C;PJA2;HIPK2;DAB2IP
gsea,histone lysine demethylation (GO:0070076),-0.4356620712873018,-1.3802426733203503,0.1171875,0.2187818511062582,1.0,10/20,20.19%,KDM5B;KDM7A;KDM2B;KDM6B;JMJD1C;KDM3A;KDM4B;PHF8;KDM5D;UTY
gsea,cell chemotaxis (GO:0060326),0.3934918802594425,1.3800784637570191,0.07909604519774012,0.11380494679916484,1.0,10/30,52.67%,HMGB2;CCR6;CCRL2;ABCC1;KIT;LEF1;CX3CL1;BCAR1;ELMO2;RAB13
gsea,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.445869137310301,-1.379182998078564,0.11428571428571428,0.2183851864388754,1.0,13/21,14.96%,ZC3H12A;TYROBP;SYK;PID1;DCXR;THBS1;F2RL1;CD36;PDGFB;GADD45A;ACOD1;SLC5A3;ITGAM
gsea,regulation of interleukin-10 production (GO:0032653),0.4210292347544258,1.3786137184413432,0.10351201478743069,0.11457969215953519,1.0,3/25,11.27%,HMGB1;HSPD1;TNFSF4
gsea,steroid metabolic process (GO:0008202),0.4601270754016926,1.3756652003378502,0.10128913443830571,0.11637750331557617,1.0,9/19,33.80%,FDX1;DHCR24;FDX2;FDFT1;MSMO1;HSD17B7;FDXR;LSS;HSD17B10
gsea,negative regulation of viral process (GO:0048525),-0.37448200119137043,-1.3737389673714504,0.09072978303747535,0.22286424785763106,1.0,38/38,99.74%,CCL5;STAT1;ISG15;ZFP36;IFITM1;ISG20;IFITM2;IFITM3;IFIT1;TNF;RSAD2;HEXIM1;TRIM14;RNASEL;OAS3;TRIM8;TRIM5;SLPI;TRIM21;PLSCR1;PARP10;EIF2AK2;TNIP1;PML;MAVS;IFIH1;BST2;LTF;SHFL;MID2;TRIM35;LARP7;ILF3;SRPK1;FAM111A;TRIM28;BANF1;PPIA
gsea,negative regulation of cell differentiation (GO:0045596),0.3301893654797572,1.373682364313113,0.04013377926421405,0.11747927669368816,1.0,35/82,50.47%,ANP32B;HNRNPU;E2F1;SUZ12;CALR;MYB;PTBP1;SINHCAF;ANKRD26;LEO1;CDK6;PTCH1;ASXL1;RIOX1;MEN1;METTL14;CDC73;PTPN11;IQCB1;DLL1;MED1;CTR9;XDH;NEPRO;RB1;TWIST1;ZBTB16;EIF2AK4;NOCT;TRIB3;SPRED1;ZADH2;USF3;REST;SPRED2
gsea,regulation of cell death (GO:0010941),0.3658862235158154,1.3728557917928494,0.08183632734530938,0.11792428235261672,1.0,12/41,22.91%,PARK7;PHB;EIF4G1;RAD18;TMEM109;SRSF6;DHCR24;NOA1;VPS35;FAF1;CTSZ;MT3
gsea,renal system development (GO:0072001),0.4830427647752824,1.3726515642316468,0.11578947368421053,0.11792345732976033,1.0,2/15,11.05%,CENPF;IFT27
gsea,regulation of cell motility (GO:2000145),0.3482162772447228,1.3723105697497995,0.05271828665568369,0.1180349291621776,1.0,26/54,51.50%,RCC2;TMSB10;KIF14;PIN1;SERPINE2;AKT1;MEMO1;FLNA;ROCK2;CDK6;KIF2A;PLXND1;ROCK1;FBLN1;SLK;RHOB;TWIST1;ENPP2;HACE1;NEXN;AMOTL1;DIAPH1;TBCCD1;LMO4;PLXNA1;SPOCK2
gsea,regulation of stress fiber assembly (GO:0051492),0.37610076828328864,1.3703121751505056,0.06818181818181818,0.11924223958565074,1.0,9/41,32.21%,STMN1;PFN1;TPM1;ROCK2;ALMS1;CLASP1;CLASP2;ACTG1;PPFIA1
gsea,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.460208321579992,1.3699650955164018,0.10612244897959183,0.11935042576321601,1.0,8/15,40.99%,PARK7;CALR;CARM1;UFSP2;SAFB2;UFL1;HDAC6;AXIN1
gsea,peptidyl-tyrosine phosphorylation (GO:0018108),-0.41343301414554845,-1.3683048120465124,0.10669975186104218,0.2271975165933832,1.0,13/23,16.67%,FLT1;SYK;FES;LYN;PTK2B;HCK;CSF1R;TEC;ABI3;FGR;PDGFB;BTK;JAK2
gsea,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.4330534359739129,-1.3655137998923195,0.14177215189873418,0.22879393793015296,1.0,8/20,14.96%,TYROBP;CRTAM;SPI1;CD226;PVR;XCL1;LAMP1;ITGAM
gsea,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.46552715852991805,1.3636064731761302,0.10029498525073746,0.1234174031430791,1.0,4/20,22.93%,DNMT1;CDKN1A;TPM1;SOD2
gsea,regulation of signal transduction (GO:0009966),0.3314261203297105,1.3625156478929414,0.06643356643356643,0.12399677105259992,1.0,31/72,56.17%,PPIA;NUCKS1;NUP62;NCLN;TMEM237;UBTF;SREBF2;PTCH1;CD55;GRK2;DLL1;ACVR1;BST1;NCAM1;AXIN1;RGS12;CX3CL1;IGFBP7;POFUT1;KCTD8;CD80;TSC2;RGS2;USP33;IFT81;WDR11;YWHAG;IL3;NCK2;LLGL1;TSPAN15
gsea,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.37652691067810373,1.3624831795525596,0.09441233140655106,0.12388084404625302,1.0,16/38,48.56%,HSP90AB1;HSP90AA1;ACTB;PRKCE;MYO10;ACTR2;ACTG1;ELMO1;MYO1G;CYFIP1;FCER1G;VAV2;PLA2G6;NCKIPSD;WIPF3;PIK3CB
gsea,regulation of interleukin-8 production (GO:0032677),0.3908449341842227,1.3622493879541313,0.07931034482758621,0.12391816849564254,1.0,5/36,26.03%,HMGB1;PARK7;CD74;CACTIN;FADD
gsea,regulation of interferon-alpha production (GO:0032647),0.428056008409762,1.3609483352539893,0.12248995983935743,0.12460654348096555,1.0,6/18,40.49%,HSPD1;DHX9;DDX3X;CHUK;RIPK2;SETD2
gsea,positive regulation of lymphocyte proliferation (GO:0050671),-0.370526414231717,-1.360595944475385,0.0826271186440678,0.23287030579695445,1.0,37/37,99.16%,CCL5;CD274;CLCF1;CD86;CD38;BCL2;IL1B;PDCD1LG2;ANXA1;CD40;CD40LG;IRS2;AIF1;IL2;NFATC2;TNFSF13B;IL6ST;VAV3;GPR183;IL23A;CD81;NCK2;MEF2C;VCAM1;TNFRSF13C;CD80;CCDC88B;BST1;CD70;IL21;CD320;SLC7A1;TNFRSF4;CD74;TNFSF4;TFRC;MIF
gsea,positive regulation of response to biotic stimulus (GO:0002833),-0.4143398675607734,-1.360347268773165,0.10421286031042129,0.23153478797977298,1.0,11/22,21.07%,CCL5;PRKCA;CD180;DHX58;ADAM8;DDX60;SCIMP;LY86;ACOD1;GRN;PLSCR1
gsea,endothelial cell migration (GO:0043542),-0.4262930905724225,-1.3577606175347292,0.09302325581395349,0.23282234482051184,1.0,8/20,19.97%,STAT1;NR4A1;LGALS8;NRP1;EGR3;TNFSF12;FSTL1;ADGRA2
gsea,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.3122127046254873,1.357461069220128,0.06818181818181818,0.1268089608661132,1.0,24/77,43.90%,PPIA;NPM1;TFRC;PSMA6;DHX9;UBE2N;TRIM37;MTDH;PRDX3;RPS27A;PIDD1;TRAF2;NFKB2;RHEBL1;RPS6KA5;ERC1;CHUK;TAB1;PRKCI;MID2;RIPK2;TNFSF11;CX3CL1;NFKBIB
gsea,negative regulation of cell-matrix adhesion (GO:0001953),0.5116984147006158,1.3572824292424268,0.10698365527488855,0.1268048627031163,1.0,3/16,16.60%,RCC2;CDKN2A;CORO1C
gsea,cellular response to molecule of bacterial origin (GO:0071219),0.3598221465489379,1.3565772184287415,0.10562180579216354,0.1271467033471987,1.0,20/57,57.84%,HMGB2;HMGB1;TNFSF4;CACTIN;PLAA;CDC73;UPF1;SELENOS;TICAM2;MAPK8;CTR9;NFKBIB;CD80;CTSG;XBP1;DAB2IP;MEF2C;GFI1;SERPINE1;VIM
gsea,positive regulation of signaling receptor activity (GO:2000273),0.4213722822364142,1.3564997504334813,0.10869565217391304,0.12705031173642245,1.0,8/27,39.06%,PARK7;HDAC1;HDAC2;TAF1;BUD31;ADAM17;AREG;HDAC6
gsea,cellular protein catabolic process (GO:0044257),0.39069460908866,1.3557853692141226,0.10805500982318271,0.1274085653541652,1.0,16/29,45.09%,PSMA6;LONP1;HTRA2;CLPP;RNF5;GZMB;CHEK2;CTSZ;CLTC;YME1L1;CLPX;MDM2;TCIRG1;PISD;AP2B1;AP2A2
gsea,regulation of defense response (GO:0031347),-0.3448546395120718,-1.3557230817858417,0.06708595387840671,0.23362632446346682,1.0,46/46,95.87%,TMSB4X;SAMHD1;IRF1;ZBP1;CCR2;SEMA7A;PIK3AP1;FOXP1;USP18;ANXA1;FCGR2B;AREL1;SBNO2;PTGS2;CASP4;XCL1;HCK;DHX58;BCL6;FGR;CASP1;APOE;SPATA2;JAK2;GRN;BIRC3;CASP12;APPL2;ELMOD2;RELA;ALOX5;AKNA;BIRC2;BST1;TRAF3;UFL1;CELF1;TKFC;LACC1;LRP8;ZMPSTE24;SETD6;ERAP1;TNFSF4;PSMA6;PARK7
gsea,negative regulation of cellular catabolic process (GO:0031330),0.380026903081299,1.3535634142238089,0.09123434704830054,0.12889695612632326,1.0,18/35,43.34%,EIF4G1;AKT1;DAPL1;EIF4E;EIF4G2;FOXK2;MT3;CST3;MTOR;CPTP;ROCK1;MFSD2A;DAP;KLHL22;WDR6;EIF4G3;NRDE2;TLK2
gsea,MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.4375308696928558,-1.3534020672141602,0.1227364185110664,0.23480100645796048,1.0,7/18,16.95%,UBB;IRF7;TNIP3;CD40;CD300LF;IKBKE;CD14
gsea,plasma membrane invagination (GO:0099024),0.4765411481942096,1.3485738682784045,0.11716171617161716,0.1322907604122033,1.0,5/17,34.26%,AURKB;SH3BP1;ELMO1;MYH9;SPIRE1
gsea,negative regulation of type I interferon production (GO:0032480),-0.41146474763242846,-1.3475623988160648,0.10642570281124498,0.2400710523619125,1.0,12/22,19.94%,TNFAIP3;ISG15;REL;DDX58;SIRPA;UBE2L6;DHX58;IKBKE;HAVCR2;ACOD1;NLRC3;PTPRS
gsea,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.3845939506999224,1.3472772919821716,0.12114989733059549,0.13303678004037944,1.0,14/28,39.81%,PARK7;U2AF2;RPL5;AKT1;GTPBP4;PRMT3;PINX1;IVNS1ABP;NXN;BAG2;GNL3L;UFL1;BAG5;CTNNB1
gsea,cellular response to amino acid stimulus (GO:0071230),0.4636668265327393,1.346875579397232,0.11406844106463879,0.13321992903027235,1.0,1/15,5.24%,IPO5
gsea,sprouting angiogenesis (GO:0002040),0.43412773608772925,1.3455411596407032,0.10625,0.13393499717811125,1.0,4/25,17.10%,E2F8;E2F7;AKT1;VEGFB
gsea,cellular glucose homeostasis (GO:0001678),0.42194750589262825,1.3451735318161402,0.1076923076923077,0.13405071357680223,1.0,4/21,22.80%,NUCKS1;RACK1;PCK2;FOXK2
gsea,regulation of toll-like receptor signaling pathway (GO:0034121),-0.45720052627616564,-1.342950174032404,0.14754098360655737,0.24394211949663355,1.0,8/15,23.41%,IRF1;IRF7;FLOT1;TLR2;CD36;IRAK3;BIRC3;APPL2
gsea,positive regulation of cell motility (GO:2000147),-0.2915447515851266,-1.3416695913442092,0.052941176470588235,0.24387141908900586,1.0,104/104,92.66%,CCL5;ITGAX;RHOC;VSIR;CSF1;PIK3CD;SEMA7A;IL1B;F2R;PRKCA;NEDD9;CTSH;STAT3;MYADM;FLT1;ITGA6;GCNT2;PTK2B;THBS1;NOTCH1;CASS4;CSF1R;AIF1;DAB2;LAMC2;F2RL1;FGR;MGAT5;PDGFB;COL1A1;RET;CCL7;MMP9;ITGB1;CCN1;MMP14;CD151;FAM110C;GRN;SEMA4A;LGR6;GPNMB;SPRY2;TJP1;CCL3;IGF1;CXCL16;CCR1;ADAM9;PAK1;PLET1;CAVIN1;VEGFA;SPHK1;PDGFA;PLAU;SEMA6D;ADRA2A;HBEGF;WNT11;SEMA4B;CCR7;RIPOR1;MYO1C;NTRK3;SMIM22;F3;EDN1;GRB7;SPOCK2;SYNE2;PECAM1;XBP1;BCAR1;SEMA4C;VIL1;PPM1F;TIAM1;TWIST1;CPNE3;ACVR1;MAP4K4;LEF1;ADAM17;RUFY3;ATM;KIT;SUN2;ELP3;ACTG1;CARMIL2;ELP6;ROCK2;SOD2;ELP5;ARHGEF39;HSPA5;CCAR1;RDX;RACK1;HRAS;ACTN4;MAZ;GTSE1
gsea,cartilage development (GO:0051216),-0.44052016051228954,-1.340843630772065,0.11845102505694761,0.24327401187568792,1.0,5/16,18.39%,CD44;RUNX1;RUNX2;SULF2;CREB3L2
gsea,phosphatidylinositol 3-kinase signaling (GO:0014065),0.4601563070288398,1.3404405710365404,0.13109243697478992,0.13731234671522505,1.0,2/18,10.02%,C1QBP;AKT1
gsea,cellular response to hormone stimulus (GO:0032870),-0.3571562655054717,-1.339634657355975,0.1074561403508772,0.24305992335298085,1.0,20/39,26.12%,ZFP36L1;NR4A3;ARID5A;RARA;CTSS;NR3C1;CTSH;AR;STAT3;KLF9;SERPINB9;RAMP1;SOCS2;GAS2L1;LMO2;NCOA3;ATP1A2;CTSL;NCOA4;ATP1A3
gsea,positive regulation of protein localization to membrane (GO:1905477),0.34354407205734133,1.3385013645520334,0.09486166007905138,0.13855917985136545,1.0,20/47,40.77%,TFDP1;YWHAE;E2F1;AKT1;HRAS;TFDP2;RANGRF;SPTBN1;GZMB;PRKCE;NMT1;BID;KIF5B;BBC3;CNPY4;C2CD5;NKD2;PRKCI;MAPK8;CLIP3
gsea,protein acylation (GO:0043543),0.3952304640980958,1.3365116597668023,0.11895161290322581,0.13990840888444414,1.0,11/24,42.33%,ZDHHC2;NAA10;KAT2A;ZDHHC6;ZDHHC16;NAT10;ZDHHC12;ZDHHC13;ING5;ZDHHC21;HHAT
gsea,negative regulation of cellular biosynthetic process (GO:0031327),0.39427952371346625,1.33501850245787,0.1088560885608856,0.14087253349435244,1.0,7/28,26.54%,BRCA1;PGP;KHSRP;ACADL;PRMT3;ROCK2;ERLIN1
gsea,regulation of cilium assembly (GO:1902017),0.3733970962138846,1.3349054704835581,0.10080645161290322,0.14081904595073497,1.0,11/29,43.22%,CCP110;TBC1D7;TBC1D10B;ODF2L;SGSM3;KCTD17;IFT140;IFT88;HTT;CEP97;ARHGAP35
gsea,positive regulation of leukocyte chemotaxis (GO:0002690),0.4209264858206977,1.33152541394516,0.10737179487179487,0.1430994184289666,1.0,5/27,20.84%,HMGB1;C1QBP;CALR;VEGFB;CCR6
gsea,nitrogen compound transport (GO:0071705),0.3267362951547624,1.3313269772700793,0.07540394973070018,0.14310925211929804,1.0,27/59,46.18%,CENPF;HSP90B1;NDC1;HIKESHI;SLC7A5;SLC7A1;SLC38A1;ABCB6;SLC7A6;CEP290;CD320;SLC1A4;ABCC1;SCAMP4;ABCG2;SLC12A2;MYH9;SLC7A3;SLC19A2;SLC6A12;SLC11A1;SLC16A10;SLC15A4;SEC14L1;SLC1A5;VPS33B;SLC6A13
gsea,inositol lipid-mediated signaling (GO:0048017),-0.4191119320933294,-1.3310200092002704,0.1136890951276102,0.25211144131073904,1.0,12/20,25.59%,PIK3R1;PIK3CD;PLCB2;IRS2;INPP5F;PTAFR;CSF1R;PITPNM2;IGF1;PLCB4;PIK3C2A;PIK3CA
gsea,positive regulation of cellular catabolic process (GO:0031331),0.3205935481234073,1.3308097909962395,0.06735751295336788,0.14335615382824904,1.0,23/73,40.57%,HMGB1;HSP90AA1;KHSRP;RDX;EZR;MTDH;GRSF1;ZC3H18;VPS35;FAF1;PNPT1;OPTN;CNOT1;SUPV3L1;DXO;ENTPD5;UPF1;SVIP;UFL1;MTLN;ROCK1;MID2;PFKFB1
gsea,positive regulation of vasculature development (GO:1904018),-0.3361635244413763,-1.3305543336341086,0.07123287671232877,0.25092945458578897,1.0,51/51,96.14%,ITGAX;ETS1;ZC3H12A;PIK3CD;PLCG1;IL1B;PRKCA;HIF1A;RUNX1;CTSH;NINJ1;FLT1;CD40;THBS1;ECM1;PGF;TNFSF12;ITGB1;CCR3;GRN;SIRT1;JUP;HSPB1;PRKD2;FGF2;ITGB8;VEGFA;SPHK1;ANXA3;HMOX1;HIPK1;VASH2;SERPINE1;F3;PAK4;HIPK2;XBP1;RAMP2;PRKCB;PDPK1;AGO2;TWIST1;RHOB;PIK3R6;ANGPTL4;HK2;SP1;VEGFB;MTDH;MYDGF;BRCA1
gsea,negative regulation of signal transduction (GO:0009968),-0.2909805897391531,-1.3303318792658338,0.04451038575667656,0.24958682708496344,1.0,108/108,98.19%,CCL5;TNFAIP3;NR4A2;NFATC1;CX3CR1;PRKCZ;SPRY1;PTPRE;SLAMF1;BCL2;SOCS1;TAX1BP3;IL1B;TNF;CREB3L1;PTPRJ;SULF2;PID1;MGRN1;LYN;NLK;HHEX;THBS1;SOCS5;LRP1;TMBIM1;LGMN;SIGIRR;KCTD21;TLE1;GATA3;MMP14;IRAK3;TULP3;DLL4;TRIB1;SPRY2;SHISA2;ARRB1;IL10;PALM;FBXW7;FGF2;LRRK2;DKK3;PLEK;RNF157;BTRC;SPRY4;HIC1;PIP4K2B;HGS;TSKU;PTCH2;NRARP;SMPDL3B;SOX30;EPN2;CRY1;APLN;SFRP4;DLK2;KANK2;CHAC1;ENPP1;TSPAN15;PTPN12;GRB7;DAB2IP;RGS2;GRB10;PHACTR4;TSC2;PIK3CB;PRKCB;RPGRIP1L;LTF;METTL3;GPC1;CX3CL1;LRRC14;RB1;RITA1;ACVR1;XDH;DLL1;FRZB;SMPD1;NKD2;WWOX;OTUD4;NXN;ASXL1;PTCH1;CNOT1;CSNK2A2;CACTIN;EGFL7;CBY1;HMGXB4;NEDD4;RACK1;VCP;AKT1;MAZ;DDIT4;CALR;EZH2
gsea,cellular component disassembly (GO:0022411),-0.4037310881171503,-1.3297196650605692,0.10326086956521739,0.24866951077084998,1.0,16/23,24.13%,CD44;GSN;CAPG;CTSS;FURIN;FLOT1;PRSS2;ADAM8;TIMP2;MMP9;MMP14;LAMC1;CTSL;EXOC8;TIMP1;CAPN2
gsea,glycerophospholipid metabolic process (GO:0006650),0.3618323366381688,1.328761829463883,0.09386973180076628,0.14471503964415466,1.0,15/36,42.87%,PGP;PIGF;CRLS1;GDE1;PLA1A;PDXP;PIGQ;FAR1;PIGA;SMPD4;AGK;ACP6;PIGH;CPNE3;PIGB
gsea,positive regulation of lipid biosynthetic process (GO:0046889),0.45849806263659815,1.3273856227238652,0.13060428849902533,0.14560098013718784,1.0,8/15,39.28%,AKT1;SCARB1;LDLR;MID1IP1;MTOR;CREB1;MFSD2A;LPGAT1
gsea,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.3605311992482503,-1.3246394606673744,0.12694877505567928,0.2531159303250599,1.0,23/38,24.76%,TMSB4X;NFKBIA;CD86;ZC3H12A;PDCD4;TNFSF14;IL1B;TNF;SPI1;NFAT5;APP;NLRP3;RASSF2;EP300;TLR2;TERF2IP;C1QTNF4;TLR7;NLRC3;CD14;BCL3;ADGRG3;TLR4
gsea,peptidyl-tyrosine modification (GO:0018212),-0.39782932500763646,-1.3203792979395872,0.12895377128953772,0.2567297060563708,1.0,14/23,16.67%,FLT1;TPST2;SYK;FES;LYN;PTK2B;HCK;CSF1R;TEC;ABI3;FGR;PDGFB;BTK;JAK2
gsea,activation of GTPase activity (GO:0090630),0.3592008108481888,1.3164377930061044,0.08422664624808576,0.15399641522236912,1.0,7/50,28.57%,ECT2;RANGAP1;CORO1C;TBC1D7;ADPRH;TBC1D10B;SGSM3
gsea,ion transport (GO:0006811),0.3577821511450271,1.3102452661036936,0.10096153846153846,0.15888715652841243,1.0,20/39,57.25%,VDAC1;VDAC2;SLC25A10;PLP2;KCNN4;SLC20A1;SLC12A2;SLC24A5;SLC15A4;ANO10;SLC17A8;SLC9A8;PIEZO1;SLC4A2;SLC25A22;SLC15A1;SLC26A2;SLC15A3;GABRB1;SLC12A3
gsea,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.43959588147035145,-1.3089718557130288,0.1246684350132626,0.2691891832368793,1.0,7/17,23.91%,ANXA1;PTGS2;THBS1;NOTCH1;HDAC5;DLL4;PIK3C2A
gsea,positive regulation of biomineral tissue development (GO:0070169),0.45478795090868684,1.3077217974904236,0.14173228346456693,0.16072187449297845,1.0,1/17,0.97%,FBXO5
gsea,organic substance transport (GO:0071702),0.3236911484132023,1.307079329714712,0.08986615678776291,0.16107101237188856,1.0,17/50,40.23%,CENPF;HSP90B1;NDC1;HIKESHI;SLC19A1;ABCB6;CEP290;CD320;SCAMP4;NME4;ABCG2;MYH9;PEX3;PLEKHA8;ABCD3;MFSD2A;SLC19A2
gsea,negative regulation of innate immune response (GO:0045824),-0.42664546769878636,-1.306107487160422,0.1443089430894309,0.27115897379996257,1.0,14/19,18.63%,TNFAIP3;SAMHD1;ISG15;USP18;TRAFD1;STAT2;DHX58;OAS3;ACOD1;SLAMF8;NLRC3;TRIM21;GRN;IRAK3
gsea,positive regulation of mononuclear cell migration (GO:0071677),0.4129524205950158,1.3054781441100056,0.14432989690721648,0.162270951806937,1.0,4/21,20.84%,HMGB1;C1QBP;CALR;CCR6
gsea,cytosolic transport (GO:0016482),0.3260990525983313,1.3037073166841677,0.09012875536480687,0.1635209420997158,1.0,24/53,46.29%,RNF126;SNX5;VPS52;VPS35;EEA1;ARL1;TBC1D10B;HOOK1;DCTN1;GCC2;CLTC;HOOK2;VPS50;ERC1;EPS15;CORO7;UBE2O;PIKFYVE;ANKFY1;HEATR5A;GAK;KIF16B;KLHL20;SNX16
gsea,positive regulation of hydrolase activity (GO:0051345),0.305161983320979,1.3036516919696475,0.08073394495412844,0.1633793514069702,1.0,24/81,49.53%,HMGB2;EZH2;ECT2;PIN1;ARHGAP11A;HRAS;RACK1;CALM2;PKP4;NET1;TBC1D7;SH3BP1;SGSM3;DOCK11;MAP4K4;MAPK8;DOCK9;ADRB1;CX3CL1;DOCK8;SRGAP2;RAP1GDS1;CAV2;RSU1
gsea,organic anion transport (GO:0015711),0.3809883877872458,1.3018756027910645,0.12403100775193798,0.16477678864407058,1.0,16/27,52.34%,SLC19A1;SLC35B1;SLC25A19;SLC35A1;CYB5R1;ABCG2;SLC25A17;SLC35A3;CPTP;SLC4A8;ABCC4;SLCO2A1;SLCO4A1;SLC35C2;SLC52A2;SLC4A2
gsea,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.3415224674301151,1.301603639379632,0.10688140556368961,0.16481609882560377,1.0,12/69,43.51%,HMGB1;MIF;PHB2;PHB;HRAS;CD74;MT3;NPNT;PTPN11;SHC1;TNFSF11;CX3CL1
gsea,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.4299629817724636,1.2966756640606427,0.1592741935483871,0.16870253072660218,1.0,9/16,35.18%,BAX;CASP8AP2;DDX47;DELE1;BLOC1S2;FADD;BID;DDX3X;TNFRSF10B
gsea,regulation of T cell differentiation (GO:0045580),-0.3938288465989904,-1.2961307060407292,0.15090543259557343,0.2825492656683631,1.0,14/23,22.58%,CTLA4;TNFRSF18;TBX21;CCR2;CRTAM;RUNX1;IL2RA;ZBTB1;IFNG;FOXP3;IL2;NFATC2;GATA3;ZMIZ1
gsea,cellular calcium ion homeostasis (GO:0006874),-0.3143423579695145,-1.2951052364307838,0.08785529715762273,0.2821698676910254,1.0,57/57,96.13%,CCL5;TPT1;ATP2B4;CCL1;BCL2;CCR2;SLC30A1;ATP2A3;RYR1;ATP2B2;CALCA;CD40;CALCB;CAMK2D;ATP13A2;MICU3;ATP1B1;CCL8;CCL7;SLC8A1;CLN3;STIM2;CCL3;CCR1;STC2;MCU;TMEM203;DRD4;PTH1R;PML;PACS2;HTR2A;PLN;EDN1;MCUB;CAV2;CDH23;TNNI3;SLC24A5;TRPC1;PDZD8;KCTD17;AFG3L2;RMDN3;SLC35G1;HERPUD1;ATP13A1;CHERP;CCDC47;BAK1;LETM1;ATP13A3;ATP2A2;BAX;CALR;STOML2;YWHAE
gsea,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.40022337543418524,1.2935296916330503,0.12825278810408922,0.17112384206625805,1.0,5/24,29.74%,PHB2;PHB;ACTN4;TRIM44;DDX3X
gsea,positive regulation of catabolic process (GO:0009896),0.3808208539312794,1.2930807122548924,0.1200750469043152,0.17130390906819243,1.0,13/27,49.68%,DTL;BARD1;DDB1;VCP;FZR1;NEDD4;HUWE1;NSF;AXIN1;ATG7;HACE1;WWP1;HECW1
gsea,cellular response to oxygen-containing compound (GO:1901701),0.2962547649135328,1.2925654422050257,0.08308157099697885,0.171587996980271,1.0,38/137,39.43%,HMGB2;HMGB1;HSP90B1;SHMT1;RUVBL2;IPO5;CDK2;AKT1;VCP;TNFSF4;HTRA2;ACTB;EZR;PRDX3;INSIG1;TAF1;TPM1;GUCY1B1;PDXP;CACTIN;MT3;ROCK2;PLAA;CAMKK2;ERCC6L2;SETX;TESC;MTOR;MTR;CREB1;CDC73;UPF1;ATM;SELENOS;TICAM2;CHUK;MAPK8;CTR9
gsea,carboxylic acid transmembrane transport (GO:1905039),0.4257008017009031,1.2923345340798722,0.16153846153846155,0.17160769988913963,1.0,7/18,35.61%,SLC25A10;SLC7A5;SLC19A1;SLC38A1;SLC7A6;ABCC1;SLC16A1
gsea,negative regulation of cellular metabolic process (GO:0031324),0.45642895283016427,1.2877366314040004,0.14893617021276595,0.1752537448968975,1.0,5/17,23.54%,BRCA1;TRAP1;AATF;MT3;OPTN
gsea,positive regulation of MAPK cascade (GO:0043410),0.31191736770134637,1.2864842679781219,0.08057553956834532,0.1761878509484752,1.0,39/110,60.70%,HMGB1;MIF;EZH2;PHB2;PHB;MYDGF;HRAS;CD74;MID1;MT3;ROCK2;RYK;NPNT;KIT;GSDME;PTPN11;SHC1;ROCK1;PIK3CG;JCAD;PIK3R6;TNFSF11;CX3CL1;DUSP19;TAOK2;SEMA4C;CAV2;TMEM106A;DAB2IP;DHX33;EDN1;OSM;RAMP3;PLCG2;HTR2A;NTRK3;FFAR4;GAS6;CCR7
gsea,embryonic limb morphogenesis (GO:0030326),0.4538189431299846,1.2845037511159136,0.1757679180887372,0.1776352328398207,1.0,8/16,43.39%,HDAC1;HDAC2;PTCH1;AFF3;OSR2;CTNNB1;MAP3K20;TWIST1
gsea,T cell differentiation (GO:0030217),-0.39015108058098674,-1.2834898569865294,0.14135021097046413,0.29588211746124954,1.0,11/21,23.21%,ZFP36L2;ZFP36L1;PIK3CD;SPI1;ANXA1;IL2;MR1;CD4;GATA3;DLL4;LIG4
gsea,regulation of microtubule-based process (GO:0032886),0.4185150827944666,1.2815480360737717,0.15009746588693956,0.18002955577333393,1.0,12/21,49.79%,AURKA;MEMO1;CLASP1;CLASP2;BICD1;BICD2;ROCK1;HDAC6;TRAF3IP1;PRKAA1;DIAPH1;EPHA3
gsea,negative regulation of cell migration (GO:0030336),0.31941543979508374,1.2780612822152289,0.10738255033557047,0.1830200065944074,1.0,27/60,56.67%,MIF;CALR;GTPBP4;CD74;SINHCAF;CORO1C;TPM1;CLIC4;CLASP1;CLASP2;RAP2A;ZMYND8;RHOB;CX3CL1;DUSP22;SRGAP2;BST2;MIA3;RAP2C;ENG;DAB2IP;ARID2;NF2;HYAL2;DUSP3;PTPN23;NF1
gsea,integrin-mediated signaling pathway (GO:0007229),0.36966141548153,1.276862546612811,0.1492776886035313,0.18391318548364186,1.0,8/36,49.91%,NME2;RCC2;CUL3;MYH9;FBLN1;MADCAM1;COL16A1;BCAR1
gsea,establishment of protein localization to membrane (GO:0090150),0.35920885208158726,1.2746145342005542,0.14570858283433133,0.18578652214379776,1.0,13/28,40.71%,ZDHHC2;GORASP2;COX18;ZDHHC6;BID;ZDHHC12;PRKCI;RAB3IP;SYNE3;PIKFYVE;ZDHHC24;ICMT;ZDHHC21
gsea,response to reactive oxygen species (GO:0000302),0.3743746918092021,1.273642765976946,0.15568862275449102,0.18655634128402104,1.0,11/24,41.55%,AKT1;GPX1;PRDX3;TPM1;SOD2;CAMKK2;ERCC6L2;TXNRD2;CHUK;MAPK8;APTX
gsea,defense response to bacterium (GO:0042742),0.36485261321364054,1.2732483019950465,0.16025641025641027,0.1866970739374047,1.0,16/42,57.68%,HMGB2;DROSHA;OPTN;ANKRD17;SHC1;ADAM17;SLC11A1;SPN;LTF;FCER1G;PLA2G6;CTSG;CHGA;PGLYRP1;MAVS;SERPINE1
gsea,regulation of endothelial cell migration (GO:0010594),-0.3235073227890777,-1.2725668099596945,0.11735941320293398,0.3089725918350662,1.0,43/43,94.58%,SP100;ETS1;ZC3H12A;PIK3CD;PRKCA;FOXP1;NRP1;DNAJA4;GLUL;ACVRL1;PTK2B;THBS1;APOE;RIN2;CEACAM1;GATA3;GRN;DLL4;NRP2;PRKD2;FGF2;VEGFA;BCAS3;ANXA3;ABL1;SPARC;ITGB3;PTPRM;NF1;EDN1;DAB2IP;PRCP;FOXC2;BCAR1;PIK3CB;VASH1;RHOB;PIK3CG;SH3BP1;SCARB1;ROCK2;AKT1;CALR
gsea,Golgi to plasma membrane transport (GO:0006893),0.41180922511710727,1.272503246595417,0.1765873015873016,0.18711374909816972,1.0,7/18,38.83%,SPTBN1;OPTN;GOLGA4;EXOC4;GCC2;NSF;GGA2
gsea,regulation of innate immune response (GO:0045088),-0.3407087816520966,-1.2711176254727383,0.14549180327868852,0.30898064533302777,1.0,38/38,98.99%,CCL5;TNFAIP3;SAMHD1;IRF1;USP18;RNASEL;TRAFD1;FCGR2B;IFNAR2;DHX58;ADAM8;FGR;ACOD1;NLRC3;TRIM21;IRAK3;PARP9;PLSCR1;BIRC3;APPL2;GBP5;AKIRIN2;BIRC2;SLC15A4;POLR3F;POLR3B;PTPN11;TKFC;POLR3G;PTPN6;LRP8;POLR3D;CACTIN;ERAP1;ABCE1;DHX9;LYAR;HSP90AB1
gsea,regulation of nitric-oxide synthase activity (GO:0050999),0.38495975415524053,1.2697184753092519,0.14548802946593,0.18940055118795443,1.0,9/20,40.71%,HSP90AA1;DHFR;AKT1;SPR;SCARB1;NUS1;TERF2;DDAH2;ZDHHC21
gsea,clathrin-dependent endocytosis (GO:0072583),0.4422313915418796,1.2688752249712678,0.18216318785578747,0.1899922952919993,1.0,7/15,45.09%,CANX;CLTB;CLTC;DLL1;GAK;AP2B1;AP2A2
gsea,positive regulation of monooxygenase activity (GO:0032770),0.4133090999703857,1.267775732408437,0.14754098360655737,0.19083852500474943,1.0,7/17,35.73%,DHFR;PARK7;AKT1;SCARB1;NUS1;POR;TERF2
gsea,gonad development (GO:0008406),0.48049714386142467,1.2670811766521566,0.16503496503496504,0.19125827523042946,1.0,5/16,34.28%,NUP107;MSH2;BASP1;KIT;UTF1
gsea,positive regulation of JNK cascade (GO:0046330),0.34789270030109304,1.2634936001700685,0.13043478260869565,0.1943814744757485,1.0,11/39,52.98%,HMGB1;HRAS;TRAF2;TRAF3;AXIN1;DUSP22;DUSP19;TAOK2;PJA2;HIPK2;DAB2IP
gsea,regulation of apoptotic signaling pathway (GO:2001233),0.40183537177946904,1.261255568763811,0.16597510373443983,0.19625532606708318,1.0,4/18,23.22%,PPIA;MAZ;PTPMT1;CSNK2A2
gsea,cellular response to ketone (GO:1901655),0.4098117282813,1.261205950328505,0.16310679611650486,0.1960956088093265,1.0,7/18,32.97%,TNFSF4;SPP1;LARP1;PCK2;ROCK2;TRERF1;MAP4K1
gsea,negative regulation of stress-activated MAPK cascade (GO:0032873),0.4152755470106715,1.2582398185079833,0.17038539553752535,0.19877670421120588,1.0,6/16,31.85%,PPIA;FOXM1;EZR;AIDA;MYC;MEN1
gsea,positive regulation of macromolecule metabolic process (GO:0010604),0.27532653386577727,1.256860987509019,0.09270516717325228,0.19981471526444475,1.0,50/164,39.00%,DNMT1;TFRC;BRCA1;PARK7;PHB;E2F1;TRIM28;RPL5;HMGN5;MAZ;FUBP1;AKT1;CD74;CTCF;FAM98B;RDX;EZR;VPS35;ZPR1;PPHLN1;SETDB1;FAM98A;HCFC1;SP1;MT3;ROCK2;FMR1;GABPA;MYC;ANXA2;TNRC6A;TESC;TTN;MTOR;DDX3X;RAB27A;SETDB2;NSF;ACTG1;ATM;TADA3;CELF1;TERF2;SCRIB;OSR2;LEF1;FUBP3;ROCK1;MAPK8;MED1
gsea,stem cell differentiation (GO:0048863),0.41396053176448705,1.2543038162344902,0.18992248062015504,0.20206738177989683,1.0,9/17,43.72%,PSMD11;MTF2;SETD6;EPOP;METTL5;KIT;UFL1;SETD2;BATF
gsea,positive regulation of T cell proliferation (GO:0042102),-0.34638187321278907,-1.2536273790014836,0.15011547344110854,0.33306228479977995,1.0,30/30,99.70%,CCL5;CD274;CD86;CCR2;IL1B;PDCD1LG2;ANXA1;CD40LG;SYK;TNFSF9;AIF1;IL2;IGF1;IL6ST;EBI3;IL12RB1;IL23A;IGFBP2;NCK2;VCAM1;TNFRSF13C;CD80;CCDC88B;CD70;IL21;FADD;SLC7A1;TNFSF4;TFRC;HMGB1
gsea,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.3266533617946167,-1.252541192875586,0.16404494382022472,0.3325648412399016,1.0,41/41,96.14%,LGALS3;TNFAIP3;BCL2L1;BCL2;ICAM1;IL1B;TNF;AR;TNFSF10;ITGA6;THBS1;CSF2;TMBIM1;TCF7L2;PF4;IGF1;GSK3B;HSPA1B;HMOX1;RIPK1;FAS;MAPK7;RELA;SH3RF1;ARHGEF2;HSPA1A;SERPINE1;EYA3;ACVR1;HTT;TNFRSF10B;BIRC6;PHIP;DDX3X;FADD;TRAF2;GPX1;PSME3;AKT1;PARK7;BRCA1
gsea,positive regulation of synaptic transmission (GO:0050806),-0.38427205216202587,-1.2507673472576568,0.17752808988764046,0.3331257553504622,1.0,10/20,14.55%,PRKCZ;CCR2;BAIAP3;TNF;FLOT1;PLK2;PTK2B;APP;CCL2;LGMN
gsea,positive regulation of cell-substrate adhesion (GO:0010811),0.3590028787379123,1.250415554639414,0.16417910447761194,0.20553247084965454,1.0,8/33,35.17%,C1QBP;CALR;P4HB;FLNA;CDK6;ARL2;NPNT;TRIOBP
gsea,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.39028568807853836,-1.249880720712636,0.1623134328358209,0.3323669149277546,1.0,10/20,26.11%,ATF3;CEBPB;HIF1A;DDIT3;CREB3L1;NOTCH1;NFE2L2;MUC1;KLF2;ATF4
gsea,defense response to virus (GO:0051607),-0.29910537097109496,-1.2494827249132674,0.15551181102362205,0.3310199926269728,1.0,70/70,97.86%,STAT1;SAMHD1;IRF1;ISG15;IFITM1;IRF7;ISG20;RTP4;IFITM2;ZBP1;LYST;BCL2L1;IFITM3;BCL2;IRF2;IFIT1;IFI27;RSAD2;DDX58;RNASEL;IFIT3;CD40;RNASE6;STAT2;MAP3K14;IFNAR2;OAS3;TLR2;F2RL1;TRIM56;TRIM5;ACOD1;TLR7;PMAIP1;PLSCR1;CXCL10;RELA;EIF2AK2;BNIP3;IFIT2;MAVS;MOV10;IFIH1;RIPK3;PRF1;BST2;AGBL5;SHFL;ATG7;SERINC3;SETD2;IL21;TTC4;AKAP1;NCBP3;MLKL;FADD;FLNA;EXOSC4;SKP2;EXOSC5;NDUFAF4;CLPB;CGAS;ATAD3A;DDIT4;ABCE1;PHB;PHB2;G3BP1
gsea,response to lipopolysaccharide (GO:0032496),-0.3001474681466877,-1.2488169939807066,0.14030612244897958,0.3300932118073116,1.0,76/76,99.99%,TNFAIP3;GCH1;CD274;ZFP36;CD86;CCR5;ZC3H12A;TNIP3;CX3CR1;PDCD4;NFKB1;PDE4B;CD68;IL1B;F2R;MAPKAPK3;FOXP1;PDCD1LG2;SIRPA;SBNO2;CD180;CXCL9;NLRP3;ERBIN;CXCL2;CCL2;CASP1;SLPI;ACOD1;PF4;JAK2;CD14;IRAK3;TRIB1;NR1H3;NOS2;AXL;TLR4;IL10;ADAM9;CXCL10;CXCL13;TRIM41;SELP;TNIP2;RELA;VIM;SERPINE1;GFI1;RPS6KA3;MEF2C;DAB2IP;XBP1;CTSG;CD80;NOS1;NOCT;NFKBIB;SLC11A1;CTR9;MAPK8;TICAM2;ADAM17;MAPKAPK2;SELENOS;UPF1;CDC73;SCARB1;PLAA;LIAS;CACTIN;PRDX3;TNFSF4;HNRNPA0;HMGB1;HMGB2
gsea,regulated exocytosis (GO:0045055),0.32213812694558414,1.2483783953945737,0.11470588235294117,0.2073009490932836,1.0,19/70,33.25%,TAGLN2;MANF;TUBA4A;FAM3C;ACTN4;PCYOX1L;VEGFB;OLA1;FLNA;ALDOA;SCCPDH;SYNGR2;TTN;CYB5R1;NHLRC2;SYNGR1;PPP3CB;CHID1;MYH9
gsea,regulation of interleukin-6 production (GO:0032675),0.3344491212310455,1.246835587666449,0.1625615763546798,0.20864947930498406,1.0,22/58,60.18%,HMGB1;HSPD1;DHX9;TNFSF4;CD74;PTPN6;SELENOS;PTPN11;MAPKAPK2;POU2AF1;TWIST1;CX3CL1;IL33;GHSR;XBP1;TMEM106A;IFIH1;HYAL2;MAVS;CD200;PLCG2;GAS6
gsea,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.4328316966129124,1.2454160736830673,0.18459069020866772,0.2098082463971452,1.0,4/18,40.21%,PIN1;TTK;SNX25;ACVR1
gsea,morphogenesis of an epithelium (GO:0002009),0.44236759894927946,1.2442112083398633,0.19576719576719576,0.21073598418388023,1.0,2/15,13.69%,TIMELESS;ACTB
gsea,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.4204487943685965,1.241896487469406,0.1977491961414791,0.21273381573356853,1.0,6/21,38.86%,NUP62;AKT1;CNOT9;ADAM17;AREG;CBL
gsea,regulation of postsynapse organization (GO:0099175),0.4440204688476136,1.2380786921720615,0.1936,0.2164413063441564,1.0,2/15,18.68%,CFL1;VPS35
gsea,vascular transport (GO:0010232),0.3369718071389274,1.2349402923546635,0.16994633273703041,0.21936646523447928,1.0,19/40,46.18%,TFRC;SLC29A1;SLC7A5;SLC7A1;SLC19A1;SLC38A1;SLC1A4;ABCC1;ABCG2;SLC2A1;SLC12A2;SLC7A3;SLC16A1;SLC4A8;MFSD2A;SLC6A9;ABCC4;SLC1A5;SLC6A13
gsea,regulation of interleukin-17 production (GO:0032660),0.41489310807978785,1.2342152363952499,0.1956124314442413,0.21988329828771244,1.0,6/18,37.74%,PHB;SLC7A5;TNFSF4;IL21;LY9;SLAMF6
gsea,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.4236221143276138,-1.2311486413146027,0.19373776908023482,0.3547846180315153,1.0,5/15,11.12%,HIF1A;RUNX2;NOTCH1;NFE2L2;EP300
gsea,ameboidal-type cell migration (GO:0001667),0.3880661085332593,1.2282500205975009,0.19489981785063754,0.22564207665042837,1.0,10/21,49.98%,AKT1;CENPV;CORO1C;NANOS1;PDLIM1;SRGAP2;AMOTL1;SEMA4C;PDXDC1;PHACTR4
gsea,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.36617280111153383,-1.2240138013276907,0.17464788732394365,0.3637849667506936,1.0,14/22,23.79%,SAMHD1;ISG15;PADI2;USP18;PARP14;STAT2;IL1RN;OAS3;F2RL1;SIGIRR;IRAK3;SH2B3;NR1H3;PPARG
gsea,regulation of tumor necrosis factor production (GO:0032680),-0.29283433333266246,-1.2215709192881326,0.1815856777493606,0.3654059758444206,1.0,65/65,99.70%,TNFAIP3;VSIR;ZFP36;ZC3H12A;CX3CR1;RARA;SLAMF1;TYROBP;CCR2;FOXP1;DDX58;STAT3;IFNG;PTPRJ;SIRPA;SYK;THBS1;APP;OAS3;TLR2;HAVCR2;SYT11;C1QTNF4;LPL;PF4;NLRC3;JAK2;CD14;IRAK3;SPHK2;CCL3;IGF1;TLR4;HSPB1;IL10;RIPK1;RASGRP1;MC1R;ARHGEF2;IL23A;ARFGEF2;CD33;CIDEA;GAS6;PLCG2;MAVS;IFIH1;FRMD8;TMEM106A;GHSR;IL33;LTF;SPN;CX3CL1;TWIST1;MAPKAPK2;PTPN11;SELENOS;DICER1;PTPN6;FADD;CACTIN;DHX9;MIF;HMGB1
gsea,heart morphogenesis (GO:0003007),-0.4112861688622259,-1.221304656727937,0.18766066838046272,0.3636529225955638,1.0,8/15,23.30%,OLFM1;TGFBR3;ACVRL1;NOTCH1;ALPK2;DLC1;TGFB2;ZFPM1
gsea,TOR signaling (GO:0031929),0.3957450240617471,1.2209010586534497,0.20985010706638116,0.23310040597560264,1.0,7/18,34.30%,RPS6;AKT1;LARP1;PRR5;RHEBL1;MTOR;TIPRL
gsea,regulation of ERK1 and ERK2 cascade (GO:0070372),0.2983204262538122,1.220462349269103,0.13657056145675264,0.23332574053045083,1.0,28/97,60.70%,HMGB1;MIF;PHB2;PHB;PIN1;FAM83D;HRAS;CD74;EZR;APIP;MT3;PTPN6;NPNT;PTPN11;SHC1;FBLN1;DUSP6;CX3CL1;SPRED1;SPRED2;DAB2IP;DUSP3;RAMP3;HTR2A;NTRK3;FFAR4;GAS6;CCR7
gsea,regulation of insulin receptor signaling pathway (GO:0046626),0.3853237537699452,1.218654228472974,0.21755725190839695,0.23491890877258045,1.0,9/20,56.62%,NUCKS1;SNX5;PTPN11;GKAP1;PRKCB;TSC2;GRB10;GRB7;ENPP1
gsea,endosome organization (GO:0007032),0.3697769409273896,1.2168326298318537,0.20233463035019456,0.23666287285240034,1.0,11/24,46.17%,CORO1C;EEA1;HOOK1;PI4K2B;RAB27A;TMEM9;HOOK2;DNAJC13;SNX10;USP8;VPS33B
gsea,ERBB signaling pathway (GO:0038127),0.33764558042695497,1.2148361786197721,0.1834862385321101,0.238598600208309,1.0,20/34,55.35%,HSP90AA1;STUB1;AKT1;CUL5;RPS6KA5;PTPN11;SHC1;ADAM17;AREG;CBL;CPNE3;KIF16B;PDPK1;VIL1;MVP;BCAR1;TGFA;GRB7;PTPN12;NCK2
gsea,positive regulation of ossification (GO:0045778),-0.39835691624024205,-1.2125916424987468,0.2204724409448819,0.37539339611215516,1.0,16/16,64.82%,ISG15;GPM6B;SLC8A1;CCN1;TGFB2;BMP7;TGFB3;ALOX5;ANO6;WNT4;MEF2C;TMEM119;ZBTB16;ACVR1;OSR2;PTPN11
gsea,proteolysis involved in cellular protein catabolic process (GO:0051603),0.318601107335581,1.212361592416457,0.17281553398058253,0.24103144593800838,1.0,17/39,40.25%,PRPF19;PSMA6;STUB1;DDB1;VCP;LONP1;CLPP;RPS27A;GZMB;CTSZ;CUL4B;YME1L1;CLPX;USP9X;MDM2;HDAC6;OMA1
gsea,regulation of B cell proliferation (GO:0030888),0.3517043276301324,1.2112164022910625,0.18199233716475097,0.24201983828707957,1.0,9/31,43.16%,MIF;TFRC;CD74;TNFRSF4;CD320;ATM;IL21;BST1;TNFRSF21
gsea,protein localization to lysosome (GO:0061462),0.4114202201427384,1.21034727787982,0.21330724070450097,0.24269354562336803,1.0,4/15,29.05%,M6PR;NEDD4;AP3M1;GCC2
gsea,negative regulation of metabolic process (GO:0009892),-0.3673220173403346,-1.2082122267297146,0.2013888888888889,0.38036285685455085,1.0,11/22,26.11%,IL1B;DDIT3;IL18R1;NOTCH1;ARRDC3;MAP2K6;TLE3;NR1H3;TLR4;ARNTL;ATF4
gsea,glycolipid biosynthetic process (GO:0009247),0.38693587250101025,1.2079789791013187,0.2070393374741201,0.24492926945721366,1.0,8/18,44.56%,PIGF;SCCPDH;PIGU;PIGQ;PIGA;PIGH;PIGB;ST3GAL5
gsea,hexose metabolic process (GO:0019318),0.39645389830628697,1.2073522913659966,0.23270440251572327,0.24535876120187955,1.0,10/18,44.65%,GALK1;PMM1;ALDOA;ADPGK;PGM1;FUOM;HK1;OMA1;SLC37A4;CHST15
gsea,regulation of cell adhesion (GO:0030155),-0.3011061409477342,-1.2072969889071354,0.18064516129032257,0.37968041241821343,1.0,60/60,98.42%,CCL5;DUSP1;RIPOR2;TNFRSF18;CXCR3;CYTH1;TNF;PRKCA;TGFBI;ADGRG1;TGM2;MYADM;PTPRJ;FES;PRSS2;LYN;ACVRL1;PTK2B;ADAM8;RASA1;FUT7;RET;PLXNB2;C2CD4A;MINK1;PRKD2;CXCR4;VEGFA;ABL1;PLAU;PDE3B;LPXN;C2CD4B;TFE3;PLXNC1;CCR7;ATXN3;PLXNA1;RSU1;MIA3;SPN;PIK3CG;FBLN1;ROCK1;DLL1;PTPN11;ATM;PLXND1;TESC;PPP1CB;ROCK2;ARHGDIG;DSCAM;TPM1;PKP4;ZDHHC2;P4HB;ARHGDIA;KIF14;C1QBP
gsea,regulation of neuron projection development (GO:0010975),0.29928245119613817,1.2069610773548967,0.16548042704626334,0.2455462235292966,1.0,18/62,43.51%,FKBP4;CFL1;HDAC2;AKT1;MT3;MBOAT1;SETX;RTN4IP1;RUFY3;ABI2;BAG5;ARSB;PRKCI;MFSD2A;PAQR3;GAK;ARHGAP35;CX3CL1
gsea,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.3224247785035026,-1.2054029667518718,0.18382352941176472,0.38061874757576575,1.0,33/33,96.16%,CCL5;RGS16;MGRN1;USP20;PPP1R9B;RIC8B;TULP3;C3;GRK5;PLEK;RNF157;SYP;GNG4;CRY1;RAMP3;PDE6A;GNAT1;EDN1;SAG;USP33;RGS2;RPGRIP1L;KCTD8;SLC39A14;RGS12;ROCK1;NMT2;FNTB;METAP1;ROCK2;NMT1;PHB;METAP2
gsea,positive regulation of mRNA catabolic process (GO:0061014),-0.3618136755437859,-1.199615578367889,0.19322709163346613,0.38768264427722743,1.0,27/27,88.58%,BTG2;ZFP36;ZFP36L2;ZFP36L1;ZC3H12A;TOB1;PRR5L;NANOS3;EIF4ENIF1;MOV10;RIDA;AGO2;METTL3;GIGYF2;PABPC1;NANOS1;FTO;ROCK1;CELF1;UPF1;METTL14;TNRC6A;CNOT1;ROCK2;PNPT1;METTL16;KHSRP
gsea,natural killer cell activation (GO:0030101),0.4115443559431393,1.1992585745938475,0.22093023255813954,0.2536897140406745,1.0,5/15,37.51%,PRDX1;ULBP1;KAT7;RABL3;SNX27
gsea,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.3090077750787022,1.1979357540824196,0.18197573656845753,0.2549500620360725,1.0,19/46,52.58%,HSP90AB1;PIN1;STUB1;STRAP;RPS27A;GIPC1;PRDM16;MEN1;SNX25;ADAM17;TRIM33;EID2;MTMR4;PDPK1;SPRED1;SPRED2;BAMBI;HIPK2;ENG
gsea,post-Golgi vesicle-mediated transport (GO:0006892),0.32289006383225816,1.196899140311398,0.20281124497991967,0.25582816318700446,1.0,13/36,44.62%,HSPA8;AP1M1;MYO5A;TXNDC5;AP1G2;EXOC4;CLTC;RP2;EPS15;CORO7;VAMP8;KIF16B;KLHL20
gsea,cellular response to virus (GO:0098586),0.3793498018882254,1.1967270369903602,0.21611001964636542,0.2557363756299281,1.0,10/19,39.80%,EIF5A;HSP90AA1;BAX;RRP1B;FMR1;DDX3X;GSDME;IL21;CHUK;POU2AF1
gsea,positive regulation of organelle organization (GO:0010638),0.3928292020205968,1.1962642212534522,0.24947145877378435,0.2560208100311008,1.0,5/17,33.83%,LMAN1;HTRA2;LNPK;ANXA2;C2CD5
gsea,regulation of keratinocyte differentiation (GO:0045616),0.40330984697274813,1.1945545622204663,0.24074074074074073,0.2576684659552574,1.0,5/16,23.53%,NME2;SRSF6;ETV4;NUMA1;ROCK2
gsea,response to molecule of bacterial origin (GO:0002237),0.36577694906101177,1.193822404328449,0.22937293729372937,0.2581840496723697,1.0,9/30,46.36%,HMGB2;HNRNPA0;PRDX3;LIAS;MAPKAPK2;ADAM17;SLC11A1;NOCT;NOS1
gsea,negative regulation of cold-induced thermogenesis (GO:0120163),-0.3672771672771673,-1.193229722324917,0.22297297297297297,0.39589325767066164,1.0,21/21,63.38%,DDIT3;IL18R1;NOTCH1;ARRDC3;MAP2K6;TLE3;NR1H3;TLR4;ARNTL;ATF4;TFE3;PLCL1;ID1;WNT10B;CIDEA;PCTP;ABHD6;DOCK7;FOXC2;RB1;ADAM17
gsea,response to amino acid starvation (GO:1990928),0.3257947090999308,1.192140713252221,0.1950286806883365,0.2597504105153814,1.0,17/36,48.72%,EIF2S1;DAPL1;CDKN1A;LARP1;GCN1;SEH1L;MTOR;ITFG2;DEPDC5;MAPK8;DAP;TCIRG1;NPRL3;EIF2AK4;MIOS;MLST8;WDR24
gsea,positive regulation of TOR signaling (GO:0032008),0.4090284031311843,1.1893203077668448,0.2196969696969697,0.26272292275569353,1.0,3/16,23.68%,PIH1D1;TELO2;SEH1L
gsea,regulation of phagocytosis (GO:0050764),0.3791656070728203,1.188812042483971,0.2551369863013699,0.26308635335666647,1.0,9/28,46.11%,LYAR;CALR;RACK1;LMAN2;SCARB1;RAB27A;SLC11A1;IL15RA;FCER1G
gsea,regulation of fat cell differentiation (GO:0045598),-0.3150584438280986,-1.1874673587691298,0.19654427645788336,0.40333088539633977,1.0,38/38,95.10%,ZFP36;ZFP36L2;ZFP36L1;CEBPB;ZC3H12A;FOXO1;TNF;SMAD3;RORA;WNT1;LPL;WWTR1;GATA3;SIRT1;ID2;ZFPM1;PPARG;TMEM64;TRIB2;ARNTL;YAP1;ALOX5;WNT10B;ENPP1;WDFY2;XBP1;ZADH2;TRIB3;NOCT;ZBTB16;FTO;FRZB;CREB1;ASXL1;CARM1;ANKRD26;AKT1;E2F1
gsea,organic acid transport (GO:0015849),0.32591226162465936,1.1874303171493357,0.2247787610619469,0.2643842844299982,1.0,19/38,46.18%,GOT2;SLC25A10;SLC7A1;SLC19A1;SLC38A1;SLC7A6;SLC1A4;ABCG2;SLC25A17;SLC7A3;SLC16A1;SLC25A32;ACSL1;MFSD2A;SLC6A12;ABCC4;SLC16A10;SLC1A5;SLC6A13
gsea,acylglycerol metabolic process (GO:0006639),-0.3922879778161906,-1.1853491216388197,0.2290249433106576,0.4046263872078633,1.0,9/15,25.31%,DGKA;DGAT1;DGKH;APOBR;APOE;LPL;DGKD;DGKG;LMF1
gsea,neuron differentiation (GO:0030182),0.33244856311381843,1.182763615678849,0.1829105473965287,0.26958972803241216,1.0,23/54,50.40%,MANF;PIN1;CASP3;DDIT4;TDP2;EPOP;MYEF2;RYK;ACSL3;SRF;THOC2;RUNX3;PBX4;ERCC3;CTNNB1;WNT10A;ADNP2;NIF3L1;ACSL4;PBX3;PBX2;ERCC2;XBP1
gsea,lysosome organization (GO:0007040),0.36013552558810047,1.1813056148829397,0.24807692307692308,0.2708917052877034,1.0,11/21,50.69%,CORO1A;HOOK1;MTOR;HOOK2;CLN6;ARSB;GNPTAB;NAGPA;ZKSCAN3;VPS33A;TFEB
gsea,cell junction organization (GO:0034330),0.36552537420492126,1.1792010669435498,0.2314647377938517,0.27305974230391294,1.0,12/24,47.66%,PIN1;ACTB;FLNA;SH3BP1;TJP2;ACTG1;PPFIA1;PRKCI;RAB39B;MARVELD2;PPFIBP1;NLGN2
gsea,epidermal cell differentiation (GO:0009913),0.3952425711291824,1.1791019426736473,0.25735294117647056,0.2728997556828727,1.0,9/18,40.56%,HDAC1;HDAC2;CASP3;CLIC4;ST14;MED1;ERCC3;CTNNB1;KRT10
gsea,actin filament organization (GO:0007015),0.29250675502821427,1.1785696937230548,0.20411392405063292,0.27323216074626855,1.0,41/81,50.99%,TPM3;NEBL;TPM4;LCP1;CORO1C;MYO5A;TPM1;FLII;FLNA;ALDOA;CORO1A;MARCKSL1;GAS2L3;ZBED3;SH3BP1;GAS2;MPRIP;TTN;ERMN;CARMIL2;CD2AP;ELMO1;SPIRE1;RUFY3;TRIOBP;ACTN1;ABI2;NEB;DSTN;CORO7;MYO1G;SVIL;RHOB;LMOD3;PLS3;INPPL1;VIL1;SCIN;BCAR1;GHSR;ELMO2
gsea,positive regulation of fat cell differentiation (GO:0045600),-0.35160088699169867,-1.1778810420806063,0.22660098522167488,0.41491111522279006,1.0,23/23,98.45%,PIM1;ZFP36;ZFP36L1;CEBPB;ZC3H12A;PTGS2;LPL;METRNL;VSTM2A;ID2;PPARG;TMEM64;BMP7;TFE3;WDFY2;XBP1;NOCT;ZBTB16;FRZB;CREB1;CARM1;AKT1;HNRNPU
gsea,cation transmembrane transport (GO:0098655),0.40532821770814814,1.17784702814392,0.25321100917431194,0.2738183795166633,1.0,7/15,40.06%,SFXN1;SLC7A5;SLC7A1;SLC25A19;SFXN2;SLC7A3;SLC6A9
gsea,negative regulation of defense response (GO:0031348),0.34009569985770066,1.1771927518179657,0.2254160363086233,0.27433122072198607,1.0,12/38,55.75%,C1QBP;LYAR;VPS35;CACTIN;MVK;SELENOS;RB1;TRAF3IP1;AOAH;GHSR;FEM1A;IL13
gsea,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.4024362497634298,-1.1770873427324362,0.24036281179138322,0.4139703650542495,1.0,7/15,25.23%,TNFAIP3;PDCD4;IFNG;AIF1;TRIB1;PPARG;IL10
gsea,cellular response to interleukin-6 (GO:0071354),-0.3897286829976307,-1.1770843843687615,0.24843423799582465,0.4117033681822029,1.0,9/16,24.93%,STAT1;NFKB1;SPI1;STAT3;SBNO2;PID1;ST3GAL6;JAK2;IL6ST
gsea,Rho protein signal transduction (GO:0007266),0.37354825319593565,1.175920889843918,0.23380726698262244,0.27554579397116774,1.0,4/24,23.53%,CFL1;ARHGDIA;ARHGDIG;ROCK2
gsea,organonitrogen compound catabolic process (GO:1901565),0.33666949531463486,1.1754060096644179,0.23941068139963168,0.27585987015539987,1.0,19/29,52.66%,UCHL3;BCKDK;ERAP1;TXN2;MTOR;CLPX;ADO;CLN6;NPEPPS;ENPP2;CTH;PLA2G6;GGACT;RIDA;PDXDC1;NPL;NAGK;GNPDA1;TRIM24
gsea,positive regulation of cell junction assembly (GO:1901890),-0.40364215322679364,-1.1706249217899085,0.2649402390438247,0.4200477407778141,1.0,15/15,75.28%,S100A10;FLOT1;NRP1;PTPRJ;DLG5;CLSTN1;VEGFA;TSC1;ABL1;NLGN2;PPM1F;COL16A1;MAP4K4;ROCK1;BHLHB9
gsea,positive regulation of MAP kinase activity (GO:0043406),0.3432476143277764,1.169506549560131,0.24867724867724866,0.28282401276358204,1.0,13/31,54.50%,EZH2;HRAS;TRAF2;KIT;MAP3K4;PIK3CG;PIK3R6;TNFSF11;DVL2;DUSP19;MAP3K7;DAB2IP;EDN1
gsea,positive regulation of angiogenesis (GO:0045766),-0.28449211093669935,-1.1686571864513586,0.18005540166204986,0.42098021386509277,1.0,60/60,96.14%,ITGAX;ETS1;ZC3H12A;PIK3CD;PLCG1;IL1B;PRKCA;HIF1A;RUNX1;CTSH;S100A1;NINJ1;FLT1;CD40;THBS1;ITGA5;ECM1;PGF;TNFSF12;ITGB1;CCR3;GRN;SIRT1;TJP1;JUP;HSPB1;PRKD2;FGF2;ITGB8;VEGFA;SPHK1;ANXA3;HMOX1;HIPK1;KLF4;VASH2;SERPINE1;F3;PAK4;HIPK2;SIRT6;XBP1;SMAD1;FOXC2;RAMP2;PRKCB;PDPK1;AGO2;TWIST1;RHOB;PIK3R6;DLL1;ANGPTL4;HK2;SP1;VEGFB;MTDH;MYDGF;PKM;BRCA1
gsea,positive regulation of T cell differentiation (GO:0045582),-0.3811990765411569,-1.168104753730763,0.26459143968871596,0.41967966351322084,1.0,10/18,22.58%,VSIR;SOCS1;DUSP10;ZBTB1;IL4I1;TNFSF9;ADAM8;BCL6;GATA3;ZMIZ1
gsea,cell-substrate junction assembly (GO:0007044),0.37638642228385283,1.1670648966314807,0.27079303675048355,0.2855531786468062,1.0,8/19,67.01%,RCC2;ACTN1;TAOK2;BCR;SORBS1;CTTN;ITGB4;COL17A1
gsea,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.32379308197166595,-1.1650438230435347,0.23076923076923078,0.4227188429161748,1.0,32/32,95.87%,LGALS3;SP100;TNF;AR;TMC8;TNFSF10;ITGA6;THBS1;MADD;TCF7L2;TNFSF12;LTBR;IGF1;TRAF1;RIPK1;FAS;RELA;SH3RF1;PML;HYAL2;ACVR1;HTT;FEM1B;TNFRSF10B;WWOX;BIRC6;PHIP;BID;FADD;TRAF2;PSME3;PARK7
gsea,phosphatidylinositol-mediated signaling (GO:0048015),0.3524713043413277,1.1648998592166302,0.25380710659898476,0.2878889064884655,1.0,13/30,60.53%,C1QBP;AKT1;EZR;PIK3CG;PI4KA;PIK3CB;EDN1;PIK3R2;PLCH1;NF1;PLEKHA1;HTR2A;CD160
gsea,protein localization to membrane (GO:0072657),0.2671483268397223,1.164688865110631,0.21305841924398625,0.2878507705073039,1.0,30/90,41.76%,NDC1;TMED2;ZDHHC2;NUP155;BSG;NUP54;RDX;EZR;MYO5A;SPTBN1;FLNA;PDZD11;ROCK2;PTCH1;BID;CLASP2;TESC;EHD4;FGF13;SAV1;AP3D1;C2CD5;RAP2A;NKD2;SCRIB;TM9SF4;ROCK1;SYNE3;GAK;MADCAM1
gsea,response to lipid (GO:0033993),0.31339895230713466,1.1636311793707215,0.24149108589951376,0.2887867505364342,1.0,15/46,48.93%,HMGB2;HNRNPA0;SPP1;PRDX3;PCK2;LIAS;ASXL1;CDKN2D;MAPKAPK2;ADAM17;CTNNB1;SLC11A1;NOCT;NOS1;ALPL
gsea,positive regulation of ATP metabolic process (GO:1903580),-0.3645607487002859,-1.1635998798655631,0.2374429223744292,0.422790021340258,1.0,18/18,96.52%,TMSB4X;PINK1;HIF1A;IFNG;PID1;NUPR1;APP;ZBTB20;IGF1;BEND3;SLC4A4;PFKFB3;ARNT;PRKAA1;PFKFB1;ENTPD5;VCP;ENO1
gsea,autophagosome organization (GO:1905037),0.3850151225590787,1.1632051404309662,0.26147704590818366,0.28901867028005346,1.0,7/15,43.66%,ATP2A2;NSFL1C;UBQLN1;ATG9B;RAB23;UBXN2B;ATG7
gsea,axonal transport (GO:0098930),0.37693936617243246,1.1631538029677677,0.273224043715847,0.2888048720851605,1.0,8/20,39.23%,DYNC1H1;DCTN1;BLOC1S2;AP3S1;OPA1;AP3M1;AP3D1;AP3B1
gsea,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.3066831491099684,1.1588727714334501,0.22486288848263253,0.29372491200869916,1.0,15/41,46.01%,ANLN;PFN1;HRAS;CCP110;FAM98A;FMR1;RALA;ACTR2;CARMIL2;KCTD17;ABI2;DOCK11;HTT;ARHGAP35;CYFIP1
gsea,stress-activated MAPK cascade (GO:0051403),-0.32716790465087253,-1.1585939292757572,0.22983870967741934,0.4290468815931375,1.0,30/30,90.52%,UBB;ZFP36;ZFP36L1;NFKB1;PTGER4;SH2D3C;MAPK13;TRIB1;MINK1;MAP3K11;MAP3K13;TNIP2;BTRC;MAP3K8;ADORA2B;MAP3K5;IKBKG;TAB3;MAP3K7;TAOK2;MAP3K20;RIPK2;MAPK8;TAB1;CHUK;MAP2K3;CUL1;RPS27A;GPS1;UBE2N
gsea,regulation of protein autophosphorylation (GO:0031952),0.3646918453173285,1.156430948078973,0.3008130081300813,0.29641623111139587,1.0,6/19,34.42%,RAD50;NBN;CALM2;PPP2R5D;DDX3X;RAP2A
gsea,regulation of bone mineralization (GO:0030500),-0.342659439675591,-1.155977156142157,0.2494331065759637,0.4313665734116939,1.0,11/23,25.62%,ISG15;GPM6B;S1PR1;PTK2B;ECM1;SLC8A1;CCN1;CCL3;TXLNG;CCR1;BCOR
gsea,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.3084616485382378,-1.15505721252159,0.23410404624277456,0.4306760740068993,1.0,36/36,87.71%,JAML;ICAM1;CRTAM;L1CAM;ALCAM;CDH1;PVR;ITGAM;EMB;CEACAM1;FLRT3;DSG2;ITGB1;PTPRS;PLXNB2;TGFB2;SELP;MPZL2;MILR1;NECTIN2;NECTIN4;CDH17;MMP24;PTPRM;CADM1;CLDN10;VCAM1;PECAM1;PALLD;CDH23;NEXN;ADGRL1;ACVR1;SELL;DSCAM;BSG
gsea,regulation of GTPase activity (GO:0043087),0.2607917133598414,1.1548815406725574,0.20279720279720279,0.2980102416723071,1.0,34/104,50.86%,EZH2;RCC2;ECT2;PIN1;ARHGAP11A;TMED2;HRAS;RACK1;RRP1B;RDX;PKP4;NET1;TBC1D7;TBC1D10B;SH3BP1;ADAP1;ARL2;SGSM3;PLXND1;DOCK11;MAP4K4;DOCK9;ADRB1;CX3CL1;DOCK8;ARFGEF1;VAV2;SRGAP2;RAP1GDS1;GPSM1;CAV2;RSU1;EPHA3;PLXNA1
gsea,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.3831771304886639,-1.1542662216421873,0.2839756592292089,0.42976932347234276,1.0,8/17,24.76%,UBB;IRF7;CD40;CD300LF;IKBKE;CD14;BIRC3;TLR4
gsea,regulation of response to biotic stimulus (GO:0002831),-0.3628031076188829,-1.1532524179640928,0.24550898203592814,0.42920429928624126,1.0,19/19,81.57%,SAMHD1;IRF1;FOXP1;FCGR2B;DHX58;FGR;TRIM5;CD36;BIRC3;APPL2;ELMOD2;BIRC2;CX3CL1;TRAF3;TKFC;CD55;LRP8;ZMPSTE24;ERAP1
gsea,regulation of sprouting angiogenesis (GO:1903670),0.3847840527125731,1.152459475056745,0.29009009009009007,0.30074206196442976,1.0,2/20,15.13%,PKM;E2F2
gsea,regulation of protein secretion (GO:0050708),-0.27614732509172335,-1.1518715370811372,0.22929936305732485,0.42933954275628233,1.0,58/58,99.74%,CCL5;ITPR2;IL1B;TNF;PRKCA;ABCG1;RSAD2;GLP1R;IFNG;ADAM8;ATP13A2;APOE;FRMD4A;DISP1;CACNA2D2;SYT7;IGF1;TGFB2;NOS2;CLOCK;ADAM9;ARNTL;MYOM1;MYO18A;KCNG2;P3H1;PICK1;ITPR3;TGFB3;ALOX5;DRD4;ADRA2A;RAPGEF4;CD33;APBB3;ACHE;SYTL4;UNC13B;STXBP5;LLGL1;RHBDF1;ITPR1;MYH10;APBB1;RHBDF2;CACNA1A;EXPH5;DPP4;SLC12A2;SLC2A1;PPP3CB;CD2AP;TTN;HADH;EZR;HMGCR;PPID;PPIA
gsea,regulation of viral entry into host cell (GO:0046596),0.39089972638351056,1.1470326360834986,0.2865853658536585,0.30716580698132695,1.0,5/16,39.95%,LY6E;P4HB;CD74;LGALS1;MID2
gsea,phosphatidylcholine biosynthetic process (GO:0006656),0.40797930587381315,1.1458824779069798,0.3046875,0.3083034787950132,1.0,6/15,38.81%,LPCAT1;STARD7;CSNK2A2;PCYT1A;GPAT4;MFSD2A
gsea,positive regulation of p38MAPK cascade (GO:1900745),-0.37263137039901284,-1.1396344929910807,0.2678185745140389,0.4482560066357826,1.0,16/16,97.82%,GADD45B;ZC3H12A;IL1B;SPI1;RELL1;GADD45A;NCF1;MINK1;GADD45G;VEGFA;SPHK1;MFHAS1;PJA2;XDH;MAP3K4;PRMT1
gsea,"phagocytosis, engulfment (GO:0006911)",-0.417014447234964,-1.139534421332168,0.29941860465116277,0.44612908045978283,1.0,10/15,17.54%,GSN;ARHGAP25;FCGR2B;THBS1;AIF1;CD36;ITGAM;MSR1;ARHGAP12;DOCK1
gsea,sensory organ development (GO:0007423),0.36761412900986984,1.1395099543240035,0.2958199356913183,0.3159985749975869,1.0,11/23,52.22%,SMCHD1;ZDHHC16;PBX4;AHI1;WNT10A;SCO2;SMOC1;PBX3;PBX2;SMG9;HIPK2
gsea,regulation of chemokine production (GO:0032642),-0.36286425681014284,-1.139336362491112,0.27074235807860264,0.4442346128684993,1.0,13/21,15.71%,EGR1;TNF;HIF1A;FOXP1;IFNG;APP;CSF1R;AIF1;TLR2;F2RL1;LPL;TLR7;SIGIRR
gsea,negative regulation of response to external stimulus (GO:0032102),0.3100644059640584,1.1390997828518161,0.2594268476621418,0.3162375918358399,1.0,18/47,62.92%,C1QBP;LYAR;VPS35;CACTIN;MVK;SELENOS;RB1;TRAF3IP1;LTF;AOAH;GHSR;FEM1A;IL13;DUSP3;SERPINE1;FFAR4;KLF4;SMPDL3B
gsea,regulation of Wnt signaling pathway (GO:0030111),-0.28709674859001305,-1.138928995115921,0.2403846153846154,0.4426972049812784,1.0,45/45,89.95%,TNFAIP3;NFATC1;TAX1BP3;MDFIC;RUNX1;FAM53B;SULF2;FOXP3;NLK;HHEX;WLS;APP;SKI;LRP1;TLR2;TLE1;MACF1;LGR6;SHISA2;FZD7;LRRK2;BTRC;ITGA3;HIC1;CTNND2;TSKU;SOX30;SFRP4;GRB10;CDK14;TSC2;TIAM1;AXIN1;CTNNB1;FRZB;NKD2;CDC73;WWOX;NXN;CBY1;HMGXB4;TMEM237;RACK1;SMARCA4;DEPDC1B
gsea,positive regulation of phospholipase C activity (GO:0010863),0.4039953372574444,1.1378201353162545,0.3027950310559006,0.31753773161151483,1.0,4/17,34.20%,PHB2;PHB;HRAS;KIT
gsea,positive regulation of neuron apoptotic process (GO:0043525),-0.38248335081679175,-1.1360183073075476,0.2925170068027211,0.4455356185488529,1.0,11/15,26.11%,TYROBP;TNF;DDIT3;FOXO3;NUPR1;ITGAM;GRN;CCL3;TGFB2;FBXW7;ATF4
gsea,negative regulation of blood vessel morphogenesis (GO:2000181),-0.30639029998583095,-1.1334853419405353,0.26536312849162014,0.447775818944205,1.0,35/35,95.02%,STAT1;ATP2B4;CCR2;GTF2I;HHEX;THBS1;ATF2;FOXJ2;PF4;SPRY2;FOXO4;TGFB2;PPARG;RGCC;CXCL10;STAB1;PDE3B;AGO1;SPARC;HGS;ALOX5;AMOT;PTPRM;WNT4;KLF4;CD160;PML;DAB2IP;SPRED1;VASH1;SERPINF1;CTNNB1;ROCK1;ROCK2;PGK1
gsea,carboxylic acid transport (GO:0046942),0.33096151864781664,1.1315165612072131,0.26422018348623855,0.32522280862977915,1.0,14/26,46.18%,SLC25A10;SLC7A5;SLC7A1;SLC38A1;SLC16A3;SLC7A6;SLC1A4;SLC16A1;SLC16A13;SLC6A9;SLC6A12;SLC15A4;SLC1A5;SLC6A13
gsea,glycoprotein metabolic process (GO:0009100),0.3288112098850746,1.1307092443911537,0.2928709055876686,0.32590548713329653,1.0,10/25,48.41%,PARK7;PRKCSH;STT3B;GANAB;B4GALT5;AGA;FBXO44;MAN2A1;OGA;MAN1B1
gsea,actin polymerization or depolymerization (GO:0008154),0.33885725404361666,1.129334314983067,0.2702702702702703,0.3273396898126772,1.0,15/29,51.56%,DIAPH3;CFL1;FLII;SPIRE1;ABI2;DSTN;CORO7;SVIL;VIL1;MICAL3;CFL2;DIAPH1;SCIN;GHSR;WASHC5
gsea,positive regulation of phagocytosis (GO:0050766),0.3704607295433797,1.1289740916620512,0.3062200956937799,0.327495918414976,1.0,7/27,46.11%,LYAR;CALR;LMAN2;RAB27A;SLC11A1;IL15RA;FCER1G
gsea,autophagosome assembly (GO:0000045),0.36841362270697586,1.125689168236075,0.3150684931506849,0.33153874256082,1.0,7/16,43.66%,ATP2A2;NSFL1C;UBQLN1;ATG9B;RAB23;UBXN2B;ATG7
gsea,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.2851525783348916,-1.1199369377118096,0.26096491228070173,0.4693693784145462,1.0,45/45,98.99%,TNFAIP3;STAT1;ZBP1;SOCS1;TNF;RUNX1;USP18;RNASEL;ELF1;IFNG;SYK;IFNAR2;MADD;TNFRSF1A;SPATA2;SIGIRR;JAK2;IFNGR2;LIFR;IRAK3;BIRC3;AXL;SPHK1;TRAF1;SOCS3;RIPK1;HIPK1;SPPL2B;GAS6;IKBKG;AGPAT2;IL3;BIRC2;CLIP3;AGPAT1;CHUK;PTPN11;TRIM44;PTPN6;FADD;TRAF2;RACK1;CD74;ABCE1;HSP90AB1
gsea,negative regulation of intracellular signal transduction (GO:1902532),-0.24489996072625592,-1.1196653147426738,0.2484725050916497,0.46755027232166235,1.0,102/102,97.71%,TNFAIP3;TMSB4X;STAT1;PINK1;DUSP1;ZC3H12A;ATP2B4;TNIP3;BCL2L1;BCL2;PER1;SPI1;ARHGAP25;MYADM;TMEM127;DDIT3;PTPRJ;MGRN1;LYN;THBS1;PIK3IP1;ABCA7;RORA;NLRP3;ARHGAP12;NLRC3;DGKD;MMP9;TLE1;DLG5;SH2B3;PLAUR;ADGRG3;SIRT1;DGKG;TNFAIP8L1;UBR1;FNIP1;ARNTL;WWC1;HDAC7;TRIM39;BANK1;TSC1;DAG1;PLEK;RNF157;BMP7;AJUBA;RIPK1;PDE3B;RELA;PHLPP1;TNIP1;OTUD7B;SH3BP4;MAPKAPK5;PLEKHA1;NF1;DUSP3;PIK3R2;HYAL2;DAB2IP;AKT1S1;ITPR1;TSC2;PIK3CB;CPNE1;SPRED1;PHLPP2;TRIB3;PRKAA1;STAMBP;PDE10A;NPRL3;TWIST1;THEM4;XDH;GPD1L;MDM2;DEPDC5;MAP2K3;TANK;TSPAN6;CD2AP;DDX3X;TRIM59;HERPUD1;SH3BP1;PHLDA3;CACTIN;TBC1D7;USP10;URI1;RACK1;PPIF;AKT1;CDC34;DDIT4;NOC2L;PEBP1;CIT
gsea,neuron projection morphogenesis (GO:0048812),-0.277759816699112,-1.1180628058238467,0.26939655172413796,0.46808951112738617,1.0,53/53,95.65%,S100A6;UBB;KLK8;IMPACT;ALCAM;PACSIN1;SGK1;APP;TNIK;SHTN1;TAOK1;FLRT3;ACTBL2;MINK1;SHANK1;NRCAM;ALS2;PAK1;LRRK2;ARC;KLF7;BMP7;LMTK2;CTNND2;MAP6;CTTN;DIP2A;MAP2;NCKAP1;LLGL1;ANKRD27;BAIAP2;DVL1;DAB2IP;DOCK7;APBB1;FARP1;CPNE1;TAOK2;SRGAP2;EIF2AK4;MAP1A;CTNNB1;MAP4K4;ROCK1;DCLK1;ABITRAM;AFG3L2;DICER1;RYK;ACTB;NEFH;KIF20B
gsea,positive regulation of cell migration (GO:0030335),-0.23746291742520667,-1.11636833857528,0.2197452229299363,0.46869578846529636,1.0,134/134,99.05%,CCL5;ITGAX;RHOC;VSIR;S100A11;TNFRSF18;CSF1;CCR2;PIK3CD;PLCG1;SEMA7A;IL1B;F2R;PRKCA;NEDD9;HIF1A;CTSH;STAT3;MYADM;NRP1;FLT1;IFNG;GLIPR2;ITGA6;GCNT2;PTK2B;THBS1;NOTCH1;CASS4;CSF1R;AIF1;DAB2;LAMC2;F2RL1;FGR;MGAT5;PDGFB;COL1A1;FN1;RET;SHTN1;CCL7;MMP9;ITGB1;CCN1;DOCK1;MMP14;CD151;FAM110C;GRN;DMTN;DOCK5;SEMA4A;LGR6;GPNMB;SPRY2;TJP1;CCL3;IGF1;TGFB2;CXCL16;CCR1;ADAM9;PAK1;PLET1;VEGFA;SPHK1;PDGFA;PLAU;SEMA6D;ARHGEF2;RAB25;RAPGEF2;ADRA2A;HBEGF;WNT11;SEMA4B;RIPOR1;MYO1C;NTRK3;PLCG2;SMIM22;F3;EDN1;CCN4;GRB7;DAB2IP;SYNE2;PECAM1;XBP1;BCAR1;MIA3;SEMA4C;VIL1;PPM1F;AGO2;TIAM1;ENPP2;CPNE3;MADCAM1;ACVR1;HDAC6;MAP4K4;LEF1;ADAM17;RUFY3;ATM;KIT;SUN2;ELP3;ACTG1;CARMIL2;MTOR;CLASP2;CLASP1;ELP6;PLAA;ROCK2;SOD2;PRKCE;ELP5;ARHGEF39;HSPA5;CCAR1;RDX;RACK1;HRAS;PFN1;ACTN4;MAZ;GTSE1;KIF20B;C1QBP;FBXO5
gsea,vesicle cytoskeletal trafficking (GO:0099518),0.3770236782551931,1.1154603242990555,0.314873417721519,0.3445817872269088,1.0,6/20,41.36%,ACTN4;NDE1;MYO5A;KIF5B;HTT;MYO1G
gsea,regulation of protein localization to cell surface (GO:2000008),0.3613290992405446,1.114269082411751,0.3188118811881188,0.3459163709290722,1.0,7/17,44.21%,HSP90AB1;RANGRF;KCNAB2;TM9SF4;GPD1L;CTNNB1;MAP1A
gsea,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.3443796088649005,1.1105869019225008,0.33271375464684017,0.35066496187432533,1.0,9/21,55.85%,PHB;PIN1;EZR;FBLN1;DUSP6;SPRED1;SPRED2;DAB2IP;DUSP3
gsea,neurotransmitter transport (GO:0006836),0.3428662154850055,1.1095754460288956,0.3240418118466899,0.35166894346734623,1.0,12/24,54.40%,SLC29A1;HSPA8;PDZD11;SLC38A1;PPFIA1;UNC13A;GLS2;GLS;SLC17A8;LIN7A;DVL1;NAAA
gsea,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.3395425323052339,-1.1080051989224013,0.30515463917525776,0.48140279460861585,1.0,22/22,91.30%,ITGA1;SPRY1;ERRFI1;CBLB;PTPRJ;SOCS5;SPRY2;PTPN3;HGS;EPS15L1;STAM;HBEGF;BTC;DUSP3;DAB2IP;TGFA;MVP;STAM2;CBL;AREG;EPS15;RNF126
gsea,cell junction assembly (GO:0034329),0.33983031266130453,1.1041658146093476,0.31891891891891894,0.3587657340148061,1.0,8/26,32.16%,ACTB;PKP4;DSCAM;FLNA;SH3BP1;RYK;PLXND1;ACTG1
gsea,cellular response to amino acid starvation (GO:0034198),0.302877273357081,1.104079389209075,0.30206378986866794,0.35853269612336214,1.0,16/35,48.72%,EIF2S1;DAPL1;CDKN1A;GCN1;SEH1L;MTOR;ITFG2;DEPDC5;MAPK8;DAP;TCIRG1;NPRL3;EIF2AK4;MIOS;MLST8;WDR24
gsea,nervous system development (GO:0007399),0.24935179574578992,1.1021504461548453,0.2907488986784141,0.36073276759394873,1.0,53/137,48.96%,ECT2;STIL;ACTL6A;NRGN;HMGCR;PRPS1;SDHA;UTP11;WDR62;THOC6;IGSF8;DSCAM;SREBF2;MARCKSL1;SPG7;LRCH4;CHERP;PPP2R5D;TMEM223;DCTN1;CDK5RAP2;RYK;GMFB;GSS;PAFAH1B3;DPYSL2;FGF13;PLXND1;MTR;ELP3;NAB1;SLC2A1;IGF2BP3;DHX30;SMPD1;ROGDI;DCLK1;BPNT1;AHI1;RITA1;ANKLE2;RBM45;DPYSL5;ZBTB16;ARNT2;ATN1;RAPGEF5;NLGN2;HAPLN4;WWP1;DNM3;APAF1;SCIN
gsea,positive regulation of proteolysis (GO:0045862),0.32221786520054707,1.101298993301682,0.3155963302752294,0.361580311047722,1.0,10/32,36.87%,PLK1;HDAC2;STUB1;BAK1;FADD;BAG2;WDR48;TANK;NKD2;CLN6
gsea,negative regulation of angiogenesis (GO:0016525),-0.2860089100519877,-1.0998657827557206,0.3038961038961039,0.49394105160771606,1.0,42/42,95.02%,STAT1;ATP2B4;CCR2;TNF;CREB3L1;GTF2I;HHEX;THBS1;ATF2;FOXJ2;PF4;SPRY2;FOXO4;TGFB2;PPARG;RGCC;KLF2;CXCL10;STAB1;PDE3B;AGO1;SPARC;HGS;ALOX5;AMOT;PTPRM;KLF4;EPN2;CD160;PML;SERPINE1;DAB2IP;PIK3CB;SPRED1;VASH1;SERPINF1;CTNNB1;ROCK1;SLC12A2;ROCK2;E2F2;PGK1
gsea,protein localization to plasma membrane (GO:0072659),0.27054425763992807,1.0996971652257992,0.2968197879858657,0.3633937979688607,1.0,19/64,38.24%,TMED2;ZDHHC2;BSG;RDX;EZR;GORASP2;MYO5A;SPTBN1;FLNA;ROCK2;PTCH1;CLASP2;TESC;EHD4;FGF13;C2CD5;RAP2A;NKD2;ROCK1
gsea,purinergic nucleotide receptor signaling pathway (GO:0035590),0.42502176736293507,1.0995810462939164,0.353322528363047,0.36321038827400487,1.0,4/15,62.59%,HSP90AB1;ENTPD5;CTSG;ANO6
gsea,negative regulation of proteolysis (GO:0045861),0.3801226907842031,1.0962807691709153,0.3576388888888889,0.36741288801333316,1.0,5/17,39.06%,SERPINE2;AKT1;CST3;ROCK1;HDAC6
gsea,positive regulation of axonogenesis (GO:0050772),0.3747507573309607,1.0945570469351642,0.3283582089552239,0.3694348370321645,1.0,5/16,34.93%,ARHGDIA;METRN;GOLGA4;PLXND1;RUFY3
gsea,positive regulation of interferon-gamma production (GO:0032729),0.3271430971302918,1.0935927433913817,0.3403041825095057,0.37039838796596314,1.0,8/26,42.08%,HSPD1;SLC7A5;TNFSF4;FADD;IL21;SCRIB;SLAMF6;SLC11A1
gsea,positive regulation of immune response (GO:0050778),-0.29277942673561264,-1.0887755855536214,0.35023041474654376,0.5114687225841169,1.0,35/35,93.33%,CCL5;RSAD2;CD226;IFNG;FCGR2B;ADAM8;IL2;NLRP3;F2RL1;ITGAM;GRN;SPHK2;PLSCR1;SIRT1;TGFB2;IL6ST;IL10;IL12RB1;IL23A;CCR7;CD81;GBP5;AKIRIN2;XBP1;SLC15A4;EIF2AK4;POLR3F;POLR3B;POLR3G;FADD;POLR3D;CD74;TNFSF4;MYB;DHX9
gsea,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.3175931006092646,1.087950948669151,0.32978723404255317,0.37804787604564094,1.0,10/31,50.08%,HMGB1;AKT1;SP1;NUS1;ADAM17;MAP2K3;JCAD;STAT5A;PDPK1;FOXC2
gsea,cell-cell junction organization (GO:0045216),-0.3113905503320592,-1.0846840537330542,0.3106267029972752,0.5166563635642136,1.0,30/30,83.30%,PKP3;F2R;MYADM;CDH1;LIM2;PVR;SMAD3;CSF1R;F2RL1;DSG2;FSCN1;TJP1;JUP;TGFB2;PKP2;TGFB3;CTNND2;AFDN;NECTIN2;NECTIN4;CDH17;CADM1;CTNND1;DSP;NLGN2;MARVELD2;PRKCI;CTNNA1;TJP2;PKP4
gsea,response to peptide hormone (GO:0043434),0.31597599803130894,1.0845159738219725,0.3515151515151515,0.38235255648726135,1.0,10/26,38.24%,EIF6;AKT1;EIF2B3;EIF2B1;EIF2B5;ROCK2;ZBED3;EIF2B4;CREB1;ROCK1
gsea,positive regulation of metabolic process (GO:0009893),0.2894497124049135,1.0842024013351594,0.3432601880877743,0.38245680080050415,1.0,21/54,43.26%,FABP5;FASN;ACADL;EPAS1;GATM;HADH;ALMS1;ACACA;DYNC1H1;DECR1;ACLY;HSF1;PRDM16;PIGA;EHMT1;ACSL1;CPT2;AGPAT1;OMA1;ADRB1;ELOVL6
gsea,regulation of cardiac conduction (GO:1903779),-0.3231280884885625,-1.083807097317614,0.33827160493827163,0.5158428542789724,1.0,23/23,87.24%,ATP2B4;ITPR2;ATP2A3;RYR1;ATP2B2;FXYD1;FXYD7;ATP1B1;SLC8A1;ATP1A2;ATP1A3;FXYD2;ITPR3;TMEM65;FXYD3;ASPH;ITPR1;NPPC;NOS1;TRPC1;AHCYL1;ATP1A1;ATP2A2
gsea,regulation of JUN kinase activity (GO:0043506),-0.3430380501926435,-1.0834106826960712,0.3232931726907631,0.5141301538814029,1.0,19/19,74.70%,PDCD4;DUSP10;TNF;DNAJA1;DVL3;MAP3K11;PAK1;ARHGEF5;MAP3K5;MAPK8IP1;EDN1;DAB2IP;HIPK3;MAP3K7;DUSP19;DVL2;MAP3K4;AIDA;TRAF2
gsea,regulation of cell migration (GO:0030334),-0.21618758774988428,-1.0830625938059741,0.23353293413173654,0.5123594541739381,1.0,185/185,99.16%,CCL5;TMSB4X;OSGIN1;ITGAX;RHOC;VSIR;IFITM1;CSF1;PIK3CD;DUSP10;SEMA7A;IL1B;SMAD7;F2R;PRKCA;NEDD9;CTSH;ANXA1;DDX58;CITED2;STAT3;MYADM;LMNA;FLT1;SRGAP3;CDH1;ITGA6;PTPRJ;FOXO3;SPATA13;SGK1;GCNT2;ACVRL1;PTK2B;THBS1;PRR5L;NOTCH1;CASS4;CSF1R;AIF1;DAB2;LAMC2;ABI3;F2RL1;FGR;DLC1;PTPRK;MGAT5;PDGFB;COL1A1;RET;CCL7;CEACAM1;MMP9;ITGB1;CCN1;DLG5;MMP14;CD151;MACF1;SCAI;FAM110C;GRN;SEMA4A;CLN3;LGR6;PLXNB2;GPNMB;ADGRG3;SPRY2;TJP1;MINK1;CCL3;IGF1;CXCL16;APPL2;TTBK2;CCR1;ADAM9;IGSF10;LIMCH1;VCL;TCAF1;FGF2;PAK1;PLET1;VEGFA;SPHK1;PDGFA;AMOTL2;PLAU;DAG1;FUZ;SEMA6D;AFDN;MCTP1;MITF;AMOT;ADRA2A;RAP2B;HBEGF;WNT11;SEMA4B;PLXNC1;TMSB15A;RIPOR1;MYO1C;NTRK3;SERPINE1;SMIM22;F3;NF1;DUSP3;EDN1;GRB7;NF2;ARID2;ENG;RAP2C;PLXNA1;SYNE2;PECAM1;LMO4;XBP1;BCAR1;TBCCD1;MIA3;BST2;SEMA4C;AMOTL1;SRGAP2;VIL1;PPM1F;TIAM1;NEXN;HACE1;ENPP2;DUSP22;CX3CL1;RHOB;SLK;CPNE3;ACVR1;MAP4K4;ROCK1;ARSB;LEF1;ADAM17;ZMYND8;RUFY3;RAP2A;ATM;KIT;SUN2;ELP3;ACTG1;PLXND1;CARMIL2;KIF2A;ELP6;ROCK2;SOD2;CLIC4;ELP5;FLNA;ARHGEF39;HSPA5;TPM1;CORO1C;CCAR1;RDX;SINHCAF;RACK1;CD74;HRAS;GTPBP4;AKT1;ACTN4;SERPINE2;MAZ;GTSE1;KIF14;TMSB10;RCC2;MIF
gsea,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.30083557475298545,1.0824319502815267,0.33558178752107926,0.38456883283656884,1.0,13/41,51.04%,MIF;CD74;HAX1;LRP8;PTPN6;PTPN11;RIPK2;ACVR1;BST1;ENPP2;CD80;PECAM1;RAP2C
gsea,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.3472139096630129,1.0823135513466704,0.3333333333333333,0.3843598013420419,1.0,7/18,35.18%,BRCA1;PARK7;GPX1;TRAF2;FADD;DDX3X;TNFRSF10B
gsea,regulation of BMP signaling pathway (GO:0030510),-0.3053458803078279,-1.0816752008031005,0.32904884318766064,0.5124675538263149,1.0,13/26,23.79%,SMAD7;CRIM1;SKIL;ACVRL1;NOTCH1;SKI;WNT1;TWSG1;FST;CCN1;FSTL1;HTRA3;PPARG
gsea,regulation of dendrite morphogenesis (GO:0048814),0.3720153770830439,1.0803585921580707,0.35145631067961164,0.3867462006941037,1.0,5/15,34.47%,CAPRIN1;NEDD4;SS18L2;RAP2A;FBXW8
gsea,protein localization to cell periphery (GO:1990778),0.26421942681942157,1.0783078367445629,0.3225255972696246,0.38932346343992436,1.0,38/64,61.33%,TMED2;ZDHHC2;BSG;RDX;EZR;MYO5A;SPTBN1;FLNA;PDZD11;ROCK2;PTCH1;CLASP2;TESC;EHD4;FGF13;C2CD5;RAP2A;NKD2;ROCK1;GAK;TSPAN32;SLMAP;RAMP2;FAM126B;LIN7A;FLOT2;RAB13;LRP6;AP4M1;TSPAN15;MAP7;EHD3;RAMP3;PACS2;CD81;GAS6;ANK1;TSPAN33
gsea,negative regulation of protein kinase B signaling (GO:0051898),0.34164476106989256,1.0771510969473943,0.35080645161290325,0.39057102588444426,1.0,9/18,49.49%,AKT1;RACK1;PHLDA3;XDH;THEM4;TRIB3;PHLPP2;PIK3CB;TSC2
gsea,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.31338710380159607,-1.0765296555920219,0.3656565656565657,0.5196216797121364,1.0,27/27,88.26%,S100A6;APP;SHTN1;ACTBL2;MINK1;NRCAM;KLF7;LMTK2;MAP6;UNK;MAP2;LLGL1;BAIAP2;MEF2C;DVL1;DOCK7;APBB1;FARP1;TAOK2;MAP1A;RB1;MFSD2A;ABITRAM;AFG3L2;RYK;ACTB;NEFH
gsea,long-chain fatty acid metabolic process (GO:0001676),0.3357954793692497,1.0761112365534016,0.34744525547445254,0.39174293064894733,1.0,14/29,47.25%,ACSL5;GPX1;ACADL;ACAD9;AIG1;ACSL3;FADS1;ACSL1;CPT2;FADS2;ACSL6;ELOVL6;HACL1;ACSL4
gsea,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.3584136286897557,1.071414267241687,0.3913713405238829,0.3980623828553899,1.0,7/23,51.41%,EZH2;MTOR;LEF1;CTNNB1;TWIST1;TIAM1;BAMBI
gsea,cell-cell junction assembly (GO:0007043),-0.33484780584208085,-1.0691179466030722,0.35698924731182796,0.53088683992242,1.0,21/21,86.34%,RHOC;PKP3;SMAD7;PRKCA;LIM2;PIP5K1C;FSCN1;TJP1;JUP;VCL;PKP2;CTNND2;CD9;CTNND1;RAMP2;GJB2;CTNNB1;CTNNA1;ACTG1;PKP4;ACTB
gsea,positive regulation of endothelial cell migration (GO:0010595),0.28537895421895737,1.0689964827643044,0.37433155080213903,0.4011452118191986,1.0,16/47,50.08%,HMGB1;CALR;AKT1;SP1;ROCK2;SCARB1;NUS1;ADAM17;MAP2K3;PIK3CG;RHOB;STAT5A;PDPK1;PIK3CB;BCAR1;FOXC2
gsea,innate immune response (GO:0045087),0.25448975469362406,1.0687514925008763,0.3274478330658106,0.4011205458540433,1.0,46/107,59.74%,HMGB1;PPP1R14B;SHMT2;PHB2;PHB;TRIM28;ATAD3A;CD74;CLPB;SKP2;CAPZA2;SRPK1;CORO1A;TRIM59;TRIM35;AKAP1;DDX3X;ANKRD17;TKFC;TTC4;SMPD1;CHUK;PIK3CG;MID2;RIPK2;SETD2;SERINC3;SLC11A1;SHFL;LTF;FCER1G;BST2;ANKHD1;POLR3A;PJA2;NUB1;IFIH1;CHGA;IRF5;PGLYRP1;RELB;MAVS;KYNU;PLCG2;PML;IKBKG
gsea,striated muscle contraction (GO:0006941),0.36217142773757155,1.0680039322899753,0.375,0.40181102738038454,1.0,9/19,46.45%,TPM1;ALDOA;RCSD1;TTN;GRK2;TNNT1;LMOD3;NOS1;TNNI3
gsea,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.2324248890433671,-1.0623052508622841,0.33460076045627374,0.5415105288761644,1.0,105/105,97.30%,TNFAIP3;S100A4;STAT1;RHOC;LITAF;MALT1;PINK1;PIM2;ZC3H12A;TNIP3;REL;PER1;IL1B;TNF;F2R;TRIM14;TNFSF10;CD40;CARD11;TRAF5;WLS;PLK2;CXXC5;MAP3K14;RORA;TIFA;F2RL1;TRIM8;TRIM5;TNFRSF1A;IKBKE;CD4;TERF2IP;CASP1;ECM1;NLRC3;TLE1;TRIM21;UNC5CL;SPHK2;LTBR;SIRT1;BIRC3;HSPB1;TRIM39;TRAF1;NEK6;TNIP2;HMOX1;RIPK1;TRIM25;RELA;MAP3K3;TRAF4;TNIP1;OTUD7B;CCR7;IKBKG;PLCG2;TAB3;MAVS;DAB2IP;TMEM106A;MAP3K7;BIRC2;BST2;CC2D1A;CPNE1;PRKCB;PDPK1;LTF;CX3CL1;RIPK2;MID2;TRAF3;CHUK;TICAM2;UFL1;TNFRSF10B;TANK;TSPAN6;ZDHHC13;SLC20A1;ANKRD17;LGALS1;FADD;TRIM59;TRAF2;TMEM101;OPTN;CACTIN;PIDD1;FLNA;USP10;MTDH;DDX21;CD74;PPP5C;EEF1D;UBE2N;DDX1;NUP62;ECT2;TFRC;GAPDH
gsea,negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.24748385711998763,-1.0580662047636067,0.3441108545034642,0.546986633563315,1.0,70/70,96.47%,TNFAIP3;TMSB4X;NFKBIA;SP100;PIM1;ZC3H12A;BHLHE40;SMAD7;SPI1;MTURN;DDIT3;FOXP3;XCL1;NUPR1;NLRP3;ERBIN;HAVCR2;ACOD1;TCF7L2;SIGIRR;ANXA4;NLRC3;HDAC4;TRIM21;IRAK3;TRIB1;ADGRG3;SIRT1;ID2;PARP10;PRMT2;ARRB1;FZD6;BTRC;PRNP;BMP7;KLF4;ID1;GAS6;SFRP4;CD200;GFI1;DAB2IP;NFKBIE;EIF2AK4;LRRC14;ID3;RB1;DAP;TRAF3;CHUK;UFL1;MEN1;USP7;KEAP1;TAF3;PTCH1;SETD6;CACTIN;EOMES;EGLN1;FLNA;TAF1;TRIM37;PAXIP1;TNFRSF4;TNFSF4;HDAC2;CDKN2A;PHB2
gsea,positive regulation of signal transduction (GO:0009967),0.24160979750403533,1.0550825284999563,0.3412322274881517,0.4203251456268569,1.0,35/119,43.44%,UCHL5;PHB;PIH1D1;DEPDC1B;TEDC1;BAX;SMARCA4;CD74;SMARCB1;SNX5;BAK1;VPS35;FLNA;TEDC2;BMP2K;MT3;ASXL1;TRIM44;PHIP;CDC73;ING5;LANCL2;PTPN11;TUBD1;GKAP1;DLL1;PRKCI;POGLUT1;HTT;AGPAT1;JCAD;NEPRO;TNFSF11;FGFBP3;SLC39A14
gsea,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.35651537335285505,-1.053879885768423,0.37254901960784315,0.5526500222290963,1.0,15/15,64.43%,ERRFI1;CBLB;APP;SOCS5;NCF1;FBXW7;ADRA2A;HBEGF;BTC;NCK2;TGFA;CBL;AREG;ADAM17;SHC1
gsea,regulation of cytokine production (GO:0001817),0.267531337800638,1.0530228880770656,0.36809815950920244,0.42295741388422853,1.0,32/70,61.58%,MIF;GAPDH;POLA1;TNFSF4;KAT2A;MAST2;GLMN;RPS6KA5;IGF2BP3;IL21;MAPKAPK2;IRF8;TRAF3;PIK3CG;AGPAT1;SLC11A1;CCDC88B;BATF;LTF;IL33;RIPK3;IFIH1;CCN4;AGPAT2;IGF2BP2;CADM1;BTN1A1;FFAR4;CIDEA;CCR7;TXK;ASB1
gsea,glycosaminoglycan biosynthetic process (GO:0006024),-0.28531246178305003,-1.0525715997179101,0.3761261261261261,0.5527154044800481,1.0,34/34,71.60%,IL1B;UST;CHSY1;GCNT2;XYLT1;SDC3;ST3GAL1;ST3GAL6;SDC4;ABCC5;CHST2;HEXA;CHPF2;DSE;SDC1;ST3GAL4;CHST11;VCAN;HS6ST1;ST3GAL3;DSEL;CSGALNACT2;CHSY3;PXYLP1;B4GALT4;SLC35D2;GPC1;B4GAT1;CHST15;HS2ST1;B3GNT3;B4GALT5;B3GALT6;CHPF
gsea,regulation of response to external stimulus (GO:0032101),-0.24482752658974263,-1.05188708484174,0.33796296296296297,0.5514769416988182,1.0,64/64,96.16%,TMSB4X;SAMHD1;IRF1;ZBP1;CCR2;SEMA7A;PIK3AP1;F2R;FOXP1;USP18;ANXA1;FCGR2B;AREL1;SBNO2;PTGS2;CASP4;XCL1;HCK;DHX58;BCL6;F2RL1;FGR;TRIM5;CD36;CASP1;SPATA2;JAK2;GRN;ADGRA2;BIRC3;CASP12;APPL2;EFNB2;CXCR4;P2RX4;ELMOD2;RELA;ALOX5;PDE6A;GNAT1;AKNA;SAG;BIRC2;CX3CL1;BST1;TRAF3;NMT2;UFL1;CELF1;TKFC;FNTB;LACC1;CD55;LRP8;METAP1;ZMPSTE24;SETD6;NMT1;ERAP1;TNFSF4;USP14;PSMA6;PARK7;METAP2
gsea,regulation of cellular component movement (GO:0051270),-0.312869720079753,-1.0501014753802334,0.3709677419354839,0.5524356985448776,1.0,24/24,90.14%,SP100;ETS1;ZSWIM6;ZSWIM8;INPP5F;FES;TGFBR3;LYN;ZSWIM4;ARAP1;VEGFA;ABL1;HBEGF;BTC;CD9;DIAPH1;HDAC6;ROCK1;ADAM17;ACTN1;CDK6;ROCK2;MEMO1;ACTN4
gsea,negative regulation of cellular component organization (GO:0051129),-0.2761426561869769,-1.0483636385972246,0.3762993762993763,0.5533690493063759,1.0,40/40,88.69%,LGALS3;PRKCZ;TNF;AR;TMC8;PEX5;IMPACT;DNAJA4;ABCA7;EP300;SYT11;IRAK3;SPRY2;GSK3B;ULK1;PACSIN3;DNAJB1;VEGFA;HSPA1B;CRYAB;DNAJB2;MCTP1;HSPA1A;EPHA3;HSPA2;TRAF3IP1;SACS;TFIP11;HDAC6;SVIP;TERF2;CARMIL2;DDX3X;HSF1;AIDA;HSPA5;RTEL1;XRCC5;RDX;HSPA8
gsea,regulation of defense response to virus by host (GO:0050691),0.347521777650764,1.0454200667099602,0.39165009940357853,0.4339576952877782,1.0,6/16,28.39%,HSP90AA1;DHX9;CGAS;SIN3A;TARBP2;TRIM44
gsea,regulation of cell-cell adhesion (GO:0022407),0.3434406961859571,1.0453094847650317,0.4090056285178236,0.4337074724268228,1.0,8/17,53.60%,GTPBP4;ZDHHC2;DPP4;ADA;FUT4;B4GALNT2;FLOT2;NF2
gsea,regulation of JNK cascade (GO:0046328),0.26768669231509584,1.044056242549804,0.35887850467289717,0.43530087102565146,1.0,20/52,60.70%,HMGB1;HRAS;COPS5;TRAF2;AIDA;MEN1;RAP2A;TRAF3;MAP4K4;AXIN1;DUSP22;DUSP19;TAOK2;PJA2;HIPK2;DAB2IP;DUSP3;MAPK8IP1;MAP3K5;CCR7
gsea,chemical homeostasis (GO:0048878),-0.29822846670739156,-1.042006477066244,0.38461538461538464,0.5631786067185868,1.0,26/26,70.28%,IRS2;SLC4A7;ABCB4;PNPLA8;ATP13A2;ACOX1;NR1H3;ZBTB20;PPARG;SLC4A5;FBXW7;VGF;KLHL3;WNK1;ADCK1;ABHD4;SLC4A4;SLC4A2;THADA;ACOXL;TENT4B;TLCD1;TLCD2;SLC4A8;EIF5A2;DDX3X
gsea,positive regulation of cold-induced thermogenesis (GO:0120162),0.29347153967477024,1.040120341604987,0.3847328244274809,0.44089886213072293,1.0,16/45,43.26%,FABP5;ACADL;EPAS1;GATM;HADH;ALMS1;DYNC1H1;DECR1;HSF1;PRDM16;EHMT1;ACSL1;CPT2;OMA1;ADRB1;ELOVL6
gsea,organelle transport along microtubule (GO:0072384),0.34364328829601365,1.0382954593863774,0.40461215932914046,0.443175189549303,1.0,11/16,39.84%,NDE1;LRPPRC;COPG1;TMEM201;KIF5B;BICD1;RHOT2;COPG2;BICD2;ARHGAP21;HTT
gsea,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.28507411689249407,1.0371671658571244,0.39107142857142857,0.4444763041520874,1.0,17/38,55.85%,NUP62;RNF126;AKT1;CNOT9;WDR54;EPS15;AREG;CBL;STAM2;MVP;RHBDF2;TGFA;CCDC88A;DAB2IP;PTPN12;RHBDF1;DUSP3
gsea,regulation of protein localization to plasma membrane (GO:1903076),-0.27376772415780487,-1.0357818789739368,0.3854166666666667,0.572893587332752,1.0,41/41,90.00%,LGALS3;ATP2B4;BCL2L1;PIK3R1;TNF;AR;IFNG;PID1;LRP1;DAB2;ABI3;TMBIM1;ITGB1;MMP14;CLN3;RHOQ;ITGA3;SORBS1;ZDHHC5;PLS1;RAMP3;PICALM;AKAP5;PTPN9;EPHA3;ZDHHC8;PDPK1;VAMP8;CLIP3;PRKCI;NKD2;CNPY4;CLTC;PPFIA1;KIF5B;PRKCE;SPTBN1;RANGRF;ACTB;ZDHHC2;AKT1
gsea,gland development (GO:0048732),0.3307492568750651,1.034494678482219,0.4015503875968992,0.44804847518225277,1.0,6/25,26.03%,PRKCSH;EZR;TG;GFER;IGSF3;FADD
gsea,lytic vacuole organization (GO:0080171),0.3263846086470341,1.0297947305477657,0.4107485604606526,0.4548558701606438,1.0,9/19,50.69%,HOOK1;MTOR;HOOK2;CLN6;ARSB;GNPTAB;NAGPA;ZKSCAN3;TFEB
gsea,positive regulation of interferon-beta production (GO:0032728),0.3098801291150769,1.0294863277991935,0.41818181818181815,0.45487556738337565,1.0,13/24,57.62%,HSP90AA1;DHX9;POLR3D;DDX3X;POLR3G;PTPN11;RIPK2;POLR3B;POLR3F;POLR3A;IFIH1;IRF5;MAVS
gsea,cellular response to organic substance (GO:0071310),-0.25511574488299865,-1.0284037340672396,0.4074074074074074,0.5849542278994722,1.0,56/56,95.87%,CCL5;IL1B;TNF;STAT3;NFAT5;IL18R1;PID1;ACVRL1;SMAD3;RAMP1;CSF1R;SOCS2;TIPARP;CCL2;PDGFB;CASP1;PTPN13;NCOA3;SIGIRR;CLEC3B;CCL3;FLT3;CXCR4;PTPN5;LRRK2;SPHK1;NCOA1;NCOA2;MAPK7;STAT5B;ADRA2A;KLF4;CCR7;RAMP3;PTPN23;PTPN12;NDOR1;PTPN9;RAMP2;NOS1;CPNE3;ACVR1;CTNNB1;HDAC6;MAPK8;LEF1;SHC1;PTPN11;PTPN6;PTPN7;URI1;HAX1;HTRA2;RACK1;KHSRP;PARK7
gsea,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.331813081127896,-1.0280900771869748,0.41570438799076215,0.5829370378331152,1.0,21/21,88.70%,ZFP36L1;CSF1;TNF;PRKCA;RUNX1;IFNG;FES;CD4;PF4;ID2;CCR1;RIPK1;IL23A;LIF;TNFSF11;LEF1;TESC;HSF1;FADD;HAX1;CD74
gsea,regulation of blood vessel endothelial cell migration (GO:0043535),-0.2819789907050272,-1.0254620874672502,0.43023255813953487,0.5855642777333939,1.0,35/35,99.70%,TMSB4X;ETS1;ATP2B4;PLCG1;TNF;PRKCA;HIF1A;CD40;ACVRL1;THBS1;PDGFB;GADD45A;APOE;SIRT1;JUP;PPARG;RGCC;HSPB1;PRKD2;FGF2;VEGFA;P2RX4;NF1;MEF2C;PRCP;PDPK1;STAT5A;VASH1;MAP2K3;ADAM17;NUS1;SH3BP1;SP1;AKT1;HMGB1
gsea,lipid homeostasis (GO:0055088),0.30508329921337285,1.025002399941713,0.40854700854700854,0.46152361291632593,1.0,8/27,50.40%,POLD1;DDX3X;TLCD2;TLCD1;PRKAA1;ACOXL;THADA;XBP1
gsea,negative regulation of cellular protein localization (GO:1903828),-0.3169812659407475,-1.0247520390629024,0.4142857142857143,0.5843888063513838,1.0,21/21,90.24%,RIPOR2;GPM6B;LATS2;TAX1BP3;SPI1;DNAJA1;ACTN2;GSK3B;TTBK2;MFHAS1;LATS1;OTUD7B;PICALM;LZTFL1;MAP1A;UBXN2B;CTNNA1;ROCK2;SIN3A;NSFL1C;CDT1
gsea,regulation of osteoblast differentiation (GO:0045667),0.3020493989138496,1.0213107464603544,0.43270622286541244,0.46699683901371913,1.0,17/36,54.35%,FBXO5;CDK6;PTCH1;RIOX1;MEN1;NPNT;ACVR1;TWIST1;HEMGN;LTF;NOCT;SMOC1;REST;BAMBI;TMEM119;MEF2C;CCN4
gsea,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.2860089561321377,1.0197267139278878,0.4329159212880143,0.46893359397526313,1.0,16/34,56.21%,HSP90AA1;VEGFB;ROCK2;ELMO1;MAPKAPK2;ROCK1;CYFIP1;VAV2;PIK3CB;BCAR1;ELMO2;DAB2IP;BAIAP2;PIK3R2;NCK2;NCKAP1
gsea,hemopoiesis (GO:0030097),0.2820654488810531,1.0196968864287204,0.4380952380952381,0.46853799212537556,1.0,12/46,38.20%,MELK;GLRX5;ASH2L;PRRC2C;PRDX3;ARMC6;KAT8;KIT;RUNX3;PGM3;BMI1;DLL1
gsea,blood vessel morphogenesis (GO:0048514),-0.3145947774016381,-1.0179896116692115,0.4387990762124711,0.5952966356784198,1.0,19/19,78.37%,SMAD7;NRP1;FLT1;SYK;TGFBR3;RASA1;ADM;EFNB2;ITGB8;VEGFA;RASIP1;ID1;NF1;CUL7;ENG;RAMP2;TNNI3;GLMN;EGFL7
gsea,vesicle organization (GO:0016050),0.30207434672617745,1.0160507024643308,0.4269870609981516,0.47382796780433145,1.0,12/26,51.89%,CORO1A;HOOK1;PI4K2B;HOOK2;EPS15;DNAJC13;SNX10;USP8;VPS33B;CAV2;WASHC5;ALS2CL
gsea,positive regulation of GTPase activity (GO:0043547),0.2310343202040794,1.0159477536629906,0.4249201277955272,0.4735424838104196,1.0,53/110,67.03%,EZH2;ECT2;RANGAP1;PIN1;ARHGAP11A;HRAS;RACK1;CORO1C;PKP4;NET1;TBC1D7;ADPRH;TBC1D10B;SH3BP1;SGSM3;SCRIB;DOCK11;MAP4K4;DOCK9;ADRB1;ARHGAP24;CX3CL1;DOCK8;TIAM1;SRGAP2;RAP1GDS1;GPR65;CAV2;RSU1;DOCK7;TBC1D5;RAB3GAP1;PICALM;BCR;NF1;USP6NL;TBC1D1;SYDE2;TBC1D30;NTRK3;CCR7;ARHGAP27;WNT11;ARHGEF26;RASGRF1;RAPGEF2;TBC1D8B;RASGRP2;GRTP1;AFDN;CCL25;RABGAP1;CCL17
gsea,cellular response to nutrient levels (GO:0031669),0.2799721986918977,1.014809146800455,0.4384133611691023,0.4748874742248409,1.0,12/30,51.55%,EIF4G1;HSPA8;SREBF2;EHMT2;MTOR;FADS1;MFSD2A;ATG7;PRKAA1;XBP1;TFEB;USP33
gsea,protein dephosphorylation (GO:0006470),-0.2444953987563534,-1.0137676890458702,0.4221014492753623,0.6011626891960502,1.0,63/63,95.66%,DUSP2;DUSP5;PPP1R15A;DUSP4;DUSP1;PPM1J;PTPRE;DUSP10;PTPRJ;DUSP16;SSH2;CTDSP2;PPP2R2C;SSH1;MTMR3;PTPRK;PTPN13;PTPRS;PTPN5;BTRC;PPTC7;PTPN3;DUSP7;PPP4R1;PPM1L;PTPRM;SBF1;DUSP3;PDP1;PTPN12;PPM1M;DUSP18;RPAP2;PTPN9;RPRD1A;CTDSP1;PPM1F;PPP4R2;CTDNEP1;UBLCP1;DUSP22;EYA3;MTMR4;DUSP6;LHPP;PPP2R1B;TAB1;CTDP1;PPP2R3A;PTPN11;PPP3CB;DUSP12;PPP2CB;PTPN6;PPP1CB;PPP2R5D;PDXP;PTPN7;RPRD1B;PPP5C;PPM1G;TIMM50;PGP
gsea,ephrin receptor signaling pathway (GO:0048013),0.3165198579917607,1.0128351663289077,0.4391785150078989,0.47753760349959057,1.0,12/28,49.79%,HRAS;ACTB;ROCK2;ACTR2;ACTG1;PTPN11;ROCK1;AP2B1;AP2A2;TIAM1;VAV2;EPHA3
gsea,stress-activated protein kinase signaling cascade (GO:0031098),-0.327341985926288,-1.0103590674784793,0.43415637860082307,0.6055544782249678,1.0,17/17,81.62%,UBB;NFKB1;MAPK13;CCDC88C;TNIP2;BTRC;MAP3K8;MAP3K5;IKBKG;MAP3K7;TAOK2;MAP3K20;MAPK8;CHUK;KAT7;CUL1;RPS27A
gsea,protein-containing complex disassembly (GO:0032984),0.2964852761315963,1.0072508714512942,0.4446601941747573,0.485871029505838,1.0,16/23,54.06%,VCP;HSPA8;UBQLN1;VPS16;MYC;PYM1;CTNNB1;AXIN1;VAMP8;DVL2;VPS33B;VPS33A;VAMP7;STX17;DVL1;LRP6
gsea,cellular response to lipid (GO:0071396),0.24523767370590666,1.001955308565945,0.4402420574886536,0.4939134452732876,1.0,32/100,50.40%,HMGB2;HMGB1;RUVBL2;TNFSF4;HTRA2;SPP1;INSIG1;URI1;CACTIN;ROCK2;PLAA;ATP1A1;SETX;TESC;CREB1;MAP4K1;CDC73;UPF1;ATM;SELENOS;TICAM2;MAPK8;MED1;CTR9;TFPI;NFKBIB;ADNP2;CCDC62;CD80;CTSG;EPHA3;XBP1
gsea,central nervous system development (GO:0007417),0.23936995682493098,1.0014379738861638,0.45468277945619334,0.4942735688761531,1.0,39/93,48.96%,PHGDH;DDIT4;TUBGCP2;EIF2B5;UTP3;THOC6;ZPR1;MARCKSL1;EOMES;ABCB6;CDK5RAP2;PTCH1;PAFAH1B3;SETD1A;SPATA5;ELP3;SLC2A1;DHX30;PTPN11;CHD8;ROGDI;DHX37;DCLK1;DLL1;POMK;MFSD2A;PBX4;BPTF;AHI1;ANKLE2;ZBTB16;ARNT2;ATN1;HAPLN4;PBX3;SCYL2;WWP1;PBX2;SCIN
gsea,protein O-linked glycosylation (GO:0006493),0.2501028941325939,1.0005705393443105,0.42299794661190965,0.4951495672854291,1.0,29/50,53.01%,SDF2L1;GALNT1;POGLUT2;B4GALT5;RXYLT1;PGM3;GALNT7;PLOD2;POGLUT3;POGLUT1;POMK;POMT2;GALNT18;ST6GALNAC4;EOGT;B3GNT3;B3GLCT;B4GAT1;GALNT14;POFUT1;POMT1;ST6GAL1;MUC6;OGA;POMGNT1;B3GALNT2;XXYLT1;FKRP;SLC35C1
gsea,neuron migration (GO:0001764),0.3357752559070246,0.9985682353309004,0.4897579143389199,0.49785914338131787,1.0,6/18,36.28%,DDIT4;TUBGCP2;CEP85L;FGF13;ELP3;USP9X
gsea,sphingolipid metabolic process (GO:0006665),-0.25572285469457706,-0.9983670272454013,0.45566502463054187,0.6271516859681723,1.0,42/42,74.57%,GM2A;SGPL1;FUT7;ALDH3B1;ST6GALNAC3;GLA;CERK;HACD4;SGMS1;SPHK2;ABCA2;HEXA;GALC;NEU1;TEX2;PRKD2;SPHK1;ST6GALNAC6;SAMD8;PPM1L;CERS6;FA2H;GBA2;ALDH3A2;ELOVL2;PLPP2;PDXDC1;HACD1;PRKD3;ENPP2;CERKL;ELOVL4;ELOVL6;SMPD1;CPTP;PLPP1;AGK;SMPD4;ACER3;HACD2;SUMF2;HACD3
gsea,COPII-coated vesicle budding (GO:0090114),0.3030876299234284,0.9962700097095151,0.46124031007751937,0.5011399054210246,1.0,14/25,44.67%,LMAN1;TMED2;CTSZ;SEC23B;NSF;CUL3;SCAP;SEC23IP;SEC24D;AREG;ANKRD28;PPP6R3;PPP6R1;USO1
gsea,response to calcium ion (GO:0051592),0.2884408125842417,0.9960279319785149,0.47479674796747967,0.5010428577875692,1.0,15/41,48.39%,ECT2;PPIF;SLC25A13;CALM2;NEDD4;CLIC4;TTN;AHCYL1;CPNE2;SMPD1;ADD1;CPNE3;TRPC1;PRKAA1;CPNE1
gsea,actin filament bundle organization (GO:0061572),0.32625817248522615,0.9918032694947071,0.48293515358361777,0.5075288431489193,1.0,8/19,54.95%,LCP1;EZR;ADD1;PLS3;PAWR;USH1C;BAIAP2;RFLNB
gsea,phosphatidylinositol metabolic process (GO:0046488),-0.2499731945570232,-0.9901751145825665,0.4859437751004016,0.641210307404131,1.0,53/53,80.81%,PIK3R1;INPP4B;PIK3CD;PLCG1;PLBD1;PLCB2;PGAP1;INPP5F;CSF1R;PIK3R5;PGAP3;PITPNM2;MTMR3;PLA2G4A;PTPN13;SLC27A1;RAB4A;SYNJ2;PIP5K1C;PLA2G4F;LCLAT1;RUFY1;MTMR12;PIK3C2A;SYNJ1;PIK3CA;FGF2;PLEK;PI4KB;PIP4K2B;FIG4;SBF1;MTMR1;PLCG2;PLEKHA1;PIK3R2;PIK3CB;INPPL1;PIK3R4;PI4KA;CDIPT;MTMR4;PIK3R6;PIKFYVE;LPGAT1;PIK3CG;INPP5B;PLEKHA8;MTMR14;VAC14;PI4K2B;SACM1L;PLA2G12A
gsea,receptor internalization (GO:0031623),0.3137566637221429,0.990033726361891,0.4811643835616438,0.5099875737505648,1.0,9/24,48.33%,TFRC;NEDD4;GTF2H2;GRK2;CLTC;FCER1G;SCYL2;RAMP2;DNM3
gsea,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.29989253874460825,-0.988712433365021,0.4562899786780384,0.6413843254720637,1.0,22/22,82.93%,NR4A1;ANXA1;NRP1;FLT1;NOTCH1;EGR3;PGF;DLL4;SPRY2;HSPB1;PIK3CA;PRKD2;VEGFA;SPHK1;RELA;ERN1;DAB2IP;RAMP2;MAP2K3;MAPKAPK2;NUS1;VEGFB
gsea,cellular response to insulin stimulus (GO:0032869),0.24322255959774353,0.9885875788432438,0.4936936936936937,0.5118731099133884,1.0,26/61,50.40%,PKM;PARP1;AKT1;PCK2;INSIG1;MYO5A;PRKDC;AP3S1;ATP6V0A2;PHIP;NAMPT;C2CD5;SELENOS;SHC1;PRKCI;SLC25A33;TCIRG1;SLC39A14;GOT1;TRIB3;PDPK1;CAV2;BCAR1;FOXC2;GRB10;XBP1
gsea,regulation of wound healing (GO:0061041),-0.31491972203518476,-0.988156348653291,0.4628712871287129,0.6397780633983587,1.0,18/18,91.89%,TNFAIP3;F2R;ANXA1;F2RL1;ITGB1;DMTN;FGF2;PLAU;ALOX5;ADRA2A;HBEGF;SERPINE1;VIL1;ARFGEF1;ACTG1;PRKCE;HRAS;SRSF6
gsea,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.323387909276873,0.9881313933402136,0.492600422832981,0.5121940657417838,1.0,7/17,35.21%,HSP90AB1;ABCE1;TTLL12;CACTIN;FADD;PTPN6;PTPN11
gsea,substrate adhesion-dependent cell spreading (GO:0034446),0.3449370687671409,0.9877677269731243,0.4643510054844607,0.5122988878563394,1.0,5/15,56.89%,KIF14;MEGF9;SRGAP2;ATRNL1;ANTXR1
gsea,negative regulation of ERBB signaling pathway (GO:1901185),-0.30093619936261623,-0.9841155395252378,0.4532520325203252,0.6450368572052276,1.0,22/22,91.30%,ITGA1;SPRY1;ERRFI1;PTPRJ;LGMN;SPRY2;PTPN3;HGS;EPS15L1;STAM;HBEGF;BTC;DUSP3;PTPN12;DAB2IP;TGFA;MVP;STAM2;CBL;AREG;EPS15;RNF126
gsea,cell-matrix adhesion (GO:0007160),-0.25915956712811744,-0.9822725570108345,0.46218487394957986,0.6458954859838185,1.0,37/37,95.97%,ITGA1;CD44;PEAK1;L1CAM;ACTN2;ITGB7;DLC1;PTPRK;FN1;CD63;ITGB1;ITGA4;ADAM9;VCL;ITGB8;TSC1;ITGA3;BCAM;COL17A1;ITGB4;CTTN;ITGB3;SIGLEC1;SORBS1;FBLN5;ITGA10;ITGA7;HPSE;BCR;VCAM1;TAOK2;TIAM1;MADCAM1;ACTN1;NPNT;PPFIA1;RCC2
gsea,positive regulation of apoptotic signaling pathway (GO:2001235),0.2874552136902718,0.9818000231209119,0.4990328820116054,0.5214602613719174,1.0,10/27,34.48%,BAX;RACK1;BCLAF1;TRAF2;FADD;BID;BBC3;WWOX;ING5;GSDME
gsea,inorganic cation import across plasma membrane (GO:0098659),-0.28794973281518527,-0.9794320041670361,0.4707792207792208,0.6491136872500279,1.0,25/25,75.96%,ATP2B4;SLC9A9;SLC12A6;SLC12A7;KCNJ8;ATP1B1;TRPV2;SLC8A1;ATP1A2;SLC12A5;SLC12A4;SLC9A2;ATP1A3;FXYD2;SLC9A1;KCNJ14;KCNJ10;CACNA2D1;SLC12A3;SLC39A14;SLC39A4;SLC39A6;SLC12A2;SLC39A10;ATP1A1
gsea,ceramide metabolic process (GO:0006672),0.32087468607000785,0.9771581420139142,0.5085066162570888,0.528693925241985,1.0,6/17,36.87%,ACER3;SMPD4;AGK;PLPP1;SMPD1;CLN6
gsea,positive regulation of cytokine production involved in immune response (GO:0002720),0.32674895647041863,0.9768124652271052,0.4853801169590643,0.5287834198033557,1.0,6/15,34.20%,SLC7A5;TNFSF4;TRAF2;CD55;LACC1;KIT
gsea,embryonic organ development (GO:0048568),0.33031138314190234,0.9755312172759346,0.4796084828711256,0.5304187689680675,1.0,9/21,48.13%,STIL;RPL10;KIT;MFSD2A;PBX4;ERCC3;ALDH1A3;PBX3;PBX2
gsea,glycerophospholipid biosynthetic process (GO:0046474),0.22316451587190697,0.974564326711162,0.4675324675324675,0.5315647029221715,1.0,37/90,48.56%,TAMM41;AGPAT5;CRLS1;PLA2G12A;LPCAT1;STARD7;CSNK2A2;SACM1L;PCYT2;PCYT1A;FAR1;PI4K2B;GNPAT;VAC14;MTMR14;AGK;GPAT4;ACP6;PTDSS2;PLEKHA8;SELENOI;MFSD2A;PIK3CG;GPD1L;PIKFYVE;AGPAT1;PIK3R6;CPNE3;PISD;MTMR4;CDIPT;PI4KA;PIK3R4;INPPL1;DGKE;CPNE1;PIK3CB
gsea,negative regulation of secretion by cell (GO:1903531),-0.31451674208887864,-0.9690714407249634,0.4925,0.667801536047965,1.0,16/16,87.96%,SLC30A1;RSAD2;ANXA1;NOTCH1;TNFRSF1A;SYT11;APOE;DRD4;LIF;OSM;CHGA;RHBDF1;SYT4;RHBDF2;VAMP8;HMGCR
gsea,receptor metabolic process (GO:0043112),0.28825785266159776,0.9683416618790939,0.5130293159609121,0.5413766081147047,1.0,12/28,48.33%,TFRC;NEDD4;GRK2;CLTC;SNX25;NSG1;KIF16B;REP15;PIK3R4;FCER1G;RAMP2;DNM3
gsea,positive regulation of Ras protein signal transduction (GO:0046579),-0.26731874998960503,-0.9668444569825114,0.48672566371681414,0.6698226313550344,1.0,32/32,92.88%,F2R;F2RL2;GPR174;ADGRG1;IRS2;LYN;RASGEF1A;NOTCH1;RAPGEF1;F2RL1;ERBIN;ARHGEF3;NOTCH2;GPR55;GPR35;JAK2;IGF1;ARRB1;ALS2;RASGRP1;GPR18;RASGRF1;EPOR;GPR65;PIK3CB;SHOC2;F2RL3;PIK3CG;MAP4K4;SHC1;NET1;LRRC59
gsea,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.25371474054881493,-0.9666882680049533,0.5023255813953489,0.6673426551700251,1.0,39/39,94.40%,UBB;PMEPA1;SPRY1;SMAD7;CRIM1;SKIL;BCL9L;SMAD3;NOTCH1;SKI;WNT1;FST;HTRA3;SPRY2;SIRT1;PPARG;SPRED3;RBPMS2;LEMD3;CIDEA;HSPA1A;SMAD5;HIPK2;BAMBI;SPRED2;SMAD1;SPRED1;PDPK1;MTMR4;EID2;ACVR1;TRIM33;ADAM17;SNX25;PRDM16;RPS27A;STRAP;STUB1;PIN1
gsea,circulatory system development (GO:0072359),0.25048093176919667,0.9664743592701428,0.5140495867768595,0.5439871286913,1.0,24/52,57.05%,CACYBP;MTHFD1;CDKN1A;KAT2A;ZDHHC16;SMYD4;NXN;SRF;PTPN11;PDLIM7;ACVR1;POPDC2;PDLIM1;DVL2;TNNI3;RAMP2;TSC2;FOXC2;SMG9;WDR11;MEF2C;NCOA6;NF1;POPDC3
gsea,phosphatidylinositol biosynthetic process (GO:0006661),-0.2291259511783507,-0.9633941853675991,0.5067178502879078,0.6712115061988341,1.0,65/65,84.59%,CISH;PIK3R1;SOCS1;INPP4B;ITPKB;PIK3CD;INPP5F;SOCS5;SOCS2;PIK3R5;PGAP3;PITPNM2;MTMR3;PTPN13;SLC27A1;RAB4A;SYNJ2;TTC7B;PIP5K1C;RUFY1;MTMR12;PIK3C2A;SYNJ1;PIK3CA;FGF2;SOCS3;PIGC;PI4KB;PIP4K2B;FAM126A;PGAP2;PIGV;FIG4;SOCS6;PIGN;SBF1;MTMR1;PLCG2;PLEKHA1;PIK3R2;IP6K2;PIGL;PIGG;FAM126B;PIK3CB;INPPL1;SOCS7;PIK3R4;PI4KA;CDIPT;MTMR4;PIGB;PIGH;PIK3R6;PIKFYVE;PIK3CG;PLEKHA8;MTMR14;PIGA;VAC14;PI4K2B;PIGQ;SACM1L;PIGU;PIGF
gsea,hematopoietic progenitor cell differentiation (GO:0002244),0.34209222038779186,0.9623132238200789,0.4882943143812709,0.5504565526039923,1.0,6/16,43.72%,MLF1;PRRC2C;ARMC6;KIT;UFL1;BATF
gsea,aminoglycan biosynthetic process (GO:0006023),-0.3273548072230356,-0.9608784838462401,0.506578947368421,0.6736275133478149,1.0,15/15,67.34%,GCNT2;XYLT1;SDC3;B3GALT5;SDC4;HEXA;SDC1;HS6ST1;PXYLP1;SLC35D2;GPC1;B4GAT1;HS2ST1;B3GNT3;B3GALT6
gsea,positive regulation of epithelial cell migration (GO:0010634),-0.23224844824626753,-0.9561103785703715,0.5535248041775457,0.6806228176536021,1.0,53/53,94.58%,ETS1;ZC3H12A;PIK3CD;PLCG1;PRKCA;HIF1A;CTSH;FOXP1;NRP1;IFNG;GLIPR2;PTK2B;THBS1;IQSEC1;RIN2;MMP9;DOCK1;GATA3;GRN;DOCK5;NRP2;TGFB2;ADAM9;PRKD2;FGF2;VEGFA;BCAS3;ANXA3;ABL1;SPARC;ITGB3;RAB25;PLCG2;EDN1;FOXC2;BCAR1;PIK3CB;VIL1;PPM1F;ENPP2;RHOB;HDAC6;PIK3CG;MAP4K4;MTOR;CLASP2;CLASP1;SCARB1;ROCK2;PRKCE;PFN1;AKT1;CALR
gsea,skeletal system development (GO:0001501),0.2773425781700116,0.9559602589250694,0.5398230088495575,0.5604331198209581,1.0,15/40,54.95%,PRDX1;TCOF1;VKORC1;RPL13;WWOX;DYM;FRZB;TRPS1;ZBTB16;PLS3;HAPLN4;ALPL;HYAL2;RPS6KA3;RFLNB
gsea,embryonic heart tube morphogenesis (GO:0003143),0.319435241103082,0.9555968088393421,0.5126811594202898,0.5605251378442343,1.0,7/16,40.84%,STIL;EOMES;SETDB2;SRF;DLL1;ACVR1;AHI1
gsea,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.27342532754125776,0.9552268346793548,0.5204460966542751,0.5606275931074238,1.0,13/30,51.41%,PIN1;STUB1;STRAP;RPS27A;PRDM16;SNX25;ADAM17;EID2;MTMR4;PDPK1;SPRED1;SPRED2;BAMBI
gsea,regulation of vesicle-mediated transport (GO:0060627),-0.25566743880895143,-0.9536151892328096,0.535796766743649,0.6828819927545323,1.0,35/35,75.83%,HIP1;NRP1;INPP5F;SYK;PACSIN1;FES;HCK;RAB5B;RUFY2;FGR;RAB4A;SYT7;RUFY1;RAB3D;PACSIN3;LRRK2;SPHK1;ABL1;HIP1R;HAP1;ZFYVE16;RAB25;STXBP5;PICALM;STON1;RAB13;TSC2;STON2;DNAJC13;RINT1;PACSIN2;NSF;USP7;RALA;SCARB1
gsea,B cell differentiation (GO:0030183),0.28647322616702076,0.9447585019266753,0.5443037974683544,0.5776620446228052,1.0,7/30,36.65%,SLC25A5;MSH2;TCF3;DCAF1;RABL3;KIT;ADAM17
gsea,sodium ion transport (GO:0006814),-0.29732698645184913,-0.9424567395184807,0.5173267326732673,0.7030585365685051,1.0,18/18,70.34%,SGK1;ATP1B1;SCN1B;SLC8A1;ATP1A2;SCN4B;SLC4A4;SLC6A11;ANO6;SLC12A3;SLC9B2;SLC6A6;SLC6A13;SLC6A12;SLC6A9;SLC4A8;SLC12A2;FGF13
gsea,negative regulation of multicellular organismal process (GO:0051241),-0.21256227230711633,-0.9414174228648413,0.5885714285714285,0.7023882580753145,1.0,88/88,94.58%,ATP2B4;SPRY1;DUSP10;IL1B;TNF;SMAD7;F2R;SPI1;OVOL2;PTGER4;EVL;DDIT3;IFNG;IL18R1;CHSY1;FCGR2B;FOXP3;PARP3;NOTCH1;ARRDC3;ALPK2;SYT11;MAP2K6;TLE3;SLAMF8;TWSG1;TIFAB;GATA3;GRN;GPNMB;KREMEN2;SPRY2;NR1H3;TIMP1;GSK3B;ADM;RGCC;TLR4;IL10;ARNTL;ATF4;SPRED3;WWC1;PROCR;LOXL2;KLF7;PFN2;TFE3;HDAC9;PLCL1;WNT11;RPS6KA6;ASB1;ID1;WNT10B;CIDEA;GAS6;FFAR4;PCTP;ABHD6;PTPN23;IL13;FOXA1;MEF2C;DAB2IP;RAB11FIP1;DOCK7;RGS2;SPRED2;FOXC2;USF3;SPRED1;SLC11A1;RB1;ROCK1;ADAM17;TNNT1;RPS6KA5;SRF;SFMBT1;PTCH1;ROCK2;CORO1C;WDR77;HMGCR;SRSF6;BRCA2;CALR
gsea,regulation of chemotaxis (GO:0050920),-0.32056837353707657,-0.9407247025050417,0.5433070866141733,0.7008707745371116,1.0,15/15,90.44%,ZSWIM6;ZSWIM8;THBS1;AIF1;F2RL1;PDGFB;ZSWIM4;ADGRA2;EFNB2;CXCR4;P2RX4;GPR183;DUSP3;PPM1F;USP14
gsea,phospholipid translocation (GO:0045332),-0.316373840897999,-0.9396006091458847,0.5462184873949579,0.7002612360109886,1.0,15/15,68.43%,ABCB4;ABCA7;PLSCR4;PLSCR1;ABCA1;ATP8B2;ATP8A1;ATP11A;ANO6;ATP10A;PLSCR3;ATP8B4;MFSD2A;ATP11C;ABCC1
gsea,positive regulation of actin filament bundle assembly (GO:0032233),-0.2671101801139406,-0.9393312641592809,0.546236559139785,0.6980039217644044,1.0,28/28,89.10%,RHOC;S100A10;EVL;NRP1;ARHGEF10L;RGCC;LIMK1;LIMCH1;FHOD1;PAK1;ABL1;ARHGEF5;PLEK;SYNPO;TGFB3;PFN2;WNT11;NF2;CCDC88A;SORBS3;GPR65;VIL1;PPM1F;CX3CL1;ROCK2;SYNPO2;TPM1;PFN1
gsea,heart development (GO:0007507),0.24454115496020237,0.936390253267612,0.5837173579109063,0.591182053685703,1.0,23/57,57.05%,CACYBP;MTHFD1;CDKN1A;KAT2A;ZDHHC16;SMYD4;SRF;PTPN11;PDLIM7;ACVR1;POPDC2;PDLIM1;DVL2;TNNI3;RAMP2;TSC2;FOXC2;SMG9;WDR11;MEF2C;NCOA6;NF1;POPDC3
gsea,sulfur compound biosynthetic process (GO:0044272),0.24442551399289508,0.9356241630203072,0.5619389587073609,0.5919928526349174,1.0,24/43,60.55%,GSTO1;METTL16;MAT2A;GSTZ1;LIAS;GSS;CHPF;B4GALT5;GGCT;B3GNT3;CHST15;B4GAT1;CTH;SLC35D2;CHAC2;CBS;B4GALT4;GSTM5;SLC26A2;CHAC1;CHSY3;GCLC;CSGALNACT2;DSEL
gsea,positive regulation of protein localization to cell periphery (GO:1904377),-0.2640163935667237,-0.9354099463003954,0.533066132264529,0.7031378809481624,1.0,30/30,90.95%,LGALS3;ATP2B4;PIK3R1;TNF;IFNG;LRP1;EPB41;ITGB1;ITGA3;SORBS1;ZDHHC5;PLS1;RAMP3;AKAP5;PTPN9;EPHA3;ZDHHC8;PDPK1;CLIP3;PRKCI;NKD2;CNPY4;KIF5B;EPB41L2;PRKCE;SPTBN1;RANGRF;NUMA1;AKT1;GPSM2
gsea,sphingolipid biosynthetic process (GO:0030148),0.2896664150450439,0.9337670126456996,0.56,0.5945639935072522,1.0,12/27,48.23%,HACD3;HACD2;ACER3;SMPD4;AGK;PLPP1;SMPD1;ELOVL6;ELOVL4;ST3GAL5;PRKD3;HACD1
gsea,positive regulation of protein localization to plasma membrane (GO:1903078),-0.26233348162145687,-0.9323726089025346,0.5544147843942505,0.7064995030127611,1.0,31/31,90.00%,LGALS3;ATP2B4;PIK3R1;TNF;IFNG;LRP1;ITGB1;CLN3;ITGA3;SORBS1;ZDHHC5;PLS1;RAMP3;CNST;AKAP5;PTPN9;EPHA3;ZDHHC8;PDPK1;CLIP3;PRKCI;NKD2;CNPY4;KIF5B;ACSL3;PRKCE;SPTBN1;RANGRF;RACK1;ZDHHC2;AKT1
gsea,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.3190957327969082,-0.9307770591205462,0.5534883720930233,0.7068354384201859,1.0,15/15,90.00%,BCL2L1;BCL2;IL1B;TNF;CSF2;RET;PF4;INHBA;HSPA1B;MAPK7;HSPA1A;EYA3;PPP2R1B;HTRA2;AKT1
gsea,axonogenesis (GO:0007409),0.21556733673467293,0.9279896249467269,0.5883333333333334,0.603882398262411,1.0,39/84,54.84%,HSP90AB1;HSP90AA1;NEFH;BSG;ACTB;EZR;SPTBN1;DSCAM;RYK;KIF5B;AFG3L2;RPS6KA5;PPP3CB;C9ORF72;B4GALT5;PTPN11;SHC1;PDLIM7;USP9X;SPG11;NCAM1;SPTAN1;ARHGAP35;MAP1A;NEXN;GPC1;CYFIP1;TAOK2;SEMA4C;PIK3CB;PALLD;EPHA3;GRB10;APBB1;USP33;DOCK7;KIF5C;GRB7;BAIAP2
gsea,synapse assembly (GO:0007416),0.329627778530653,0.9273515382027822,0.5694682675814752,0.6043684539777174,1.0,10/15,53.33%,DSCAM;RYK;FGF13;PLXND1;LGI2;NLGN2;DNM3;FARP1;SPOCK2;DVL1
gsea,cellular response to mechanical stimulus (GO:0071260),-0.2758818472168292,-0.9270484768938391,0.5462184873949579,0.7114816448710118,1.0,25/25,92.67%,IRF1;TNFSF14;NFKB1;IL1B;PTGER4;CD40;MAP3K14;TNFRSF1A;GADD45A;CASP1;TLR7;LTBR;TLR4;SLC9A1;FAS;BNIP3;HABP4;MAP3K1;PIEZO1;MAPK8;TNFRSF10B;FADD;BAK1;CASP8AP2;CHEK1
gsea,phosphatidic acid biosynthetic process (GO:0006654),0.28668121811044567,0.926829228651353,0.5594149908592322,0.6046810914963968,1.0,8/23,40.15%,AGPAT5;PLA2G12A;LPCAT1;GNPAT;GPAT4;ACP6;GPD1L;AGPAT1
gsea,spermatid development (GO:0007286),0.32954337404093,0.9223982593911656,0.5967213114754099,0.6116413280978856,1.0,6/15,48.09%,CEP57;RNF8;YTHDC2;SPINK2;CDYL;IQCG
gsea,very long-chain fatty acid metabolic process (GO:0000038),0.3329565383738995,0.9206383897302899,0.5506807866868382,0.6139702991323592,1.0,10/16,51.67%,HACD3;HACD2;ABCD3;ACSL1;ACSL6;ELOVL6;ELOVL4;PEX2;HACD1;SLC27A2
gsea,cellular response to peptide hormone stimulus (GO:0071375),0.23590743585900664,0.9188062862252735,0.6036697247706422,0.6164330191589044,1.0,23/49,56.62%,PKM;PARP1;AKT1;PCK2;INSIG1;MYO5A;PRKDC;PRKAR2A;C2CD5;SELENOS;PRKAR2B;PRKCI;SLC25A33;SLC39A14;GOT1;TRIB3;PDPK1;XBP1;RAB13;PIK3R2;TSHR;CAPN10;ENPP1
gsea,regulation of heart contraction (GO:0008016),-0.24163863653931533,-0.9176236049985251,0.6006493506493507,0.7279864563812932,1.0,36/36,87.24%,ATP2B4;ITPR2;SMAD7;S100A1;ATP2A3;RYR1;ATP2B2;FXYD1;CAMK2D;FXYD7;ATP1B1;SLC8A1;ATP1A2;RNF207;TGFB2;ATP1A3;FXYD2;KCNG2;P2RX4;ITPR3;TMEM65;FXYD3;TBX2;APLN;PLN;ASPH;ITPR1;NPPC;NOS1;TRPC1;AHCYL1;ATP1A1;TPM1;CALM2;CELF2;ATP2A2
gsea,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.2881612204608276,0.9134305517487646,0.5851272015655578,0.6239598134438669,1.0,12/22,44.67%,LMAN1;TMED2;CTSZ;NSF;CUL3;SEC23IP;SEC24D;AREG;ANKRD28;PPP6R3;PPP6R1;USO1
gsea,COPII vesicle coating (GO:0048208),0.2881612204608276,0.9134305517487646,0.5851272015655578,0.6239598134438669,1.0,12/22,44.67%,LMAN1;TMED2;CTSZ;NSF;CUL3;SEC23IP;SEC24D;AREG;ANKRD28;PPP6R3;PPP6R1;USO1
gsea,vesicle coating (GO:0006901),0.2881612204608276,0.9134305517487646,0.5851272015655578,0.6239598134438669,1.0,12/22,44.67%,LMAN1;TMED2;CTSZ;NSF;CUL3;SEC23IP;SEC24D;AREG;ANKRD28;PPP6R3;PPP6R1;USO1
gsea,myelination (GO:0042552),0.300032884047423,0.9095438210677573,0.5684210526315789,0.6299244090740814,1.0,6/18,45.72%,EIF2B5;EIF2B4;ACER3;B4GALT5;TNFRSF21;GPC1
gsea,visual perception (GO:0007601),0.2885631510829072,0.909533591015297,0.5948795180722891,0.6293894387210205,1.0,10/28,45.77%,OAT;RABGGTB;OPA3;OPA1;CRYZ;RP2;CEP250;CRYBG3;EYA3;REEP6
gsea,protein K63-linked deubiquitination (GO:0070536),0.29048520098086744,0.9087161711041352,0.5949119373776908,0.6300940370562477,1.0,9/17,45.28%,SHMT2;PSMD14;BRCC3;ABRAXAS1;USP7;OTUD4;STAMBPL1;USP8;STAMBP
gsea,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.2617221985986071,-0.9038972008101205,0.5870020964360587,0.7534179949936376,1.0,28/28,93.89%,TNFAIP3;TNF;SYK;CASP4;MADD;F2RL1;TNFRSF1A;CASP1;SPATA2;BIRC3;SPHK1;TRAF1;HSPA1B;RIPK1;HIPK1;SPPL2B;GAS6;IKBKG;HSPA1A;BIRC2;CPNE1;CLIP3;CHUK;ADAM17;FADD;TRAF2;RACK1;TRAIP
gsea,amide biosynthetic process (GO:0043604),0.32964069997474466,0.9031301584937864,0.58887171561051,0.6390709451341383,1.0,5/15,35.82%,NMRAL1;NANP;SMPD4;AGK;SMPD1
gsea,muscle organ development (GO:0007517),-0.28658611009398266,-0.9030442580280924,0.6,0.7521607336855146,1.0,18/18,71.42%,UTRN;EGR3;ZBTB42;CHD2;IGF1;VAMP5;CXCL10;FKTN;HBEGF;SPEG;ITGA7;MRAS;COL6A3;MEF2C;TCF12;NEB;SMTN;COPRS
gsea,regulation of anatomical structure morphogenesis (GO:0022603),-0.21519934216139214,-0.8992459966370516,0.6586538461538461,0.7568226379480236,1.0,59/59,93.16%,TNFAIP3;SP100;ETS1;LZTS1;PID1;BCL9L;STAT2;ABI3;BCL6;TNIK;PDLIM5;FMNL2;CEACAM1;ADGRA2;GPNMB;GSK3B;KIF1A;STRIP1;FGF2;PAK1;CXCL13;LRRK2;ARC;DAG1;SH3D19;KIF13B;HMOX1;SIPA1L1;SPARC;ZDHHC15;TANC2;HECW2;PHLDB2;VASH2;NF1;ZMYM3;MEF2C;KNDC1;HECW1;VASH1;ZMYM4;ARHGAP35;CTNNB1;POGLUT1;DLL1;CAMSAP1;PDZD8;ABI2;RUFY3;RAP2A;PLXND1;PHIP;CLASP2;INF2;CLASP1;EGLN1;NEDD4;LARP4;CFL1
gsea,plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.2784473766980562,-0.8978565507800639,0.5849056603773585,0.7566584600702743,1.0,22/22,95.65%,UBB;KLK8;PACSIN1;SGK1;TNIK;SHTN1;TAOK1;MINK1;ALS2;PAK1;LRRK2;BMP7;CTTN;NCKAP1;ANKRD27;DAB2IP;TAOK2;SRGAP2;MAP4K4;DCLK1;DICER1;KIF20B
gsea,regulation of cell morphogenesis (GO:0022604),0.28532239141687743,0.8961338370595475,0.5932203389830508,0.6502464453263146,1.0,8/19,47.51%,CFL1;LARP4;PHIP;PDZD8;CAMSAP1;MFSD2A;ZMYM4;VIL1
gsea,glycoprotein biosynthetic process (GO:0009101),0.24147373285648124,0.8956907951005473,0.6152416356877324,0.6504002583883827,1.0,16/36,51.43%,DDOST;SERP1;ALG3;NUS1;B3GALT6;B4GALT5;MPI;SERP2;FUT4;FAM20B;B3GNT3;ST3GAL5;ALG10B;B3GALNT2;COG7;TMEM106A
gsea,axon development (GO:0061564),0.2739310344770571,0.8950988079386102,0.6297640653357531,0.6508610486640712,1.0,14/24,56.03%,DHFR;NEFH;ACTB;ZPR1;RYK;AFG3L2;MTR;ARHGAP35;MAP1A;TAOK2;APBB1;DOCK7;BAIAP2;LLGL1
gsea,determination of heart left/right asymmetry (GO:0061371),0.3052305914859219,0.8931102810244407,0.6078431372549019,0.6530732772064395,1.0,6/15,40.84%,STIL;EOMES;SETDB2;SRF;DLL1;AHI1
gsea,heart looping (GO:0001947),0.3052305914859219,0.8931102810244407,0.6078431372549019,0.6530732772064395,1.0,6/15,40.84%,STIL;EOMES;SETDB2;SRF;DLL1;AHI1
gsea,positive regulation of cell projection organization (GO:0031346),0.2364356653647883,0.8905011366406365,0.6424682395644283,0.6570466668814072,1.0,21/44,53.64%,ARHGDIA;CAPRIN1;METRN;SS18L2;SETX;CARMIL2;PLXND1;FBXW8;ARSB;PRKCI;CDKL3;ARHGAP35;CX3CL1;DVL2;TIAM1;EPHA3;PLXNA1;DAB2IP;CUL7;DVL1;TOX
gsea,zymogen activation (GO:0031638),-0.308244561334579,-0.8883039148033075,0.6416861826697893,0.7731539698454715,1.0,15/15,95.02%,VSIR;PERP;FURIN;CTSH;LGMN;MMP14;CTSL;PLAU;PLAT;ASPH;OMA1;RIPK2;FADD;BAK1;PGK1
gsea,negative regulation of TOR signaling (GO:0032007),0.27335999275054734,0.8870494515647328,0.6375968992248062,0.6624140984970329,1.0,10/23,55.18%,DDIT4;TBC1D7;ITFG2;ATM;DEPDC5;NPRL3;PRKAA1;TSC2;AKT1S1;RNF152
gsea,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.31408490472625517,0.8855192650122424,0.6013400335008375,0.6644824042988888,1.0,6/16,68.44%,LRRC59;SHC1;SHOC2;EPOR;RASGRF1;RASGRP1
gsea,JNK cascade (GO:0007254),0.28291968362412667,0.884983693223574,0.6073619631901841,0.6647845536856241,1.0,6/18,39.98%,UBE2N;GPS1;RPS27A;TAB1;MAPK8;RIPK2
gsea,cellular response to retinoic acid (GO:0071300),0.3295568277615385,0.8845088261183544,0.6305916305916306,0.6649891298224151,1.0,5/17,34.33%,HTRA2;SETX;TESC;CREB1;ATM
gsea,regulation of protein tyrosine kinase activity (GO:0061097),-0.29982406454627886,-0.8827783935116333,0.6077481840193705,0.7815599827659478,1.0,15/15,73.89%,NEDD9;APP;CASS4;CSF1R;PDGFB;SH3BP5;PRNP;RAP2B;GAS6;NCK2;HYAL2;RAP2C;MVP;SHC1;LRP8
gsea,mRNA destabilization (GO:0061157),-0.2728110842041261,-0.8819002906154557,0.6303939962476548,0.7804075482922759,1.0,22/22,91.68%,ZFP36;ZFP36L2;ZFP36L1;ZC3H12A;RC3H2;PLEKHN1;MOV10;DIS3L2;RIDA;METTL3;GIGYF2;FTO;ROCK1;ZC3H12D;CELF1;UPF1;METTL14;CNOT1;ROCK2;METTL16;KHSRP;TARDBP
gsea,regulation of cardiac muscle contraction (GO:0055117),-0.28451047907050014,-0.880286361324884,0.6567901234567901,0.7807551839701278,1.0,16/16,87.24%,ZC3H12A;PDE4B;SMAD7;ATP1B1;SLC8A1;RNF207;SLC9A1;P2RX4;PLN;CHGA;RGS2;TNNI3;NOS1;PIK3CG;CALM2;ATP2A2
gsea,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.26081040986841636,-0.8796118814432727,0.6539278131634819,0.7791468812190809,1.0,27/27,88.70%,CSF1;ZBP1;HIF1A;PARP14;CASP4;CD300LF;CASP1;C1QTNF4;PARP9;AXL;CXCR4;HSPA1B;RIPK1;TXK;GAS6;HSPA1A;MAVS;AGPAT2;GFI1;EDN1;CPNE1;AGPAT1;TICAM2;ADAM17;TRIM44;FADD;CD74
gsea,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.2981531808080057,0.8794818210989789,0.6319018404907976,0.6730750398893681,1.0,6/16,50.41%,PARK7;HERPUD1;OPA1;SELENOS;XBP1;BOK
gsea,regulation of MAP kinase activity (GO:0043405),-0.2214003417845586,-0.8794083548966967,0.6692111959287532,0.7765874784171622,1.0,48/48,98.19%,DUSP1;SPRY1;IL1B;TNF;CD300A;FLT1;CD40;PTPRJ;LYN;ADAM8;PIK3R5;PDGFB;APOE;IRAK3;SH2B3;TRIB1;SPRY2;TRIB2;KSR1;FGF2;FLT3;VEGFA;LRRK2;PDGFA;BMP7;RASGRP1;SPRY4;HGS;DUSP7;ADRA2A;NF1;CDK12;EDN1;HYAL2;DAB2IP;RGS2;PIK3CB;DUSP19;TRIB3;TNFSF11;PIK3R6;PAQR3;PIK3CG;UCHL1;SMPD1;KIT;HRAS;EZH2
gsea,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.2327146535773553,-0.8772346763381756,0.6270161290322581,0.7778757597532958,1.0,38/38,90.40%,UBB;NFKBIA;REL;TNF;CARD11;MAP3K14;TLR2;TIFA;TNFRSF1A;TLR7;NLRC3;CD14;BCL3;TBKBP1;BIRC3;TLR4;RIPK1;RELA;IKBKG;TAB3;RELB;DAB2IP;MAP3K7;BIRC2;NKIRAS2;RIPK2;ROCK1;TAB1;CHUK;ERC1;TICAM2;TANK;TRAF2;ROCK2;RPS27A;IRAK1BP1;AKT1;PRDX4
gsea,regulation of cell adhesion mediated by integrin (GO:0033628),-0.2895668090298963,-0.8734685122851007,0.6484018264840182,0.7822268735853305,1.0,16/16,71.11%,SYK;LYN;RET;MUC1;TGFB2;ADAM9;PLAU;PDE3B;LIF;SERPINE1;FOXC2;ADA;PIK3CG;DPP4;PTPN11;TESC
gsea,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.284739645209946,0.8720168271406453,0.6490630323679727,0.6852306554289435,1.0,9/21,49.68%,STK39;NEDD4;RANGRF;PRKCE;FGF13;GPD1L;SLMAP;NETO1;HECW1
gsea,negative regulation of cell junction assembly (GO:1901889),0.3469671747486424,0.869277549067979,0.6535433070866141,0.6891266887840386,1.0,6/15,43.97%,RCC2;CORO1C;ROCK2;CLASP2;ROCK1;DUSP22
gsea,glycolipid metabolic process (GO:0006664),-0.26322927660220646,-0.8692255120143896,0.6276803118908382,0.7875771102912653,1.0,22/22,78.81%,GM2A;PGAP1;NAGA;PGAP3;ST3GAL6;ST6GALNAC3;GLA;CERK;ABCA2;B3GNT5;HEXA;GALC;NEU1;ST3GAL4;ST6GALNAC6;GBA2;ST6GALNAC4;SMPD1;CPTP;SMPD4;SUMF2;SCCPDH
gsea,negative regulation of protein secretion (GO:0050709),-0.28011054939765656,-0.8691566401815002,0.6229050279329609,0.784747714627156,1.0,16/16,87.96%,IL1B;F2R;RSAD2;APOE;MIDN;NR1H3;DRD4;ADRA2A;CD200;CHGA;RHBDF1;RAB11FIP1;SIRT4;REST;RHBDF2;HMGCR
gsea,phosphatidic acid metabolic process (GO:0046473),0.26634293605771514,0.8686596204423017,0.6390423572744015,0.6895682665602595,1.0,10/24,47.61%,AGPAT5;PLA2G12A;LPCAT1;GNPAT;GPAT4;ACP6;GPD1L;AGPAT1;DGKE;PLA2G6
gsea,positive regulation of Notch signaling pathway (GO:0045747),-0.2612688383043513,-0.8675525445083028,0.6595238095238095,0.7850649378034348,1.0,23/23,78.83%,MAML2;STAT3;NOTCH1;EP300;TSPAN5;WNT1;AAK1;DLL4;ZMIZ1;TGFB2;IL6ST;CREBBP;YAP1;MAML3;ENHO;EPN2;KAT2B;JAG2;NEPRO;POGLUT1;PRKCI;DLL1;BMP2K
gsea,regulation of interferon-beta production (GO:0032648),0.24237981845446518,0.8658819330234914,0.6873786407766991,0.6936262464326668,1.0,17/32,57.62%,HSP90AA1;DHX9;CACTIN;POLR3D;YY1;DDX3X;POLR3G;PTPN11;TRAF3;RIPK2;POLR3B;POLR3F;POLR3A;IFIH1;IRF5;RELB;MAVS
gsea,potassium ion transmembrane transport (GO:0071805),-0.24144254278728605,-0.865742038185339,0.7407407407407407,0.785507770318714,1.0,31/31,75.96%,SLC9A9;SLC12A6;SLC12A7;KCNJ8;ATP1B1;KCNC1;ATP1A2;KCNK7;SLC12A5;SLC12A4;SLC9A2;ATP1A3;FXYD2;SLC9A1;KCNG2;KCNK10;KCNAB1;KCNK13;KCNJ14;KCNQ3;KCNJ10;SLC12A3;KCNK5;SLC9A8;ABCB8;CCDC51;SLC12A2;KCNQ5;KCNN4;KCNAB2;ATP1A1
gsea,regulation of hydrolase activity (GO:0051336),0.2581163031336069,0.8639495438282181,0.662431941923775,0.6962665018214196,1.0,11/27,53.45%,RDX;TDG;TBC1D10B;ADAP1;PLXND1;NOS1;VAV2;EPHA3;PLXNA1;DAB2IP;RAB3GAP1
gsea,glycosphingolipid metabolic process (GO:0006687),-0.27800829875518673,-0.8636185401788725,0.6600790513833992,0.7868176810906383,1.0,17/17,72.27%,GM2A;ST6GALNAC3;GLA;CERK;ABCA2;HEXA;GALC;NEU1;ST6GALNAC6;ST8SIA1;GBA2;ST3GAL5;CLN6;SMPD1;CPTP;SMPD4;SUMF2
gsea,cellular response to peptide (GO:1901653),-0.25247794747199936,-0.8635139924397492,0.662303664921466,0.7840870467235855,1.0,28/28,94.42%,ZFP36L1;ICAM1;ADRB2;FCGR2B;CASP4;APP;LRP1;CD36;LGMN;IGF1;GSK3B;ITGA4;TLR4;ATP1A3;TRIM41;PRNP;ARHGEF2;GRIN1;VIM;CACNA2D1;VCAM1;XBP1;CACNA1A;RIPK2;MDM2;ABCC1;DDX11;TIMELESS
gsea,regulation of epithelial cell migration (GO:0010632),-0.24010045829634652,-0.8633022121023418,0.6675,0.7815975425096838,1.0,28/28,89.10%,DUSP10;PLCG1;HIF1A;CTSH;EVL;IFNG;GLIPR2;GLUL;CEACAM1;DOCK1;MACF1;DOCK5;TGFB2;PFN2;RAB25;PLCG2;PTPN23;DAB2IP;VIL1;PPM1F;ENPP2;HDAC6;ARSB;CLASP2;CLASP1;PRKCE;CORO1C;PFN1
gsea,organonitrogen compound biosynthetic process (GO:1901566),0.22390143400535137,0.8616661771017042,0.7335203366058906,0.6993959094704523,1.0,37/70,60.91%,GSTO1;NMRAL1;NANP;GSTZ1;TYW1;LPCAT1;STARD7;CSNK2A2;HACD3;PCYT1A;ALAS1;HACD2;ACER3;TYW5;B4GALT5;GPAT4;PLPP1;MFSD2A;GPHN;ELOVL6;ELOVL4;PRKD3;HACD1;ASS1;PCSK1;GSTM5;SLC44A1;PLPP2;ELOVL2;ALDH3A2;PCTP;SLC25A15;LCMT2;ARG1;SLC25A2;ACHE;FA2H
gsea,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.2827678789358067,-0.8614994072834717,0.6604774535809018,0.7821962179457363,1.0,17/17,71.79%,NFATC1;PLCB2;NLK;TCF7L2;FZD6;AGO1;WNT11;FZD3;PDE6A;FZD4;MOV10;MAP3K7;AGO2;CTNNB1;LEF1;PPP3CB;TNRC6A
gsea,monocarboxylic acid transport (GO:0015718),-0.26700036625564644,-0.8610026322620207,0.652452025586354,0.7803163969397258,1.0,20/20,73.38%,RXRA;ABCB4;SLC16A6;CD36;SLC27A1;CEACAM1;SLCO3A1;NCOA1;NCOA2;SLC6A11;STARD5;SLC16A11;SLC6A13;SLCO2A1;ABCC4;SLC6A12;SLC16A13;SLC16A1;ABCG2;SLC16A3
gsea,Wnt signaling pathway (GO:0016055),-0.21941497893167833,-0.8530657271428205,0.7435064935064936,0.7925483860073741,1.0,45/45,81.62%,UBB;NR4A2;WLS;BCL9L;WNT1;TCF7L2;RARG;DVL3;CCDC88C;GSK3B;FZD7;CSNK1G1;CSNK1E;LRRK2;CPE;FZD6;BTRC;WNT11;WNT4;WNT2B;WNT10B;SFRP4;WNT6;PLCG2;WNT3;FZD3;FZD4;LRP6;DVL1;STRN;WNT10A;DVL2;AXIN1;CTNNB1;FRZB;LEF1;DIXDC1;DDX3X;NXN;RYK;USP34;TCF7;CUL1;VPS35;RPS27A
gsea,eye development (GO:0001654),0.2833240820679076,0.8501771129653742,0.6888217522658611,0.7184125454267771,1.0,10/21,53.45%,ZDHHC16;CEP290;PBX4;SCO2;SMOC1;PBX3;PBX2;SMG9;HIPK2;RAB3GAP1
gsea,modulation of chemical synaptic transmission (GO:0050804),-0.2239952023088455,-0.8442102479919632,0.7171717171717171,0.8060054791759571,1.0,35/35,88.43%,CX3CR1;BAIAP3;IL1B;TNF;MCTP2;APP;DLGAP4;SYN1;ABR;HOMER1;ITGB1;ATP1A2;KCNMB4;CLN3;CLSTN1;LRRK2;ARC;TMEM108;MCTP1;NPTX1;IQSEC2;CACNA1B;BCR;MEF2C;DGKI;NLGN2;CACNA1A;UNC13A;SLC4A8;SLC12A2;KCTD13;LRP8;FMR1;USP46;PSMC5
gsea,cellular response to calcium ion (GO:0071277),0.2733995587571313,0.8423363761305355,0.6926994906621392,0.730903130361428,1.0,13/25,58.73%,ECT2;PPIF;CLIC4;CPNE2;SMPD1;ADD1;CPNE3;PRKAA1;CPNE1;MEF2C;SYT4;CPNE9;PLCG2
gsea,negative regulation of fat cell differentiation (GO:0045599),0.2682470511761974,0.8403606861685715,0.6783625730994152,0.7334899534035054,1.0,7/20,60.46%,E2F1;ANKRD26;ASXL1;TRIB3;ZADH2;ENPP1;WNT10B
gsea,muscle contraction (GO:0006936),0.23880075765773687,0.835335017444456,0.7207792207792207,0.7411607175037619,1.0,16/38,46.45%,TPM3;TPM4;TPM1;ALDOA;ROCK2;CACNA1S;TTN;SMTN;TNNT1;NEB;ROCK1;MYL6B;MYLPF;LMOD3;NOS1;TNNI3
gsea,regulation of transport (GO:0051049),-0.26968569511208856,-0.833062045298687,0.6854663774403471,0.8234398755784067,1.0,17/17,86.34%,PINK1;DNAJA1;NRP1;FES;MYO6;EPB41;WWC1;LRRK2;TRAT1;RAB25;CLDN10;ICA1;REEP6;GAPVD1;ACTG1;YRDC;ACTB
gsea,dephosphorylation (GO:0016311),-0.19943637599085723,-0.8312491751521164,0.7981132075471699,0.823867365478731,1.0,65/65,95.66%,DUSP2;DUSP5;DUSP4;DUSP1;PPM1J;PTPRE;DUSP10;PTPRJ;DUSP16;SSH2;CTDSP2;SSH1;MTMR3;PTPRK;PTPN13;PTPRS;ACP2;PTPN5;BTRC;PTPN3;DUSP7;PPP4R1;PPM1L;PTPRM;DUSP23;SBF1;PLPP2;PXYLP1;DUSP3;PDP1;PTPN12;PPM1M;DUSP18;PTPN9;ALPL;CTDSP1;PPM1F;PPP4R2;CTDNEP1;UBLCP1;MTMR4;DUSP6;LHPP;PLPP5;PPP2R1B;TAB1;CTDP1;PPP2R3A;PLPP1;ACP6;PPP3CB;DUSP12;PPP2CB;PTPN6;FRA10AC1;PPP1CB;HDHD2;PPP2R5D;PDXP;PTPN7;PSPH;PPP5C;PPM1G;TIMM50;PGP
gsea,anterograde axonal transport (GO:0008089),0.2630764276274072,0.8309647104693705,0.7163375224416517,0.7478757799833275,1.0,13/21,59.12%,BLOC1S2;AP3S1;AP3M1;KIF5B;AP3D1;AP3B1;MAP1A;KIF1C;AP3M2;KIF5C;NEFL;KIF3A;BLOC1S5
gsea,sensory perception of light stimulus (GO:0050953),0.2621166319167081,0.8299663747298162,0.7298937784522003,0.7488062243299185,1.0,13/27,55.88%,OAT;RABGGTB;OPA3;OPA1;CRYZ;RP2;CRYBG3;EYA3;CDH23;USH1C;RPGR;TRPM1;GNAT1
gsea,protein localization to Golgi apparatus (GO:0034067),0.2789845319600184,0.8296188259653827,0.6935817805383023,0.7487279394229817,1.0,6/15,41.40%,ARL1;OPTN;GCC2;BICD2;PAQR3;GAK
gsea,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.26021755912801964,-0.8288085761467702,0.7126213592233009,0.8253100972167363,1.0,21/21,89.48%,PPP1R15A;CEBPB;BCL2;ATP2A3;DDIT3;CASP4;ATF4;MAP3K5;CHAC1;ERN1;DAB2IP;ITPR1;TRIB3;QRICH1;TNFRSF10B;BBC3;TRAF2;DNAJC10;BAK1;AIFM1;BAX
gsea,actin cytoskeleton reorganization (GO:0031532),-0.2324682649608199,-0.8270859897463214,0.7135678391959799,0.8253754246315932,1.0,31/31,85.34%,GSN;NEDD9;ANXA1;NRP1;S1PR1;S1PR2;CASS4;TNIK;RICTOR;DMTN;PARVB;MINK1;FARP2;PAK1;PLEK;SIPA1L1;MCU;CTTN;PDLIM4;ANTXR1;CAPN10;THSD7B;PLEK2;BCAR1;GPR65;RAP2A;KIT;MYH9;RALA;FLNA;EZR
gsea,regulation of cytoskeleton organization (GO:0051493),0.22285261646115664,0.8249643460742474,0.7634069400630915,0.755643582273915,1.0,25/52,52.60%,EZR;IQGAP3;CORO1A;CLIC4;ROCK2;SH3BP1;CLASP1;MTOR;BICD1;IQGAP2;BICD2;ROCK1;BST1;TRAF3IP1;ARHGAP35;RHOB;NEXN;PRKAA1;TAOK2;MLST8;DIAPH1;BST2;EPHA3;SORBS3;CCDC88A
gsea,lymphocyte differentiation (GO:0030098),0.2294627941220284,0.82130652630063,0.7571214392803598,0.7608260876680769,1.0,16/42,58.73%,SLC25A5;MSH2;TCF3;DCAF1;KAT7;RABL3;KIT;ADAM17;TPD52;VCAM1;TOX;IKZF1;JAG2;RELB;LYL1;PLCG2
gsea,synapse organization (GO:0050808),0.2267583138780495,0.8203122948392507,0.7395833333333334,0.7617483955101187,1.0,20/40,53.33%,PIN1;CHCHD10;NEDD4;DSCAM;DCTN1;RYK;PLXND1;PPFIA1;RAB39B;UNC13A;GPHN;CX3CL1;CYFIP1;PPFIBP1;NLGN2;DNM3;REST;FARP1;SPOCK2;DVL1
gsea,canonical Wnt signaling pathway (GO:0060070),-0.22624434389140272,-0.8191330386405914,0.8129496402877698,0.836653400079191,1.0,34/34,77.48%,NR4A2;FRAT2;BCL9L;WNT1;TCF7L2;GATA3;RARG;DVL3;GSK3B;FZD7;CSNK1E;LRRK2;FZD6;WNT11;WNT4;WNT2B;WNT10B;SFRP4;WNT6;WNT3;FZD3;FZD4;LRP6;DVL1;SCYL2;WNT10A;DVL2;AXIN1;CTNNB1;FRZB;LEF1;DIXDC1;RYK;TCF7
gsea,membrane protein proteolysis (GO:0033619),0.25472052959760655,0.8189273565757049,0.7282608695652174,0.7633046293264819,1.0,9/21,48.18%,CLPP;ERAP1;PARL;RBMX;AFG3L2;MYH9;ADAM17;TMPRSS6;MBTPS2
gsea,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.24385398064731562,0.8187441239111614,0.7323651452282157,0.7629544980013815,1.0,9/23,39.00%,PHB;NEDD4;SAFB;DDX54;TRERF1;TADA3;PLPP1;ARID1A;MED1
gsea,regulation of developmental growth (GO:0048638),-0.26916030338520897,-0.8173646849252507,0.7192118226600985,0.8368847426102719,1.0,15/15,77.06%,LATS2;OLFM1;APP;APOE;IGF1;GSK3B;NRCAM;ABL1;CTTN;STAT5B;LATS1;STAT5A;MFSD2A;DLL1;SIN3A
gsea,positive regulation of signaling (GO:0023056),-0.27757442654953635,-0.8099252928775995,0.7116704805491991,0.846748125111656,1.0,15/15,72.31%,TNF;INPP5F;WLS;HOMER1;GATA3;ECE1;CLSTN1;RAMP3;PTPN23;EDN1;CD80;SCRIB;KCTD13;NSF;ANXA2
gsea,regulation of epithelial to mesenchymal transition (GO:0010717),0.23900676797025597,0.8082350906680169,0.7530487804878049,0.779016154972201,1.0,15/37,53.93%,EZH2;CLASP1;CLASP2;MTOR;LEF1;CTNNB1;TWIST1;TIAM1;SPRED1;USF3;EPHA3;SPRED2;BAMBI;DAB2IP;FOXA1
gsea,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.28423491480972873,0.8070463128849195,0.735494880546075,0.7802053028505115,1.0,6/17,39.45%,HTRA2;TRAF2;FADD;BID;WWOX;PPP2R1B
gsea,membrane lipid biosynthetic process (GO:0046467),0.2571113980233401,0.8065306727081227,0.7702265372168284,0.7803199220607714,1.0,12/25,57.20%,SCCPDH;HACD3;HACD2;ACER3;PLPP1;ELOVL6;ELOVL4;PRKD3;HACD1;PLPP2;ELOVL2;ALDH3A2
gsea,potassium ion transport (GO:0006813),-0.2418172936003908,-0.805450946957921,0.8006872852233677,0.851284808424414,1.0,23/23,75.90%,SLC9A9;KCNJ8;KCNC1;ATP1A2;KCNK7;KCNMB4;SLC9A2;SLC9A1;KCNG2;KCNK10;KCNAB1;KCNK13;KCNJ14;KCNMB1;KCNQ3;KCNJ10;KCNK5;SLC9A8;ABCB8;CCDC51;KCNQ5;KCNN4;KCNAB2
gsea,diterpenoid metabolic process (GO:0016101),-0.26177690993409813,-0.7999089939850932,0.7233502538071066,0.857669049955817,1.0,17/17,73.89%,LRP1;SDC3;APOE;LPL;RDH12;SDC4;ADH4;SDC1;DHRS3;ALDH3A2;AWAT2;AKR1B10;GPC1;RDH11;PECR;BCO1;LRP8
gsea,regulation of filopodium assembly (GO:0051489),-0.2574782181335695,-0.7987976504594647,0.7790432801822323,0.8564964906679848,1.0,18/18,77.08%,RIPOR2;PIK3R1;NRP1;ARAP1;DMTN;FNBP1L;FSCN1;PALM;BCAS3;RHOQ;TGFB3;CCR7;DOCK11;ABITRAM;FXR2;RALA;FMR1;MYO10
gsea,response to peptide (GO:1901652),-0.2536530403716287,-0.7985872054850651,0.7683982683982684,0.8538304284868045,1.0,20/20,85.90%,STAT1;STAT4;ANXA1;STAT3;STAT2;ERBIN;MMP9;STAT6;PRNP;STAT5B;RAMP3;CACNA1B;IRF5;STAT5A;CACNA1A;EIF2B4;KAT7;EIF2B5;EIF2B1;EIF2B3
gsea,cellular response to metal ion (GO:0071248),0.21608952266964904,0.7971975902014781,0.7898305084745763,0.7939801201189796,1.0,16/48,48.39%,ECT2;AKT1;PPIF;CLIC4;MT3;HSF1;SLC12A2;CPNE2;SMPD1;CHUK;MAPK8;ADD1;CPNE3;TIGAR;PRKAA1;CPNE1
gsea,positive regulation of wound healing (GO:0090303),0.2782458164210914,0.7968026464633207,0.7905511811023622,0.7938925755783608,1.0,8/18,50.40%,HRAS;PRKCE;MTOR;ACTG1;ENPP4;ARFGEF1;FOXC2;XBP1
gsea,sodium ion transmembrane transport (GO:0035725),-0.24114774114774115,-0.7949117721193133,0.7622950819672131,0.8568707031560642,1.0,21/21,75.96%,SLC9A9;ATP1B1;SCN1B;SLC8A1;ATP1A2;SCN4B;SLC9A2;ATP1A3;FXYD2;SLC9A1;SLC4A4;SLC6A11;ANO6;SLC12A3;SLC6A6;SLC6A13;SLC6A12;SLC6A9;SLC4A8;SLC12A2;ATP1A1
gsea,positive regulation of receptor-mediated endocytosis (GO:0048260),0.2532395689218596,0.7939106565896578,0.7594501718213058,0.7976332691138597,1.0,11/20,59.31%,HNRNPK;FMR1;ANXA2;BICD1;CBL;AHI1;SCYL2;TBC1D5;SGIP1;SERPINE1;SFRP4
gsea,regulation of secretion by cell (GO:1903530),-0.2478329874252228,-0.791479602036972,0.7511520737327189,0.8594341360674269,1.0,20/20,75.29%,ANXA1;MCTP2;SYN1;DISP1;KCNMB4;RAB3D;P3H1;HAP1;MCTP1;SCG5;STXBP5;LLGL1;RHBDF1;MEF2C;RAB13;RHBDF2;VAMP8;NSF;RALA;FMR1
gsea,axon guidance (GO:0007411),-0.1872135270166793,-0.7913198796904843,0.8490566037735849,0.856725382068368,1.0,68/68,87.71%,PIK3R1;PIK3CD;PLCG1;SEMA7A;PRKCA;L1CAM;EVL;ALCAM;NRP1;IRS2;NOTCH1;LAMC2;SCN1B;RET;EMB;NOTCH2;UNC5A;SEMA4A;NRP2;LGR6;PLXNB2;DOK2;GFRA2;PIK3CA;EFNB2;CXCR4;VEGFA;TUBB3;DAG1;KLF7;EFNB3;SPTA1;SEMA6D;MAPK7;GFRA4;SOS1;FEZ1;PTPRM;ENAH;SEMA4B;PLXNC1;DRAXIN;GRB7;KIF5C;USP33;PLXNA1;GRB10;EPHA3;PALLD;PIK3CB;SEMA4C;CYFIP1;GPC1;NEXN;ARHGAP35;SPTAN1;NCAM1;PDLIM7;SHC1;PTPN11;RPS6KA5;PLXND1;KIF5B;RYK;DSCAM;SPTBN1;EZR;BSG
gsea,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.2617130307467057,-0.7901146113542343,0.7827380952380952,0.8556692701105965,1.0,15/15,73.89%,NEDD9;CASS4;CSF1R;PDGFB;NCF1;FBXW7;PRNP;ADRA2A;HBEGF;BTC;GAS6;TGFA;AREG;ADAM17;LRP8
gsea,response to steroid hormone (GO:0048545),-0.250583026217918,-0.7885744223295431,0.7922848664688428,0.8551076630816926,1.0,17/17,82.27%,NR3C1;AR;PAQR7;THBS1;ATP1A2;ABCA2;NR1H3;TGFB2;ATP1A3;YAP1;TGFB3;MGARP;SOX30;TFPI;MED1;ATP1A1;URI1
gsea,amino acid transport (GO:0006865),0.25713795834285197,0.7829178763746456,0.7789473684210526,0.8130277718060164,1.0,10/20,49.80%,SLC7A5;SLC7A1;SLC38A1;SLC7A6;SLC1A4;SLC7A3;SLC6A12;SLC16A10;SLC1A5;SLC6A6
gsea,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.2645114610909589,0.7759994644383085,0.7655068078668684,0.8224183268562227,1.0,10/19,66.24%,BSG;DSCAM;NEXN;PALLD;PECAM1;CADM1;PTPRM;CDH17;NECTIN4;NECTIN2
gsea,cytoskeleton organization (GO:0007010),0.19854804456040812,0.7660456341300497,0.8581081081081081,0.8355325948910999,1.0,24/60,48.86%,DIAPH3;CFL1;PRPF40A;LARP4;TPM1;MAST2;DPYSL2;PHIP;PACSIN2;ABI2;PDZD8;CAMSAP1;PRKCI;SYNE3;FMNL3;ARHGAP10;RHOB;ZMYM4;PPP2R3C;KLHL20;MICAL3;NCKIPSD;DIAPH1;PALLD
gsea,collagen fibril organization (GO:0030199),0.23380633978063825,0.7638511923533711,0.8227474150664698,0.8377926867223837,1.0,16/32,67.01%,P4HB;COLGALT1;PLOD2;CRTAP;COL16A1;ADAMTS14;COL12A1;COL6A3;NF1;PLOD3;COL7A1;P4HA1;COL27A1;COL4A4;ITGB4;COL17A1
gsea,negative regulation of macroautophagy (GO:0016242),0.26164937323877796,0.7528957689393451,0.8074766355140187,0.8518429624331159,1.0,7/15,50.48%,AKT1;UBQLN4;MTOR;TMEM39A;PHF23;TSC2;USP36
gsea,cell morphogenesis involved in differentiation (GO:0000904),0.22383995639960264,0.7520583187758608,0.8209459459459459,0.85222001502333,1.0,13/26,65.01%,KIF14;MEGF9;ACTN1;ABI2;RB1;METTL3;SRGAP2;ATRNL1;MEF2C;ANTXR1;UNK;RAB25;ITGB3
gsea,inorganic cation transmembrane transport (GO:0098662),-0.16984778789098443,-0.7410477838194209,0.9359756097560976,0.9215121333551902,1.0,71/71,87.24%,ORAI1;ATP2B4;SLC9A9;SLC30A1;ATP2A3;KCNJ8;SLC39A13;ATP1B1;SCN1B;TRPV2;SLC41A1;SLC8A1;KCNC1;ATP1A2;SCN4B;KCNK7;SLC9A2;ATP1A3;TRPA1;SLC25A14;SLC9A1;KCNG2;P2RX4;HVCN1;KCNK10;ATP6V0E2;KCNAB1;SLC4A4;OTOP1;KCNK13;SLC6A11;KCNJ14;CACNA2D4;SLC39A1;ANO6;KCNQ3;KCNJ10;GAS6;SLC12A3;SLC30A4;MCOLN2;SLC39A3;KCNK5;TRPM1;SLC6A6;DMAC2L;SLC9A8;CACNA1A;SLC6A13;SLC24A5;SLC39A11;TRPC1;SLC39A14;SLC11A1;SLC39A4;SLC6A12;SLC6A9;ABCB8;COX15;SLC4A8;ABCB7;SLC39A7;CCDC51;SLC39A6;SLC12A2;SLC30A6;KCNQ5;KCNN4;KCNAB2;ATP1A1;ATP2A2
gsea,regulation of axon extension (GO:0030516),-0.229520205103162,-0.7349246922915216,0.8344226579520697,0.9264160999374886,1.0,20/20,77.12%,SEMA7A;OLFM1;L1CAM;APOE;SHTN1;MACF1;TRIM46;PTPRS;GSK3B;LIMK1;NRCAM;MAP3K13;ABL1;CTTN;MAP2;CDKL3;RUFY3;GOLGA4;SIN3A;MT3
gsea,regulation of glucose import (GO:0046324),-0.2384717393761012,-0.7323591704151372,0.8534278959810875,0.9266052425267824,1.0,16/16,90.00%,PIK3R1;C1QTNF12;IRS2;PID1;IGF1;APPL2;RHOQ;SORBS1;PRKAG2;ENPP1;CAPN10;GRB10;PRKCI;PTPN11;SELENOS;AKT1
gsea,regulation of actin filament polymerization (GO:0030833),0.21187862263841353,0.7290133202524851,0.853195164075993,0.880402087664879,1.0,16/30,66.78%,PFN1;HAX1;PRKCE;ABITRAM;ARFGEF1;VIL1;WASHC5;BAIAP2;NCK2;NCKAP1;GBA2;CDC42EP1;CCR7;LATS1;PFN2;CTTN
gsea,plasma membrane organization (GO:0007009),0.21663882373175103,0.7276571638492236,0.8758389261744967,0.8813021217270283,1.0,14/28,62.59%,SERP1;SPTBN1;NSF;MYH9;PACSIN2;SMPD1;TLCD2;TLCD1;OSBPL2;PLSCR3;SYTL4;ABCD1;FA2H;ANO6
gsea,epithelial cell migration (GO:0010631),-0.23116736614301447,-0.7252786961529253,0.8946015424164524,0.9324900179044106,1.0,19/19,92.62%,STAT1;ZEB2;NRP1;TNFSF12;FSTL1;ADGRA2;PIK3CA;LOXL2;ABL1;LPXN;KANK2;PTP4A3;NANOS1;ROCK1;DPP4;KIT;PLXND1;GIPC1;ANLN
gsea,inositol phosphate metabolic process (GO:0043647),-0.22336002799750598,-0.7229221485102069,0.8631790744466801,0.9322726360711103,1.0,21/21,87.63%,INPP4B;ITPKB;PLCG1;PLCB2;PLD4;PLCB4;SYNJ1;FGF2;PLCG2;PPIP5K2;PLCH1;IP6K2;IPPK;INPPL1;IPMK;NUDT11;INPP5B;NUDT10;PPIP5K1;ISYNA1;NUDT4
gsea,visual system development (GO:0150063),0.24956106429790348,0.7221913461345862,0.8333333333333334,0.8868194041737557,1.0,8/19,52.22%,ZDHHC16;PBX4;SCO2;SMOC1;PBX3;PBX2;SMG9;HIPK2
gsea,metal ion homeostasis (GO:0055065),-0.23310495375024595,-0.7204891931123465,0.8495370370370371,0.9321106200017483,1.0,16/16,82.82%,CIB2;FAM20A;SLC12A6;SLC12A7;SELENON;SLC7A8;SLC8A1;SLC12A5;SLC12A4;TMTC2;GRIN1;SLC12A3;CNNM2;SLC12A2;MT3;LETM1
gsea,cholesterol transport (GO:0030301),0.2580776819689933,0.7197579797720755,0.8544891640866873,0.8889159937673439,1.0,4/18,38.29%,STARD4;SCARB1;LDLR;OSBP
gsea,regulation of Notch signaling pathway (GO:0008593),0.20647574527973944,0.7186191476392616,0.9040650406504065,0.8893988833982743,1.0,18/38,61.20%,AKT1;BMP2K;SREBF2;EGFL7;DLL1;PRKCI;POGLUT1;RITA1;NEPRO;METTL3;POFUT1;LLGL1;TSPAN15;JAG2;CHAC1;DLK2;KAT2B;EPN2
gsea,endocytic recycling (GO:0032456),0.23379109532162165,0.7179323062754158,0.8719512195121951,0.8894674875647217,1.0,10/17,56.63%,VPS52;VPS35;EHD4;VPS50;SNX27;EPS15;RAB13;ANKRD27;PTPN23;EHD3
gsea,chloride transport (GO:0006821),-0.21675418243985833,-0.715283832121139,0.9025157232704403,0.9351256933967004,1.0,22/22,78.39%,FXYD1;SLC12A6;SLC12A7;TTYH3;GLRA1;CLIC5;SLC12A5;SLC12A4;CLCN6;ANO7;FXYD3;ANO6;TTYH1;SLC12A3;GABRB1;ANO8;ANO10;GABRR1;SLC4A8;PACC1;SLC12A2;CLIC4
gsea,response to retinoic acid (GO:0032526),0.2350381954167733,0.7136397961188489,0.8813314037626628,0.8933803632057756,1.0,14/24,62.65%,HTRA2;ASXL1;SETX;CDKN2D;TESC;CREB1;ATM;ADNP2;EPHA3;FZD4;WNT3;WNT6;WNT10B;WNT11
gsea,regulation of cellular catabolic process (GO:0031329),0.19606231170394126,0.7128511439717837,0.9036363636363637,0.893515493089486,1.0,16/34,52.16%,USP10;TYSND1;KEAP1;KAT8;C9ORF72;ATM;DEPDC5;ROCK1;RAB39B;HDAC6;MTMR4;TRIB3;WDR24;BOK;USP33;ITPR1
gsea,retinoid metabolic process (GO:0001523),0.24295895973957377,0.7116200583191947,0.8706395348837209,0.894079039437741,1.0,7/23,45.72%,DHRS13;SCPEP1;LRP8;BCO1;RDH11;ALDH1A3;GPC1
gsea,icosanoid metabolic process (GO:0006690),-0.23048188738994957,-0.7096240489171114,0.8599439775910365,0.9383991130247948,1.0,16/16,87.46%,ALOX5AP;EPHX1;PTGS2;PNPLA8;PLA2G4A;CYP2S1;PLA2G4B;PON3;LTC4S;ALOX5;PTGS1;PTGR1;MAPKAPK2;ABCC1;FADS1;GPX1
gsea,lysosome localization (GO:0032418),-0.22085215480405324,-0.7093328642983997,0.8601694915254238,0.9356123991965385,1.0,20/20,77.98%,NR4A3;PIK3CD;PLEKHM1;PLEKHM2;RAB34;MILR1;MAP6;SYTL4;CHGA;TFEB;VPS33A;DEF8;VPS33B;HDAC6;PIK3CG;KIT;MYH9;KIF5B;BLOC1S2;FAM98A
gsea,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.2311456202312765,0.7036658928670766,0.8623853211009175,0.9017351175188275,1.0,9/18,52.37%,GSTO1;CALM2;F2RL3;CX3CL1;TRPC1;NOS1;PDPK1;DIAPH1;JPH4
gsea,polyol metabolic process (GO:0019751),-0.21770134336603147,-0.6984232044109597,0.9020408163265307,0.9445237656103258,1.0,21/21,87.63%,INPP4B;ITPKB;PLCG1;PLCB2;PLD4;SLC5A3;PLCB4;SYNJ1;PLCG2;PPIP5K2;PLCH1;IP6K2;IPPK;INPPL1;IPMK;NUDT11;INPP5B;NUDT10;PPIP5K1;ISYNA1;NUDT4
gsea,regulation of receptor-mediated endocytosis (GO:0048259),0.24081786932583413,0.6974557012228765,0.8803738317757009,0.9073733063970214,1.0,8/15,57.68%,HNRNPK;BMP2K;BICD1;CBL;PIK3CB;PICALM;SGIP1;SERPINE1
gsea,cortical cytoskeleton organization (GO:0030865),-0.21879210827192214,-0.6945284075451054,0.8912037037037037,0.9453979687936822,1.0,20/20,86.85%,RHOC;TNF;RHOF;RND3;FMNL2;STRIP1;FHOD1;RHOQ;PLEK;RHOBTB3;NCKAP1;LLGL1;RAB13;PPP2R3C;RHOB;FMNL3;ROCK1;ROCK2;EZR;LCP1
gsea,positive regulation of developmental growth (GO:0048639),-0.24036115178135675,-0.6926079646878759,0.8823529411764706,0.9442448032240798,1.0,15/15,76.02%,SEMA7A;L1CAM;SHTN1;MACF1;LIMK1;MAP3K13;RNF157;CPNE9;SYT4;GHSR;UNC13A;DLL1;RUFY3;GOLGA4;PLAA
gsea,regulation of actin cytoskeleton organization (GO:0032956),0.19377888712971475,0.6924139175707025,0.9273301737756714,0.9115384965982959,1.0,18/45,49.79%,ARHGDIA;EZR;IQGAP3;CORO1A;ROCK2;SH3BP1;MTOR;IQGAP2;C9ORF72;NEB;ROCK1;BST1;ARHGAP35;RHOB;TAOK2;MLST8;BST2;EPHA3
gsea,regulation of cell-matrix adhesion (GO:0001952),-0.18529675619271874,-0.6794301574016378,0.9099099099099099,0.9539867621965028,1.0,36/36,92.69%,CSF1;UTRN;GPM6B;PEAK1;PTK2B;THBS1;RASA1;CD36;MACF1;MINK1;JUP;GSK3B;LIMCH1;VCL;PLET1;SLC9A1;TSC1;PLAU;CCL25;CCR7;NF1;DUSP3;NF2;EPHA3;PIK3CB;CX3CL1;SLK;BST1;MAP4K4;ROCK1;ACTG1;CLASP1;CDK6;ROCK2;CORO1C;CDKN2A
gsea,negative regulation of cell adhesion (GO:0007162),0.20839000967672322,0.674334695578474,0.9116279069767442,0.9274573800158116,1.0,14/30,57.68%,ARHGDIA;GTPBP4;DSCAM;ARHGDIG;PLXND1;FBLN1;CX3CL1;B4GALNT2;SPN;MIA3;PLXNA1;NF2;FZD4;SERPINE1
gsea,regulation of autophagosome assembly (GO:2000785),-0.214085194678384,-0.6712104679156885,0.9176954732510288,0.9583538014979467,1.0,18/18,78.65%,PINK1;NUPR1;MTMR3;TBC1D14;LRRK2;SMCR8;PIP4K2B;RAB3GAP2;RALB;FEZ1;RAB3GAP1;NPRL3;PIKFYVE;IFT88;PHF23;C9ORF72;TMEM39A;ADPRH
gsea,positive regulation of actin filament polymerization (GO:0030838),-0.19494629134332592,-0.6696925830971058,0.9264705882352942,0.9565686960658376,1.0,23/23,89.10%,GSN;EVL;CDC42EP3;PTK2B;HCK;SNX9;FCHSD2;CDC42EP2;BAIAP2L1;CTTN;PFN2;CCR7;SPIRE2;CDC42EP1;NCKAP1;NCK2;BAIAP2;SCIN;LMOD3;SPIRE1;CARMIL2;PRKCE;PFN1
gsea,negative regulation of catalytic activity (GO:0043086),-0.22823605123860224,-0.6670527352820319,0.9151376146788991,0.9556997267571407,1.0,15/15,79.55%,GZMA;IFIT1;NOTCH1;TMBIM1;PARP9;CLN3;APBA3;SIRT1;TIMP1;PLN;NOS1;HDAC6;CCAR2;MT3;CAND1
gsea,O-glycan processing (GO:0016266),-0.20426589359033273,-0.6637020991166384,0.9166666666666666,0.9553220965483393,1.0,22/22,85.64%,GALNT6;GALNT10;GCNT1;GXYLT1;ST3GAL1;MUC20;MUC1;B3GNT5;ST3GAL4;ST3GAL3;GALNT3;XXYLT1;POMGNT1;MUC6;ST6GAL1;POFUT1;GALNT14;B3GNT3;ST6GALNAC4;GALNT7;B4GALT5;GALNT1
gsea,regulation of sodium ion transport (GO:0002028),0.22763044628893395,0.6571176929571996,0.9200710479573713,0.9406675507857523,1.0,8/16,47.20%,NEDD4;RANGRF;ATP1A1;AHCYL1;NKAIN1;GPD1L;NOS1;SLMAP
gsea,mononuclear cell differentiation (GO:1903131),-0.22340165934602246,-0.6563819142286009,0.9056603773584906,0.9582026861231437,1.0,15/15,77.71%,LYN;CSF1R;CSF2;BATF3;LY6D;PPARG;AXL;FLT3;VEGFA;GAS6;RELB;IKZF1;IRF8;MYH9;THOC5
gsea,wound healing (GO:0042060),-0.18420730961985088,-0.647923186893395,0.963963963963964,0.9614115672658597,1.0,30/30,81.66%,JAML;PLEC;SMAD3;SYT11;MACF1;DST;SYT7;IGF1;TGFB2;FZD7;FGF2;PAK1;EVPL;PDGFA;HMOX1;ITGB3;TSKU;SYTL4;HPSE;NF1;PRCP;MIA3;DSP;SLC11A1;SMPD1;DCBLD2;MYH9;SRF;SCARB1;TPM1
gsea,unsaturated fatty acid metabolic process (GO:0033559),0.23206372600784497,0.6400288484548121,0.9204892966360856,0.9521332748715756,1.0,5/16,40.90%,GPX1;FADS1;ACSL1;PTGR1;FADS2
gsea,cation transport (GO:0006812),-0.16927592954990214,-0.6357266457330235,0.9857954545454546,0.9668550499673806,1.0,35/35,83.16%,SLC3A2;SGK1;KCNJ8;ATP1B1;SLC41A1;SLC7A8;SLC8A1;KCNC1;ATP1A2;SCN4B;KCNK7;KCNMB4;CLN3;KCNG2;KCNAB1;SLC4A4;SLC39A1;ANO6;KCNMB1;KCNJ10;GRIN1;SLC12A3;KCNK5;SLC9B2;TRPM1;SLC36A4;PIEZO1;SLC6A6;ANO10;SLC6A9;SLC12A2;FGF13;SLC7A6;KCNN4;SLC7A1
gsea,positive regulation of neuron projection development (GO:0010976),-0.17626245129857165,-0.6347298064952918,0.9752808988764045,0.9644068658964977,1.0,31/31,91.44%,CAMK1D;ITGA6;PACSIN1;FES;LYN;PTK2B;RAPGEF1;EP300;KIDINS220;SCN1B;APOE;RET;PLXNB2;P3H1;NDNF;BMP7;ZDHHC15;RAPGEF2;CAMK1;NTRK3;TOX;DAB2IP;EPHA3;CX3CL1;ARHGAP35;PRKCI;ARSB;SETX;LRP8;BHLHB9;CAPRIN1
gsea,negative regulation of epithelial cell proliferation (GO:0050680),0.1779095116791345,0.6283466520306685,0.9771929824561404,0.9587508061930465,1.0,14/34,56.67%,BRCA2;WDR77;TINF2;CDK6;CDC73;RUNX3;MED1;XDH;PEX2;VASH1;CAV2;DAB2IP;MAGED1;NF1
gsea,blood circulation (GO:0008015),0.22413564260733773,0.6280357339980676,0.9341500765696784,0.9581207659297646,1.0,7/19,46.45%,GPX1;GUCY1B1;ROCK2;SCPEP1;ROCK1;GUCY1A1;TNNI3
gsea,regulation of ossification (GO:0030278),-0.21217667154709616,-0.6237791369577184,0.9371069182389937,0.9686279962927652,1.0,15/15,78.83%,S1PR1;CHSY1;NOTCH1;ECM1;KREMEN2;TGFB2;TXLNG;ENPP1;LRP6;MEF2C;ZBTB16;TWIST1;ACVR1;PTPN11;BMP2K
gsea,regulation of focal adhesion assembly (GO:0051893),0.18320772792910484,0.5979855019329914,0.9748743718592965,0.9730299621109229,1.0,13/32,49.79%,RCC2;CORO1C;ROCK2;CLASP1;CLASP2;ACTG1;ROCK1;MAP4K4;SLK;DUSP22;COL16A1;PPM1F;EPHA3
gsea,oligosaccharide metabolic process (GO:0009311),-0.1880112318398242,-0.5951884888824499,0.96579476861167,0.9807400625945063,1.0,20/20,81.26%,ST8SIA4;NAGA;ST3GAL6;FUT7;ST6GALNAC3;GLA;FUT8;B3GALT4;B3GALT5;NEU1;ST3GAL4;ST6GALNAC6;ST3GAL3;ST8SIA1;MAN1B1;B4GALNT2;FUT4;ST6GALNAC4;MAN2C1;MPDU1
gsea,chemical synaptic transmission (GO:0007268),0.1597246524582277,0.5942109403435893,0.9933510638297872,0.9739068381369331,1.0,38/68,62.53%,NRGN;HSPA8;PDZD11;GIPC1;PRKAR2A;CAMKK2;EXOC4;SLC1A4;GABRR1;ERC1;PRKAR2B;UNC13A;SPG11;NSG1;CACNA1A;NAPB;NPY;NLGN2;SLC17A8;LIN7A;PNOC;DVL1;LRP6;NAAA;RPS6KA3;ATXN3;AKAP5;CACNA1B;GABRB1;PDE7B;GRIN1;HTR2A;UNC13B;KCNQ3;NPTX1;KCNMB1;CAMK1;PMP22
gsea,regulation of actin filament-based process (GO:0032970),0.17494194820580872,0.593845898281002,0.9772036474164134,0.9732792029622422,1.0,17/36,54.84%,EZR;IQGAP3;CORO1A;ROCK2;SH3BP1;MTOR;IQGAP2;ROCK1;BST1;ARHGAP35;RHOB;TAOK2;MLST8;BST2;EPHA3;CCDC88A;BAIAP2
gsea,bone development (GO:0060348),-0.19719341061622941,-0.5934321475135884,0.9538461538461539,0.9784120697155073,1.0,16/16,80.33%,PTGER4;TGM2;SULF2;SKI;WNT1;P3H1;SH3PXD2B;SFRP4;LRP6;MBTPS2;PLS3;LTF;DYM;OSR2;RPL13;VKORC1
gsea,adherens junction organization (GO:0034332),-0.19487338063718754,-0.5877956314800736,0.9575,0.9778072634616768,1.0,17/17,86.34%,SMAD7;CDH1;PVR;PIP5K1C;TJP1;JUP;VCL;AFDN;NECTIN2;NECTIN4;CDH17;CADM1;CTNND1;RAMP2;CTNNB1;CTNNA1;ACTB
gsea,positive regulation of endocytosis (GO:0045807),0.18389655945551112,0.5802118209228656,0.9833055091819699,0.9779087854941992,1.0,7/22,40.77%,HNRNPK;BICD1;SMPD1;DLL1;CBL;ANKFY1;CLIP3
gsea,epidermal growth factor receptor signaling pathway (GO:0007173),0.17399275219666996,0.5788035910959926,0.9720767888307156,0.9776212017063961,1.0,14/26,55.35%,AKT1;RPS6KA5;PTPN11;SHC1;ADAM17;AREG;CBL;KIF16B;PDPK1;VIL1;BCAR1;TGFA;GRB7;NCK2
gsea,insulin receptor signaling pathway (GO:0008286),-0.15662526589246945,-0.5705699975629231,0.9844097995545658,0.9815766563947761,1.0,32/32,90.00%,PIK3R1;FOXO1;PDK2;IRS2;BCAR3;FOXO4;GSK3B;PIK3C2A;PIK3CA;RHOQ;ATP6V0E2;SH2B2;SOS1;SORBS1;IDE;ATP6V1G3;PIK3R2;BAIAP2;GRB7;GRB10;FOXC2;BCAR1;CAV2;SLC39A14;TCIRG1;SHC1;C2CD5;NAMPT;PHIP;ATP6V0A2;AP3S1;AKT1
gsea,inorganic anion transmembrane transport (GO:0098661),0.1849813824212831,0.569216599769714,0.9706840390879479,0.9802843935356638,1.0,9/22,57.25%,SLC25A10;SLC20A1;SLC12A2;SLC4A8;GABRR1;SLC37A4;SLC26A2;GABRB1;SLC12A3
gsea,regulation of ion transport (GO:0043269),-0.186544929097753,-0.565259015423544,0.9771428571428571,0.9803211380117738,1.0,16/16,82.29%,PER1;HFE;KCNJ8;SYT11;SYT7;P2RX4;WNK1;ITGB3;KCNJ14;KCNJ10;CLDN10;SYT4;NOS1;NKAIN1;ATP1A1;NEDD4
gsea,regulation of cell-substrate adhesion (GO:0010810),-0.16634098680996579,-0.5612889108181496,0.9925187032418953,0.9785757622263881,1.0,23/23,83.42%,MYADM;GCNT2;NOTCH1;PDGFB;WNT1;JAK2;DMTN;MINK1;FBLN2;FZD7;NDNF;TSC1;NF1;FZD4;ATXN3;RSU1;PIK3CB;PPM1F;CX3CL1;BST1;NPNT;ARL2;CORO1C
gsea,regulation of dendrite development (GO:0050773),0.17901544534513603,0.5336932831847787,0.9872727272727273,0.9891644599966563,1.0,8/18,52.98%,NEDD4;LRP8;RTN4IP1;RAP2A;MFSD2A;HECW1;KNDC1;DAB2IP
gsea,glycosaminoglycan metabolic process (GO:0030203),0.15788367700935754,0.5092702514450066,0.9964028776978417,0.9928724861870258,1.0,11/19,58.88%,GUSB;B3GALT6;CLN6;HS2ST1;GPC1;SLC35D2;HGSNAT;HYAL2;PXYLP1;HPSE;NAGLU
gsea,anterograde trans-synaptic signaling (GO:0098916),0.11933982387529875,0.40810918428481835,1.0,0.9993335788785155,1.0,27/49,62.53%,NRGN;GIPC1;PRKAR2A;CAMKK2;EXOC4;GABRR1;PRKAR2B;SPG11;CACNA1A;NPY;NLGN2;PNOC;LRP6;RPS6KA3;ATXN3;AKAP5;CACNA1B;GABRB1;PDE7B;GRIN1;HTR2A;UNC13B;KCNQ3;NPTX1;KCNMB1;CAMK1;PMP22
